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ABSTRACT
The pathophysiological mechanism of contrast media (CM) acute renal failure (CM- 
ARF) is still not clearly understood, partly because of the lack of reproducible animal 
models and relevant diagnostic renal markers. This work describes a reproducible rat model 
of uranyl acetate(UrAc) -induced CM-ARF as well as evaluating other potential risk factors 
such as old age, different strain and 5/6 nephrectomy. The role of renal markers in the 
different renal models was also evaluated.
In normal (control) rats typical examples of three types of CM, the ionic monomer 
iothalamate, non-ionic monomer iohexol and the dimer iodixanol, all induced the release of 
tubular enzymes (the brush border ALP, GOT and the lysosomal NAG) and also increased 
urinary protein excretion. Another indication of the CM-induced tubular proteinuria was the 
increased aj-microglobulin shown in the first 3-6 hours following CM administration.
These tubule-related markers declined to baseline levels implying only transient CM 
tubular effects rather than any irreversible epithelial injury. There was no clear correlation 
between CM-induced changes in these tubule markers and renal function assessed by 
creatinine and GFR. These tubular markers therefore possess no diagnostic role in the 
initiating period leading to CM-ARF with normal animals which appear to be resistant.
The rat with partially compromised renal function (e.g. old age and 5/6 
nephrectomy) tolerated CM without further impairment in renal function. This indicates 
that CM-induced tubular effects were tolerated by the rat even in compromised renal 
models. It was only with UrAc-induced early degenerating and extensive tubular necrosis 
together with the added risk of dehydration that ARF could be induced reproducibly by CM 
in Wistar Albino rat. Interestingly only the low osmolar CM iodixanol and iohexol induced 
ARF in this model.
In support of the recognised role of urinary electrolytes as functional parameters in 
predicting renal failure, it was also shown that both Na and K are suitable as early 
indicators in CM-ARF. Evaluation of endogenous proximal tubule metabolites by NMR 
showed the potential of these metabolites to diagnose (and possibly predict) CM-induced 
tubular effects.
Although all three types of CM induced similar biochemical changes, formation of
111
vacuoles in the epithelial cell of the PCX (assessed by LM and EM morphology) and iodine 
retention (determined by an in house X-ray fluorescence method) were most pronounced 
with iodixanol and iohexol. Retention of CM and vacuole formation in the cortical tubules 
were affected by renal function and tubular cell status (increased with UrAc-induced tubular 
necrosis). Therefore, increased CM retention and hence vacuole formation in renal failure 
could represent an early indicator of CM-ARF that requires further follow up.
The cellular proliferation capacity of the rat tubular epithelia did not show any 
differences after administering CM. Therefore, the capacity of the proliferating rat tubular 
epithelium was sufficient enough to tolerate any CM-induced effect or even damage.
In the isolated perfused rat kidney (IPRK) which allowed the simultaneous 
monitoring of biochemical markers and functional changes, a range of different CM showed 
an increase in the filtrate (urine) proteins and enzymes (especially ALP and GOT) which 
were increased before any decrease in renal perfusate flow (RPF). Thus the release of 
tubular markers appeared to be due to direct CM effects on the tubular epithelia rather than 
to CM-related decreased RPF. Increased endothelin release after CM in the IPRK system 
indicated that this vascular constrictor peptide (of renal origin) plays a role in inducing CM- 
related reduction of RPF.
Renal impairment (whether induced before or after CM administration) delayed CM 
excretion, and hence could expose the renal vasculature to continuous high CM levels 
which could sustain the decrease of RPF. Therefore, CM showed dual effects on renal 
tubules both through direct PCX epithelial cell effects and reduced renal perfusion
In summary, this study indicates that the integrity of the tubular epithelia is an 
important factor in the development of CM-ARF.
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Chapter 1
INTRODUCTION
1. INTROD UCTIO N
1.1 CONTRAST MEDIA
X-ray contrast media (CM) are generally compounds or formulations used for a 
variety of imaging diagnostic radiology procedures. The term used in this thesis however 
refers only to iodinated CM used for angiography, urography, and contrast enhanced CT. 
They have been used for the imaging of organs and blood vessels for over 70 years. 
During this period there were developments in the structure of CM which increased their 
attenuation and reduced their toxicity.
An ideal CM would have the maximal object contrast attenuation of X-ray and 
measure the difference in attenuation between that object and its surroimdings. Other 
criteria for an ideal CM are that they should have no side effects. CM have been 
developed into safe imaging agents, so the primary criteria for safety are that they are 
excluded from cells and stay extracellularly, do not undergo metabolism and are 
chemically stable. Therefore, they are considered to exhibit no significant effects on 
living cells. To achieve an ideal CM, efforts were aimed at increasing attenuation and 
minimising side effects by changing their physical and chemical properties {cf. Almen, 
1995).
1.1.1 History of CM development
There are several atoms that are better attenuators of radiation than iodine, but 
iodine containing CM have been the leading media because of their fewer biological side 
effects. The first iodine containing CM, introduced by Cameron in 1918 and Osborne et 
al, (1923) was sodium iodide. But this compound is not in use as it produces too many 
adverse side effects.
Chronologically CM may be classified into four groups according to their iodine 
atoms' contents and ionic distribution:
1) It was the work of Binz and Rath in 1920s that introduced the organic water soluble 
CM, based on a covalently bound iodine atom to pyridine compounds, which included 
sodium salts of pyridine. It began with the development of Uroselectan containing one 
iodine atom per anion (a ratio of 0.5 /compound). The compound had lower animal
1
toxicity than sodium iodide (Binz, 1931). It was later superseded by another ionic 
pyridone compound with 2  iodine atoms per anion such as iodomethamate with a ratio of
0. 67. These were used until 1950s.
2) In 1950s, the benzene compounds with ionic molecules were introduced. They consist 
of 3 covalently bound iodine atoms (tri-iodinated benzene ring) per anion (ratio of 1.5) 
and had lower toxicity. Diatrizoate and iothalamate were first synthesised in the 1960s as 
sodium salts (sodium as the cation). The osmolarities of these ionic compounds are in 
the range of 1500-2500 mOsm/kg water i.e. more than 5 times the osmolarity of plasma 
but with a low viscosity.
o
|C— O
o
C —  NH—  CH3HN
Iothalamate
3) Almen, (1969) hypothesised that CM side effects were due to the hypertonicity of 
ionic CM and as a result the non-ionic low osmolarity metrizamide, without the carboxyl 
group, was developed. This was achieved by replacing the dissociating cation portion 
with non dissociating sugar chain. Despite being an excellent CM metrizamide turned 
out to have low thermal stability and thus could not be autoclaved. This led in 1980’s to 
the introduction of the second generation of non-ionic monomers which included 
iopamidol, ioversol, iopentol and iohexol.
c —  NH R
—  NH R
R=CH2—  CHOH —  CH2 OH 
Iohexol
Present day CM continue to be based on the tri-iodinated benzene ring. CM 
cations are either sodium or meglumine. Meglumine as an organic cation (C16H23N2 O8) 
was chosen because of its lower pharmacological activity and better tolerance as 
compared to sodium. But as it is a larger ion it produces a higher viscosity medium. To 
achieve a safer CM the ionic content and osmolarity of the CM were considered. The 
basic principle for lowering osmolarity was either to make the agents non-ionic, thereby 
halving the osmotic particles per iodine to half, or to maintain the ionic character but 
double the number of iodine atoms per anion, i. e. proportionally halve the number of 
osmotic particles. The second approach was achieved by joining two CM molecules to 
produce a dimer with six iodine atoms. The only example of this group is ioxaglate.
HOCH2CH2NHCO
I
NHCOChbNHCO
N(CH3)C0CH3
CONHCH3
Ioxaglate
4) Further development focused on reducing the osmolality even further and resulted in 
the production of the non-ionic dimers like iodixanol and iotrolan which are isotonic to
plasma. They have the largest molecular mass amongst CM and are characterised by 
completely substituted tri-iodinated benzene rings, evenly distributed hydroxyl groups 
around the molecule and the absence of carboxyl groups. However, the new LOCM are 
more expensive than the old generation of HOCM (Goel et al, 1990) .
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1.1.2 Pharmacokinetics
CM are relatively low MW compounds. Their MW range from about 780 for the 
monomers to 1630 for the dimers. There is no clear evidence of any CM metabolism 
(Jakobsen et al, 1996) and they exhibit low protein binding (Krause and Niehues, 1996). 
They are excreted almost exclusively by the GBM in a normally filtering kidney. The 
plasma levels are dose dependent and the filtered CM are proportional to GFR and 
plasma levels (Katzberg, 1988; Svaland et al, 1992). There is no evidence of any tubular 
secretion or reabsorption i. e. CM are totally cleared by the glomeruli like inulin. In man 
the maximal blood concentration is reached within a few minutes of administration, while 
the distribution phase m the extracellular space usually lasts for 2 hours (Jakobsen,
1993). In healthy volunteers with normal renal function the average elimination half life 
of CM is less than two hours, but may be more than 14-fold slower in cases of renal 
failure (Jakobsen et al, 1992). For example the elimination half life of iodixanol, 
iopamidol, iotrolan, ioversol, diatrizoate and iohexol is between 110-130 minutes in 
healthy volunteers (Svaland et al, 1992), while in cases of renal failure it reaches 20-40 
hours (Nossen et al, 1994). The decline in concentration is dependent mainly on renal 
elimination in a normal functioning kidney and 1 -2 % on extrarenal elimination mainly
through a faecal route. This extrarenal faecal elimination increases to 7 % in cases of 
renal failure. From values of the apparent volume of distribution (VD) of CM it is 
indicated that they are distributed only to extracellular fluid both in normal cases and in 
patients with renal failure e.g. for iohexol and iodixanol VD is 0.23 1/kg body weight 
(Svaland et al, 1992; Jakobsen et al, 1994; Nossen et al, 1994).
1.1.3 Side effects
CM are associated with a range of different side effects which include respiratory, 
renal, neurological and cardiovascular features. Amongst the most common side effects 
are nausea, vomiting, itching, urticaria, bronchospasm, heat sensation, dyspnea, 
hypotension, pain on injection, chest pain, loss of consciousness, and ventricular 
fibrillation (Katayama et al, 1990). These side effects were assigned mainly to:
1. Osmotoxicity: Hypertonicity and ionic character of the contrast medium molecule may 
contribute to its side effect. In CM, iodine provides the radio-opacity while other 
elements in the molecule act as a carrier, increasing solubility, reducing toxicity and 
increasing osmolarity. Osmolarity is dependent on the number and not the size of 
particles in the solution. Therefore, the cations in the ionic CM have no useful effect but 
are responsible for increasing the osmolarity. The high osmolarity of various ionic CM 
results in fluid shift to extracellular spaces and contributes to changes in cellular function. 
This motivated early developments in producing lower osmolar and nonionic CM 
(Almen, 1969).
2. Chemotoxicity: The clinical side effects of CM not only result from high osmolarity, 
but also from their own specific pharmacology, which mediates chemotoxic effects 
(Dawson, 1985). At the molecular level the interaction between the CM molecules and 
the different biological systems had been examined and found to be dependent on the 
binding of contrast media to biomacromolecules (Lang & Lasser, 1971; Levitan & 
Rapoport, 1976). A relationship between the lipophilicity of CM and their affinity 
towards proteins and their toxicity was established (Lasser and Lang, 1971). Therefore, 
binding to proteins is not an acceptable property of modem CM as they should not 
significantly bind to any macromolecule. There is a significant correlation between 
hydrophilicity (partition coefficient) and some side effects parameters like the degree of 
histamine release, haemolysis, and complement activation (Krause and Niehues, 1996). It
was also suggested that incorporating a large number of hydroxyl groups in each 
iodinated molecule would produce the desired high water solubility (Almen, 1985).
Progress in CM development was aimed at reducing these two chemical properties
i.e. osmolarity and chemotoxicity. With the decrease of their ionicity and chemotoxicity 
there was decrease of the direct irritant effect (Barrett et al, 1992b). In m vivo studies 
there was a considerable decrease of CM toxicity, as the LD50 in mice after intravenous 
administration in g(iodine)/kg, was 7.2 for diatrizoate, 8  for iothalamate, 18.4 for 
iohexol and 23 for iotrolan (the LD50 for sodium iodide was 0.9) (Rosati et al, 1992). 
Therefore, non-ionic low osmolar (LOCM) have been associated with a lower incidence 
of most of the systemic adverse effects (Dahlstrom et al, 1985; Kinnison et al, 1989; 
Moore et al, 1989; Barrett et al, 1992; Lawrence et al, 1992; Steinberg et al, 1992), but 
it is still not known whether this lowered osmolarity decreased the harmful effects on the 
kidney.
1.2 Contrast media nephropathy
Although generally safe, CM may produce renal effects which become clinically 
important when combined with a background pathological conditions like renal 
impairment or diabetes. Due to large number of procedures that are carried out world­
wide, CM are recognised as one of the most common hospital induced renal failure drugs 
(Porter, 1993; Deray and Jacobs, 1995; Brady et al, 1996; Morcos et al, 1997).
1.2.1 Are CM nephrotoxic?
The term contrast media nephropathy was defined by Mudge (1982) as “a sudden 
change in renal status after the administration of contrast media and no other aetiology 
appearing likely from the clinical record”. However, there is no agreed threshold change 
in renal function to define a “case”, and CM may not be the sole but rather a 
contributory factor to the decline in renal function.
The misleading term that is used to describe renal effects of CM is “contrast 
media nephrotoxicity”. In addition to the routine practice of dehydration (with its 
potential renal risk) to attenuate CM, radiology procedures are mostly carried out in 
patients with progressive renal diseases. Renal failure after these two contributing risk
factors i.e. progressive renal disease and dehydration, may not necessarily be due to CM 
per se. To correctly define an event as nephrotoxicity it is important that other possible 
causes of renal impairment, other than CM, should be ruled out. Otherwise, renal failure 
could be associated with the CM procedure rather than being due to CM renal damage 
alone. The debate hinges on the clinicians’ rather loose usage of toxicity being any 
adverse effect and the toxicologists rather tighter definition being defined molecular or 
cellular injury. And until there is clear evidence that CM have a direct nephrotoxic 
effect, the term “contrast media nephrotoxicity” remains debatable. Therefore, it would 
be better termed as CM associated acute renal failure (CM-ARF), and this term is used 
throughout the thesis.
1.2.2 Diagnosing CM acute renal failure (CM-ARF)
CM-ARF is diagnosed from the clinical features of ARF, such as post CM- 
induced oliguria with urine volume of less than 400 ml/day. However, CM-ARF could 
exhibit a wide range of clinical features from asymptomatic non oliguric and transient 
increase of serum creatinine, to acute irreversible renal failure (Porter, 1993). Changes 
in serum creatinine (sCr) have become the practical parameter to define CM-ARF. At 
present, two different expressions of sCr changes are used; the percent change from 
baseline and the absolute change. Generally CM-ARF is diagnosed by routine serial 
biochemical analysis and any increased serum creatinine ( >  44 jimol/1 or an increase > 
25% above base line) and decreased creatinine clearance values, which peaks between 
24-96 hours after CM, is an acceptable definition of CM-ARF.
As interassay or day-day variations of sCr could lead to a mistaken CM-ARF 
diagnosis, Jakobsen et al, (1991) proposed and adopted higher plasma creatinine limits, 
that of above 88 pmol/1 or an increase greater than 50% above baseline values as their 
criteria for CM-ARF.
CM-ARF is characterised by a rapid reversible deterioration of renal function 
over a period of hours and days and m the majority of cases creatinine levels will return 
to baseline values. Spontaneous recovery is to be expected within 7-10 days as permanent 
renal dysfunction leading to chronic renal insufficiency is uncommon. Those requiring 
dialysis are less than 10% of the cases (Manske et al, 1990; Barrett et al, 1992b; Deray 
and Jacobs, 1995). Deaths due to CM-ARF is rarely reported (Katayama et al, 1990),
however, there is one report by Levy et al, (1993) that showed a high rate mortality that 
of 37 % in patients who develop CM-ARF.
1.2.3 Incidence
The incidence of all renal changes has been reported to vary from 0 to more than 
90% (Davidson et al, 1982; D’Elia et al, 1982; Davidson et al, 1989; Moore et al, 1989; 
Schwab et al, 1989; Katayama et al, 1990; Lautin et al, 1991; Barrett et al, 1992; 
Lawrence et al 1992; Rudnick et al, 1992; Rudnick et al, 1994). This enormous range is 
due to many factors such as differences in defining the cause with a significant change in 
renal function, prospective and retrospective study design, exclusion and inclusion 
criteria, patient population and small sample size, lack of controls, cases missed due to 
lack of follow up, the hydration state, and the dose of CM. In patients with chronic renal 
insufficiency, the incidence was 7 % compared to the control of 1.5% i. e. the relative 
risk of CM was 4.7 (Parfrey et al, 1989; Deray and Jacobs, 1995). It was difficult in 
most of these studies to exclude patients where the cause of renal failure was due to 
deterioration of other causes. It is crucial when diagnosing CM-ARF to exclude other 
potential causes. CM may be only one of several factors contributing to the decline of 
renal function such as dehydration, background deterioration of renal status and 
concomitant administration of other nephrotoxic drugs in a hospitalised patient.
In the context of the very large number of CM procedures carried out every day, 
even these very low percentages of patients developing CM-ARF could represent a 
burden on health resources.
Renal effects were thought to be due to high osmolarity (Almen, 1969). Several 
studies have indicated that LOCM may be beneficial (Schwab et al, 1989; Harris et al, 
1991; Moore et al, 1992; Katholi et al, 1993). But most of these studies failed to 
demonstrate an important role for LOCM in prevention of CM-ARF. Randomised clinical 
trials could not confirm a significant difference in the renal effects between the high and 
low osmolar CM in patient with normal renal function (Jevnikar et al, 1988; Aron et al, 
1989;; Katayama et al, 1990; Lautin et al, 1991; Lawrence et al, 1992; Barrett et al, 
1992a; 1992b; 1992c; Moore et al, 1992; Katholi et al, 1993; Rudnick et al, 1995).
Other workers could not demonstrate any significant difference in nephrotoxicity between 
LOCM and HOCM in patients with high risk factors (Davidson et al, 1989; Parfrey et al.
1989; Gomes et al, 1989). However, a number of clinical studies involving high risk 
azotemic patients demonstrated that the non-ionic CM iohexol was associated with 
significantly less renal failure cases than ionic CM, while in non-azotemic patients there 
was no evidence of reduced nephrotoxicity with the use of the non-ionic agent iohexol 
compared to the ionic (Rudnick et al, 1991; 1994; 1995). This discrepancy in CM-ARF 
findings was due to many factors in the study design such as the lack of appropriate 
control groups and limited post CM periods for evaluation of renal function.
1.2.4 Diuresis and the risk of dehydration
Dehydration, although an established risk factor, continues to be used in order to 
enhance the image. The essence of dehydration, is to increase CM image, i.e. to increase 
CM concentration in the renal tubules. In order to drive the countercurrent system of 
water absorption, the osmotic concentration in the medullary interstitium must be slightly 
higher than that in the collecting duct lumen. In dehydration, and as the interstitium tries 
to conserve water by producing concentrated urine (with an osmolarity of more than 1500 
mOsom/kg water), the medullary osmolarity should be increased to achieve this. Until 
reabsorption ceases, this could generate a hyperosmolar extracellular environment which 
would increase tubular cell work load and cellular protective adaptation to compensate 
for the external hyperosmolarity environment.
Alternatively, hydration and extracellular volume expansion have an opposite 
effect on the medullary osmolar burden. Numerous studies have evaluated the effects of 
hydration, diuretics, and extracellular fluid expansion on preventing CM-ARF, possibly 
due to decreased urinary electrolytes concentration which could lead to increased renal 
blood flow (RBF) (Cochran et al, 1983; Gomes et al, 1989; Solomon et al, 1994). 
Furthermore, the rapid flow of filtrate induced by diuresis decreases the tubular fluid 
transit time and any potential direct effects such as the effects of concentrated tubular 
fluid including CM on tubular epithelia. It was shown that changes of urine flow rate 
play an important role in the degree of iodine retention as lithium-induced diuresis 
decreased the retention percentage of iodine in the rat kidney (Avades et al, 1992). In 
conclusion, hydration before CM is highly recommended although special care should be 
taken with heart failure patients.
In view of the lack of experimental or clinical data to relate dehydration directly
to CM-ARF, the role of dehydration/hydration will be considered within the context of 
this thesis.
1.2.5 Risk factors
In general CM-ARF appears to be associated with renal insufficiency. But risk 
factors which trigger CM-ARF could include in general:
• Pre-excising renal insufficiency; the most frequently cited risk factor in all studies is 
when serum creatinine >  133pmol/L. More than 90% of reported cases of CM-ARF 
occur in patients with renal insufficiency (D’Elia et al, 1982; Lautin et al, 1991; Barrett 
et al, 1992; Moore et al, 1992; Rudnick et al, 1994). It was concluded that the higher the 
serum creatinine value before the injection the greater the danger of CM-ARF (D’Elia et 
al, 1982; Barrett et al, 1992; Moore et al, 1992). Patients with renal insufficiency are 
predisposed to ARE due to the effects of known nephrotoxic drugs such as 
aminoglycosides and cyclosporins.
• Diabetes with concurrent nephropathy appears to be a significant risk factor 
(Harkonen and Kjellstrand, 1977; Manske et al, 1990) as CM-ARF may not be 
reversible. Diabetes alone without nephropathy, appears not to be associated with CM- 
ARF (Parfrey et al, 1989).
• Dehydration and extra cellular volume depletion have been considered as another risk 
factor (Ansari and Baldwin, 1976; Webb et al, 1981; Aron et al, 1989) (for further 
details see 1.2.4).
•  Elderly patients are susceptible to ARE as the ageing kidney has less functional 
reserve and less cellular regenerative power and functional recovery capacity (Cochran et 
al, 1983; Rich and Crecelius, 1990).
• Other known risk factors are renal hypoperfusion due to atherosclerosis and low 
cardiac output in congestive heart disease and shock (Gussenhoven et al, 1991), and 
hypertensive cases were associated with CM-ARF (Deray and Jacobs, 1995).
• Multiple myeloma is frequently cited as a potential risk factor in the development of 
CM-ARF (Vix, 1966; Myers and Witter, 1971; Alexanian et al, 1990, Huang et al, 
1993). The intra-tubular precipitation of the Bence-Jones protein with the Tamm-Horsfall 
glycoprotein is the most likely factor in the development of renal failure in patients with 
multiple myeloma
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• Large volumes of contrast media; some studies demonstrated a significant correlation 
between the volume of CM administered and CM-ARF (Gomes et al, 1989; Manske et 
al, 1990) while no relationship was found in other studies (D’Elia et al, 1982; Barrett et 
al, 1992; Moore et al, 1992).
As expected, the likelihood of incidence of CM-ARF is greater in patients who 
exhibit a number of such risk factors, for example 60-100% of patients with three or 
more risk factors developed CM-ARF (Rich and Crecelius, 1990).
Most of these CM-ARF risk factors were identified from clinical experience and 
the known renal failure risk factors in general. There have been relatively few studies 
designed specifically for the evaluation of these risk factors. Experimental animals 
provide notoriously poor models. The only common denominator of these risk factors is 
that there is a background renal impairment. It would be more valid to understand the 
pathogenesis behind these risk factors.
1.2.6 Preventive measures of CM-ARF
In certain circumstances it may be necessary to carry out an imaging procedure in 
a patient who clearly presents some high risk parameters. In such cases the following 
measures were proposed to minimise the adverse renal effects of CM:
1. Employ the smallest possible CM dose (Rosovsky et al, 1996)
2. Increase the time intervals between radiological procedures.
3. Expand the volume with fluids (Katzberg et al, 1983b; Solomon et al, 1992; 1994) or 
by pre-treatment with high salt diet. The intensity of any vasoconstrictive phase can be 
reduced by volume repletion and extracellular volume expansion.
4. Diuretics could protect against CM-ARF by inducing an increase in the tubular flow 
rate leading to reduced contact of CM with tubular epithelial and direct tubular toxicity 
by the effect of washing out, and thus reduce tubular obstruction. Frusemide causes 
reduced tubular O2 demand, and it affects the active sodium reabsorption by the mTAL 
(Heyman et al, 1988). It was shown from randomised perspective studies that furosemide 
may increase the incidence of CM-ARF in uremic diabetic patients (Solomon et al,
1992). However, diuretics could cause unrecognised negative fluid balance.
Administering hypertonic maimitol is another suggested prophylactic method as it 
leads to renal vasodilation and osmotic diuresis. However, mannitol could also increase
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cortical blood flow and decrease medullary blood flow (Weaver and Sica, 1987; Liss et 
al, 1996) hence, decreases outer medullary oxygen tension while cortical oxygen tension 
remains unchanged. Therapeutic benefits of mannitol have not been demonstrated in 
prospective controlled studies to date (Po et al, 1992, Solomon et al, 1992; 1994).
5. Vasoconstrictor antagonists were shown to be useful. Theophylline (adenosine 
antagonist) has a protective effect on CM-induced intrarenal vasoconstriction as 
demonstrated in a double-blind study with both HOCM and LOCM (Erley et al, 1992). 
Atrial naturitic factor (ANF) blocks CM-induced decreased RBF and GFR in dogs (Deray 
et al, 1991), and attenuates a reduction in creatinine clearance and RBF (Kenneth et al, 
1991). Calcium antagonists inhibit intrarenal vasoconstriction in dogs (Bakris and 
Burnett, 1985; Bakris et al, 1990; Deray et al, 1990) and eliminate or protect against the 
effects of CM on GFR, proteinuria, and enzymuria (Neumayer et al, 1989). Renal 
vasodilation by low dose dopamine have been shown to have protective effects against 
CM-ARF in preliminary studies (Hall et al, 1992) but was not shown to be protective in 
high risk patients (Weisberg et al, 1993).
6 . The use of LOCM may be justified with patients with pre-existing renal impairment 
as illustrated from the incidence of CM-ARF (for further incidence details seel.2.3) 
However, several recent cases were reported of renal failures which developed after the 
use of LOCM (Deray and Jacobs, 1995). Better understanding of the aetiology of CM- 
ARF will help in evaluating the prophylactic measures, and avoid unnecessary 
intervention.
1.3 Role of renal tubules in kidney function
The renal proximal tubule is the first part of the nephron that tubular fluid 
encounters after filtration in the glomeruli. The composition of the filtering fluid through 
the glomerulus is similar to the soluble component of plasma, except for macromolecules 
greater than 70 KDa, which cannot readily cross the glomerular filtration barrier (GBM). 
To understand the fimction of the proximal tubule it is important to consider its structure.
The proximal tubule (PT) is divided into initial convoluted (pars convoluta) and 
subsequent straight (pars recta) tubules. Based on morphology and ratio of PAH 
secretion it is divided into Sj, S2 and S3 (cf. Maunsbach and Christensen, 1992). The Sj 
is the initial segment immediately adjacent to the glomerulus, while the S3 forms the last
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part of PST. Epithelial cells of Sj segment possess a tall brush border and a well 
developed vacuolar lysosomal system. The basolateral membrane is extensively 
interdigitated, and many long mitochondria fill the basal portion of the cell, an 
arrangement that is characteristic of epithelia involved in active transport. Epithelial cells 
of the S2 segment are not as tall as those of the Si, and possess a shorter brush border and 
fewer apical vacuoles and mitochondria than the Si cells. The number and size of 
lysosomes vary between species and sexes. The S3 segment comprises the distal portion 
of straight segments of the medullary rays, which extends to the junction of the outer and 
inner stripe of the outer medulla. The S3 cells have rare apical vacuoles and fewer and 
smaller lysosomes and mitochondria than Si and S2 cells. Lateral cell processes and 
invaginations are absent. Distinguishing features of the three cell types are observed best 
by electron microscopy and by perfusion fixation.
In addition to morphological differences between the three segments, the early 
segments also display greater membrane surface areas, enhanced numbers of 
mitochondria, and greater rates of solutes and water reabsorption. Maximal solute 
gradients cannot be achieved in the early segments, because the paracellular pathways are 
leaky to ions and other solutes. In the S3 transcellular solute transport rates are lower 
than in the Si and S2  segments, but the paracellular pathways are less leaky and maximal 
solutes concentration gradient can be achieved. Vacuolar apparatus and receptor mediated 
endocytosis are most prominent in the Si segment under normal conditions but can be 
observed in the S2 segment. The lysosomal proteolytic enzyme activities are higher in Si 
but increase in S2 during proteinuric conditions.
The proximal tubule segments contain the largest variety of transport mechanisms 
for sodium, potassium, chloride, bicarbonate, calcium, phosphate, and other solutes.
Both transport mechanisms through cellular and transcellular pathways are known 
(Brown and Stow, 1996). The transport functions take place primarily in the convoluted 
part and the major part is the S2 segment. It is a high capacity energy requiring system 
that absorbs 50-100% of filtered solutes and water.
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Figure 1-1 Schem e of a typical epithelial cell showing apical and baso-lateral membranes
The proximal tubule cell possesses two distinct membranes as seen in fig 1-1, an 
apical membrane that faces the tubule lumen and consists of microvilli (brush border); 
and a basolateral membrane that faces the renal interstitium and the peritubular capillary 
and an interdigitated intercellular to give a large surface area. Proximal tubular (PT) cells 
are connected by a tight junctions that are present at the luminal side of the epithelium 
and possess characteristic features similar to tight junctions in other epithelia (Alpem, 
1990). These tight junction complexes, that form a physical barrier between the two 
membrane regions, serve to make the lumen compartment tight.
1.3.1 Renal failure due to tubule dysfunction
Acute renal failure may be classified according to aetiology (Solez, 1992) into:
1. Prerenal azotemia; due to diminished renal microvascular perfusion, as occurs in 
patients with congestive cardiac failure, atherosclerosis and shock.
2. Postrenal causes; which may arise as a result of intratubular obstruction of urine 
outflow when both ureters or pelvis become blocked simultaneously. Causes include 
obstruction by protein casts, blood clots and crystals such as uric acid and calcium 
oxalate.
3. Intrinsic causes; which are associated with tubular necrosis and ischaemia. This thesis 
will focus mainly on the intrinsic causes of renal failure induced by tubule dysfunction or
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acute tubular necrosis, as they are most relevant causes of drug-induced renal failure.
In general, nephrotoxins cause renal injury by inducing a varying combination of 
intrarenal ischaemia, direct tubule toxicity and tubule obstruction.
1.3.1.a) Toxic tubular necrosis
Besides ischaemia, direct toxic effect are primarily responsible for acute tubular 
damage leading to necrosis of the tubular apparatus. Clinically, acute tubular necrosis, 
has been divided into three stages. The first stage is the critical initiating stage, which 
lasts from the insult to the start of clinically diagnosed acute renal failure. This is 
followed by the oliguric stage which is diagnosed clinically by the rise of sCr which 
could last from 4 days to 4 weeks before the patient enters the polyuric (diuretic) stage by 
the return of GFR and sCr to normal values. Some patients never become oliguric and 
pass directly to polyuric stage. This nonoliguric form of ARF carries a better prognosis.
Cellular events in the initiating injury phase of acute tubular necrosis are due to:
1 ) renal cell injury mainly by a direct effect on the proximal tubule epithelia.
2 ) haemodynamics changes with decreased renal perfusion, which will lead to ischaemic 
necrosis of tubular cells when the blood flow is sufficiently compromised. Prerenal 
azotemia and ischaemic ATN are part of spectrum of manifestation of renal 
hypoperfusion. In prerenal azotemia, and unlike with ischaemic ATN, the integrity of 
renal parenchyma is maintained and corrected rapidly on restoration of renal perfusion. 
There is decrease of urine flow and formation of a concentrated urine (high omsolality).
1.3A.b) Pathological changes o f acute tubular necrosis
Histopathological features of ischaemic tubular necrosis were described by 
percutaneous renal biopsy procedures carried out during different stages ( Solez et al, 
1979; Solez, 1992; Brady et al, 1996). As ischaemic tubular necrosis is acute and most 
patients recover, a pathological follow up is not a routine procedure. However, of the 
most described pathological changes are:
i) Glomerulus
The glomerulus usually shows no significant change by light microscopy. But the 
cells lining Bowman’s capsule are prominent and take the appearance of tubular cells, 
this was termed as “tubulisation” which is found in biopsies taken after recovery and may
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be related to regeneration of proximal tubular cells (Solez, 1992) through the increased 
expression of proliferating-related growth factors.
ii) Tubules
The proximal convoluted tubular epithelium shows a variety of changes which 
depends on time and type of injury. All types of tubular cells in ischaemia appear to be 
able to adjust to an energetically feasible survival level by reducing their cellular 
compartment, in particular their active surface area (brush border). Early morphological 
changes with ischaemia include the formation of blebs in the apical membrane of PCT 
cells (Spencer et al, 1991). Diffuse effacement and thinning of the brush border are one 
of common features of human ATN (Brady et al, 1996), but this returns to normal 
shortly after recovery. Thinning or absence of the brush border has been consistently 
described in experimental models of ischaemic renal injury and may be difficult to 
differentiate PCT cells from other cell types like the distal tubules cells. There appears to 
be a correlation between the loss of the integrity of brush border and impairment of renal 
function (Howie et al, 1990). PCT cells lose their polarity and the tight junctions become 
disrupted, perhaps as a consequence of alteration in the actin and microtubule cytoskelton 
(Abbate et al, 1994). Proximal tubules in response to ischaemic tubular necrosis are 
frequently dilated and lined by flattened epithelium. The predominant site of injury in 
ATN is S3 segment (pars recta) which is the most severely affected segment in ATN, 
but injury is also observed in other tubular segments including the mTAL (Thadhani et 
al, 1996).
iii) Tubular obstruction in renal cell injury
Tubular obstruction is an important pathophysiological event in the oliguria of 
acute renal failure. Early studies showed that one hour of ischaemia causes a dramatic 
increase in proximal tubular pressure (Tanner and Steinhausen, 1976). There is evidence 
to show that abnormal cell-cell adhesion may be attributed to binding of Pj-integrins 
expressed apically on injured cells to their receptors on fragments of matrix protein 
present on exfoliated renal cells (Molitoris et al, 1992; Goligorsky and DiBona, 1993). It 
was postulated that adhesion of detached renal epithelial cells to sublethally injured cells 
that remain attached to the basement membrane may contribute to obstruction after
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ischaemic injury in vivo (Humes, 1995).
Of the various types of casts which are found in the collecting ducts the hyaline 
casts are fairly common. They represent an aggregation of Tamm-Horsfall glycoprotein 
(THG), a substance normally produced in the thick ascending limb of the loop of Henle 
(Hoyer and Seiler, 1979). The consequence of stasis compounded by an increased protein 
concentration, leads to THG aggregation and the formation of more casts. Other type of 
casts are granular casts that consist of degenerated tubular cells or their constituents such 
as blebs of PCT cells cytoplasm and brush borders.
iv) Interstitium
The fluid barrier formed by the tubular cells and tight junction becomes 
increasingly permeable in ATN, resulting in leakage of tubular fluid (back leak) into the 
interstitium with a corresponding development of oedema and the separation of tubules 
from one another. This may be due to both tubular necrosis and ischaemia (Olsen and 
Solez, 1993 ).
1.3.1.C) Electron microscopy morphology o f ATN:
In support of the light microscopy morphology, electron microscopy of ATN is 
characterised by defects in the epithelial lining of the tubules which correspond to 
missing cells. Some of these desquamated cells show signs of viability (Racusen et al, 
1991). The basement membrane is usually intact below the site where the cells are 
missing. Cell necrosis and desquamation are more marked in the medulla and medullary 
rays rather than in convoluted tubules in the cortex (Olsen and Hansen, 1990). Most 
proximal tubules show some degree of disappearance of the brush border, and may show 
some features allowing them to be identified as PCT cells. The “simplification” of the 
proximal luminal cells surface make them similar to distal tubules i.e. become without 
brush border (Olsen and Solez, 1993).
1.3.1.d) Drug induced ATN
Drugs in general could cause renal impairment by different mechanisms:
• Decreased renal perfusion such as NSAID and cyclosporin.
• Direct tubular toxicity such as cyclosporin and gentamicin.
• Intracellular obstruction by sulfonamide.
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• Haemolytic uraemia syndrome such as cyclosporin.
• Allergic such as with NSAID.
The two most commonly used drugs to cause hospital induced intrinsic renal 
failure are CM and aminoglycosides. While aminoglycosides nephrotoxicity is well 
established, CM-mduced renal failure is still not well characterised.
1.3.2 Pathophysiology of CM-ARF
The exact mechanism of renal injury due to CM remains unclear, however, 
potential reported causes of CM-ARF are:
• Ischaemia due to decreased renal perfusion with or without cellular necrosis.
• Direct toxic tubular cellular injury from evidence of induced enzymuria, proteinuria, 
and vacuole formation.
• Obstructive tubular injury; evidence from increased uric acid, oxalate, THG 
excretion.
• Immunological reaction; antibody-mediated immunological reaction have been 
postulated to cause CM-ARF.
More evidence is emerging on the role of ischaemia and direct renal damage on CM- 
induced acute tubular necrosis than upon other causes which trigger ARF.
1.3.2.a) Renal ischaemia
Diphasic haemodynamic response in the total renal blood flow (RBF) is a typical 
feature following CM administration (Talner and Davidson, 1968; Caldicott et al, 1970; 
Porter et al, 1971; Morris et al, 1978; Katzberg et al, 1983a; 1983b; Tomquist et al, 
1984; Vari et al, 1988). Initial transient renal artery vasodilation and increased RBF is 
followed by decline and prolonged vasoconstriction, which may result in ischaemic injury 
to renal tubular cells. Almost all CM change the vessel tone with vasodilation generally 
being the predominant first effect, while during angiography coronary artery vasospasm 
may also occur (Bishop and Rees, 1988; Satoh et al, 1990; Karstoft et al, 1995). The 
decline in RBF has been shown to be severe and long lasting in kidneys subjected to 
multiple insults such as multiple injections, ischaemia or dehydration (Deray et al, 1995). 
Others had illustrated that the infusion of LOCM decreases medullary blood flow which 
could be the contributing mechanism to the pathogenesis of CM-ARF (Nygren et al,
1988).
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In general, the heterogeneity of intrarenal blood flow leads to different 
susceptibility of parts of the kidney to ischaemic changes. The glomeruli and collecting 
ducts are relatively resistant to hypoxia, while the proximal and distal tubules especially 
S3 and the mTAL are intrinsically susceptible to hypoxia (Brezis and Rosen, 1995; Brady 
et al, 1996). Intrarenal gradients of oxygenation together with variation in susceptibility 
determine the distribution of tubular injury after kidney ischaemia. Tubules in the outer 
medulla are susceptible to hypoxia because they have a high oxygen requirement. 
Ischaemic damage in these tubules causes swelling of epithelial and endothelial cells and 
neutrophil adherence (Mason et al, 1989), leading to vascular congestion and decreased 
blood flow (Vetterlein et al, 1986).
There is evidence that CM directly cause hypoxia in the renal medulla, as was 
shown by microelectrode measurements in rats (Heyman et al, 1991). A leftward shift of 
the 0-Hb dissociation curve takes place in vitro when CM are added to the whole blood, 
leading to a decrease in oxygen availability to tissues (Heyman et al, 1991) The tissue pO 
is low within the renal medulla compared with the cortex, and as the mTAL cells have a 
high metabolic rate due to an active ion pump, therefore, medullary hypoxia could play a 
central role. The renal lesions observed in a rat model of CM-ARF of multiple insults are 
localised to the medulla, involving necrosis and cellular fragmentation of cells lining the 
medullary thick ascending limb mTAL (Heyman et al, 1988). No other structural damage 
was noted elsewhere in the kidney. A correlation between the severity of mTALs damage 
and renal failure was found.
RBC aggregation after CM leading to decrease in medullary blood flow was 
demonstrated in renal medullary vessels (Nygren et al, 1988; Liss et al, 1996) and also 
reported in mesenteric vessels (Read et al, 1960; Meyer and Read, 1964) and muscles 
vessels (Read and Meyer, 1963). This aggregation supports findings by Heyman et al, 
(1991) of the effects of trapping of RBC in renal medullary vessels and medullary 
hypoxia after CM.
1.3.2.b) Renal vasoactive autocoids
CM may reduce renal function by modulating tubular regulatory mechanisms and 
production of renal vasoactive autocoids (Heyman et al, 1994). The most relevant 
autocoids which are reported to be associated with renal ischaemic effects of CM are
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discussed below:
i) Prostaglandin
Considering the evidence that the prostaglandin inhibitor, indomethacin, is 
reported to induce CM-ARF in animal models (Heyman et al, 1991), it is possible that 
prostaglandins play a role as renal vascular mediators in CM-ARF. Prostaglandin E2 , 
produced by the medulla, dilates medullary vessels and inhibits oxygen consumption in 
tubular cells (Chou et al, 1990).
ii) Calcium
Hypoxia in rat proximal tubules is associated with a significant rise in [Ca+] that 
provides evidence of membrane damage (Edelstein et al, 1997). Depletion of cellular 
ATP (due to ischaemia and interference with mitochondrial energy metabolism) leads to 
an increase in cytosolic calcium which would lead to epithelial cellular toxicity. An 
elevated intracellular Ca”^  ^concentration can initiate membrane bleb formation, mostly 
due to Ca"^  ^binding to anionic groups of phospholipids and glycolipids in the membrane 
and thereby reduce membrane fluidity. It was suggested that the impaired maintenance of 
low intracellular calcium by “ATP” could lead to release of cellular enzymes (Schmidt 
and Schmidt, 1987; Rodicio et al, 1990). Therefore, calcium may be another mediator 
for these haemodynamic changes as the calcium antagonist verapamil abolishes the CM 
vasoconstrictor effects (Deray et al, 1990), and calcium chelation attenuates the 
magnitude and duration of CM-induced intrarenal vasoconstriction (Bakris and Burnett, 
1985). The administration of calcium blockers reduces the vasoconstriction and provides 
for better oxygenation and nutrient flow to renal tissue. It was observed that calcium 
channel blockers significantly diminished urinary enzyme excretion in CM treated 
patients (Neumayer et al, 1989; Rodicio et al, 1990).
iii) Adenosine
It was shown that urinary excretion of adenosine was increased by CM (Deray et 
al, 1990; Deray and Jacobs, 1995). Recent studies have implicated the role of adenosine 
in CM-ARF and its antagonist theophylline in preventing CM-ARF (Erley et al, 1992; 
Katholi et al, 1993). Exogenous adenosine administration is known to cause a biphasic 
change in RBF and a sustained decrease in GFR (Arend et al, 1984). These similarities
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between renal actions of CM and adenosine have led to conclude that adenosine mediates 
the haemodynamic changes such as vasoconstriction caused by CM (Arend et al, 1987). 
Also the inhibitor of adenosine uptake ‘dipyridamole’ potentiates CM-induced 
vasoconstriction (Arend et al, 1985).
A major role for adenosine was shown in the development of iohexol-induced 
renal deterioration (Arakawa et al, 1996). The initial vasodilation was mediated by Az 
receptors while the sustained vasoconstriction was mediated by adenosine Aj receptors. It 
was suggested that the alteration in relative contribution of adenosine A  ^and Ag receptor 
subtypes to CM-induced renal responses may be responsible for the divergent renal 
haemodynamic responses observed in normal and impaired renal function.
iv) Nitric oxide (NO)
The local vasodilator nitric oxide is synthesised predominantly in the medullary 
thick ascending limbs. Inhibition of nitric oxide synthesis predisposes the individual to 
medullary injury and renal failure. Manipulation of the nitric oxide system may interfere 
with the regulation of medullary blood flow and oxygen balance (Brezis et al, 1991). An 
imbalance between NO and endothelin was proposed to lead to a decrease in medullary 
blood flow and thus tubular cell damage.
v) Endothelin
The endothelins (Et) are a highly potent vasoconstrictor family of peptides with 
three isoforms (ET-1,-2,-3) produced and secreted by endothelial cells. Like other 
peptides they are synthesised from a precursor molecule Big Et and then cleaved to their 
active forms by an endothelin converting enzyme acting at two receptor subtypes ET-A 
(predominantly vasoconstrictive) and ET-B (predominantly vasodilator) (Yanagisawa et 
al, 1988) (for further details see 5.1.3.b).
It is now clear that Et peptides regulate diverse aspects of renal physiology. On a 
molar basis Et is 30 times more potent than angiotensin in its vascular effects. In the 
isolated perfused kidney exogenous Et (added to the perfused) in a dose dependent 
manner, increases the renal vascular resistance that partially depends on the presence of 
extracellular Ca (Simonson, 1993). CM increase the release of both plasma and urinary 
Et in the rat (Heyman et al, 1992) and in man (Margulus et al, 1992) as well as from
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cultured endothelial cells (Heyman et al, 1992) with HOCM and to a lesser extent with 
LOCM. Et antagonists abolish the observed CM induced fall in RBF with the IPRK 
(Oldroyd et al, 1995). As a potent endogenous renal vasoconstrictor Et could play a role 
in pathogenesis of CM-ARF (Heyman et al, 1993), however it is unclear how Et effects 
per se can be sustained over the duration of the renal failure period.
1.3.2.C) Reperfusion injury
Ischaemia induces the expression of intracellular adhesion molecules on 
endothelial cells which leads to local aggregation of neutrophils and platelets. Adherence 
of neutrophils to vascular endothelium leads to extravasation of these cells into ischaemic 
tissue (Marks et al, 1989). Activation of complement cascade and local formation of C5a 
lead to neutrophil chemotaxis. After adhesion and chemotaxis, neutrophils release 
reactive oxygen species, protease and elastase thereby starting a chain of tissue injury 
processes (Brezis and Rosen, 1995; Humes, 1995; Thadhani et al, 1996). Furthermore, 
the rapid burst of oxygenated blood after reperfusion and the formation of partially 
reduced oxygen species can cause marked tissue injury. Bakris et al, (1990) raised the 
possibility that CM may induce renal injury by oxygen free radical formation. Their 
evidence was based on findings that the use of oxygen free radical scavenger inhibited the 
fall in GFR but had no effect on renal blood flow after CM.
1.3.2.d) Ischaemia and tubular damage
In contrast to heart and brain ischaemia which could result in permanent damage, 
the kidney can normally recover firom ischaemia. Most cases of renal ischaemia are 
reversible if the underlying cause is corrected, while severe and prolonged ischaemia may 
lead to irreversible tubular necrosis, or should it occur in already degenerated damaged 
renal tubular cells. It was proposed that CM had a direct nephrotoxic effect which was 
exacerbated by hypoxia (Heyman et al, 1994).
It was shown that after renal ischaemia the tubular epithelial cells undergo a range 
of biochemical and pathological changes, these are:
• Depletion of energy stores leads to breakdown of ATP, purine depletion, and 
formation of adenosine, all of which can leak out of cells, constrict intrarenal 
arterioles, and contribute to the formation of reactive oxygen species (Thadhani et al.
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1996).
• After cell energy depletion, the PT cells swell and lose their microvilli brush border 
with the formation of blebs in the apical membrane
• PT cells lose polarity and the integrity of their tight junctions is disrupted, as a 
consequence of alteration in the actin and microtubules cytoskeletal networks 
(Molitoris et al, 1992).
• Collapse of electrolyte gradient leads to Na/K -ATPase redistributing from basolateral 
to apical membrane (Molitoris et al, 1992).
• Integrins are redistributed to the apical surface causing live and dead cells to slough 
off into the tubular lumen and leading to cast formation (Goligorsky and DiBona, 
1993).
• Casts increase the intratubular pressure and decrease GFR.
• Loss of the epithelial cell barrier and of tight junctions between viable cells may 
result in back leakage of the filtrate thus reducing the effective GFR (Thadhani et al, 
1996).
These lesions do not necessarily cause ARF directly but they predispose to the 
condition by inducing tubular cell necrosis. Ischaemia also causes rapid DNA 
fragmentation suggestive of apoptosis along the medullary thick limbs and selective 
induction of growth response (Beeri et al, 1995).
The tubular proliferative repair process in acute renal failure could be responsible 
for the ability of the kidney to reverse the severe organ failure that results from ischaemia 
and toxic injury. The importance of this repair process for survival is reflected in a 
highly evolved system of growth factors which initiate the replicative process (Humes, 
1995).
1.32.e) Effects o f CM on renal epithelial cells in culture
Many studies that have focused on the study of the relative toxic effects of CM on 
renal cell culture have suggested that LOCM are less nephrotoxic than diatrizoate on 
isolated PCT cells (Humes et al, 1987; Messana et al, 1988). Equimolar concentration of 
the hypertonic mannitol had no detrimental effects on cell viability parameters. (Humes et 
al, 1987). Suspension of proximal tubular segments exposed to diatrizoate showed 
several markers of cellular injury, which were potentiated by hypoxia and were more
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pronounced with HOCM (Messana et al, 1988).
Andersen et al, (1995) showed that the cytotoxicity to LLC (proximal) and 
MDCK (distal) tubule cells was higher with HOCM than with LOCM, although the 
difference was not significant. They demonstrated a concentration-dependent effect of six 
different HO and LOCM and found cellular appearances consisting of increased cellular 
vacuolisation and demonstrated the release of brush border and lysosomal marker 
enzymes to the culture medium (Andersen et al, 1994). Both brush border and lysosomal 
enzymes varied with CM dose and cell lines. Intracellular uptake of CM was also 
reported in cultured renal cells (Nordby et al, 1989; Kolev et al, 1995).
The kidney is a heterogeneous organ, with different cell types that interact with 
each other, and any in vitro toxicity study would not be adequate to study the integrated 
mechanisms of CM-ARF. The effects of CM on one cell type would not be enough to 
understand the pathophysiological mechanisms, as the cell-cell communications would be 
ignored. Also the haemodynamic ischaemic effect of CM-ARF should be considered in 
any toxicological evaluation. The ideal in vitro system to include all these requirements 
would be an isolated perfused rat kidney, as it is the only in vitro preparation in which 
glomerular filtration and tubular functions are retained. It is uniquely suited for studies of 
the relationship between the control of renal perfusion and renal function (for further 
details see 5.1).
1.4 Assessment of the kidney function
The two proposed aetiologies of CM-ARF are almost similar in regard to the final 
state of dysfunctional and structural outcomes inflicted on the PCT, as tubular necrosis is 
the end result of any tubular ischaemia or direct tubular toxic damage by chemicals and 
drugs. Tubular cell necrosis could disrupt the highly functioning proximal tubular cells 
which would lead further on to desequamation of tubular cells, intratubular obstruction, 
and transtubular back leakage of the tubular fluid which would decrease the glomerular 
filtration (as discussed in 1.3.2.d)
Kidney function can be monitored by following a number of well established 
assays, but most of these assays are not sufficiently sensitive to indicate early renal 
impairment as they would indicate final impairment of renal function rather than any of 
the progressing pathological processes (Woods, 1996). A search for early non-invasive
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markers with reliable predictive value is crucial in order to detect and monitor renal 
impairment before irreversible changes. Renal impairment is an evolving process and any 
initiating stage need to be monitored allowing for prophylactic measures to be taken 
before any further deterioration of the renal condition (Stonard et al, 1987; Foulkes, 
1993). Therefore, structural and functional markers that could indicate CM-induced 
tubular damage that is predisposed to ATN would be potential markers in the initiating 
stage of CM-ARF.
1.4.1 Renal function parameters
Normal renal function requires the maintenance of diverse functions, such as renal 
blood flow, glomerular filtration, tubular reabsorption and secretion, and the capacity to 
concentrate and dilute the urine. Therefore, a battery of tests is required when assessing 
kidney function.
The kidney excretes a variety of substances which can be used to assess its 
excretion function, therefore the urine is the major body fluid for any non-invasive 
investigation of damaged and dysfunctional renal tubules. Routine renal function 
parameters that could be followed simultaneously from urine and plasma samples include 
plasma creatinine, urea, urine electrolytes and osmolality which could form a broad 
picture of the functional status of the kidney.
1.4.1.a) Plasma urea, creatinine and creatinine clearance
Plasma urea in most conditions correlates well with creatinine, however, the fact 
that urea fluctuates greatly with varying protein intake and breakdown, which could be 
seen during different experimental conditions, does not make it sufficiently reliable i.e. 
its protein origin makes it less reliable (Murray and Ferris, 1985). As urea can be 
reabsorbed from tubular lumen at different rates, increased plasma urea levels could 
accompany decreased urine flow with intravascular volume depletion such as in 
dehydration (Rickers et al, 1978).
In contrast to urea, creatinine is more reliable as it is derived from muscle 
creatinine and phosphocreatinine, hence is determined largely by the muscular mass 
rather than protein. Also the fact that creatinine is excluded firom the tubular cells makes 
it better indicator than urea. The biochemical measurements of plasma creatinine is still 
the Jaffe reaction with various modification using alkaline picrate method (Folin
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and Wu, 1919; Bonsnes and Taussky, 1945). However, the major disadvantage of this 
method is interference with acetoacetate resulting in apparently higher levels in starvation 
(Mascioli ef <2 /, 1984).
The best marker of acute renal failure due to ATN is the decrease of GFR which 
provides an accurate method that enables the detection of functional alteration for 
estimating the risk of subnephrotoxic drugs. GFR is calculated by measuring the 
clearance of a solute which is freely filterable at the glomeruli and which is neither 
secreted nor reabsorbed in the tubules. It is well known that indices of tubular damage 
correlated with creatinine clearance (Schainuck et al, 1970). Since creatinine clearance 
closely approximates to GFR, it has become an accepted measure of GFR (Tobias et al, 
1962). However, trace amounts of creatinine are secreted by the renal tubule, making 
creatinine clearance value more than GFR measured by inulin clearance (Bauer et al, 
1982).
lA .l .b )  Urine osmolarity and electrolytes
The most critical function of the proximal tubule is the iso-osmotic reabsorption 
of water and solutes. PCT is responsible for the reabsorption of 80%-90% of filtered 
water, sodium, potassium, glucose, phosphate, bicarbonate and protein, especially low 
molecular weight (LMW) proteins that escape the filtering action of the glomerulus. 
Therefore, any tubular dysfunction would impair this reabsorptive process.
The osmolarity reflects the number of molecules which are present in a 
determined volume, and is independent of the molecular weight of the solute. When 
concentration ability is impaired such as in ATN, urinary osmolarity becomes a more 
accurate indicator of renal function than specific gravity (Pru and Kjellstrand, 1985). In 
renal azotaemia due to ischaemic or nephrotoxic renal failure, there is decreased urine 
osmolarity.
Urinary sodium and potassium excretion (uNa and uK) is mediated by changes in 
tubular reabsorption. Reabsorption of more than 90% of the filtered Na and K occurs in 
the renal tubules with more than 75% of this being in the proximal tubule. The 
reabsorption process is carried out by Na-K-ATPase which requires a direct input of 
energy. Therefore any proximal tubular dysfunction due to ischaemic necrosis will reduce 
iso-osmotic water reabsorption at this site and impair solute reabsorption by the PCT
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cells which will increase Na and K levels in the tubular lumen. So the urine will contain 
inappropriately high concentration of sodium and potassium, these can even be shown 
with normal plasma creatinine (Pru and Kjellstrand, 1985).
The concentration of Na and K in the urine represents the ratio of electrolytes to 
water and hence would be affected by the amount of water reabsorbed by the tubules, 
secretion of aldosterone, secretion of ADH and the hydration state. This makes net 
urinary Na and K concentrations not specific for ATN, as during the early phase of 
ischaemic ATN low urinary sodium may be observed, while diuresis at a later stage of 
ATN or that induced by diuretics may raise uNa and uK (Harrington and Cohen, 1975; 
Pru and Kjellstrand, 1985). Therefore, urinary electrolytes are better presented as 
fractional excretion and renal failure indices, to overcome this confounding effect of 
diuresis. Fractional excretion (FE) of both Na (FE ^a,) and K (FE k ,) (see 2.6 Renal 
function tests) could provide a method for correcting the concentration in urine for the 
amount of water reabsorbed throughout the nephron and could be related to the filtered 
load of Na and K. The FE provides a better index for differentiating between prerenal 
and renal failure than the uNa concentration by itself (Espinel, 1976; Mathew et al, 1980; 
Pru and Kjellstrand 1985). Renal failure index (RFI) is the other way to express 
electrolytes for both Na (RFI ) and K (RFI as described first by Handa and Morrin, 
(1976) and investigated further by Miller et al, (1978). RFI is used to measure urine 
electrolytes (uNa and uK) factored by urine/plasma creatinine whilst ignoring the filtered 
load of electrolytes. In practice and with serial blood sampling during a short interval the 
serum electrolytes would remain within almost narrow range. Therefore, RFI could be 
used instead of FE (as serum electrolytes are not included in the formula) for short 
interval follow up of 6-48 hours. Furthermore, RFI values were found to mirror the FE 
values in patients with renal failure (Pru and Kjellstrand, 1985). Also since RFI requires 
3 parameters to measure, unlike FE that requires a fourth serum electrolyte value, 
therefore RFI values could be within a narrow range. Both FE and RFI indices have been 
used to improve the specificity for diagnosing ischaemic ATN(Pru and Kjellstrand, 1985).
CM administration is commonly associated with urinary electrolyte disturbances; 
directly after CM filtration and within few hours there is an increase of uNa and FE^a for 
short interval before any decline below baseline leading to low uNa and low FE^a even 
with an oliguric presentation (VanZee et al, 1978 ;Fang et al, 1980; Jevinkar et al, 1988;
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Brown et al, 1992). Generally, in any ischaemic or nephrotoxic damage, leading to 
oliguric ARF, both uNa and FE^a &re increased. Some of the ionic CM contain sodium as 
the cation, therefore uK should replace uNa in assessing the kidney function for the first 
few hours after CM administration whilst CM is still excreted.
As the kidney can compensate for up to 50% impairment before any change in 
function, any routine functional parameters would not be sensitive enough to detect early 
structural changes. The search for an early and sensitive biochemical change that could 
indicate tubular cell damage which would lead to renal dysfunction is important for 
predictive and diagnostic purposes.
1.4.2 Renal enzymes
Urinary enzymes which are released from tubule epithelial cells may originate 
from the cytosolic compartment, the brush border membrane or the lysosomes.
lA .l .a )  Enzyme distribution along the nephron
Subcellular organelles and plasma membrane structures exhibit heterogeneous 
distributions along the nephron, typical marker enzymes follow the distribution pattern of 
cellular organelles morphology. Enzyme distribution patterns differ between species e. g. 
the activity of NAG is higher in the PST than in the PCT in humans and mice, and vice 
versa, in rat and rabbit nephron. NAG appears to be distributed homogeneously within 
the renal lysosomes of the rat in contrast to acid phosphatase which is generally taken as 
the lysosomal marker enzyme (Le Hir et al, 1980), an example of NAG distribution 
within the nephron is illustrated in Fig 1.2.
The brush border enzyme ALP is equally distributed along the luminal membrane 
and is similar in both PST and PCT of humans and rats but decreases in PCT to PST in 
the mouse (Schmid and Guder, 1992). The cytosolic enzymes show marked segment 
specificity, so the gluconeogenic enzyme fructose-1 ,6 -biphospahatase is confined to the 
proximal tubules, while the glycolytic enzyme pyruvate kinase is highly enriched in the 
distal tubule (Burch et al, 1984), and lactate dehydrogenase is distributed more equally 
along the nephron (Schmid and Guder, 1992). Aldose reductase which catalyses the 
formation of osmolytes sorbitol from glucose is located in the thin limbs and collecting 
tubules of medulla and papilla (Sands et al, 1989).
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Figure 1.2 Variations in NAG distribution in the nephron of the rat, m ouse and man. (Data 
from Schmid and Guder, 1992)
Heterogeneity in the kidney is not only intranephron but there are differences 
between superficial and juxtra-medullary nephrons. As the proximal tubules constitute 
major part of the nephron, the highest activities of most diagnostically relevant enzymes, 
at least under physiological conditions, are in this region predominantly at the brush 
border (Mattenheimer and Burchardt, 1992). The enzymatic distribution undergoes 
adaptation to the metabolic condition e. g. NAG exhibits various changes in distribution 
along the PCT in reported experimental conditions (Fig 1.3) (Schmid and Guder, 1992). 
This change of pattern may represent a variation in the mechanism which leads to cellular 
damage and enzyme release.
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Figure 1.3 Changes in NAG distribution patterns in diabetes and cyclosporin nephropathy in 
the rat (Data from Schmid and Guder, 1992)
lA .l .b )  Enzymuria
Enzymes in a variety of body fluids can be used as diagnostic tools to establish 
changes in the pathophysiological status. Since assays of few enzymes may help to 
identify damaged tissue, therefore, a knowledge of the pattern of enzyme changes 
together with other clinical findings is required for useful interpretation to be made. A 
good clinical example is ischaemic myocardium which is associated with the release of 
different diagnostic myocardial cells enzymes like CK, LDH and AST. The diagnostic 
value of these cardiac enzymes is enhanced when carried out in conjunction with other 
functional tests, such as electrocardiograph changes.
Urine enzymes are promising indicators of site-specific renal damage. It is well 
known that the tubular epithelia are the main source of enzymes in the urine, with the 
exclusion of other contributing factors like plasma, blood cells, micro-organisms and the 
urinary tract. Of the large number of enzymes that are excreted in urine only few are 
used for diagnostic purposes (Price, 1982; Schmid and Guder, 1992). The kidney tubules 
consist of various parts which differ in length, cellular morphology, metabolic and 
transport function. This heterogeneity would be the cause for different enzyme release 
(Guder and Ross, 1984).
Cellular damage leading to an enzyme release is not necessarily irreversible.
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Should the toxic stimulus be removed a decrease in urinary enzyme activity would 
accompany the return of tubular cell function to normal (Paddock et al, 1985). In early 
stages of injury, reduction or even a complete disappearance of brush border (BB) could 
lead to an increase of BB enzymes like GGT and ALP in the urine with the decrease of 
the tissue enzyme component. Urine enzyme levels depend on total tissue enzyme content 
and the capability of the nephron to recover from injury. In chronic progressive renal 
failure the total amount of tissue alkaline phosphatase activities in kidney sections from 
patients are significantly reduced (Scherberich et al, 1989a). The time-dependent of urine 
enzyme release is critical if the change is to be detected, since levels of enzyme release 
peak before they drop (Scherberich et al, 1989a ; 1989b). Changes in intranephron 
enzyme distribution under pathological condition demonstrate that a variety of events at 
the molecular level account for functional and structural impairment of renal tubular 
cells. This implies different sources of enzyme release from tubular cells into urine, 
which might complicate the interpretation of urinary enzyme patterns.
Hypoxia and ischaemia contribute to the release of cellular enzymes in most 
organs. The amount of enzymes release correlates with the degree of deterioration of the 
cellular energy state. As the glomeruli are resistant to ischaemic injury, whereas the 
PCT, especially the brush border is susceptible to ischaemic injury, PCT brush border 
enzyme in particular are the most sensitive to any renal ischaemia or nephrotoxins. It was 
suggested that urinary enzyme release especially those of LDH, ALP and NAG may be a 
useful diagnostic measurement for the assessment of the extent of ischaemic injury 
(Burchardt and Scherberich, 1992). By using a ratio of LDH excretion activity to GFR 
Kehre et al, (1989) could confirm the extent and duration of ischaemic injury to canine 
kidneys.
The main causes of urine enzyme release can be as follows:
1) The majority of urinary enzymes derive from the tubular cells, especially from the 
brush border which sloughed off into the tubular lumen.
2) The shedding of membrane-bound enzymes is related to bleb formation (for further 
details see 1.5.4) and sequestration of PCT cell material into the tubular lumen (tissue 
proteinuria) which could be found under many pathological conditions associated with 
diminished energy supply.
3) Tubular cell atrophy leads to an increase in the protein concentration in the final urine
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through the diminished reabsorption of LMW proteins while the release of cell enzymes 
is decreased.
4) Under normal conditions only a few enzymatic activities from the serum (e.g. 
lysozyme and amylase) enter the urine by filtration. Enzymes are not normally excreted 
into the urine on account of their large molecular weights.
2.4.2.c) Urine enzymes in toxic studies
Enzymes that have been employed as markers of different sites of tubular 
epithelium dysfunction and injury include those that are shown in tablel.l.
Site of renal injury Enzyme released
Brush border alanine aminopeptidase, GGT, ALP, a-glucosidase
Lysosomal p-glucuronidase, NAG, cathepsin B, p-galactosidase, acid 
phosphatase
Cytosolic lactate dehydrogenase, leucine aminopeptidase, ligandin, 
p-glucosidase.
Table 1.1 Release of main urinary enzym es due to various site-specific renal injuries.
Amongst the most widely studied enzymes in renal toxicological studies are:
i) Alkaline phosphatase (ALP)
Orthophosphoric-monoestricphosphohydrolase (alkaline optimum) [EC 3.1. 3.1] 
(ALP) is a zinc containing glycoprotein which splits many phosphate esters. Three 
different forms of ALP from distinct genes are found in human and most mammals 
(Miura et al, 1988). These are placental, intestinal and the tissue nonspecific types (liver, 
bone, and kidney). In the kidney ALP is the mtrinsic constituent of the brush border of 
proximal tubule epithelial cells. Thus urinary ALP (MW of 75-124 Kda) is exclusively of 
tubular origm in the well functioning normal kidney and is most unlikely to be of plasma 
origin (Pfleiderer û/, 1980).
ii) Gamma-glutamyl -peptide amino acid g-glutamyltransferase (GGT)
GGT [EC 2.3.2.2.] is a glycoprotein of 90-120KDa its function is to catalyse the
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cleavage of the cytoprotective glutathione into glutamic acid. It is localised on the luminal 
face of the tubular epithelial cells. GGT occurs in high secretion or absorption capacity 
organs like the kidney and intestine. Its highest activity was found in the kidney histo- 
chemically located in brush border of PCX (Nemesanszky and Lott, 1985) and loop of 
Henle’s (Heinle et al, 1977). The entire urinary GGT activity in healthy individuals is 
released by physiological disintegration, and its activity is 2 - 6  fold higher than that of 
serum (Rosalki, 1975).
iii) N-acetyl-p-D-Glucosaminidase (NAG)
The lysosomal enzyme N-acetyl-p-D-Glucosaminidase (2-acetamido-2-deoxy-p-D- 
glucoside acetamidodeoxyglucohydroxylase [EC 3.2.1.3]) catalyses the hydrolysis of N- 
acetyl-D-glucosaminopyranoside from P-glycosidic linkages. It has a MW of 150-160 
KDa and is predominantly localised in the lysosomes of many tissues (Conchie et al, 
1959). Two NAG isoenzymes A & B characterised by different isoelectric points, have 
been identified in kidney homogenates (Srivastava et al, 1973). The urine of a healthy 
human contains both the A & B forms, which are stable in this environment. Low levels 
of NAG in normal urine result from the normal exocytosis and pinocytosis of epithelial 
cells (Price, 1982). It was suggested that changes in the lysosomal enzymes pattern 
activities may represent a variation in the mechanism which leads to cellular damage and 
hence tubular enzyme release of the lysosomal contents into the urine (Burchardt and 
Scherberich, 1992).
iv) Cytosolic enzymes
Enzymes like glutathione transferase and LDH are of cytosolic origin. Although 
various isoenzymes of LDH can be isolated from the urine, LDH does not correlate with 
microscopical changes (Rebel et al, 1992). LDH is found in all cell types, including those 
which compose the renal cortex and medulla. The presence of LDH activity in the urine 
has been interpreted as a general measure of injury, not only to the kidney, but also to 
the urogenital tract as well (Woods, 1996). Furthermore, the presence of LDH in blood 
cells could lead to confusing values after any renal vascular injury (Mattenheimer and 
Burchardt, 1992).
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Forced diuresis has been shown to cause an increase of u r inary  enzymes excretion 
whereas the volume activity decreased because of dilution (Jung and Schulze, 1986). It 
was suggested that enzymes should be detected in terms of urinary excretion rate (urine 
flow rate) or to an equivalent reference preferably urine creatinine (Jung, 1991).
Enzymes, such as brush border enzymes are localised on the surface of the plasma 
membrane, and any change in luminal flow withm the tubules could therefore lead to 
release of the enzymes by simple avulsion (Burchardt and Jung, 1992). As this simple 
avulsion of the brush border may not change the intracellular integrity of tubular cells, 
lysosomal enzymes need not be affected.
1.4.2.d) Contrast media enzymuria
Many studies have documented a constant direct rise in urinary excretion of 
various enzymes due to CM in animals (Hofineister et al, 1986; Donadio et al, 1988;
1990 Thomsen et al, 1988; Thomsen, 1990) and in human (Parvez et al, 1990; Jakobsen 
et al, 1991; 1992; 1994; 1996; Hunter and Kind, 1992). Other types of enzymes that 
radicated CM-induced changes on PCT ceUs were LDH and GGT in rats, GGT in rabbits 
and LDH and catalase in dogs. These changes were mostly in the first 6-24 hours 
following CM administration. There is not enough evidence to indicate that these enzyme 
changes lead to ARE. It was shown that the early effects of CM on urinary enzyme 
excretion is partly related to increased diuresis (Jakobsen et al, 1993)
1.4.3 Proteinuria
The glomerulus acts as a selective filter for plasma proteins. Despite its 
extraordinary permeability to water and small solutes the GBM imposes an efficient 
barrier to the passage of plasma proteins. The permeability of the basement membrane is 
indicated by the glomerular sieving coefficient (GSC). Neutral polymers such as dextrah 
with an effective molecular radius > 4  nm i.e. close to albumin (3.6 nm) are excluded 
from glomemlar filtration. On these basis the effective pore radius of the ultrafiltration 
unit has been estimated at 4-5 nm. Apart from molecular radius the difference of GSC 
has been attributed to net charges (Rennke et al, 1978) and molecular configuration 
(Rennke et al, 1979). After percolating through the glomemlar filter, proteins enter 
Bowman’s space and then transverse down the nephron where absorption occurs.
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Absorption is highly efficient and more than 90% of the filtered protein is removed from 
the tubular fluid. Albumin absorption in PCT was found to be 2.6 that of PST, while it is 
negligible in the collecting duct (Bordeau et al, 1972). Under normal conditions 
absorption of many low molecular weight proteins is near complete. While the kidney 
plays an important role in the removal of circulating LMW proteins, its contribution to 
the metabolism of proteins close to the size of albumin or larger, is m inim al (Maack et 
al, 1979). Generally small peptides are cleaved extracellularly by the brush border 
ectopeptidases whereas larger peptides and proteins are reabsorbed by endocytosis and 
subsequently catabolised in lysosomes (Christensen and Nielsen, 1991).
An enhanced glomerular permeability to proteins gives rise to an increased 
urinary excretion of HMW proteins. The predominant protein in glomerular proteinuria 
is albumin but, large MW proteins like transferrin and IgG may also be present in high 
amounts. Proteinuria could be due to structural alteration of the glomerular capillary wall 
leading to increased leakiness and porosity, or to the loss of glomerular polyanion and 
hence of charge-selectivity of the glomerular filter, or to haemodynamic changes such as 
a decrease of RBF with a longer capillary transit time and an increase in filtration 
fraction (Bernard and Lauwerys, 1991; Beetham and Cattell, 1993). Therefore, the 
amount of proteins filtered at any time could depend on the glomerular sieving 
coefficient, GFR, and plasma proteins. However, the exact mechanism whereby 
proteinuria occurs due to reduced RBF is not very clear.
The two mechanisms that could lead to an increased excretion of LMW mass 
proteins (Maack et al, 1979; 1992) are due to:
1. High plasma concentration: The serum concentration of LMW proteins represents a 
balance between primary production of these proteins and their removal and degradation 
by various tissues.
2. Decreased tubular reabsorption by tubular damage “tubular protineuira”. The two 
proposed causes for tubular proteinuria are
i. due to atrophic or damaged tubule epithelia as a low rate of intracellular degradation 
increases the amount of LMW protein in the final excreted urine; or
ii. due to functional causes; whereby an inhibition of LMW proteins reabsorption 
suggests that competition with other substances for common endoplasmic transport sites 
at the luminal membrane of PCT cells could occur.
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LMW protein reabsorption, under normal conditions, is nearly complete at 99% 
(Maack et al, 1979; 1992; Bernard and Lauwerys, 1991) whilst that of albumin is about 
90%. This efficient LMW protein reabsorption process means that impaired reabsorption, 
due to tubular injury, leads to a higher relative increase in LMW proteins excretion in 
comparison to albumin.
The total protein concentration of a male rat is significantly more than that of 
human but the total daily excretion is almost equal. Total protein concentration 
(determined by TCA precipitation) is 4.5 mg/ml in a rat in comparison to 0.05 mg/ml in 
a human male. As the urine volume is lower in a rat (14 ml in comparison to 1400ml in 
human), the total protein excretion in the rat is 60mg/day in comparison to 70 mg/day in 
man (Olson et al, 1990; Bankir, 1996).
lA.Z.a) Characteristics o f the main urinary proteins
i) Tamm-Horsfall glycoproteins (THG)
These are the most abundant proteins of renal origin in normal urine. They have a 
MW of 7 X 10 ,^ and consists of non-covalantly linked subunits. They contain 30% 
carbohydrates and are localised on the membrane of the epithelial cells of the thick 
ascending Ihnb of loop of Henle. It is the major constituent of urinary casts. The urinary 
excretion of THG can increase following injury to the distal part of the tubule (Thomley 
et al, 1985). It is the only known protein which is produced and secreted by the tubule 
into the lumen filtrate.
ii) Albumin
(Quantitatively it is the major protein derived from plasma. In humans its 
concentration is 5 times higher than that of other high MW proteins and 50 times higher 
than that of LMW proteins.
An increased albuminuria can reflect either an enhanced glomerular filtration or a 
defect in tubular transport. Massive albuminuria accompanying a proteinuria can be 
ascribed to glomerular leakage whereas a smaller increase in albumin 
(microalbuminuria), is also accompanied by an increase of LMW proteins, which results 
from impaired tubular reabsorption encountered in toxic nephropathies (Peterson et al, 
1969; Mogensen, 1987). Microalbuminuria depends on the concentration and proportion
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of low and high MW protein in urine. When microalbuminuria is observed in the absence 
of LMW proteinuria, it is most likely due to glomerular permeability. The possibility of a 
specific defect in the tubular uptake of albumin is unlikely in view of the nonselective 
character of the tubular reabsorption process of protein (Bemand et al, 1987; 1988). At 
high filtered loads, albumin decreases the tubular uptake of the LMW proteins most 
likely by competition for a common transport mechanism (Theilemans et al, 1994).
Albuminuria is sensitive to variations in the renal haemodynamics. Transient and 
totally reversible elevations in albumin excretion (as well as with other urinary proteins 
and enzymes) may be observed in various situations producing changes in GFR and its 
determinants such as circadian rhythm, heavy exercise and fever (Bemand and Lauwerys, 
1991; Van Acker et al, 1993).
iii) Transferrin
The iron transporting protein transferrin occurs in urine, as in plasma, at a 
concentration which is 15 times lower than that of albumin. It has a larger effective 
molecular hydrodynamic radius (>  4 nm) than albumin (3.6 nm). It was suggested by 
Alfrey et al, (1992) that the noxious effects of protienuria may be mediated by 
transferrin. The filtered transferrin may be presented to tubule fluid as a result of 
glomerular leakage which could lead to release of free iron. Therefore, iron may cause 
tubular cell damage at the level of the brush border membrane following a pH-dependent 
dissociation of iron from transferrin in the tubular lumen. It was speculated that iron in 
turn is available in a form capable of catalysing oxygen radicals resulting in lipid 
peroxidation of tubule cell membrane (Alfrey et al, 1989). It was shown that 
transferrinuria could release iron in a low urine pH and hence iron would exist in a form 
that could catalyse hydroxyl radicals and could cause lipid peroxidation of cell 
membranes (Alfrey et al, 1989; Alfrey and Hammond, 1990; Alfrey, 1992; Harris et al, 
1995). Marked accumulation of iron within lysosomes of proximal tubular cells with 
proteinuric chronic renal failure were also observed in humans (Nankivell et al, 1992) 
and animals (Nankivell et al, 1994).
iv) Gamma Globulins
37
In glomemlar proteinuria, HMW gamma globulins are excreted in urine 
predominately as IgG, IgA, and immunoglobulin light chains. The urinary excretion of 
IgG has been used for assessing the selectivity of the glomerular type proteinuria . It is 
presently regarded as a reliable index of the nonselective pathway damage of the 
glomemlar basement membrane (Bernard and Lauwerys, 1991)
v) aj-microglobulin
Also called protein HC, this is a glycosylated protein with a MW between 26- 
33kda. It is present in serum, either free or bound to high MW proteins such as albumin 
and IgA, the free is readily excreted by the kidney and efficiently taken by renal tubules. 
The liver is the main site of ai-microglobulin synthesis, therefore, it is low in liver 
failure and high in renal failure (Bernard and Lauwerys, 1991). The efficiency of its 
renal uptake, which critically determines its sensitivity to a tubular insult, has been 
proposed as a marker of proximal tubular dysfunction (Yu gr al, 1983). It is stable in acid 
urine and relatively high in concentration compared to other LMW (Donaldson et al,
1989).
vi) cc2-microglobulin (cc2u-globulin)
This is a LMW plasma protein (MW 21.4KDa), also called retinol binding protein 
(RBP). The free RBP is rapidly eliminated by glomemlar filtration then reabsorbed and 
catabolised by PT cells (Bernard and Lauwerys, 1991). In the rat this a 2o-globulin is a 
sex-dependent protein synthesised by the young male liver which is freely filtered and 
taken up by tubules with a lower efficiency than other LMW proteins so it is poorly 
reabsorbed and accumulates in PCT. As the rat gets older the relative contribution of 
a 2u-globulin to total protein decreases whereas that of albumin increases as a consequence 
of old age nephropathy (Stonard et al, 1986; Olson et al, 1990).
vii) P2-microglobulin
This is a small protein with MW of 11.8KDa. The urinary excretion of P2" 
microglobulin is considerably enhanced in a case of renal tubular dysfunction e.g. as seen 
in Cadmium and Balkan nephropathy, also acute tubular necrosis caused by various 
chemicals, lead to a marked increase in p2-microglobulin (Bernard et al, 1987). But the 
fact that it is unstable in urine makes it an unreliable indicator of PCT damage.
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1.4.3.b) Methods to determine urinary proteins
Many methods are employed to measure total and specific proteins excretion 
which depend on the sensitivity required, the reproducibility and the ease with which the 
test can be performed (Chavers and Vernier, 1986):
i) Precipitation methods
This may be performed either by a sulfosalicylic acid precipitation test or by a 
heat and acetic acid test. The urine sample becomes turbid when precipitation occurs and 
protein levels are measured by the amount of turbidity (Free et al, 1957). The 
precipitation methods give false positive results if the urine contains dyes or CM, or is 
highly concentrated (Young et al, 1975). Therefore these precipitation methods are 
relatively insensitive and their detection limit is above 1 0 0  mg/1
ii) Chemical methods
Proteins are precipitated with TCA acid, dissolved with sodium hydroxide and 
reacted with copper carbonate solution (Biuret or Folin-Lowry techniques). This 
approach is generally not suitable because it is not sufficiently sensitive to detect 
proteinuria in human (Bernard and Lauwerys, 1991), and the assay is only linear over a 
narrow range of concentration.
iii) Dye binding methods
Bradford Coomassie Brilliant Blue is the most practical assay used for protein 
determination due to its reproducibility and sensitivity. Although it fails to measure 
LMW proteins of less than 3kda, it is still considered the best and most convenient 
routine assay for urine proteins (Bradford, 1976) (further details in 2.2).
iv) Immunological methods
Modem immunological methods are far more sensitive in determining the 
concentration of different urinary proteins. But these methods require specific antisera to 
individual proteins or the use of a specific protein antigen amongst these methods are:
• The single radial immunodiffusion method with an albumin sensitivity of 1.25mg/l 
but requires 2-3days (Mancini et al, 1965).
• Immunoelectrophoresis with an albumin sensitivity of 5 mg/1 which requires 4-6hours
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(Laurell et al, 1966).
• An immimotiirbidemetric assay based on the formation of insoluble antigen-antibody 
complexes and their measurement either by microturbidity its sensitivity to albumin is 5 
mg/1 and requires 30 minutes (Teppo, 1982), or by nephelometry which is based on the 
measurement of light scattering its sensitivity to albumin is 750 pg/1 and requires 6 hours 
(Hemmingsen and Skaarup, 1975).
• A radioimmunoassay which is based on using radioactively labelled antigens. This has 
become a sensitive method for different urine proteins, its sensitivity to albumin is 6 pg/1 
but it requires 2-3 days to complete and a labelled antigen (albumin) isotopes, (Woo et al,
1978).
• ELISA is the most sensitive assay for specific urinary proteins, e.g. the limit of 
detection for albumin being 3 pg/l with assay periods firom 5 hours to 3 days depending 
on different procedures (Fielding et al, 1983).
1.43.C) Contrast media proteinuria
CM protienuria is a well known effect, it was shown to be more with the HO than 
with the LOOM (Holtas, 1978; 1984; Tomquist et al, 1984; Holtz et al, 1987; Thomsen 
et al, 1991; 1993; Jakobsen et al, 1993; Walday et al, 1995). CM also induced LMW 
proteinuria, shown as increased p2 microglobulin (Jakobsen et al, 1992 ), and aj- 
microglobulin (Donadio et al, 1990). It was shown that isosmolar CM impair the tubular 
reabsorption of cytochrome-C and thus provides a possible explanation for the transient 
proteinuria observed with most types of CM. The recovery of ^^I-labelled cytochrome-C 
when co-administered with iodixanol was found to be 30% lower than when cytochrome- 
C was administered alone (Dobrota et al, 1995).
Changes in the release and excretion of these enzymes and LMW proteins in urine 
usually occur long before any renal function impairment is detected by routine clinical 
chemistry such as by plasma creatinine and GFR. Therefore, and to assess early marker 
of tubular damage it is necessary to evaluate these tubular markers.
1.4.4 Endosome-lysosome system
The principle site of absorption of all proteins and macromolecules is the luminal 
site of the proximal tubule with its prominent and well developed endocytotic apparatus 
(Cortney et al, 1970; Maunsbach and Christensen, 1992). The proximal tubule is
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uniquely specialised for bulk reabsorption of fluid, electrolytes and macromolecules that 
are present in the filtrate. Its apical membrane surface is amplified many times by the 
presence of an extensive brush border. A high rate of apical endocytotic activity can be 
detected in the proximal tubule epithelial cells. In the rat there are numerous endocytic 
invaginations, vacuoles, and lysosomes in Sj and S2 , while they are less developed in S3 
(Christensen and Nielsen, 1991). The luminal plasma membrane is covered with a thick 
external coat and a cytoplasmic coat containing extensive clatharin coat which is observed 
corresponding to the endocytic invaginations at the base of the brush border microvilli 
(Kerjaschki et al, 1984; Brown et al, 1987 ; Brown et al, 1988). However, fluid phase 
endocytosis of luminal tracers may occur also by a clatharin-independent mechanisms 
(Brown and Stow, 1996). The two mam cellular components which participate in protein 
uptake and disposal in the PCT cells are the endocytic vacuole and the lysosome (Fig
1.1). Proteins are reabsorbed and catabolised via segregation into the endocytotic 
vesicles, absorption is initiated by binding the protein to the microvilli of proximal 
tubular epithelium (Foulkes, 1982), after binding the protein migrates to the base of 
microvilli where the apical plasma membrane is backed by a highly developed clathrin 
coat (Rodman et al, 1984). This is followed by segregation into endocytic vesicles, fusion 
with lysosomes, proteolysis and release of amino acids into the circulation (Beetham and 
Cattell, 1993). On the other hand, in the slow fluid phase endocytosis 2% of the tubular 
fluid is internalised m a nonspecific manner (Wall and Maack, 1985).
It is generally believed that protein uptake in the PT is characterised by a low 
affinity high capacity system (Christensen and Nielsen, 1991). Some workers found a 
strong correlation between the net positive charge of the polypeptides and the bindiug 
process, the more cationic the protein the stronger the affinity to the anionic sites present 
on the surface of plasma membrane (Grinnell et al, 1975; Just and Haberman, 1982). It 
was shown that LMW cationic proteins and LMW and HMW anionic proteins can 
increase each other’s urinary excretion by competitive inhibition (Bernard et al, 1988). 
They also reported that high protein doses induced a lysosomal enzymuria.
Lysosomal overload can also be induced by the administration of indigestible 
lysosomoatropic substances which include some peptides, sucrose, mannitol, dextran and 
also chloroquine that compete with protein degradation (Christensen and Maunsbach,
1979). The rate of degradation varies with age, or other experimental and pathological
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conditions (Christensen and Nielsen, 1991). Lysosomal enzyme activity (Cathepsin B and 
L) increases in response to glomemlar proteinuria which is consistent with an increase of 
tubular protein catabolism (Olbricht et al, 1984).
1.4.5 CM-Vacuoles
High doses of CM in experimental animals produce large endocytic vacuoles in 
PCT cells (Powell et al, 1985; Powell et al, 1989; Tervahartiala, 1992; Dobrota et al, 
1995; Tervahartiala et al, 1991; 1993; 1997). These vacuoles were first reported with 
high osmolar ionic CM in man and was consequently described as osmotic nephrosis 
(Moreau et al, 1980). However as vacuolation was greater with the low osmolar CM and 
particularly extensive with isosmolar dimeric CM (Powell et al, 1989) these vacuoles 
were considered as not being osmotically determined. CM-induced vacuoles are like 
enlarged hyaline (protein) droplets which range in their electron density from almost 
empty vacuoles to the dense droplets (Dobrota et al, 1995; Morcos et al, 1996). They are 
similar in appearance to the cytoplasmic swellings formed following dextran 
administration, therefore, CM appear to be also lysosomoatropic. The intracellular uptake 
of CM appears to occur by fluid phase endocytosis and results in the appearance of large 
vacuoles or droplets, which probably represent a distinct class of lysosome.
1.4.6 Iodine retention
CM are taken up by PCT cells by endocytosis and retained in vacuoles which 
represent part of the lysosomal compartment (Powell et al, 1989). Intracellular uptake of 
CM has been demonstrated in cultured cells (Nordby et al, 1989; Kolev et al, 1995) and 
in the PCT cells of both the rat kidney (Nordby et al, 1990) and the human kidney 
(Jackobsen et al, 1992). Using whole body autoradiogrphy the biodistribution in rats of 
^^I-CM disappeared rapidly from all organs except for the kidney and thyroid which 
persisted for more than 24h (Bourrinet et al, 1994). When the extent of vacuolation 
(quantitated by morphometric analysis of electron microscopic films) was correlated with 
iodine retention (measured by X-ray fluorescence), a dose response was obtained with 
increasing amounts of the isosmolar dimers iodixanol and iotrolan (Laftah, 1993). 
Increased CM retention was shown with vacuole-forming CM, whüe lack of iodine 
retention with high osmolar ionic CM was consistent with a very low level of vacuolation 
(Avades et al, 1992).
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It was also shown that iodixanol was retained in the rat kidney, 40% of the 
cortical radiolabelled was in the particulate fractions of the kidney cortex (i.e. in 
organelles, microsomes, and mitochondria) confirming its uptake into intracellular 
organelles rather than being diffused in the cytosol(Morcos et al, 1996). The proportion 
of administered radiolabelled dextran taken up by the PCT cells was very similar to that 
of ^"^C-iodixanol, as total renal accumulation after 4 hours being 1 % of the injected dose 
(Christensen and Maunsbach, 1979; Morcos et al, 1996).
There is not enough experimental evidence to link CM-induced vacuoles with 
renal changes leading up to ARF (Battenfield et al, 1991). And it is still not known 
whether the delayed nephrogram (due to iodine retention) is a risk factor for CM-ARF or 
simply a consequence of it.
1.5 Experimental CM-ARF models
Most attempts to develop a reproducible animal model of CM-induced renal 
failure have generally not been successful. Evaluation of the renal toxic effect of CM has 
been largely performed in experimental animals with adequate renal function e. g. dogs , 
rabbit and rats. Rats given quite large amounts of CM intravenously usually fail to show 
evidence of even temporary renal impairment.
Site specific renal damage like gentamicin (tubules), adriamycin (GBM), glycerol 
(vasomotor nephropathy), cyclosporin (preglomerular vasoconstriction) and indomethacin 
(prostaglandin inhibition) could not induce CM-ARF (Thomsen et al, 1990; 1993). The 
response to CM injections was not uniform from one animal study to the other, nor it was 
from one animal and CM to the other. Other models that have been tried were based on 
known CM risk factors such as high doses of CM, renal impairment, dehydration, and 
the administration of NSAH). Because of the multiple homeostatic mechanism that 
protects the kidney, the impairment of several protective mechanisms appears to be 
necessary to produce any renal injury. Most models were based on com bining multiple 
insults in one animal, whereby each insult alone would not cause substantial renal injury. 
The most cited model of CM-ARF in rat (Heyman et al, 1988) utilised multiple m in o r 
insults such as uninephrectomy, salt depletion, indomethacin and furosemide.
Comparable findings were described in a rabbit model by Vari et al, (1988). However, 
neither Thomsen et al, (1990), nor Hans et al, (1990) were able to reproduce this model
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in their CM studies. Vaamonde et al, (1989) studied diabetic rats and old age rats, and 
found that except for transient albuminuria no renal injury was caused by CM. Verbaeys 
et al, (1995) concluded that the nephrotoxic properties of CM cannot be detected with 
standard functional methods in rats after multiple renal insults.
There appears to be no adequate animal model of CM-ARF. Also it is not well 
known why the rat as the most studied experimental animal model, could not show any 
CM-ARF even with large doses and different renal insults. It was concluded that the rat 
is particularly resistant to renal haemodyanmic changes (Morcos et al, 1996). Whether it 
is due to a species difference or any other protective mechanism is still not well 
understood.
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1.6 Aims
The lack of a reproducible animal model has hindered research into understanding 
the pathophysiology of CM-ARF. Also, as the increase of creatinine was a late indication 
of the loss of larger number of nephron functions, an evaluation was required of early 
markers or indicators of renal impairment due to CM-ARF. Search and validation of 
these markers in humans is not ethical and requires the recruitment of high number of 
subjects.
My approach is to study different experimental animal models and follow changes 
in their renal parameters. The aim was to induce renal failure after CM and to compare 
the renal effects of both HO and LOCM.
The aim of this work was to achieve goals of this working hypothesis:
1. Critically evaluate and search for an appropriate animal model.
2. Evaluate the difference in renal effects of the two extremes of CM i. e. LOCM and 
HOCM.
3. Relate CM-ARF to pathological changes and vacuolation (CM retention).
4. Follow renal changes after CM and compare them with those of CM-ARF.
5. Evaluate a set of urinary and plasma renal markers that could indicate and predict 
CM-ARF at an early stage.
6 . Evaluate changes that are due to CM in an in vitro IPRK model.
7. Provide a protocol for preventing CM-ARF in high risk patients.
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Chapter 2 
Materials and Methods
2. M A TERIALS AN D M ETH O D S
2.1 Renal function parameters
To study the effects of CM on renal function different markers of renal 
impairment were evaluated. The nature of the kidney is underlined by its complex 
structure and various functions. Many of the current routine renal function tests e.g. 
plasma urea, creatinine, creatinine clearance, and electrolytes can be used as initial 
screens for renal damage. Although these renal function tests lack specificity and 
sensitivity they may provide valuable information on renal injury. In combination with 
more selective measurements such as urinary enzymes (of specific tubular segment 
origin) and the separation of urinary proteins according to MW (SDS-PAGE) it is 
possible to gain further insight into the severity, location and possible mechanisms of the 
lesion. Having established a substance has renal effect it is necessary to introduce more 
selective methods to assess the site, degree and even the cause of renal injury. The range 
of non-invasive parameters available for screening renal damage is extensive but few are 
sufficiently region-specific and sensitive. It was shown that the pattern of protein and 
enzyme excretion quantitatively and qualitatively varied with the site and severity of renal 
damage, and it was suggested that both enzymes and proteins have the potential to detect 
subtle changes of tubular function if reliable assay could be used (Jung et al, 1993). 
Stonard et al, (1987) have illustrated examples of site specific acute renal lesions which 
were produced with hexachloro-l-3-butadiene that in the proximal tubule, puromycin in 
the glomerulus and papillary necrosis with 2-bromoethanamine. Both selective urinary 
enzymes and MW pattern of urinary proteins had been used to provide diagnostic 
information about the possible site of renal damage.
Urine is the major body fluid for non-invasive investigation of renal injury. Daily 
collection of urine samples allows the onset and recovery from a renal lesion to be 
followed and to identify critical sampling time in order that any transient effects are not 
overlooked.
The appearance of abnormal quantities of protein in urine is often the first 
indication of renal injury. Measuring proteinuria is commonly used in the diagnosis.
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assessment and prognosis of glomerular diseases. While measuring total protein in urine 
may provide evidence of nephrotoxicity it often fails to indicate the site of renal injury. It 
has been shown that primary tubular disorders can be discriminated from glomerular 
injury by the ratio of high to low molecular weight proteins (Bernard and Lauwerys, 
1991). The application of molecular weight separation methods to urinary proteins of 
anim al species has yet to be established as a quantitative and qualitative method for renal 
injury. One way of measuring different protein profiles is by hnmunochemical methods. 
The most widely used in clinical chemistry is the immuno-precipitation methods as Ag- 
Ab precipitating assay utilising nephlometric and turbidimetric assay. Several hum an  
plasma proteins, which are also present in urine, could be measured by these automated 
assays. However, a more sensitive immunoassays like ELISA and RID would be more 
accurate to quantify these proteins
Promising indicators of site specific damage include enzymes of renal origin 
which increase or leak into the urine when damage occurs (Price, 1982). Measurements 
of urinary enzymes have been proposed as a useful tool for the evaluation of renal 
function in vivo (for further details see 1.4.2). In. normal situations small amounts of 
enzymes can be detected in urine due to shedding of tubular epithelial ceUs. As the MW 
of urinary enzymes is above the limit for glomerular filtration these enzymes must be 
definite of tubular origin. Although many urinary enzymes have been evaluated, enzymes 
which are well characterised as markers are limited. In the present study urinary enzymes 
like ALP, NAG and GGT and the molecular weight pattern of protein excretion have 
been evaluated as indicators of CM injury.
Optimal conditions are required to achieve interpretable results from proteins and 
enzymes excretion levels. Urine constitutes are unfavourable environment which may 
interfere with the quantitative measurement of enzymes and protein excretion. Factors 
which may interfere are urine pH, presence of bacteria, low molecular weight inhibitors 
and the urine flow rate. Care should be taken with collection and storage of urine under 
cooling temperature to avoid bacterial growth and protein deactivation, removal of 
inhibitory substances by dialysis or desalting. With gel filtration (desalting) after 
collection and storage at -20°C most enzymes maintain their activities for long period 
(Mattenheimer and Burchardt, 1992).
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The rate of protein and enzyme excretion during the day is fluctuated due to 
variation in many experimental conditions, circadian rhythm, and physical activities 
(Burchardt and Jung, 1992; Jung and Maruhn, 1992). Therefore, a long duration of urine 
collection is required for accurate measurements. To reduce the variation of these 
markers due to inconsistent dilution/concentration of urine samples, adjustment to 
reference parameters is necessary to be independent of urinary flow urine. U rinary  
creatinine is the most frequently used reference value to express urine parameters 
especially enzymes (Jung and Maruhn, 1992). The urinary enzyme concentration is 
influenced by urine volume directly by the tme influence of flow rate on the excretion of 
enzymes (Jtmg and Schulze, 1986) and indirectly by the diluted urine sample. It was 
reported that when urinary parameters were expressed per urine creatinine the values 
obtained were good predictors of the 24 hours urine proteins (Rodby et al, 1995) and 
urine enzymes (Jung, 1991).
Renal function was monitored in plasma by creatinine, urea, potassium and 
sodium, and in urine by creatinine, potassium, sodium, enzymes, protein and its profiles. 
Creatinine clearance, fractional excretion and renal failure index (Na and K) in timed 
samples were evaluated from these measurements. The follow up of these markers before 
and after CM administration could evaluate these markers for the diagnosis and 
prediction of CMN.
2.2 Urine samples
Urine collection and storage were as described in detail in 3.2.3. For enzyme and 
protein assay samples were processed and assayed on same day of collection.
2.2.1 Treatment of urine for enzyme assays
Urine samples were pre-treated prior to enzyme analysis to remove low molecular 
weight substances. The process involves elution with 0.9% NaCl through a gel exclusion 
column and follows the procedure recommended by Pharmacia'^ioi desalting.
Procedures:
• Prepacked disposable Nap-5 column® (Pharmacia™) containing Sephadex® G-25 
medium.
• Remove the top cap and bottom and pour off the excess liquid.
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• Support the column over a suitable receptacle and wash the column with 3 times 10 
ml of 0.9% NaCl.
• Allow the equilibration buffer to completely enter the gel bed.
• This is the point when the column stops dripping. These columns cannot run dry as 
the gel material is covered with a plastic sinter which stops the elute flow by 
capillarity.
• Place 0.5 ml of fresh urine onto the column and allow this to soak into the bed.
• Discard the elute displaced by the urine sample
• Put a 1.5 ml Eppendorf microcentrifuge tubes for sample collection under the 
column.
• Place 1 ml of 0.9% NaCl onto the column and collect the 1 ml eluted from the 
column.
• All enzyme activity will be eluted in the first 1.0 ml (low MW substances remain on 
the column).
It is important to correct for the dilution (0.5 ml to 1 ml) in the final calculation 
of the enzyme activity.
2.3 Cobas Bio® reagents and kits
The colorimetric analysis was achieved by automated centrifugal analyser Cobas 
Bio® for its reproducibility, high number of samples measured simultaneously, and 
minimum pipetting error. Cobas Bio® (Roche™) centrifugal analyser was used to analyse 
the varying assays listed below. Parameter settings for different assays are listed in 
Appendix 1.
2.3.1 Alkaline phosphatase
ALP catalyses the hydrolysis of p-nitrophenyl phosphate to yield p-nitrophenol 
which is quantitated at 405 nm (Tietz et al, 1983). A commercial (ALP*) kit supplied by 
Boehringer Mannheim GmbH Diagnostica was used based upon the recommended IFCC 
kinetic colorimetric method. Activity for ALP is expressed in lU/L.
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2.3.2 N-acetyl-p-D-glucosaminidase (NAG)
A kinetic colorimetric assay for detection of iV-acetyl-P-D-glucosaminidase in 
urine was used (Yuen et al, 1982; 1984). The assay is based on the hydrolysis of the 
substrate 2-methoxy-4-(2’-nitrovinyl)-phenyl 2-acetamido-2-deoxy- p-D-glucopyranoside 
(MNP-GlcNAc) with the release of 2-Methoxy-4-(2 nitovinyl)-phenol and at alkaline pH 
produces a red colour that could be measured at 505nm after 5 minutes. The assay has a 
sensitivity of 15 pmol/h/l NAG.
The (PPR NAG* ) kit was supplied by PPR Diagnostics™ which also included 
three calibrants of high, medium and low standard values and quality controls. Activity 
for NAG is expressed in pmol substrate converted /hour/L.
2.3.3 y-glutamyltransferase (GGT)
GGT catalyses the hydrolysis of L-y-Glutamyl-3-carboxy-4-nitranilide to yield 5- 
amino-2-nitrobenzoate which is directly related to GGT and quantitated at 405 nm. A 
commercial (Unimate 3 GGT *) kit supplied by Roche Diagnostics™ was used for the 
measurement of GGT . Activity for GGT is expressed in lU/L.
2.3.4 Creatinine
Creatinine was measured in plasma and diluted urine (1:20) samples by the Jaffe 
colorimetric assay using the Unimate? Creatinine * kit supplied by Roche Diagnostics™.
2.3.5 Urea
Urea was measured in plasma by the enzymatic UV test, urease/GIDH method. 
Unimate 7 Urea* kit supplied by Roche Diagnostics™ was used.
2.3.6 Protein
Protein was measured by Coommassie Brilliant Blue G-250 dye binding method 
using Bio-Rad Protein assay* supplied by Bio Rad™”.The assay is based on the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts 
from 465nm to 595nm when binding to protein occurs (Bradford, 1976; Macart and 
Gerbaut, 1984). The microassay standard procedure for measuring proteins which is 
between 200-1400mg/l Bio Rad™ was modified for Cobas Bio®. The assay was 
validated for serial BSA dilution from 100-30(X) mg/L. As the standard curve
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was linear between 250-2000 mg/L, values outside this range were not considered and 
the standard curve for the automated analyser that was used with each run were between 
350-1500mg/L. Due to the possibility that the assay may display significant protein- 
protein variation, bovine serum albumin was used for the standards. Albumin constituted 
a major urine protein in animal models that were tested, although was not the case with 
young age rats. The dye binding method showed an accurate and reproducible values for 
BSA concentration as for the standard assay procedure The concentrated dye reagent was 
diluted and filtered prior to each use.
2.4 Quality control (QC)
Commercial pathological and normal sera quality control QC® supplied by Roche 
Diagnostics™ were analysed with each run, reconstituted according to manufacturer 
instructions. Assigned values were used to calibrate the Cobas Bio for creatinine and 
urea. Normal and pathological sera were used as quality control for creatinine, urea, 
ALP & GGT. All NAG QC and calibrants were supplied by PPR Diagnostics™ . For 
proteiu assay serial BSA concentrations were prepared and used. During different runs, 
values were accepted only when QC and calibrant values’ readings were within the 
confidence lim its i.e. they were within 10% of the assigned value.
2.5 Sodium and Potassium
Urinary sodium and potassium were measured by atomic absorption., (Perkin 
Elmer™ X03 ). Light source from hollow cathode lamp with slit setting of 1.4nm and 
wavelength of 589 nm for sodium and 766 nm for potassium with Air-acetylene flame 
oxidising were used. Urine samples and standards were diluted 1:1000 in 10 ml MilliQ 
water. For standard curve serial dilutions of standards were prepared from assigned 
values for Na and K concentration QC® sera supplied by Roche Diagnostics™. Sodium 
standards were between 16-512 mmol/L , while potassium standards were between 1.5- 
55mmol/L
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2.6 Renal function tests
From the plasma and urinary creatinine and electrolytes the following values were 
measured:
u. creatinine x urine, volumeCreatinine clearance (ml/min)=
p.creatinine x time(jam.)
Fractional excretion of Na (FENa)= ^ P: % 100%
u. creatinine x p. sodium
Renal failure index for Na/K (FENa/K)= p.creatinme ^
u.creatinine
2.7 Osmolarity measurements;
Osmolarity was measured with a Weascor® 5100 vapour pressure osmometer 
(sample volume 8  pi. The osmometer was calibrated with standard solutions of 290,
1000, and 100 mOsm/kg water all from Weascor® Chemical Scientific Products Ltd.
2.8 Statistical analysis
The statistics software from “Microsoft® Excel version 5.0” was used for data 
analysis. Means, standard deviations, standard error means were calculated from the 
software. Comparison between control and treatment groups was carried out by analysis 
of variance, student T-Test (two tails) was used to get the P value. Differences were 
considered significant when P<0.05.
2.9 Separation of urinary proteins by SDS-PAGE with PhastSystem®:
The PhastSystem electrophoresis for separation and development was used for 
identifying urine protein MW profiles. The system is micro-processor driven so that 
running conditions could be programmed for reproducibility. Optimised methods for 
sodium dodecyl sulphate polyacrylamide gel electrophoresis SDS-PAGE (Laemmli, 1970) 
and the corresponding staining protocols were followed according to Pharmacia™fûts. A 
modified method, of rat urine separation described by Packwood et al, (1994), for SDS- 
PAGE separation and double staining with Coomassie and silver techniques was applied.
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2.9.1 Materials
All molecular weight (MW) markers, precast gels, buffers strips, sample 
applicators, Coomassie and, silver staining kits were supplied from Pharmacia™.
2.9.1. a) HMW and LMW standard markers
The protein mixture of high MW (HMW) calibration vial consists of; 
Thyroglobulin 330 KDa, Ferritin 220 KDa, Albumin 67 KDa, Catalase 60 KDa, Lactate 
Dehydrogenase 36 KDa, and Ferritin 18.5 Kda.
The protein mixture for low MW (LMW) calibration vial consists of: 
Phosphorylasep 94 KDa, Albumin 67 KDa, Ovalbumin 43 KDa, Carbonic Anhydrase 
30KDa, Trypsin Inhibitor 20.1 KDa, and a-lactalbumin 14.4 KDa
2.9.1. b) Precast PhastGels
i) Gradient gels
Gradient gels that posses 13 mm stacking gel (4.5%T, 3%C) and 32 mm 
continues 8-25% polyacrylamide gradient gel zone (2% cross linking) with protein 
separation in the range of 6-300 Kda were used. The instructions of PhastSystem® 
Separation Technique File No 110 were followed.
ii) Homogenous 12.5 gels
Homogenous gels that posses a 13 mm stacking gel zone (6 %T, 3%C) and
separation gel zone (32 mm) of uniform PA (12.5 %) with 2% cross linking and protein 
separation in the range 15-250 Kda were used. The instructions of PhastSystem® 
Separation Technique File No 111 were followed.
2.9.1. c) PhastGel SDS Buffer Strips
Buffer strips consisting of 2% agarose 0.2M tricine(trailing ion), 0.2M Tris and
0.55% SDS pH 7.5 functioned as buffer reservoirs to generate a discontinuous buffer 
system in the gels during electrophoresis.
2.9.1.d) Sample applicator
Urine samples and MW markers were loaded onto a PhastGel sample applicator 
using either 8/1 ( 8  samples of Ipl each) or 6/4 ( 6  samples of 4pl each)
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2.9.1. e) Staining Materials
• PhastGel Blue R® Pharmacia™ Coomassie dye, a triphenylamine anionic dye. 
(Neuhoff et al, 1985)
• PhastGel Silver Kit® P/zûTTTzadû™
• Müli-Q water®,
• Trichloracetic acid (BDH), 96%, Ethanol (BDH), Acetic acid (BDH), Tris-HCl 
(Sigma), Methanol(BDH), Glycerol (BDH).
2.9.2 Urine separation by PhastSystem
Procedures for urine separation by PhastSystem * gels were carried as follows:
• Measure urine protein concentrations
• Dilute samples with distilled water if necessary so that concentration should not 
exceed 1  g/1  protein (as the case with renal damage), otherwise sample will distort 
results and overload the gel.
• Centrifuge for 15,000 x g for 10 min
• Transfer 50 pi of urine samples to microtubes.
• Add equal volume of sample buffer (which contains: 0.125M Tris-HCl pH 6 .8 , 4% 
SDS, 20% glycerol, 10% 2-mercaptoethanol).
• Add 5 pi tracking dye (1% bromophenol blue BPB in 50% glycerin/Tris buffer).
• Vortex and heat the treated aliquot for 5 minutes in a boiling water bath.
• Centrifuge for 15,000 x g for 10 min.
• Apply samples using the sample comb.
• Separate using PhastGels following the instructions by Pharmacia™fûts and manual.
• HMW and LMW calibration vials were treated like the urine samples by adding 50 
pi of DW instead of urine and stored in aliquot at -20° C.
• Urine samples were separated first by gradient gels to obtain an overview of the MW 
of urine components then separated by 12.5% homogenous gel.
2.9.3 Gel staining by Coomassie and silver stains
2.9.3. a) Coomassie blue stain
PhastSystem development techniques were followed. File No. 200 for Coomassie
and File No. 210 for silver staining and as stated below:
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• The gels were stained with 0.1 % solution Coomassie blue in 30% methanol and 10% 
acetic acid for 1 0  minutes.
• Excess Coomassie was washed out (destained) with 30% methanol and 10% acetic 
acid in distilled water for three times.
• Before running the preserving step the development method was paused and the
developing gels were inspected.
• If the bands were faint; the gels were washed twice outside the development chamber 
for 4 minutes in distilled water before start the silver staining.
• If protein bands were not faint the preserving step was carried out with 10%
glycerol.
2  P. 5. b) Silver staining method
Silver staining for protein was carried out for better protein bands resolution 
(Heukeshoven and Demick, 1985). Following instruction of PhastSystem™ Silver Kit® 
(File No 210). This complex procedure involved fixing and removal of buffer ions, fixing
and sensitising the protein in glutaraldehyhe solution, reaction with silver ions in a silver
nitrate solution, developing in formaldehyde and stopping the development in acetic acid.
2  P. 3. c) Scanning o f the developed gels
The gels after staining were scanned with Shimadzu™ CS-9001PC flying spot 
scanner.
2.10 ELISA method for rat albumin and transferrin
The two proteins were assayed by an “Enzyme Linked Immunosorbent Assay” 
using a modification of three methods (Lucertini et al, 1984; Magnotti et al, 1989; Dunn 
etal, 1991).
2.10.1 Materials
• Washing buffer
To 0.8L of DW add 50 mmol of diethylmalonic acid ( 8  g), 150 mmol of NaCl 
(9g), 1 mmol of EDTA (0.37g), 1 ml of Tween 20. Adjust pH to 7.4 with Imol/L KOH 
and make up to IL . Lastly sprinkle 2 g gelatine and dissolve with gentle stirring at 37°C.
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The clear solution may be stored at 25°C for 2 weeks. If it becomes turbid clarify the 
solution by warming it at 37°C or leave it at room temperature for few hours before use.
• Antibodies
Dilute the Goat anti-rat albumin peroxidase Ig conjugate to HRP (GARa/Alb/PO® 
was from Nordic™) and Goat anti-transferrin peroxidase Ig (PP070® was from The 
Binding site Ltd) by diluting the antibody 1:1000 in the washing buffer 20pl in 20ml 
which is enough for one plate (always prepare the antibody solution fresh).
• 0. IM Carbonate/Bicarbonate buffer
Dissolve 1.59g Na2C0 3  and 2.93 NaHCOs in DW, and make up to 1 L with D.W 
and check pH 9.6. Store at 4°C for up 2 months.
• Stock protein solution (Rat albumin / transferrin)
Dissolve pure protein (rat albumin® / rat transferrin ® ) both supplied by Sigma™ 
at conc. of 1 mg/ml in 0.1 M sodium bicarbonate (coating buffer) that is the stock 
solution and aliquot it into 1ml tubes.
• Protein coating buffer
Prepare 1000 pg/l of albumin or transferrin, by taking 20jil from the protein stock 
( 1  mg/ml) add it to 2 0 ml of the coating buffer .i.e. dilute 1 : 1 0 0 0
• Standards
Place 500 pi of the washing buffer in 10 small glass test tubes. Add 500 pi of the 
STD albiirnin/transferrin to the appropriately labelled test tubes. Make a series of 
albumin/ transferrin standards in the range : 1000, 500 ,250, 125 ,62, 31, 15.5, 7.8, 3.9,
1.8 , 0.9 ug/ml The standard curve was linear between 31 -250 ug/1.
• Substrate
Prepare the substrate by dissolving one tablet of TMB from Sigma™ (each 
containing 1 mg TMB) in 5ml deionised water. Add 5 ml of O.IM citrate-phosphate 
buffer and 6  pi of 30% H2O2
• 0.1 M Citrate-Phosphate buffer
Mix 25.7 ml of 0.2M dibasic sodium phosphate and 24.3 ml of O.IM citric acid 
Adjust pH to 5.
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2.10.2 Equipment
ELISA plate reader Multiskan® Ms with PC to control microplate reader and
window based software (Genesis-2 ®) all from Life science international
2.10.3 ELISA assay procedure
The assay procedure was carried out as follows:
First day
• Coat the 96 well Nunc immunoplate (do not use peripheral wells) with lOOpl/well of 
the coating protein solution. Seal it with polyethylene sheet and store it overnight at 
4°C
Second day
• Thoroughly remove the coating solution by emptying into a beaker and shake of 
excess and press onto tissues
• Wash the plate 4 times with 150 pl/well of the washing buffer and shake of excess 
and press onto tissues after each wash to dry thoroughly.
• Place 50 pl/well of STD in duplicate starting with the higher standard to the lower.
• To next lane add 50 pi of the unknowns in duplicate.
• Prepare and add 50 pl/well of the diluted antibody to all wells
• Rap with polyethylene sheet and store overnight at 4°C
Third day
• Tip the plates thoroughly to remove the all the solution by emptying into a beaker 
then shake off excess and press dry onto tissue.
• Wash the plate at least 5 times with successive 150 pl/well of the washing buffer and 
shake of excess and press onto tissues after each wash.
• Add 100 pl/well of the substrate to each well.
• Leave for exactly 10 min and shake continuously
• Add 25 pl/well of 2M H2SO4  and shake continuously for 30 min
• Read the plates at 450nm using plate reader.
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The unknown concentrations will be calculated from the standard curve (Fig 2.1) that 
will be plotted from the serial standard concentrations by the software of the plate 
reader.
Fig 2.1 Albumin standard curve using Nordic 
albumin Antibodies
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2.11 Isolation of a^-microglobulin:
Pooled WA rat urine samples (80  ml) were collected for 3 days from 5 female rats 
with induced tubular damage (uranyl acetate). After centrifugation at 1 5 ,0 0 0  RPM for 10  
min. samples were concentrated and desalted using 6 Centriprep 10* (Amicon™) columns 
with a lOKDa MW membrane cut off. A volume of 15 ml of the pooled urine /each 
column was span for 30 0 0  Xg at 25°C; first spin for 4 0  m in ., second spin for 2 0  min, 
and third spin for 15 m in after each spin decant the filtrate and re-spin. The pooled 
concentrated samples collected from each column were separated by the chromatographic 
method and as described below.
2.11.1 Chromatographic techniques
Gel Chromatography was used for separation of the concentrated rat urine 
(Akerstom and Landin, 1985). Sephadex G-lOO superfine was eluted with a buffer 
containing 2 0  mM Tris/HCl pH 8, 0 .1 5  NaCl and few crystals of cholrobutol at a flow
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rate of Iml/min. The fraction separation was standardised after eluting a mixture of MW 
protein markers of Dextran 200KDa, Bovine albumin 67KDa, ovalbumin 43 KDa, 
cytochrome-C 18KDa. Collected fractions were monitored continuously at 280nm 
(protein absorbency). Collected elute fractions corresponding to the 30kDa MW region 
were pooled and concentrated by Centriprep 10 as above.
Concanavalin A-Sepharose® from Pharmacia Biotech was used for the separation 
of the urine protein sub-fraction by affinity Chromatography. 1 ml of desalted 
concentrated fraction was applied to the column and eluted with a buffer which consisted 
of 50mM Tris/HCl pH7.7 IM NaCl, ImM of CaCl2 , MgCl% and MnCl2 (Con A-buffer) 
with or without 0.1 M a-methyl D-glucoside for affinity separation.
To quantify urinary rat ai-microglobulin a single radial immunodiffusion 
technique was used. As there was no commercial anti rat aj-microglobulin antibodies a 
Radial immunodiffusion kit from (NANORID®-The Binding site™ Ltd) was used. The kit 
consist of agar with three ai-microglobulin standards , calibrants and human a^- 
microglobulin-NL® antibodies (RID). The kit is for quantitative measurements of urinary 
proteins.
2.12 Immunodetection of Heat Shock Proteins
Selected urine samples were immunodetected for anti HSP-27 antibodies.
2.12.1 Preparation of HSR standards
• Weigh and freeze 0.6 g of minced rat cardiac and skeletal muscles in liquid nitrogen 
for 30 minutes.
• Crash the solid freezed tissue using Mikro Dismembrator® from Braun™ to grind it 
and make it as powder.
• Add 6  ml of 1 mM EGTA buffer to the yielded powder vortex thoroughly.
• Centrifuge at 14 000 RPM for 30 minutes and collect the supernatant.
• Take the cardiac and skeletal homogenate aliquots and selected urine samples and 
prepare 1 : 1 0  and 1 : 1 0 0  dilution.
2.12.2 Antibodies
Antibodies that were used for the assay were as follows:
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1. Primary antibodies; two sources of rabbit anti rat HSP-27 antibodies (Zantema and 
Gaestels) were used, they were gift from Dr R. King, School o f Biological Sciences. 
Antibodies dilutions were 1:1000 (PBS/0.05 % Tween).
2. Secondary antibody that were used were from Dako™ anti rabbit HRP dilution 1:1000 
(PBS/0.05% Tween).
2.12.3 Dot blot
Dot blot preparation was carried out as follows:
• Cut the nitro-cellulose membrane sufficient to the required dots that will be used.
• Soak the nitro-cellulose membrane in methanol.
• Prepare the dot blot manifold as in the instruction manual: Lower piece, 2 pieces of 
filter paper, Nitro-cellulose membrane. Upper piece (with the holes). Clamp both 
upper and lower pieces with the different layers of papers and membrane in between.
• Add the aliquot in duplicate not more than 50-70 pi of the different antigen solutions 
(from rat cardiac and skeletal muscle homogenates) with serial dilution to each well of 
dot blot manifold.
• Apply vacuum suction and leave it to dry properly.
• Cut the nitro-cellulose membrane into 2 pieces
• The membranes were immunodetected for the affinity of the two types (sources) of 
HSP-27 antibodies to the rat cardiac and skeletal muscle antigen by ECL® from 
Amersham™ and as described below.
2.12.4 SDS gel electrophoresis for separation of urine proteins 
SDS-PAGE procedures were carried out according to the method of Laemmli,
(1970) and as follows:
• Mix the following reagents for a 12% gel: 12 ml of 30% acrylamide/0.8% bis,
11.2ml of IM Tris pH 8 .8 , 150 pi 20% SDS, 6.7 ml D.W, 100 ul 10% ammonium 
persulphate, 20pl TEMED
• For stacking gel add 1.67 ml of 30% acrylamide/0.8% bis, 1.25ml IM Tris pH 6 .8 , 
50 ml 20% SDS, 7 ml D.W, 50 ml 10% Ammonium persulphate, lOpl TEMED
• Always add Ammonium persulphate and TEMED just before pouring the gels.
• By swirling or inverting gently, pipette solution gently so that it descends along the 
spacer gently layer about 1 cm of water, allow to get polymerise for 30-60 min.
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• Running Electrophoresis buffer
3 g Tris, 14.4 g glycine, 1 g SDS add DW to 1 litter.
• Sample preparation
Mix 100 pi of urine aliquot with 100 pi sample buffer (125mM Tris-HCl pH 6 .8 ,
4% SDS, 20% glycerol) then add 5 pi of BPB (5 ml of 1 % BPB in 50% glycerol ) with
and without 20 pi of Im DTT as a reducing agent. Boil for 5 min at lOOC. Centrifuge for
5 min at 3g
• Use Rainbow® LMW standards from Amersham for gels that will be transferred for 
western blot, as the success of the transfer could be visualised.
Prepare and assemble the electrophoresis apparatus as described in the manual and as 
follows:
• Assemble the gel in the casting apparatus as described in the instruction manual.
• Required volume of sample 8-32 pi maximum 70 pi that will be applied onto the gel
• Apply samples and top them with sample buffer.
• Transfer the plates into the running electrophoresis bath ,add running buffer to the 
sink, and apply grease on top ends and screw the black screws.
• Cover the top of the tank and pour the rest of the buffer slowly.
• Run electrophoresis use 20mA at the start for 15 min. Then increase to 25 MA Run
for 2-3 hours until the tracking dye reaches the ends.
• Take out of the tank for the western blot.
2.12.5 Western Blot
The western blot procedure were carried out according to the method described by
(Towbin & Gordon, 1984).
• Transfer buffer prepared by adding 9g Tris , 43.35 g Glycine, 15 ml 20% SDS, 600 
ml methanol. Made up to 3 L with DW. Before adding SDS degas the buffer 
extensively prior to use.
• Soak the nitro-cellulose membrane, 4 filter papers, and the Scotchbrite sponges in the
transfer buffer.
• Remove the gel and soak in transfer buffer for 30 min.
• Place gel into transfer cassette and as described in the instruction manual with this 
sequence; White side- Scotchbrite- 2 Filter papers- Nitro-cellulose- Gel- 2 filter 
papers- Scotchbrite- Black side
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Transfer overnight at 20 volts in cold room.
2.12.6 ECL immunodetection:
Immunodetection for both dot and western blots of the nitro-cellulose membranes was 
carried as follows:
Cut the membrane into 2 pieces and transfer to petri dish. At no stage touch the 
membrane with bare fingers
Block the background binding by adding 10 ml of 5% skimmed milk leave to shake 
for one hour at room temperature.
Transfer to hybrid rolling tubes
Wash 4 times with washing buffer (PBS 4- 0.05% Tween) for 25 min
Add the primary antibody diluted 1: 1000 in the washing buffer (3 pi in 3 ml) for one
hour at room temperature.
Wash 4 times with washing buffer for 25 min.
Add the secondary antibody diluted 1: 1000 in the washing buffer (3 pi in 3 ml) for 
one hour at room temperature.
Wash 4 times with washing buffer for 25 min 
Transfer to a petri dish
Detect by ECL® from Amersham™ (prepare ECL according to instructions provided) 
Wrap with polyethylene sheets and transfer to an x-ray cassette with an x-ray film 
leave for optimal exposure time 10-60 seconds.
Develop the film by the automatic X-ray fihn developer.
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CHAPTER 3
EXPERIMENTAL MODELS AND 
MARKERS OF CM-INDUCED
RENAL FAILURE
3. EX PERIM EN TA L M O D ELS AND M A R K ER S O F  CM - 
IND UCED REN A L FAILURE
3.1 INTRODUCTION
The most concerning factor of CM-ARF is that despite much work with animal 
models and human studies the underlying mechanism is still not understood. A review of 
the various animal models was unable to identify a reliable and reproducible animal 
model for studying CM-ARF nor the pathophysiological mechanism (for further details 
see 1.5). Also it is not clear if such models constitute CM-ARF or only confirm well 
established transient effects. Most of these reported CM effects were without any toxic 
manifestations, as there were no indications of any renal dysfunction. Induction of renal 
damage by glycerol, gentamicin, adriamycin, cyclosporin A, cisplastin or indomethacin 
prior to CM produced some minor changes in transient protein and enzymuria but no 
significant or persistent increase in serum creatinine after CM treatment (Thomsen et al, 
1993). Multiple insults including low sodium intake, uninephrectomy, frasemide and 
indomethacin were reported to produce reliable animal models of CM-ARF (Vari et al, 
1988; Heyman et al, 1988). These models do not appear to have been utilised by other 
workers for CM-ARF mechanistic studies indicating that they may not be readily 
reproduced by other laboratories (Deray et al, 1990; Thomsen et al, 1990). The use of 
indomethacin that suppress prostaglandin synthesis was necessary to obtain an acute renal 
failure as it decreased GFR. However, NSAID have many other physiological actions on 
cAMP, competition with aldosterone for mineralocorticoid receptors, reduction of 
angiotensin II binding to adrenal cells and inhibition of calcium transport (Dunn and 
Zamraski, 1980) which should make careful interpretation in prostaglandin physiological 
actions. After introducing different single and multiple insults particularly those of 
unilateral nephrectomy, low salt diet, indomethacin, renal artery occlusion, frusemide, 
or/and aortic clamp Deray et al, (1990) showed reversible reduction of renal function 
only when diatrizoate was injected intrarterially in a renal ischaemia model. However, 
LOCM showed no significant reduction in renal function in this ischaemic model which 
was induced by three minutes aortic clamp above the renal artery with unilateral
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artery with unilateral nephrectomy. Further development in Deray’s model was reported 
by Idee et al,(X995) by adding gentamicin-induced degenerative insult to the ischaemic 
insults. However, it was only with diatrizoate that there was significant reduction in renal 
function. These ischaemic models were unable to explain CM-ARF induced by other CM 
especially LOCM. Furthermore, to conduct such multiple insults models it is important to 
include sufficient control groups without one or more of the insults to validate any CM- 
induced reduction in renal function. Each insult of the multiple renal insults has its own 
evolving renal damage that could change during the experiment which by itself could lead 
to contradicting results. It is also necessary to include statistically sufficient number of 
animals in these multiple insults models to achieve a significant comparison.
Furthermore, the multiple insult models cannot identify the predisposing mechanism that 
lead to CM-ARF, as they include multiple and different sites of insults.
In this study various single insult models of renal impairment were considered for 
their relevance to induce CM-ARF. Of the models that were studied were those of old 
age, nephrectomy and tubular necrosis models. As old age is one of the main risk factors 
in CM-ARF (Rich and Crecelius, 1990), old age rat nephropathy model may represent an 
appropriate animal model. Old age nephropathy is characterised by enlarged glomeruli 
with mesangial deposition of matrix, progressive thickening of basement membrane of 
the glomerulus (GBM) and of the proximal tubules. Other features like atrophied tubular 
epithelia leading to tubular collapse or dilatation with hyaline eosinophilic casts of protein 
within their lumen, interstitial fibrosis and leukocyte infiltration are also common. Old 
age nephropathy might be related to compensatory changes in renal haemodynamics, 
when some glomeruli are irreversibly damaged while others undergo adaptive 
hypertrophy and may in turn become damaged (Anderson and Brenner, 1986; Goldstein 
etal, 1988).
Furthermore, ageing in rats with intact kidneys is associated with changes in 
glomerular permselectivity to macromolecules. This results in proteinurea and 
progressive glomerular sclerosis which subsequently leads to renal insufficiency 
(Anderson and Brenner, 1986). It is suggested proteinuria may trigger an interstitial 
inflammatory reaction which might contribute to renal disease progression (Remuzzi 
1995, Eddy 1989). A further problem with proteinuria may be devoted to the filtrate
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trasnferrin levels which in the case of acidic media may lead to release free iron which is 
known to be toxic to tubular cells (Alfrey et al, 1989).
Apart from ageing, focal glomerulosclerosis in rats may occur spontaneously 
especially in the Fawn Hooded rat (Kreisberg and Kamovsky, 1978). It appears that this 
rat strain develop spontaneous hypertension and may serve as a model of chronic renal 
failure in which the kidney is the main target organ for the high blood pressure 
(Provoost, 1994). To validate whether there is species susceptibility to develop CM-ARF, 
it was necessary to study a model of Fawn Hooded rat with its inherit susceptibility to 
develop glomeruloscelrosis.
As reviewed before {see 1.3.2) several workers have reported the direct effects of 
CM on tubular epithelia in vivo and in vitro. However, it is more important to identify 
whether these direct cellular effects are harmful and can lead to cellular necrosis. Uranyl 
salt is one of the tubulotoxin that has been widely used for experimental nephrotoxic 
models with tubular necrosis. The most pronounced change, resulting from uranyl salts 
administration is acute tubular necrosis affecting the S3 segment of the proximal tubule 
(Haley, 1982; Anthony et al, 1994a). Functional changes induced by UrAc include 
decrease of GFR, and RBF (Flamenbaum et al, 1974), increase of plasma urea and 
creatinine (Anthony et al, 1994a) together with diuresis. However, low uranyl salts doses 
induced transient nephrotoxicity with fairly rapid regeneration of epithelial cells after 
uranyl chemical injury (Leggett, 1989).
The best studied model of chronic renal failure involves the reduction of renal 
mass (Strauch and Gretz, 1988). Renal ablation (removal of more than 70% of the 
kidney) results in glomerular pathology like glomerular sclerosis, expansion of mesangial 
matrix, and at a later stage there is mbular atrophy, interstitial infiltration and fibrosis 
(Waldher and Gretz, 1988) similar to that observed with old age nephropathy. Four 
stages of 5/6 ablation, had been identified: after a transient acute renal failure, 
improvement of renal function occurs, leading to chronic stable renal insufficiency, and 
lastly deterioration of renal function leading to end-stage renal disease. The functional 
hypertrophy is completed within 5-6 weeks but the rapidity of stages is largely dependant 
on the extension of renal ablation nephrectomy (Kleinknecht et al, 1988). This model 
resembles human CRF more closely than any other model and is used as a uraemic 
model. But since renal ablation may induce anorexia and variation in energy intake food
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consumption is a factor that could interfere with the interpretation of results in this 
model.
Dehydration is commonly used in imaging procedures before CM studies in order 
to intensify CM concentration in renal tubules (Cattell et al, 1967). Despite the fact that 
fluid restriction is a well known risk factors for CM-induced ARF (Dundzimki et al, 
1971), dehydration is still practised to prepare patients for angiography. Therefore, 
models of dehydration and intravascular depletion were utilised as an added risk to 
increase the work load on the kidney and to concentrate the urine.
High resolution ^H NMR spectroscopy has been shown to be an effective 
technique in biochemical toxicology studies especially in nephrotoxicity, particularly 
when combined with complementary enzyme and histopathological assessments 
(Nicholson and Wilson, 1989; Anthony et al, 1994a;b). NMR enables the measurements 
of a wide range of biologically important low molecular weight endogenous metabolites, 
which represent a range of biochemical processes. Examination of ^H NMR spectra of 
urine with toxin-induced metabolic disorders has indicated that much of the information 
necessary to classify and biochemically assess experimental toxicity state is conveyed in 
the overall pattern of the metabolic resonances (Nicholson and Wilson, 1989). Many of 
the biochemical markers necessary to classify both the site and the severity of damage 
induced in vivo by a variety of nephrotoxic drugs and chemicals have been shown in the 
urinary excretion pattern of these endogenous metabolites. By a computer-based pattern 
recognition with a data base the types of endogenous metabolites derived from NMR 
spectra of urine could determine the site of nephrotoxicity. Metabolites released into 
urine after exposure to tubule toxins appear markedly different from those released after 
medullary toxins (Anthony et al, 1996).
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3.2 Experimental design
Unless stated otherwise the experimental design for the different models was as follows:
3.2.1 Animals
Animals were male (Wistar albino) rats obtained from University of Surrey 
breeding unit, unless stated otherwise in the experimental protocol. They were matched 
for age (approximately 8  weeks) and weight (250g ± 50). After acclimatisation they were 
randomly allocated to each group.
3.2.1. a) Housing
Animals were kept under standard conditions of temperature 20°C ± 3, humidity 
50% ± 10, and light 0700-1900 hours throughout the experiment. For urine collection 
they were transferred to metabolic cages.
3.2.1.b) Food and water
Pelleted Rodent Diet no.l Standard Maintenance Diet (SDS Ltd, Witham, Essex) 
and tap water were given ad libitum.
3.2.2 Contrast media administration
Contrast media and normal saline were injected i.v. via the tail vein at a rate of 1 
ml/min. Animals were restrained for i.v. dosing. Unless stated otherwise, CM were 
administered i.v. at a dose of 3.25 g I/kg while the control subgroups received an 
equivalent volume of saline. The contrast media that were used were:
• ionic monomer, iothalamate 325 mg I/ml (Conray® , May & Baker™),
• non-ionic dimers, iodixanol 320mg I /ml (Visipaque® from Nycomed Imaging™) and 
iotrolan 325 mg I/kg (Isovist® from Schering™) ,
• non-ionic monomer, iohexol 350 mg I /ml (Omnipaque® from Nycomed Imaging™)
• ionic dimer, ioxaglate 320mg I /ml (Hexabrix® from Guerbet^.
67
3.2.3 Sample collection
Unless stated otherwise, blood and urine samples were collected as follows:
3.2.3. a) Time o f collection
Blood and urine samples were collected from control and treated anim al groups at
various time points:
1. Before the start of any induced damage; these are the “baseline control levels” that are 
collected from hydrated animals (HD).
2. After the induction of nephropathy models samples were collected before the start of 
dehydration. This is the hydrated pathological sample to illustrate the degree of 
induced renal impairment (HDP). These samples were not collected from the control 
and old age models
3. Before intravenous dosing and after dehydration (DH) water was withdrawn for 16 
hours (overnight) from all animals. Next day they were transferred to metabolic cages 
for 3 hours urine collection. Animals were given water directly after i.v. dosing 
except in the “low tubulotoxic uranyl acetate dose with dehydration model (UrAc 
group C )” as dehydration was continued 3 hours after dosing.
4. After i.v. injection of CM animals were left in the metabolic cages for 3-6 h urine 
collection (according to different experimental protocol) and only urine samples were 
collected.
5. Animals were left in metabolic cages for overnight urine collection which represents 
the first overnight urine sample. After 24 hours from the i.v. dosing, blood was 
aspirated from all animals (the first 24 hour blood sample) before they were 
transferred to their normal cages. Subsequent collections of overnight urine and blood 
aspiration were repeated after 48, 72 and 96 hours after i.v. dosing of CM/saline 
(according to different experiments).
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3.2.3.b) Urine sample
Urine samples were collected from animals placed in metabolic cages. Special in- 
house made urine collector designed to minimise the degree of mixing with stool and 
allow frequent sampling and collection under ice were used. For the overnight urine 
collection animals were left for 16-20 hours in the metabolic cages according to the 
experimental protocol, next day they were transferred into their normal cages until they 
were returned back to metabolic cages for the subsequent overnight urine collection.
Urine samples were centrifuged at 15 GOOg for 10 min, desalted (further details in
2.3.1) and stored at -25°C. They were assayed subsequently in batches.
3.2.3. c) Blood samples
Blood was collected either by cutting the tip of the tail or by tail vein canulation. 
Blood drops were aspirated by capillary pressure into Microvette CB300Llf lithium 
heparin microtubes (maximum volume 300 pi) from &4R57EDT™ Germany .
Blood in microtubes was centrifuged at 3000g for 10 min. Plasma was retained 
and diluted with the appropriate amount of saline for different assays.
3.3 Animal groups with various renal conditions
3.3.1 Control animals (normal renal function)
Animals with no induced renal pathology. All animals in this group were dehydrated for 
overnight (16 hours) before i.v. dosing
3.3.1.a) Control WA rat group (Control group A)
CM were administered to normal animals without any pre-treatment that would 
compromise renal function. Twenty rats were divided into 4 control subgroups for i.v. 
dosing of saline, iohexol, iodixanol, and iothalamate . This group is referred to as 
control. In some cases experimental groups had their own control subgroups.
3.3.1.b) Intravascular depletion (Control group B)
Fifteen animals were subjected to extracellular fluid depletion by daily collection of 
1 ml blood and daily dehydration for 8  hours from 9am till 5pm for 2 days before and 2 
days after either saline, iothalamate or iodixanol were injected.
69
3.3.1.C) Control Fawn Hooded rats (different strain) (Control group C)
Ten Fawn Hooded rats, weight 250g, age 12 weeks, were divided into 2 
subgroups. This strain was chosen as it was reported to be more susceptible to 
spontaneous glomerulonephritis (Provoost, 1993). Saline, and iothalamate were i.v. 
injected after overnight dehydration.
3.3.2 Old Age models
WA male rats aged between 14-18 months were matched for weight and age 
before they were allocated into different subgroups. Animals were subjected to 16 hours 
dehydration before dosing unless stated otherwise.
3.3.2. a) Old Age with indomethacin and salt free diet (Old age Group A)
Ten old age (12 months) rats with mild renal impairment were chosen for this 
group. Animals were fed salt free rice for one week before the i.v. dosing. One hour 
before administration of saline, or iothalamate 2 0  mg/kg of indomethacin solution was 
i.v. injected. All animals were dehydrated for overnight (16 hours).
3.3.2.b) Old Age (more than 16 months age) and acidic urine model (Old age
Group B)
Fifteen rats age 16 months average weight between 650-900g. Ten of these rats 
were given drinking water which contained 1.5% NH4CI (0.28 M) for 7 days to produce 
acidic urine, urine pH was reduced to 6 , before they were divided into 2 subgroups for 
saline and iothalamate injection. Another subgroup of 5 rats were left to drink tap water 
and received iothalamate. All animals were dehydrated for 16 hours before CM injection.
3.3.2.C) Old Age (12 months age) with acidic urine (Old age Group C)
Sixteen rats age 12 months were given acidic drinking water as above (3.3.2.B). 
Animals were divided into 2 groups. One group (Group 3.3.2 C.i) was subjected to 
dehydration for 16 hours while the other (Group 3.3.2 C.ii) was not dehydrated. Both 
groups were divided into 2  subgroups for either saline or iothalamate administration.
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3.3.2.d) Old age with severe renal impairment (Old age Group D)
Twenty six rats age 16-18 months average weight between 650-900g were 
assessed and matched for their weight and age before they were divided into two 
subgroups of:
i) renal impairment model with matched weight (Old age Group Di)
Sixteen rats with mild renal impairment were matched only for their weights and 
divided into 4 subgroups for i.v. dosing of saline, iohexol, iodixanol, and iothalamate 
after 16 hours dehydration.
ii) renal impairment model with matched renal function (Old age Group D ii)
Ten rats were matched for their renal function and were divided into 2 subgroups 
for i.v. dosing of saline and iothalamate after overnight dehydration.
SALT FREE+INDOMETEÎACIN A
AGE MORE THAN 16M B 
OLD AGE REDUŒ URINE pH DEHYDRATION Ci
AGE 12 M X  X]
\  X
.HYDRATION Cii
WEIGHT Di
MATCHED FOR
RENAL FUNCTION Dii
Diagram 3-1 Development scheme of old age models (3.3.2). 
Groups letters and numbers as stated In the text headings
3.3.3 5/6 Nephrectomy model
Sixty male (WA ) rats, weight 150-170g were matched for age and weight.
3.3.3. a) Operative procedures
Animals were anaesthetised with halothane and under aseptic control the left 
kidney was exposed through a midline laparotomy. The capsule of the kidney was 
removed and the renal artery was clamped with a neurosurgical clip to m inim ise blood 
loss, 2/3 of the left kidney was removed by cutting both poles and the outer curvature of
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the cortex was then excised. The renal remnant was then covered by peritoneum and 
homeostasis was achieved by digital pressure following removal of the clip. The renal 
artery remained clamped for the shortest time possible.
The abdomen was closed in two layers with 410 Dexon and Michel® clips.
A nim als were allowed to recover with s.c. injection of 1 ml saline containing 0.05 ml 
buprenorphine 300 pg/ml /lOO g body weight, given for post operative pain relief.
Sham operation involved exposure of the left kidney and clamping of the hilus 
(artery and vein) and applying digital pressure to the kidney before closing the abdomen 
wrapping in peritoneum (as above).
Exactly one week after the first surgical procedure the right kidney was removed, 
by anaesthetising the animal and the right kidney was exposed by a loin incision. The 
renal vessels were ligated with 4/0 silk and the right kidney was removed. The abdomen 
was again closed in 2 layers and buprenophrine given on recovery as above (Sham 
operation involved exposure of the right kidney only).
3.3.3.b) Nephrectomy follow up
Following the first nephrectomy sham operated animals were housed individually 
and daily fed the average food intake quantity as those having undergone nephrectomy. 
After the renal function was stabilised 4 weeks from the last operation, animals were 
paired in first group (triplet in second groups) for level of renal function (depending on 
creatinine clearance and protein excretion) a 2 0 % difference were accepted as matched 
subgroups. A minimum number of 6  animals were chosen for each subgroup.
The first group of 5/6 nephrectomised animals were divided into two subgroups 
for i.v. saline and iothalamate , beside the third sham subgroup which received saline.
The second group of 5/6 nephrectomy was divided into 3 subgroups for i.v. 
saline, iothalamate and iodixanol. The dosing procedures for the second group was 
repeated 5 days later urine and plasma samples were collected before every i.v. dosing 
The sham operated an im als received only saline.
3.3.4 Induction of renal failure by uranyl acetate
Tubular necrosis was induced by s.c. injection of different doses of uranyl acetate 
(UrAc). Renal function was followed at different time intervals. Contrast media were 
injected after different stages of tubular necrosis. Reversible acute renal failure was
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shown by a rise of creatinine and urea as they reached high values before they started to 
decline to recovery (Anthony et al, 1994a).
3.3.4. a) High dose Uranyl acetate nephropathy (UrAc group A)
i) Six days after high UrAc dose (10 mg/kg) (UrAc group Ai)
Twenty rats, average weight 250g received 10 mg/ml dose of UrAc and 6  days 
later were divided into 4 subgroups for i.v. dosing of saline, iohexol, iodixanol, and 
iothalamate. Animals were dehydrated for overnight before i.v. dosing
ii) Five days after high UrAc dose (dehydration effects)
Twenty rats weight 250g all received a dose of 10 mg/kg UrAc and 5 days later 
they were divided into two groups one group (a) underwent dehydration (UrAc group 
Aii) and the other (b) kept on water (UrAc group Aiii), after 24 hours both groups were 
subdivided into 2  subgroups for i.v. saline and iothalamate.
3.3.4.b) Low dose uranyl acetate nephropathy (UrAc group B)
All animals were dehydrated 23 hours before i.v. dosing unless stated otherwise.
i) Five days after low dose UrAc (without dehydration) (UrAc group Bi)
Twelve rats (320-400g) were divided into 3 subgroups, 5 days after a dose of 3 
mg/kg UrAc. They received either i.v. saline, iothalamate or iodixanol.
ii) Five days after low dose UrAc (with dehydration) (UrAc group Bii)
Sixteen rats (320-360g) were divided into 4 subgroups, one subgroup for control 
i.e. no UrAc induced nephropathy which received saline, the other 3 subgroups 5 days 
after a dose of 3 mg/kg UrAc received either i.v. saline, iothalamate or iodixanol
iii) Four days after low dose UrAc (with dehydration) (UrAc group Biii)
Twelve rats (320-360g) were divided into 3 subgroups , for control i.e. no UrAc 
induced nephropathy which received iodixanol, the other two subgroup and 4 days after a 
dose of 3 mg/kg UrAc received either i.v. saline or iodixanol
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3.3.4.C) Three days after low dose UrAc (severe degenerating tubule)
Serial and frequent (3 hour) urine samples were collected after i.v. dosing in these 
groups. All animals were dehydrated 20 hours before and 3 hours after i.v. dosing unless 
stated otherwise.
i) Control with frequent urine sampling
Fifteen rats weight between 320-400g were left without the UrAc-induced renal 
failure as control.
ii) Effects of different CM (UrAc group Cii)
Fifteen rats (320-400g) had single s.c. 3 mg/kg UrAc and were left for three days 
for the induction of renal failure.
Both groups (Ci and Cii) were divided into 3 subgroups for either i.v. saline, 
iodixanol, or iothalamate
iii) Effects of different CM osmolarity (UrAc group Ciii)
Twenty rats (320-400g) with s.c. 3 mg/kg UrAc-induced renal failure after 3 days 
were divided into 4 subgroups for i.v. saline, iodixanol (osmolarity 290), iodixanol with 
20% mannitol (osmolarity 1000), and iothalamate (osmolarity 1800). All were overnight 
dehydrated as above.
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UrAc
B
C
I
High
A dose 5
lOmg/kg
DAYS BETWEEN UrAc & CM INJECTION 
6 ----- Ai
Aii
Low -------  _> -------►
dose 4 ► Dehydration Bii
3mg/kg - -  4 ► Hydi'atioii B iii
Low 3  —►Different CM C ii
dose
3mg/kg 3  —►Different osmoalrity C iii
Diagram 3-2 Development scheme of uranyl nephropathy model (3.3.4) 
Group letters and numbers as stated In the text headings
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3.4 Patient protocol for high dose CM studies
3.4.1 Radiology patients studies
Spot urine samples were collected from patients before and after angiography 
imaging procedures with ioxaglate (hexabrix) and / or ioversol angiography study. 
Samples were collected only from patients who were administered high volume of 
imaging agent greater than 50 ml. The time of collection, volume, initials, and type and 
volume of CM that was injected were all recorded (details of the clinical protocol in 
Appendix H).
3.4.2 Human urine sample preparation
After collecting the urine samples in plastic universal tubes they were stored at - 
70° C until required for the assay. Samples were thawed and then filtered through glass 
microfiber filters (Whatman 2.5 cm GF/B circles). Urine samples were diluted X 100 for 
creatinine measurements. As protein concentrations were below the detection limit of 
protein measurement by Coomassie method, urine samples were concentrated as 
described below. Concentrated urine samples were assayed for total protein and selected 
samples were then separated by SDS-PAGE electrophoresis.
3.4.3 Concentrating human urine samples:
Human urine samples were concentrated by either of two methods
A) Micron-10® Centricon concentrator from Amicon™ with 10 KDa filtration cut-off 
and follow the instruction manual to concentrate the urine samples. After placing 2ml of 
urine sample a yield sample of 50 pi which achieves 40 fold concentration.
B) Urifil® concentrator from Millipore™ with 7.5 KDa filtration cut-off and follow the 
instruction manual to concentrate the urine sample. With a starting urine volume of 3-5 
ml, as water penetrates the ultrafiltration membrane it will be absorbed by a pad whereas 
MW higher than 7.5KDa cannot cross. The yield sample volume is 50 pi which achieves 
more than 60-fold concentration.
3.4.4 NMR spectroscopy
A volume of 0.6 ml of the filtered human urine was freezed dried and 
reconstituted in 750 pi ^ H^ O. ^H NMR spectra were measured on a JEOL GSX500
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spectrometer operating at 500.14 Mhz 1 H resonance frequency at ambient probe 
temperature (298 K ) . Resonance were assigned by consideration of chemical shifts and 
from collected data base at Birckberk college {Professor JNicholson’s Group). Attempts 
were made to correct for the signal produced by CM by spiking urine samples with 
authentic ioxaglate, as it was the most commonly used CM with these patients
77
3.5 Results
This extensive result chapter represents the search for a relevant model and 
marker for CM-ARF. The data covers some “well established” models (e.g. old age , 
indomethacin in a salt depleted animal and 5/6 nephrectomy), the compounding effects of 
dehydration and the development of a tubular necrosis model induced by uranyl acetate. 
Renal function parameters were followed by frequent collection of urine and blood at 
intervals before and after different renal insults and CM adm inistration . Changes of renal 
function were assessed accordingly, to evaluate any renal failure which could be induced 
by CM. Changes in urine osmolarity, electrolytes, volume, protein and enzymes values 
were correlated with those for renal function assessed by plasma creatinine, urea and 
creatmine clearance. To account for variation in urine concentrating or diluting effects all 
proteins and enzymes were expressed per creatinine as a reference denominator value.
Experimental models of CM-ARF in rats
3.5.1 Control group
Data presented in this section represent “basal renal function parameters” before 
and after administration of CM to normal young dehydrated rats (WA and Fawn Hooded 
strain)
3.5.1. a) Control WA rat group (Group A)
This group represents baseline renal parameters which reflects how normal young 
age (2 months) healthy WA rats respond to high doses of CM.
In the control WA animals iothalamate, iohexol and iodixanol induced significant 
(P<0.05) proteinuria (Fig. 3.1 A) within the first 6  hours after administration more 
pronounced with iothalamate. Protein levels decreased back to “baseline” in samples 
collected 24 hour after the i.v, dosing. Urinary enzymes were also increased after the 
three CM, although to a much higher magnitude than that with the proteins. ALP (Fig.
3 .IB) increased significantly (P<0.05) with all three CM in the first 6  hours. The effect 
was more pronounced with iodixanol and iohexol. NAG (Fig. 3.1C) started to elevate 
after 6  hours but continued to increase significantly (P<0.05) with all three CM at 24
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hours and remained high up to 48h. No changes were detected in renal function assessed 
by creatinine or urea that could be ascribed to CM (Fig. 3 .ID).
3.5.1.b) Intravascular depletion (Group B)
In normal rats with intravascular depletion and repeated daily dehydration (Fig. 
3.2) both iothalamate and iodixanol increased protein (Fig. 3.2A) excretion significantly 
(P < 0.05) in the first 6  hours and back to baseline in 24 hours.
Iothalamate and iodixanol increased ALP (Fig. 3.2B) in 6  hours which remained 
high up to 24 hours where it started to decline. Similarly both CM increased NAG (Fig. 
3.2C) excretion which started at 6  hours with iothalamate and 24 hours with iodixanol 
but continued with both CM up to 48 hours. These changes were not associated with any 
decline in renal function, however the rise of the rise of plasma creatinine at 96 hours 
was not significant (Fig. 3.2D).
3.5.1.C) Control Fawn Hooded rats (dijferent strain) (Group C)
In the Fawn Hooded rats iothalamate increased significantly (P<0.05) ALP 
excretion in 6  hours (Fig. 3.3B) and NAG at 6-24 hour (Fig. 3.3C). There was no 
impairment of renal function judged by the similar profiles of plasma urea (Fig. 3.3D)for 
both subgroups. Renal function was routinely assessed by both plasma creatinine and 
urea. However since the trend of plasma urea was similar to creatinine and there was 
only sufficient sample to carry out the urea assay, only plasma urea is presented.
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3.5.2 Old age nephropathy results
Because of the wide variation in age of the available rats these were grouped 
according to their age (e.g. 12 or more than 16 months) and as summarised in diagram 3- 
1. All significant changes in the renal parameters, due to CM administered to different 
old age WA rat, are summarised in table 3.1.
3.5.2.a) Old age (12 months) with salt free and i.v. indomethacin before CM (Old
age Group A)
With a salt free diet (rice) for one week the two subgroups showed lowered 
excretion of protein in urine, as they were fed protein free rice. This was seen when 
comparing urinary protein levels with other similar age groups. After iothalamate there 
was no significant increase in protein excretion (Fig. 3.4 A), ALP (Fig. 3.4 B), NAG 
(Fig. 3.4 C) nor plasma creatinine (Fig. 3.4 D).
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3.5.2.b) Old age (16 months) with severe renal insufficiency and reduced urine
pH  (Old age Group B)
Reduction of urine pH to 6  with this old age group caused a significant 
impairment in renal function. The subgroup with the three insults of dehydration, reduced 
urine pH and iothalamate showed a progressive increase in plasma creatinine that reached 
significant levels (P<0.05) at 48 hours (Fig. 3.5D). Renal impairment was shown as 
increased plasma creatinine from an average of 200 pmol/1 to 400 pmol/1 in the normal 
urine and to 800 pmol/1 in the reduced urine pH subgroups after iothalamate. The 
average water consumption by the animals in ‘acidic’ subgroups was 50% less than those 
in the other subgroup which were on tap water, this possibly represented an additional 
insult. The increase of plasma creatinine especially with the acidic urine was not 
associated with any significant proteinuria (Fig. 3.5A). However, protein values were 
increased 6  hours after iothalamate alone (non acidic subgroup) and remained 
significantly high until 24 hours, while with the acidic urine there was a decreased urine 
protein concentration with time. Neither GGT (Fig. 3.5C) nor ALP (Fig. 3.5B) showed 
any increased levels by iothalamate. Due to severity of renal impairment and health 
status of some animals the experiment had to be terminated at 48 hours.
3.5.2.C) Old age (12 months) with acidic urine (Old age Group C)
i) Old age with acidic urine with dehydration prior to CM (Group C i)
Plasma creatinine was not increased (Fig. 3.6.1 A) nor did creatinine clearance 
decline after iothalamate(Fig. 3.6.1 B). RFI (Na) was significantly increased in 6  hours 
after iothalamate (Fig. 3.6.1C) but back to baseline levels. The fact that ionic 
iothalamate contains Na which would be excreted with CM could have caused this 
increased urinary Na concentration making any change due to tubular dysfunction. 
Osmolality was lowered 6  hours after iothalamate (Fig. 3.6.ID) to significant low level 
and back to baseline levels.
ii) Old age with acidic urine without dehydration prior to CM (Group C ii)
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Plasma creatinine was not changed after iothalamate (Fig. 3.6.2A), neither was 
the creatinine clearance (Fig. 3.6.2B). Both urinary Na (Fig. 3.6.2C) and RFI (Fig. 
3.6.2D) were elevated after iothalamate
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3.5.2.d) Old age with severe renal impairment (Old age Group D)
i) Renal impairment with matched weight only (Old age Group Di )
All three CM (i.e. iothalamate, iohexol, and iodixanol) increased protein 
excretion significantly (P<0.05) after 6  hours (Fig. 3.7A). High protein excretion after 
iothalamate and iodixanol was maintained throughout the follow up period with even 
higher levels at 96 hours.
The three CM significantly (P<0.05) increased ALP excretion after 6  hours of 
administration (Fig. 3.7B) which fluctuated at significant high levels throughout the 
follow up period. Only iothalamate increased NAG excretion (Fig. 3.7C) after 6  hours 
which remained high throughout the follow up period.
Renal function followed by plasma creatinine (Fig. 3.7D) was impaired 
significantly with iothalamate after 48h.
ii) Renal impairment with matched renal function (Old age Group Dii )
Animals were divided into two subgroups according to their pair matched plasma 
creatinine (Fig. 3.8D) before administering CM. Plasma creatinine (Fig. 3.8D) was 
increased (P<0.05) after 24 hours of iothalamate. There was a significant (P<0.05) 
increase in protein excretion (Fig. 3.8 A) and ALP (Fig. 3.8B) after 6  hours fi*om 
iothalamate but back to “baseline levels” afterwards. No significant changes were 
detected with NAG (Fig. 3.8 C)
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Table 3-1: DEVELOPMENT OF AN OLD AGE NEPHROPATHY MODEL SHOWING CHANGES IN
RENAL PARAMETERS
Old age nephropathy model 
groups
Significant changes due to CM in
headings as in the experimental 
design
biochemical parameters 
(urinary protein and 
enzymes)
renal function (plasma 
creatinine, urea and 
creatinine clearance)
Group A) Old age (12 months) 
with Indomethacin and salt free 
diet (Fig. 3.4)
ioth. induced no change in 
protein NAG, or ALP 
excretion.
No change in plasma 
creatinine
Group B) More than 16 months 
and acidic urine (Fig. 3.5)
ioth. with normal urine 
induced significant increase 
in protein
4 fold increase in plasma 
creatinine at 48h with ioth. in 
acidic urine
Group Ci) (12 months age) with 
acidic urine with dehydration (Fig. 
3.6.1)
Not followed. No significant changes in 
renal function
Group Oil) (12 months age) with 
acidic urine without dehydration 
(Fig. 3.6.2)
Not followed No significant changes in 
renal function
Group Di) (more than 16 months) 
renal impairment with matched 
weight only (Fig. 3.7)
ioth., iohx. and iodx. 
increased protein and ALP at 
0-6h, ioth. increased NAG 
was at 0-6 & 6-24h.
plasma creatinine was 
increased at 96h with ioth. 
only.
Group Dii) (more than 16 months) 
renal impairment with matched 
renal function (Fig. 3.8) ioth. 
increased
protein, ALP at 0-6h, and 
NAGat6-24h.
plasma creatinine at 24h
93
3.5.3 5/6 nephrectomy
The effects of CM on renal function were studied in a well established 
nephrectomy model. Animals were followed for renal function, proteins and electrolytes 
after single iothalamate and double administration of both iothalamate and iodixanol. 
Urinary enzymes were not followed.
Four weeks after the 5/6 operation renal function was depressed illustrated by two 
fold increased plasma creatinine (Fig. 3.9 C and 3.10.1 A), more than one fold increased 
urea (Fig. 3.10.1 B) and one fold decreased creatinine clearance (Fig. 3.9 D and 3.10.1
C) which were significant in comparison to sham operated.
Both single iothalamate (Fig. 3.9 A) and double dose of both CM (Fig. 3.10.2 
A) caused a significant (P<0.05) rise in urine protein in the first 6  hours, with a lower 
magnitude with iodixanol. No other renal function parameter changes were detected by 
creatinine (Fig. 3.9 C and 3.10.1 A), urea (3.10.1 B) or creatinine clearance (Fig. 3.9 D 
& Fig. 3.10.1 C).
Urinary electrolytes showed a significant increase of urinary sodium and RFI(Na) 
(Fig. 3.10.2B) with iothalamate and a significant increase of urinary potassium RFI (K) 
(Fig. 3.10.2C) with iothalamate in the first 6  hours and iodixanol at 6-24 hours.
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FIG 3.10.1: EFFECTS OF CM/SALINE ON PLASMA CREATININE, UREA AND CREATININE 
CLEARANCE IN THE 5/6 NEPHRECTOMY MALE WA RATS WITH DOUBLE CM DOSING 
(INTERVAL BETWEEN TWO DOSES WAS 5 DAYS).
STRAIGHT LINE ARROW INDICATES POINT OF CM/SALINE (TWICE) ADMINISTRATION ; 
DOTTED LINE ARROW INDICATES POINT OF 5/6 NEPHRECTOMY.
OTHER LEGEND DETAILS AS IN FIG 3.9
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FIG 3.10.2: EFFECTS OF CM/SALINE ON URINARY PROTEIN AND ELECTROLYTES IN THE 5/6 
NEPHRECTOMY MALE WA RATS WITH DOUBLE CM DOSING 
(INTERVAL BETWEEN TWO DOSES WAS 5 DAYS)
EACH POINT IS THE AVERAGE VALUE FROM 6 ANIMALS +SEM
STRAIGHT LINE ARROW INDICATES POINT OF CM/SALINE (TWICE) ADMINISTRATION; DOTTED 
LINE ARROW INDICATES POINT OF 5/6 NEPHRECTOMY. OTHER LEGEND DETAILS AS IN FIG 3.9
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3.5.4 Uranyl acetate experiments
High (10 mg/kg) or low (3 mg/kg) doses of uranyl acetate were administered to 
induce proximal tubular cells necrosis renal models. CM were administered after 
different intervals from the onset of induction of uranyl acetate nephropathy with or 
without dehydration and as summarised in diagram 3-2. All significant changes in the 
renal function parameters due to CM administered to UrAc models are summarised in 
table 3-2.
3.5.4.a) High dose Uranyl acetate nephropathÇUrAc Groups A)
i) Six days after high UrAc dose(UrAc Group Ai)
Urinary protein excretion (Fig. 3 .HA) was elevated due to uranyl acetate and 
dehydration at almost similar magnitude with the different subgroups before CM 
administration. However, there was a further significant increases of protein excretion 6  
hours after the administration of the three CM which were declined to “baseline levels” 
after 24 hours.
Increased levels of ALP excretion with iothalamate only was detected in the first 
24 hours (Fig. 3.1 ID). There was no significant changes in NAG excretion due to the 
three CM (Fig. 3.11C) due to high “UrAc baseline” levels before CM.
Levels of plasma creatinine (Fig. 3.1 IB) were increased up to 600 pmol/1 by the 
model in comparison to an average of 50 pmol/l before any UrAc-induced nephropathy 
and dehydration. All plasma creatinine values started to decline after 48 hours except 
those of iohexol that remained significantly high.
ii) Five days after high UrAc dose (dehydration effects) (UrAc Group Aii )
UrAc nephropathy with dehydration induced a 10 fold increase in protein 
excretion (Fig. 3.12.1 A) and a ftirther significant (?<0.05) increase was also detected 
after administration of iothalamate at 3 hours and at 6  hours. The increased ALP (Fig. 
3.12.IB) and GGT (Fig. 3.12.ID) due to UrAc were ftnther elevated by iothalamate 
after 3 hours. Also NAG (Fig. 3.12.1C) was elevated due to UrAc but did not rise above
98
this level with iothalamate The iothalamate-increased protein and enzymes levels were 
declined to the “UrAc baseline” levels after 24 hours.
There was decreased osmolarity after UrAc, and a significant increase with the 
osmolar iothalamate 3 hours after administration in comparison to saline (Fig. 3.12.2A). 
UrAc and dehydration caused an increase in plasma creatinine up to 400 pmol/l (Fig. 
3.12.2B), and urea (Fig. 3.12.2D) to 60 mmol/1. After both iothalamate and saline 
plasma creatinine and urea values increased to almost similar magnitude. Also similar 
pattern of effects with creatinine clearance (Fig. 3.12.2C) was observed as it was 
decreased after UrAc but no significant decrease was detected after iothalamate and saline 
administration.
iii) Without dehydration group (UrAc Group Aiii)
The already high “UrAc baseline” values of protein (Fig. 3.13.1 A) , ALP (Fig. 
3.13.IB), GGT (Fig. 3.13.1C), and NAG (Fig. 3.13.ID) due to the UrAc nephropathy 
were further increased after 3 hours from CM but only with ALP there was significant 
detected changes.
UrAc-induced polyuria decreased osmolarity (Fig. 3.13.2A) in both subgroups 
and no further significant difference between the two subgroups was observed until 48 
hours after the high osmolar iothalamate administration, whereby there was significant 
high osmolarity urine levels.
In the absence of dehydration UrAc caused a lower magnitude of renal 
impairment. Creatinine was elevated to an average of 220 pmol/1 (Fig. 3.13.2B), which 
was lower than the effect of same dose of UrAc with dehydration as it was above an 
average of 300 pmol/1 (Fig. 3.12.2B). The increased creatinine after 24h with 
iothalamate subgroup was insignificant from saline. Similar change was observed with 
urea (Fig. 3.13.2D). No changes in creatinine clearance were detected by iothalamate 
(Fig. 3.13.2C).
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5.5.4.b) Low dose UrAc (UrAc Group B)
i) Five days after low dose UrAc without dehydration (UrAc Group Bi)
There was no significant increase in protein (Fig. 3.14.1 A) or NAG (Fig.
3.14.IB) excretion after both iothalamate and iodixanol from a high “UrAc baseline” 
levels. UrAc-induced renal impairment did not show any further increase in plasma 
creatinine (Fig. 3.14.1C) by the two CM nor any decline of creatinine clearance (Fig. 
3.14.1D).
Urine sodium electrolytes (Fig. 3.14.2A) were significantly increased 6  hours 
after iothalamate and remained high up to 48 hours. There was no significant changes 
increase of urianry potassium (Fig. 3.14.2B). After presenting the urinary electrolytes as 
RFI; there was no significant difference between saline and the 2 CM with RFI(Na) (Fig. 
3.14.2C) while with RFI(K) (Fig. 3.14.2D) there was a significant increase levels with 
iodixanol in the first 24 hours which returned to baseline after 48 hours.
ii) Five days after low dose UrAc with dehydration (UrAc Group Bii)
A saline control subgroup (no UrAc-induced renal damage) was included so that 
values from UrAc subgroups were compared with this control subgroup to illustrate the 
magnitude of renal effects by UrAc Protein excretion was increased due to UrAc to 
more than 2 fold that of a control subgroup but returned after 48 hours to only one fold 
(Fig. 3.15 A). There was a significant increase in protein (Fig. 3.15 A) in first 6  hours 
after both iothalamate and iodixanol which declined to “UrAc baseline” levels after 24 
hours. Although plasma creatinine (Fig. 3.15 C) and urea (Fig. 3.15 B) did not show 
any significant increased levels, but creatinine clearance (Fig. 3.15 D) was significantly 
reduced after 48 hours from iodixanol, as it did not recover like that of saline or 
iothalamate
iii) Four days after a low dose UrAc (UrAc Group Biii)
UrAc caused increased urinary proteins (Fig. 3.16.1 A) excretion up to more than 
4 fold and with iodixanol a further significant rise to double that of saline in the first 6
105
hours and back to “UrAc baseline” after 24 hours. Renal damage induced by UrAc and 
24 hours dehydration caused further renal impairment, as indicated by increased plasma 
creatinine (Fig. 3.16.1C) to 400 pmol/1. There was a further increase in plasma 
creatinine after iodixanol at 24- 48 hours. Similar changes m renal function assessed by 
urea (Fig. 3.16.IB) and creatinine clearance (Fig. 3.16.ID) were detected illustrated by a 
significant (?<0.05) increase in urea after 48 hours and a depression in creatinine 
clearance in 24 hours compared to saline subgroup.
Comparing renal function parameters 48 hours after iodixanol that is administered 
to control subgroup (i.e. no uranyl nephropathy) to those after UrAc showed a 6  fold 
increased plasma creatinine, 1 0  fold decreased creatinine clearance but only twice urinary 
protein excretion.
RFI presented for both Na (Fig. 3.16.2A) and K (Fig. 3.16.2B) was increased 
significantly (P<0.05) 48 hours after iodixanol administration in UrAc, also the 
fractional excretion of Na (Fig. 3.16.2C) was significantly increased (P<0.05) 48 hours 
after iodixanol.
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FIG 3.16 ,2: EFFECTS OF lODIXANOUSALINE ON URINARY ELECTROLYTES 
EXCRETION IN WA MALE RATS 4 DAYS AFTER 3 MG/KG URANYL ADMINSTRATION 
(UrAc GROUP Biii).
A THIRD CONTROL GROUP WITHOUT URANYL ACETATE NEPHROPATHY RECIEVED 
lODIXANO (CONTROL+IODX.).
EACH POINT IS THE AVERAGE OF 4 ANIMALS+ SEM 
LEGEND DETAILS AS IN FIG 3.11
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3.5.4.C) Low dose UrAc groups followed at 3h intervals (UrAc Group C)
Urine samples were collected at short (3 hour) intervals for frequent follow up
i) A control group with frequent follow up (Group Ci )
No significant changes in renal function parameters could be ascribed to CM with 
plasma creatinine (Fig. 3.17.1 A), creatinine clearance (Fig. 3.17.1 B), RFI (K) (Fig. 
3.17.1 C) or RFI (Na) (Fig. 3.17.1 D).
Both iohexol and iodixanol increased urine protein excretion significantly 
(P<0.05) at the first 3 hours and up to 9 hours after iodixanol administration (Fig. 
3.17.2A) before it returned to “baseline control” level. A significant increase (P<0.05) 
in ALP (Fig. 3.17.2B) and GOT (Fig. 3.17.2 C) excretion which started during the first 
3 hours and lasted up to 9 hours with both CM before it declined to control baseline 
values.
ii) Three days after low dose of UrAc with different CM (UrAc Group Cii)
CM were administered after a low dose (3 mg/kg) of uranyl acetate and after short 
interval (3 day) of UrAc-induced nephropathy. The UrAc-induced proteinuria was 
significantly increased (P<0.05) after iothalamate, iodixanol and iohexol in comparison 
to saline in the first 3 hours (Fig. 3.18.1 A). ALP (Fig. 3.18.1 B) was significantly 
increased (P<0.05) 3 hours after iohexol and iothalamate and declined to “UrAc 
baseline” levels, while after iodixanol and as ALP was high before CM administration it 
could not show any significant increased levels. GGT (Fig. 3.18.1 C) was high due to the 
UrAc-nephropathy and there was no further significant increased levels after CM.
Both iodixanol and iohexol increased plasma creatinine (Fig. 3.18.2 A) and 
reduced creatinine clearance (Fig. 3.18.2 B) to significant levels (P<0.05) starting at 24 
hours and up to 48 hours after administration in comparison to saline, while iothalamate 
did not show any significant impairment in renal function. Two anim als from iohexol and 
two from iodixanol subgroups were anuric for 1 2  hours and a third animal from iodixanol 
remained anuric until 48 hours.
112
Following urinary sodium (Fig. 3.18.2 D) and potassium (Fig. 3.18.2 C) by RFI 
(Na)/(K) showed significant (P<0.05) rise that started after 3 hours after iothalamate, 
iodixanol and iohexol which remained high until 48 hours.
iii) Three days after low dose UrAc followed with different CM osmolarity (UrAc 
Group c iii)
Both iodixanol administration i.e. low and high osmolar iodixanol (plus mannitol) 
increased plasma creatinine to significant (P<0.05) high levels 48 hours after 
administration (Fig. 3.19 A), similar decline with creatinine clearance (Fig. 3.19 B) 
which remained significantly (P < 0.05) low with both osmolar strengths of iodixanol. 
Iothalamate did not show any significant impairment with renal function in comparison to 
saline. One animal from low osmolar and one animal from high osmolar iodixanol were 
anuric for 24 hours and a second animal from low osmolar group remained anuric for 48 
hours.
Urinary protein excretion (Fig. 3.19 C) was increased due to UrAc and 
dehydration before CM and was significantly (P<0.05) increased with the three CM 
subgroups at 3-6 and 6-12 hours. RFI (K) (Fig. 3.19 D) was significantly increased 
(P <  0.05) due to iodixanol alone in the first 12 hours.
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FIG 3.17.2: EFFECTS OF CM/SALINE ON URINARY PROTEINS AND ENZYMES IN WA 
MALE CONTROL RATS (GROUP C I).
OTHER LEGEND DETAILS AS IN FIG 3.11
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FIG 3.18.1: EFFECTS OF CM/SALINE ON URINARY PROTEIN AND ENZYMES EXCRETION 3 DAYS 
AFTER 3 MG/KG URANYL WITH DEHYDRATION (UrAc GROUP C ii)
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Table 3-2 Development of Uranyl acetate nephropathy model with changes in renal
parameters
Uranyl acetate groups Significant changes due to CM in
headings as in the 
experimental design and 
results sections
biochemical parameters 
(urinary protein and 
enzymes)
renal function (plasma creatinine, 
urea, creatinine clearance and 
electrolytes).
A!) six days after high dose 
(FIG. 3.11)
loth., iohx. and iodx. at 6h 
increased protein excretion; 
only ioth. increased ALP.
no significant changes in renal 
function, only iohx increased plasma 
creat.
Aii) five days after high 
dose (with dehydration)
ioth. increased protein and 
ALP excretion at 0-3 and 3- 
6h. and GGT 3-6h (FIG. 
3.12.1^
no significant renal impairment due to 
ioth. (FIG. 3.12.2)
Aii!) five days after high 
dose (without dehydration)
ioth. caused no significant 
difference in protein, ALP or 
NAG (FIG. 3.13.1)
ioth showed no significant renal 
impairment (FIG. 3.13.2).
Bi) five days after low dose 
(without dehydration)
no significant increase in 
protein and NAG excretion 
(FIG. 3.14.1)
no significant renal impairment (FIG. 
3.14.1). Iodx. induced significant rise 
of RFI (K) (FIG. 3.14.2)
Bii) five days after low dose 
(with dehydration) (FIG. 
3.15)
ioth. and iodx. caused 
significant increase in 
protein
decline of creat. clearance with iodx.
Biii) four days after low 
dose iodx caused
an increase in protein 
excretion at 0-6h. (FIG. 
3.16.1)
a decline in renal function at 24h 
shown by plasma creatinine, urea 
and creat. clearance. (FIG. 3.16.1) 
also increased RFI (Na and K) and 
FE (Na) at24-48h (FIG. 3.16.2)
Cii) three days after low 
dose with further 
dehydration 3 hours after 
CM and frequent follow up
ioth., iohx. and iodx. 
increased protein at 0-3h, 
and only with ioth. and iohx. 
there was increased ALP 
(FIG. 3.18.1).
only iodx. and iohx. (Not ioth) caused 
decline in renal function illustrated by 
plasma creatinine, urea and CrCI 
after 48h(Fig. 3.18.2) also increased 
RFI (K) and (Na) starting from 3h 
after CM.
Ciii) three days after low 
dose with continues 
dehydration 3 hours after 
CM frequent follow up (Fig. 
3.19)
ioth., iodx. alone and with 
mannitol caused increase in 
protein at 3-12 hours
both iodx. alone and with mannitol 
(not ioth) caused decline in renal 
function illustrtaed by plasma creat. 
and CrCI that started after 48h. After 
12h iodx increased RFI(K).
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3.5.5 Urine proteins
Proteinuria can either be an indication of glomerular or tubular renal insult, 
therefore it is necessary to evaluate the type of proteinuria and thus the site of renal 
insult. Urine proteins were separated by SDS-PAGE electrophoresis to characterise their 
protein profiles before and after CM. The Pharmacia™ Phast System® using minigels was 
used for rapid and reproducible separation of urine samples. After protein separation and 
gel staining all gels were scanned for the quantitative identification of different densities 
of separated protein bands. Total protein concentrations’ values were extrapolated from 
the raw data of the individual urine samples’ values as were measured during the follow 
up {described in detail in 2.3.2).
3.5.5. a) Electrophoresis and staining o f urine proteins
Samples were treated as described in 2.3 4. Unless stated otherwise, the gels that 
were used were of the homogenous simple concentration 12.5%, samples were applied by 
Ijil X 8  sample applicator. After protein separation by gel electrophoresis two methods 
of staining were used to locate urine protein. Fig 3.20 shows gels of protein 
electrophoresis from urine samples collected from different experimental renal lesions 
before and after CM.
i) Method development
Choice of the separation gel and staining method was based on urine protein 
concentration. Fig 3.20 gel 3.1 shows protein profiles of urine samples from three 
control animals lane 2, 3 and 8  (with protein conc. 1.5, 1.7, 2.3 pg/pl respectively). 
Urine samples were collected 6  hours after iothalamate in lane 2 and after saline in lane 
3 and 8 . The low concentration of difierent MW protein gave faint bands by Coomassie, 
in contrast to samples collected from old age rats lane 4,5,6, & 7 where there was higher 
protein excretion (with protein concentration of 15.2 , 17.7, 21, 15.8 pg/pl respectively). 
Same urine samples that were separated by homogenous gel and stained with Coomassie 
in gel 3.1 were separated again using gradient gel 3.2, applied by 4-fold volume (of that 
applied in gel 3.1) and developed by silver. As protein concentrations in the young 
control rat urine were low and hardly detectable when stained by Coomassie (Gel 3.1 
lane 2, 3 and 8 ), therefore the more sensitive silver method was necessary to visualise
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these protein bands (Gel 3.2 lane 3, 4 and 5). Samples from old age with high protein 
conctration showed overloaded lanes (as in lane 6  Gel 3.2). Therefore, Coomassie stain 
(with a sensitivity value of 5-100 ng per band) was sufficiently sensitive to develop and 
visualise the different protein bands. By increasing the sensitivity of the staining method 
with silver more protein bands with lower concentrations were visualised. Scanning of 
homogenous gels (simple concentration) that were stained with Coomassie produced 
accurate and clear scans in comparison with gradient gels or the silver stain, which both 
produced rather poor resolution because of the nature of the gels and the high background 
stain. When compared to the control, the old age nephropathy excreted higher albumin 
quantities shown as dense and wide albumin bands (Gel 3.1 and Gel 3.2), and there was 
denser and thicker protein bands both of HMW and LMW. This shows that the 
proteinuria profile in old age rats was towards HMW and albumin rather than to LMW 
compared to those of control young age rats.
ii) The effect of protein loading concentration on the protein profiles
Gel 3.3 shows profile of urine that were collected from 12 month old rats 6  hours 
after saline and iothalamate. The apparent differences in profiles may be due to variations 
in protein loading rather than in the profiles. When comparing samples collected six 
hours after saline from animal (2 ) (with protein concentration of 2 . 2  pg/pl) lane 2  and 
animal 1 (protein 13 pg/pl) lane 3 it illustrates how different protein loading 
concentrations could lead to changes in the protein profiles. Similarly when comparing 
high urinary protein concentration after saline as in lane 3 to those 6  hours after 
iothalamate from animal 3 (protein 5.5 pg/pl) lane 5 and 7  and from animal 6  (protein 
8 .7  pg/pl) at lane 8 which could confused that there were more LMW proteins in samples 
collected after saline. But it was only when comparing urine samples from the same 
animal (3) with similar protein concentration as seen before iothalamate at lane 4 (protein 
conc. 4.6 pg/pl) with those 6  h after iothalamate at lanes 5 and 7 (protein 5.5 pg/pl), 
that changes of protein profiles could be ascribed to iothalamate. Another example was 
illustrated with Gel 3.5 that showed protein profiles of urine samples collected from old 
age rat group with an acidic urine. Comparison was carried out between protein profiles 
of urines that were collected six hours after saline (1 ) (lane 2 ) with protein of 16 jag/ 
plwith saline 2 (lane 4) with protein conc. of 21 jig/ pi in comparison to those after
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iothalamate (1) protein of 22 pg/ pi (lane 3) and iothalamate (2) protein concentration 60 
pg/ pi (lane 5). Although there is an increased density of the LMW (30 KDa) band after 
saline but when the different band densites were scanned and presented proportionally to 
albumin and to total proteins, significant changes in the LMW proteins were seen with 
iothalamate not saline. This LMW proteinuria that was shown in 6  hours disappeared 
after 24 hours in urines collected from the same animals. As it is illustarted in the protein 
profile in the same gel 3.5 in samples collected after iothalamate (1) with protein of 20 
pg/ pi (lane 7) and iothalamate (2) with protein 89 pg/ pi (lane 8 ) which did not show any 
LMW proteinuria.
Different urine samples have variable protein concentrations. Therefore to 
compare different protein profiles accurately, it is necessary either to consider adjustment 
for the protein concentration by loading the same amounts (which is the normal 
procedure) or to present the different protein profiles as percentages of the total proteins 
or ratios to each other. Even when adjusting for the loading concentration by diluting the 
samples accordingly the loading volume can not be practically accurate with 1 pi loading 
volume onto the PhastSystem® small gels. The alternative approach that was employed 
was by scanning these proteins bands and the quantitative figures of different protein 
bands’ peaks and their percentages’ ratios would overcome any differences in the protein 
concentration. After scanning protein bands they were presented as a ratio of 
LMW/albumin as illustrtated in Fig 3.21, 3.22, 3.23 and table 3-3,3-4, 3-5.
iii) LMW proteinuria of 30KDa
The MW of different urine proteins was determined by reference to the protein 
standards. It is difficult to be precise about the molecular weights of the different proteins 
as the Rf values (distant travelled by the band) are not accurate with such small gels. The 
rat albumin MW was a known value while the figure 30KDa of the LMW band is an 
approximation rather than the exact MW. The pattern of increased LMW proteins after 
iothalamate in comparison to those after saline or before i.v. administration was 
illustrtaed in gel 3.3; 3.4; 3.5; 3.6; 3.8 and showed clearly the increased intensity of the 
LMW with a 30kda band in urines collected after CM .
Following same animals before and after iothalamate/saline had shown increase in 
the LMW protein at 30 KDa after iothalamate in comparison to saline. Scanning (Fig.
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3.21) of the stained gel (Gel 3.4 Fig 3.20) illustrated that the ratio of the peaks from 
30KDA LMW to those of albumin had increased after iothalamate. Quantitative changes 
of these ratios were illustrated in table 3-3.
Another example was shown with samples collected from old age rat at different 
time intervals before and after iothalamate. The same pattern of transient increased LMW 
proteins of 30KDa after iothalamate in comparison to those before or after different time 
intervals from iothalamate (gel 3.6) is also clear. Scanning of this stained gel (Fig. 3.22) 
illustrated the increased intensity of 30KDa protein shown as an increased ratio of 30 
KDa/albumin after iothalamate which was visualised at its m aximum after 6  hours but 
started to decrease after 24 hours . The protein concentration and ratio figures to album in  
are presented at table 3-4.
Urine samples collected from Fawn Hooded rats that received iothalamate were 
separated and followed in gel 3.8 findings of increased peak of the 30KDa LMW was 
also shown after 6  hours as seen in lane 3 in comparison to those before iothalamate as 
seen in lane 2 and those after 24 and 48 hours as seen in lane 4 and 5. Scanning of the 
gel as shown in (Fig. 3.23) and presented quantitatively in (Table 3-5) also illustrated an 
increased intensity of the 30 KDa LMW protein 6  hours after iothalamate which declined 
back to baseline value after 24-48 hours. This pattern of transient increased peaks of 
30KDa LMW protein was not shown after 24-48 hours from iothalamate or iodixanol as 
was illustrated with gel 3.7.
In summary the protein profiles of urine samples collected from different 
experimental models illustrated changes of pattern in protein excretion after CM. The 
increased LMW protein concentration at 30KDa was compared to albumin concentration 
as a denominator value. The ratio between the 30KDa band concentration / albumin band 
concentration could correct differences in the loading concentration by presenting the 
ratio of a LMW to albumin as a reference value rather than final concentration (intensity) 
of the band. Therefore, increase in this ratio meant there was more 30KDa protein in 
comparison to albumin, which would be an indication of tubular proteinuria.
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Figure 3.20: SDS-PAGE OF URINE SAMPLES FROM THE VARIOUS EXPERIMENTAL MODELS
Legends of gels that are shown on next page. Gel numbers are shown on the lower right side 
comer. Lane numbers are shown above the gel. Lane 1 (LMW) is LMW standards with different MW 
and as follow (A=14.4; B=20; 0=30; D=43; E=67; F=94)in Kda, black arrow a is albumin band; white 
arrow b is the 30kda band, other lanes in the different gels are as follow
Gel 3.1: Samples were collected from old and young age rats at different time intervals before and 
after ioth./ saline administration applied as 1 pi X 8 at 12.5% homogenous gel, and developed by 
Coomassie. Lane 1 LMW; lane 2 samples from control young group (6h) after ioth.; lane 3 control 
group (6h) after saline; lane 4 old age group before saline; lane 5 old age before ioth.; lane 6 old age 
24h after saline; lane 7 old age 24h after ioth.; lane 8 control group (6h) after saline
Gel 3.2: Samples were collected from old and young age rats at different time intervals before and 
after ioth. administration applied by 4 pi X 6 at gradient gel 8-25 and developed by silver stain; 
samples were as follow; lane 1 LMW; lane 2 distorted; lane 3 from control group (6h) after ioth.; lane 
4 and lane 5 from control young group (24h) after ioth.; lane 6 from old age nephropathy 24h after 
ioth.
Gel 3.3: Samples were collected from 12 months old age rats at different time intervals before and 
after ioth./ saline administration applied by 1 pi X 8 at 12.5% homogenous gel, developed by 
Coomassie ; sample were as follow: lane 1 LMW; lane 2 was 6h after saline from animal 2; lane 3 
was 6h after saline from animal 1 ; lane 4 was before ioth. from animal 3 not dehydrated; lane 5 was 
6h after ioth. from animal 3; lane 6 LMW standards; lane 7 same as lane 5; lane 8 was 6h after ioth. 
from animal 6.
Gel 3.4: Samples were collected from old age rats before and after ioth./saline applied by 1 pi X 8 at 
12.5% homogenous gel, developed by Coomassie; and were as follow: Lane 1 LMW ; lane 2 sample 
3 dehydration before ioth., lane 3 sample 3 (3h) after ioth., lane 4 dehydration before saline (sample 
5); lane 5 (3h) after saline (sample 5); lane 6 dehydration before ioth.(sample 6); lane 7 24h after 
ioth.(sample 6); lane 8 (3h) after ioth.(sample 6).
Gel 3.5 : Urine samples collected from old age with acidic urine and applied by 1 pi X 8 as follow: 
lane 1 LMW ; lane 2 collected 6h after saline (1); lane 3 sample collected 6h after ioth.(l); lane 4 
sample collected 6h after saline (2); lane 5 sample collected 6h after ioth.(2); lane 6 sample 
collected 24h after saline (1); lane 7 sample collected 24h after ioth.(l); lane 8 sample collected 24h 
after ioth.(2).
Gel 3.6: Samples were collected from old age rats at different time intervals before and after ioth. 
applied by 1 pi X 8 at 12.5% homogenous gel, developed by Coomassie; and were as follow Lane 1 
LMW ; lane 2 dehydration before ioth.,.lane 3 (3h) after ioth.; lane 4 (24h) after ioth.; lane 5 (48h) 
after ioth.; lane 6 (72h) after ioth.; lane 8 (96h) after ioth.
Gel 3.7: Samples from old age rats were collected 24h and 48h after either saline, ioth. or iodx. 
applied by 1 pi X 8 at 12.5% homogenous gel, developed by Coomassie and were as follow; lane 1 
LMW ; lane 2 (animal 1) 24h after saline; lane 3 (animal 1) 48h after saline; lane 4(animal 2) 24h 
after ioth.; lane 5 (animal 2) 48h after ioth. ; lane 6 (animal 3) 24h after iodx; lane 7 (animal 3) 48h 
after iodx.; lane 8 (animal 4) 24h after iodx.
Gel 3.8 : Follow up of urine sample before and after ioth. in Fawn Hooded rat. Samples applied by 
4pl X 6 and as follows; lane 1 LMW; lane 2 dehydrated urine; lane 3: six hours after ioth.; lane 4: 24 
hours after ioth.; lane 4:48 hours after ioth.; lane 5 :48 hours after ioth.; lane 6 was distorted.
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Figure 3.21 scans of stained Gel 3.4 (Figure 3.20).
Legend of scan graphs shown on next page.
Each graph represents one lane scanned with a flying spot scanner. The x axis represents the 
protein band density or protein concentration in that band. Y axis represents the distance from the 
point of application (travel distant) equivalent to protein MW. The different lane graphs represent 
density of different protein bands that were developed for each lane; numbers on these graphs are 
the lane number in scanned gel. Molecular weighs are extrapolated from a standard curve of LMW 
standards and their Y positions (peaks ). Peak (a) is the albumin band at Y position 34 (in this scan), 
peak (b) is the protein band at Y position 27 (in this scan), equivalent to 30 KDa. Letters on the Y 
peaks in LMW STD graphs are the different MW STD in KDa and as follow (A=14.4; B=20; C=30; 
D=43; E=67; F=94). For exact identification of each lane refer to the gel legend. The straight line at 
the base of some peaks represents the scanner system manually working out areas under the 
selected peaks and measuring the percentage (equivalent to concentration of this protein to the total 
proteins).
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Figure 3.23 Scan of stained gel 3.8 (Fig 3.20). The legend details are as in Figure 3.21
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Table 3-3 ; Quantification and numerical values obtained from scans (Fig. 3.21) of protein bands in 
gel 3.4 (Figure 3.20)
Position on the Y axis represents the distant from the starting point that is corresponding to protein 
MW. The percentages of the two Y positions represent the integrated area under the curve for that 
band per total amount of integrated areas under each curve ( equivalent to total protein bands 
concentration). This percentage represents the ratio of that protein to total protein concentration.
Sample Time of 
collection
Protein band 
at Y position 
27 (30KDa)
Protein band 
at Y position 
34 (albumin)
Ratio of Y 27 
(30kda) /Y34 
(albumin)
Lane 1 LMW markers
Lane 2 (sample 3) Dehydration 8% 81% 1/10
Lane 3 (sample 3) 3 h after ioth. 29% 58% 1/2
Lane 4 (sample 5) dehydration 3% 77% 1/25
Lane 5 (sample 5) 3 h after saline 3% 68% 1/23
Lane 6 (sample 6) dehydration 35% 73% 1/24
Lane 7 (sample 6) 24h after ioth. 3% 70% 1/23
Lane 8 (sample 6) 3 h after ioth. 12% 38% 1/3
Table 3-4: Quantification and numerical values obtained from scanning (Fig 3.22) protein bands in 
gel 3.6(Figure 3.20) Other legend details as in Table 3-4
Sample
Protein
conc.
mg/ml
Time of 
collection
Protein band 
at Y 27 
(30KDa)
Protein band 
at Y 34 
(albumin)
30KDa/ albumin
Lane 1 
&7
LMW
standards
Lane 2 16 Dehydration 7% 80% 1 / 1 0
Lane 3 2.3 3 h after ioth. 16% 70% 1/4
Lane 4 4.1 24h after ioth. 5% 86% 1/17
Lane 5 10.4 48h after ioth. 3% 91% 1/30
Lane 6 13.7 72h after ioth. 3.8% 89% 1/23
Lane 8 15.8 96h after ioth. 4% 90% 1/23
Table 3-5: Quantification and numerical values obtained from scans (Fig 3.23) of protein bands in 
serial lanes in gel 3.8.Samples were followed before and after iothalamate in Fawn Hooded rat 
Other legend details as in 
Table 3-4
Lane protein conc. 
mg/ml
Time of 
collection
Protein band 
at Y 27 
(30KDa)
Protein band at 
Y 34 (albumin)
30KDa/ albumin
1 LMW STD
2 3.7 Dehydration 7% 56% 1/8
3 2.3 6 h after ioth. 14% 62% 1/4
4 3.8 24h after ioth. 5% 55% 1/11
5 2.8 48h after ioth. 9% 62% 1/7
6 distorted
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3.5.5.b) Quantitative and qualitative measurements o f different urinary proteins:
i) ELISA detection of albumin and transferrin in the rat urine:
Protein was measured by dye reagent while albumin was measured by an ELISA 
method (section 2.9 ELISA method for albumin and trasferrin) in urine samples before 
and after iothalamate or saline administration to two subgroups of 1 2  months old age rats. 
Values for protein and albumin as presented in (Fig 3.24) show that albumin and protein 
excretion were increased 6 h after iothalamate compared to saline. The pattern of 
increased albumin excretion and subsequent decline was similar to that of total protein.
The role played by potential iron released from excreted transferrin in proteinuria 
(Alfrey et al, 19S9; for further details see 1.3.4.b) was the rationale behind developing 
an ELISA assay to quantitate urinary transferrin. As there was no commercial anti rat 
transferrin that could be used to develop an assay for measuring urine transferrin, 
attempts to measure transferrin by using anti-human transferrin antibodies and rat 
transferrin antigen failed to develop a successful ELISA assay.
Preliminary attempts were also carried out to measure endothelin levels in urine 
samples in rats, but their was undetected endothelin levels in urine samples in vivo. This 
was most likely due to the low recovery of endothelin after the extraction methods or 
perhaps due to low endothelin excretion by the kidney as there was re-uptake of 
endothelin by other tissues. Since in the isolated perfused kidney there was no re-uptake 
by other tissues, endothelin was detected in this isolated system as will be shown later in
5.2.6.
131
Fig 3.24: THE EFFECT OF SALINE/ IOTHALAMATE ON URINARY EXCRETION OF 
PROTEIN AND ALBUMIN IN OLD AGE RAT MODEL.
Protein was measured by cooomise dye reagent while albumin by ELISA method. The 
standard used for protein and albumin was rat serum albumin.
Other legend details as in Fig 3.1
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ii) Identification of the 30KDa band:
In order to confirm the identity of the 30 KDa protein band further 
characterisation of this band that was increased after CM was carried out. Two different 
antibody preparation (^ntem a and Gaestels) of Anti Heat Shock protein 27K antibodies 
(kindly provided by Professor R. King, University o f Surrey) were tested by blots against 
rat skeletal and myocardial muscles antigens for immune-cross reaction. Only one 
antibody which reacted with rat skeletal muscles was used for the immune-detection of 
the urine 30 KDa protein. Figure 3.25 shows the positive bands by dot blots that cross 
reacted with one type of antibody and with different dilution of skeletal muscle antigens.
Two pooled urine samples were collected 6  hours after either saline or iothalamate 
administration and were separated by SDS gel electrophoresis, further on they were 
transferred onto nitro-cellulose membrane for western blotting. The 30KDa MW band 
showed negative cross reaction for HSP-27 antibodies indicating that this LMW is not a 
heat shock protein.
Figure 3.25 Dot Immuno-blot of two different preparations of anti HSP-27 antibodies against serial 
dilutions of rat skeletal and cardiac muscles’ homogenates to select the appropriate AB.. A control 
antigen (HSP-27) was also applied for quality control.This blot shows that one antibody preparation 
{Zantema) could cross-react with skeletal homogenate antigenes. Neither of the cardiac nor the 
other antibody preparation could show any cross reactions. This AB preparation {Zantema) was 
selected for western blots with rat urine and as explained in the text
i n t .
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There is evidence to show that renal ischaemia and nephrotoxins could increase 
the expression of genes responsive to injury like Heat Shock Protein (HSP) (Safirstein, 
1994). It was shown that kidney proximal tubule cells respond to chemical insult of 
mercuric chloride by increasing the transcription of specific genes which encode for 
stress proteins which preceded overt renal injury (Goering et al, 1992). Heat Shock 
Proteins have been classified into protein families based on relative molecular mass, those 
of HSP-27, 70 and 90 KDa families. It is possible that with a MW of 27 KDa these HSP- 
27 could have contributed to the increased LMW proteinuria of 30KDa after CM. 
However, the negative immune-precipitation with anti-HSP-27 does not support this 
hypothesis of heat shock proteins being present in urine in response to CM.
Having shown that there is increased intensity of the 30KDa LMW protein, it was 
felt necessary to measure this LMW by a quantitative method. However, an attempt to 
measure the urine concentration of rat al-microglobulin (MW 30KDa) by a radial 
immunodifusion (RID) kit with an anti human al-microglobulin (as there is no anti rat 
antibody) was not successful. After isolating the 30 KDa molecular weight protein from 
rat urine, which was carried by gel column and by affinity chromatography, the 
commercial RID kit was unable to quantitate the yielded protein of rat al-microglobulin 
{section 2.10 isolation o f a  j-microglobulin). It was also seen that the antibody used in the 
kit did not cross react with the rat al-microglobulin by dot blot indicating no cross 
reactivity between them. Although an attempt was made to isolate and prepare the 
standard rat a l  microglobulin it was not possible to quantitate it by simply using the 
human RID antibodies. Thus clearly a specific anti rat (instead of anti human) a j - 
microglobulin antibodies would be needed for the quantitative measurement of rat a^ - 
microglobulin. Due to time constraints, no further work with this LMW was possible to 
be carried out.
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3.5.6 Analysis of radiology patients urines
Urine samples, that were collected from six selected patients who received high 
volume of CM {for details see 3.4.1. Radiology) were assayed for urinary protein levels 
(after 60-fold concentration) as shown in Table 3-6. As the protein concentration was 
below the detection limit urine samples were concentrated using Urifil®. This table 
illustrates the effects of CM on elevating urinary protein excretion. Four out of these six 
patients samples showed an increased protein excretion per creatinine ratio after CM 
(ioxaglate). However these spot urine samples were collected at different time intervals 
after CM rather than specified time interval.
Table 3-6: Urinary protein presented as mg/L and mg/mmol creatinine from 6 patients who received 
high dose of CM
Sample
ID
Protein conc. in mg/mmol 
creatinine of the 
concentrated samples
Type, Dose and time 
interval after CM
Before CM After CM
2 0.9 4.4 1h after 250 ml ioxaglate
6 0.55 0.11 24h after 200 ioxaglate
9 0.12 0.37 120 ml hexabrix and 150 
ml ioversol
10 0.05 0.38 21 h after ioxaglate
14 0.12 0.58 Ioxaglate
18 0.45 0.07 100 ml hexabrix
Effects of ioxaglate on protein profiles were studied by SDS-PAGE of urine 
concentrated by Urifil-10 from two patients before and after CM. Figure 3.26 shows 
separated urine samples which were stained either by Coomassie alone as in gel 3.9, or 
by Coomassie and then silver, as in gel 3.10. Urine samples collected from patients 2 and 
9 before CM (lane 2 and 4) were compared to those after 24 h (lane 3 and 5) 
respectively; protein profile was compared to that of old age rat 6 h after CM (lane 6 ).
As is illustrated, after comparing these two gels, silver stam could increase the sensitivity 
but would produce a dark background which led to loss of contrast.
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Two methods of urine concentration were evaluated for the separation pattern and 
density measurement of different MW proteins before and after CM. Gel 3.12 compares 
the two methods of concentration; Urifil® concentrate the sample X60 lane 6,7,8 and 
Microcon® concentrate X 40 lane 2,3,4, 5. Lane 2 and 6  from the same urine sample A, 
lane 3, 7 and 8  from sample B, lane 5 from sample C. As shown concentration with 
Urifil® gave a better resolution from same samples.
Concentrating urine samples at a higher magnitude X 100 by Urifil® increased the 
protein concentration with more bands being visualised with Coomassie stain as shown in 
gel 3.11. However, the protein profile was not changed after scanning this gel as there 
was no apparent change of protein profiles towards LMW proteinuria after ioxaglate. The 
pattern of increased LMW proteinuria, as was shown from the previous experimental 
animal work, was not shown in these human samples. It could be that the spot human 
urine samples were collected after 24 hours from CM, which as was concluded from the 
animal work would be decreased at this time. Therefore, at an earlier time point 
(immediately after CM excretion) spot human urine might show the expected protein 
profile changes that were obtained from the experimental work.
As shown from the stained gel, the Urifil® method concentrated human urine 
samples sufficiently for proteins to be separated by PhastSystem minigels and to be 
stained by Coomassie, by using the concentrating Urifil® tube method (which is faster, 
easier and cheaper in comparison to the other method of concentration by Microcon®). 
The improved resolution with Coomassie for the purpose of scanning, even with its lower 
detection limit, makes it an ideal staining procedure for concentrated human urine 
samples. Also concentrating human urine samples for SDS electrophoresis with these 
minigels would be better than using a highly sensitive staining methods (like silver 
staining) with its drawbacks like a black background. In summary, this method had 
described a practical way for human urine concentration, separation by SDS and staining 
by Coomassie for the purpose of quantitative scanning of the different protein MW 
bands.
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Figure 3.26; Separation of different urine samples from radiology patients
Gel numbers are shown on the lower right side corner. Lane numbers are shown above the gel. 
Lane 1 (LMW) is LMW standards with different MW and as follow (A=14.4; B=20; C=30; D=43;
E=67; F=94)in Kda, black arrow a is albumin band, other lanes in the different gels are as follow
Gel 3.9 & 3.10: Urine samples from two patients before and after CM were concentrated by Urifil ®. 
Urine samples were selected for protein separation by 12.5 homogenate gel and applying samples 
at 4 ml X 6, gel 3.9 was stained for Coomassie, while gel 3.10 was stained for Coomassie and then 
for silver.
Lane 1 LMW standards, lane 2 sample from patient (2) before CM, lane 3 from patient (2) 24h 
after CM, lane 4 sample from patient (9) before CM, lane 5 sample from patient (9) after CM was 
contaminated, lane 6 from old age rat 6h after CM.
Gel 3.11: Urine samples that were concentrated using Urifil® concentrate the sample X 100 were 4 
pi X 6 of the sample were applied onto 12.5 homogenous gel; lane 1 LMW standards; lane 2 patient 
(2) before ioxaglate; lane 3 patient (2) after 250 ml ioxaglate; lane 4 patient (9) before CM; lane 5 
patient (9) after 120 ml ioxaglate and 150 ml ioversol; lane 6 patient (10) after ioxaglate (see Table 
3-6 for protein concentration values)
Gel 3.12; Two methods of concentration were compared by applying 1 pi X 8 samples onto 12.5 
homogenous gel using Microcon® concentrate X 40 lane 2,3, 5 ; and Urifil® concentrate 60X lane 
6,7,8 both were for the same samples A,B, C collected after CM. Lane 1 LMW standards.
1 2 3 1 2  3 4
H *5^ é
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c -
1 2  3 4 5 6
1 2 3 4 5 6 7
D- -  
E- -  
F- "
c -  
0 -
E - '  
F -
3,11
3.12
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3.5.7 NMR spectroscopy
Low molecular weight metabolites studied by NMR for site specific markers 
were compared before and after CM administration. NMR spectral profiles 
representing alteration in the excretion of various low molecular weight metabolites over 
24-hours time course after CM was studied.
The difference in NMR spectra of urine samples that were collected before and 
after ioxaglate together with that of authentic ioxaglate is illustrated in Figure 3.27. 
Examination of NMR spectra of authentic ioxaglate illustrated an NMR profile that 
had masked most of the potential endogenous proximal tubule metabolites that may be 
occurring following administration of CM and could identify the site specific damage of 
CM. However, even with the predominance of CM in the urine some of the endogenous 
metabolites were detectable. The important endogenous proximal tubule biochemical 
metabolites (shown in Figure 3.27), that have been reported (Nicholson and Wison,
1989; Anthony et al, 1994a, 1994b; 1996) to be consistent with proximal tubular cell 
damage, are hippurate, formate, acetoacetate. These three according to a pattern 
recognition are PCT and S2 specific. Scanning of another urine sample had shown 
other metabolites those of a-glucose which is Sj specific, glycine which is Si and S2 
specific and alanine which is S2 and S3 specific. However, these NMR profiles were seen 
in two out of six post ioxaglate patient urine samples that were examined. The 
interpretation of these LMW scans peaks were carried out by Prof. J  Nicholson (NMR 
group Birkberck College) by a pattern recognition classification of the site of 
nephrotoxicity which was based on the metabolic data derived from NMR spectra of 
urine. The computer based pattern recognition procedures of non-linear mapping and 
principal-component analysis have been applied to analyse ^H NMR-generated metabolic 
data on the biochemical effects of 15 acute nephrotoxin treatments affecting the renal 
cortex , medulla and papilla in rats (Anthony et al, 1994b 1996).
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Figure 3.27NMR spectrum of urine sample
Urine samples were from same patient collected before (upper scan) and after (middle scan) 
ioxaglate, also scan of spiked authentic ioxaglate (lower scan).The sign (*) on the spectrum peaks 
indicates signals from spiked ioxaglate shown in the post CM scan which had masked possible 
signals from toxic metabolites. Hippurate, formate and acetacetate are three of the LMW metabolites 
signals which were not masked by ioxaglate and were shown in the middle scan indicated released 
endogenous metabolites after ioxaglate.
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3.6 Discussion
3.6.1 Animal models
The extensive recent search for an animal model of CM-ARF (Vammonde et al, 
1989; Deray et al, 1990; Deray and Jacobs, 1995; Thomson e/ûZ, 1990; 1991; 1993; 
Hans et al, 1990; Idee et al, 1995; Morcos et al, 1996) was based only on expected 
mechanisms as the aetiology of CM-induced renal damage is not well understood. The 
best approach continues to reproduce a model from risk factors that are reported to 
induce CM-ARF in patients and to follow the different renal function parameters after it. 
Although being a different species with a different renal system it is more practical and 
ethical to study CM-ARF in the rat than in the human. Furthermore, experimental animal 
work, unlike clinical human studies, is cheaper, easier to conduct, easier to control and 
to allocate animal groups into carefully matched subgroups with their appropriate 
controls. However, as the essence of the rat model is to extrapolate the results for human 
use, findings from experimental work have to be validated for clinical diagnosis.
Rat models of CM-ARF in this work were designed from known potential risk 
factors identified from high risk patient groups especially old age (Cochran et al, 1983; 
Rich and Crecelius, 1990), renal insufficiency (D’Elia et al, 1982; Lautin et al, 1991; 
Barrett et al, 1992; Moore et al, 1992; Rudnick et al, 1994) and dehydration (Ansari and 
Baldwin, 1976; Webb et al, 1981; Aron et al, 1989). Nephrotoxic injury like any other 
toxic injury, is due to an interaction between the host (experimental animals) and any 
potential toxin (CM). Therefore, different host factors such as the strain, age, renal 
status, state of hydration on one hand and the type and dosage of contrast media 
administration on the other hand should be tested to determine the extent of renal 
damage. The range of CM tested were extremes from the ionic monomer (iothalamate), 
to a ‘safer’ non-ionic monomer (iohexol) and finally the isosmolar non-ionic dimer 
(iodixanol). The dosage of CM that was used was 3-fold higher than the upper limit of 
any recommended CM human dose. The experimental nephropathy models and the 
induced renal insults were selected to represent different sites of renal damage and risk 
factors (histopathological changes are shown in detail in 4.3.1). Of these models that 
were studied and developed in rats were the 5/6 nephrectomy with mainly
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glomerulopathy (Waldher and Gretz, 1988; Kleinknecht et al, 1988), the old age with 
diffuse and multiple sites of renal injury (Anderson and Brenner, 1986 ; Goldstein et al,
1988), and the tubulotoxin uranyl acetate-induced tubular necrosis (Haley, 1982; Anthony 
et al, 1994a). General effects also tested were those of a different rat strain (Fawn 
Hooded), double CM dosing, dehydration, and reduction of urine pH.
3.6.1. a) Control groups
All different types of CM that were studied in the control WA groups induced 
almost similar renal changes with the urinary parameters. These changes were 
characterised by rapid (within 6  hours) and transient increased excretion (back to baseline 
with in 24-48 hours) of urinary proteins (Fig. 3.1 A; 3.2 A; 3.17.2 A), the brush border 
enzymes ALP (Fig. 3 .IB; 3.2 B; & 3.17.2 B), GGT (Fig. 3.17.2C) and the lysosomal 
(NAG) enzyme (Fig. 3.1 C; 3.2 C) without any detected renal failure. These changes 
were in accord with observations by others (further details in 1.4.3). The magnitude of 
increased levels of urinary protein, ALP and NAG was higher after the induced 
hypovolaemia by dehydration and vascular depletion (Fig. 3.2 A, B & C).
Renal changes induced by CM were not strain related as similar changes were 
shown in the Fawn Hooded rat strain similar to those in WA. Iothalamate increased 
urinary enzymes excretion (Fig. 3.3 B & C) likewise in control WA, these changes did 
not trigger any renal dysfunction that would lead to CM-ARF. Even the Fawn Hooded 
rat strain, that is reported to possess a higher susceptibility to glomerulosclerosis 
(Kreisberg and Kamovsky, 1978; Provoost, 1994), tolerated iothalamate without any 
deterioration in renal function.
3.6.Lb) Old age nephropathy
It is well known that the albino rat develops, as it ages, a spontaneously 
progressive nephropathy (Anderson and Brenner 1986; Goldstein et al, 1988). The 
pathological changes of the old age nephropathy (Fig 4.6 & 4.12 ) are mainly of crescent 
formation, glomerulosclerosis, thickening of the capsule and glomerular basement 
membrane with enlarged glomeruli, mesangial deposition, tubular necrosis and atrophy 
leading to tubular collapse and hyaline casts formation, and massive interstitial infiltration 
with fibrous tissue formation i.e. there is a background of multiple susceptible sites of 
pathological renal lesions.
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Recent evidence for the role of proteinuria in renal insult is based mainly on that 
related to transferrin (Alfrey et al, 1989; Alfrey and Hammond 1990; Alfrey, 1992; 
Harris et al, 1995). They showed that urinary transferrin excretion has the potential to 
damage the renal tubules by the release of free iron in an acidic media (Alfrey et al,
1989). Since the transferrin sieving coefficient is equivalent approximately to that of 
albumin, therefore, with an induced proteinuria (mainly albuminuria in old age ) there 
would be increased transferrin excretion. The model was based on reducing the normally 
alkaline rat urine to a slightly acidic pH and with CM-induced proteinuria, iron would be 
released inflicting direct renal damage. Therefore, a rapid and transient proteinuria (and 
thus transferrinuria) could lead to sudden release of iron free radicals in the acidic urine 
which could damage the PCT cells by the formation of oxidative radicals. Renal damage 
induced by iron as in the form of iron nitrilotriacetate (Fe-NTA ) causes acute severe 
tubular necrosis and tubulointerstitial infiltration (Preece et al, 1989) as a result of 
increased lipid peroxidation and DNA damage by active oxygen radicals (Okada et al, 
1993). However, none of these Fe-NTA reported lesions were observed with any CM- 
induced renal damage. It is possible, that CM-induced transferrinuria with lower iron 
levels could have lead to rather subtle changes. However, this acidic proteinuric urine in 
an old age rat model ( 1 2  months) with or without dehydration did not induce any 
significant decline in renal function (Fig. 3.6.1 A & B; Fig. 3.6.2 A & B). In an older 
age group of animals (more than 16 months) and with dehydration prior to CM reducing 
urine pH showed a significant decline in renal function after iothalamate as it induced a 
four-fold increase in plasma creatinine (Fig. 3.5 D).
Although iothalamate in the acidic urine of the old age rat, illustrated a model of 
induction of severe renal failure this approach was abandoned for a number of reasons. 
Firstly all changes that were induced by iothalamate were enhanced by a longer 
dehydration period due to a lower consumption of the acidic water rather than due to CM 
per se. And secondly, to evaluate the effects of acidic urine on the released iron, it would 
be crucial to meastue transferrin levels and the release of free iron. Failure to quantitate 
transferrin excretion by ELISA hindered the efforts to evaluate the role of transferrin.
The combination of unilateral nephrectomy, salt depletion with the inhibition of 
protective prostaglandin synthesis (in a state of renin-angiotensin stimulation) was 
reported to cause a temporal pattern of CM-ARF (Heyman et al, 1988). A modification
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of this, Heyman’s animal model, whereby old age nephropathy animals (instead of 
unilateral nephrectomy) with salt depletion was also tested. Iothalamate could not show 
any renal failure, and surprisingly it did not even induce the consistent transient 
proteinuria nor enzymuria (Fig. 3.4A, B & C).
Old age animals (>16 months, weight and renal function matched), with an added 
risk of dehydration prior to CM, showed a transient increase in plasma creatinine after 
iothalamate only (Fig. 3.7 D & 3.8 D), an effect which was reported by other workers 
(Duarte and Ellis, 1990). When compared with other CM neither iodixanol nor iohexol 
showed any decline in renal function in the old age group (Fig. 3.7 D). These 
iothalamate-related findings in the old age nephropathy were in accord with others who 
also showed in other renal models that the HOCM rather than the LOCM induced CM- 
ARF (Heyman et al, 1988; Deray et al, 1990; Idee et al, 1995). However, Vaamonde et 
al, (1989) were unable to demonstrate CM-induced ARF in the old age Sprague-Dawley 
rat with diabetic nephropathy and dehydration.
After testing different models of old age nephropathy only those of more than 16 
months showed a transient elevation of plasma creatinine after iothalamate. However, it 
is difficult to claim that they are reproducible models of CM-ARF. Fluctuations in the 
renal function parameters (such as increased plasma creatinine) were also due to 
dehydration and the increased baseline parameters in an old age animal apart from CM 
effects. Renal insults during the experiments may have also induced independent renal 
changes of these potential insults, and apart firom CM, were dehydration, stress induced 
by handling old age animals, leaving the animals in metabolic cages, blood aspiration, 
individual baseline changes in renal status and i.v. injection of an irritant CM, as 
iothalamate injection caused local and even generalised irritability. The unstable renal 
condition with a fluctuating renal function baseline as seen in (Fig. 3.5 D & 3.7 D) could 
contribute to changes seen after CM. It was thus necessary to account for confounding 
background effects such as plasma creatininie and urinary proteins in addition to essential 
criteria like age and weight, before any renal insult could be attributed solely to CM.
This was achieved by pair matching the animals according to their renal function (plasma 
creatinine) (as illustrated in Fig. 3.6.1 A; 3.6.2A; 3.8D). A of difference of up to 20% in 
plasma creatinine between two animals was deemed as acceptable for each pair. Old age 
animals that were matched for their renal function had shown a short interval of
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significant decline in their renal function with iothalamate which was correlated with an 
increase in urinary enzymes and proteins (Fig 3.8).
In summary, young and 12 months old animals were resistant to CM-ARF. Renal 
function was only compromised in old age (>16 months) with added insults by severe 
dehydration and reduced urine pH, although care in interpreting these results is 
necessary.
3.6.1. c) Renal ablation
The pathological changes in the remnant kidney consisting of glomerular 
hypertrophy, glomerulosclerosis, expansion of mesangial matrix and interstitial 
infiltration which should present a high risk model. This model was used by others to 
reproduce what is thought to simulate human chronic renal failure (Waldher and Gretz, 
1988; Kleinknecht et al, 1988). After an early surgical insult there would be progressive 
renal changes to an end-stage renal failure (Gretz et al, 1988). However, background 
renal pathological changes that were detected at 4 weeks (Fig 4. 7 & 4.13) were not 
severe enough compared to those obtained in old age or UrAc nephropathy i.e. in regard 
to the degree of glomerulosclerosis, interstitial infiltration and fibrosis. Also we were not 
able to test dehydration as a further risk factor in this model. After four weeks from 5/6 
nephrectomy there was a decline in renal function illustrated by 1 -2 -fold impairment in 
renal function parameters (Fig. 3.9 A, B & C and Fig. 3.10.1 A, B& C). Six hours 
following both a single (Fig. 3.9 D), and two repeated doses of iothalamate (Fig. 3.10.2 
A) urine proteins were increased, however, they were not associated with any decline in 
renal function. In this hypertrophied remnant kidney neither a single dose of iothalamate 
nor a repeated dose of either iodixanol or iothalamate caused further decline in renal 
function, indicating an adaptive tolerance of the hypertrophied 1 / 6  of the kidney after 
nephrectomy. In addition to the rat generally being extremely resistant to renal insult it is 
possible that the 5/6 nephrectomy model would respond to acute CM doses with two 
specific modifications:
1. A longer period after the renal ablation to develop severe glomerulosclerosis and 
chronic persistent renal failure.
2. A stricter protocol for surgical resection of the kidney is required. Although the 
surgical procedures in our model were scheduled to excise 5/6 of the kidneys after
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weighing the excised tissue indicated that less than 5/6 of the renal mass was 
removed.
3.6.1.d) Uranyl acetate models
Uranyl acetate (UrAc), an S3 segment specific renal toxin (Anthony et al, 1994), 
was administered singly to induce renal insult and impair renal function by tubular 
epithelial cells necrosis. The UrAc nephropathy model was characterised pathologically 
by a wide spread tubular cells necrosis, hyaline casts formation, and massive interstitial 
infiltration (for pathological findings see 4.3.2) in agreement with others (Haley, 1982, 
Anthony et al, 1994b). In the process of validation of the uranyl acetate model two 
uranyl doses (10 and 3 mg/kg) and renal damage intervals (6 , 5, 4 and 3-day interval) 
were evaluated before the final characterisation of a reproducible model. CM were 
injected either at a late interval whereby there was an initial improvement of the declined 
renal function or at an early stage shortly after the renal injury.
The high UrAc dose (10 mg/kg) caused a several-fold increase in plasma 
creatinine, urinary proteins and enzymes, therefore any added renal effect by CM was 
masked by the already high magnitude of declined renal function (Fig. 3.11 B; 3.12.2 B, 
C& D; 3.13.2 B, C & D) and increased biochemical parameters (Fig. 3.11C; 3.12.1C;
3.13.1 A, C & D ) . None of the CM showed any fiirther deterioration in renal function, 
only iothalamate showed an increased protein and ALP excretion in a dehydrating 
protocol (3.12.1 A & B).
Further development of the model required reduction of the high “baseline UrAc 
parameters” by reducing the dose of UrAc from 10 to 3 mg/kg so that the induced toxic 
renal damage was at a lower magnitude unmasking the CM-renal effects that could be 
evaluated and distinguished from a high baseline UrAc effects. This was shown as the 
baseline plasma creatinine after 5 days was reduced from a range of 300-400 with the 
high dose to 120-80 jimoI/1 with the low dose (Fig. 3.12.2 B and 3.15 C) whilst that of 
CrCl from less than 0.2 in the high dose to a range of 0.6-1.2 ml/min with the low dose 
(Fig. 3.12.2 C and 3.15 D) and protein from a range of more than 2 in the high dose to
0.4-0.5 g/mmol creatinine in the low dose (Fig. 3.12.lA ; 3.15 A) before administering 
CM.
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Administering CM at the fifth day after UrAc resulted in delayed improvement of 
CrCl after 48h from iodixanol (Fig. 3.15 D). An earlier administration of iodixanol on 
the fourth day showed an increased plasma creatinine at 24-48 hour and urea at 48 hours 
(Fig. 3.16.1 B & C). The most significant changes were shown when CM were 
administered on the third day; as iodixanol and iohexol significantly induced renal failure 
illustrated clinically by anuria and raised plasma creatinine with declined CrCl that was 
followed until 48 hours with some animals even showing irreversible changes that 
required termination (3.18.2 A & B; 3.19 A& B).
Therefore, the interval between the start of UrAc insult and CM administration 
was of crucial importance. After the short “3-day interval” of a low UrAc dose (3 
mg/kg) both types of the LOCM the dimer iodixanol and the monomer iohexol induced a 
significant decline in renal function with even some cases of CM-induced irreversible 
renal damage and anuria. The importance of the “short interval” was shown as iodixanol- 
induced renal failure was not clear when iodixanol was administered after 4 - 6  days firom 
a low or high dose of UrAc. These time-related changes could indicate a healing process 
that could have started and prevented renal failure.
Induction of CM-ARF after low UrAc dose model could be more of a synergism 
rather than a summation of two renal insults. Each renal insult alone i.e. CM with their 
trivial renal effects and 1/3 of the high UrAc dose showed separately reversible renal 
changes. Therefore, after combining these two renal insults, the induced irreversible 
renal failure could be caused by potentiating the low sublethal dose of UrAc with the 
trivial renal effects of CM.
The main developments in the model were to optimise the dose of UrAc and the 
interval before administering CM to obtain a reversible model. ARF was induced when 
CM was administered at a time of maximal renal tubular necrosis i.e. when the kidney 
was in the initiating stage and still responding to the first insult before the start of any 
repair mechanism.
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Diagram 3-3 Scheme of the proposed synergism between mild cellular effects by CM and sublethal 
dose tubular necrosis by UrAc in producing ARF.
The most likely explanation for iodixanol-induced renal failure in tubular necrosis 
is that the tubular epithelia and their contents played an important role in this 
pathogenesis. It is tempting to suggest that both dehydration and the viscous CM have the 
ability to change the tubular lumen contents which could be risk factors in inducing ARF 
with UrAc. In the early stages of UrAc injury there was tubular epithelial cell necrosis 
and shedding, leading to tubular obstruction and hyaline cast formation, adding to the 
effects of dehydration and the viscous dimer and ending up into renal tubules blockage. 
Alternatively, unlike iodixanol and iohexol, iothalamate did not predispose to CM-ARF 
in the UrAc model, which could indicate that the high osmolarity or the low viscosity did 
not predispose to CM-ARF at least in this model. If the tubular blockage was the cause of 
renal failure then it is tempting to speculate that the high osmolar-induced diuresis 
prevented tubular obstruction. However, increasing iodixanol osmlarity to 1000 by 
mannitol induced similar changes of impaired renal function to those of isosmolar 
iodixanol (Fig. 3.19 A & B).
The initiating period between an insult and clinical findings of renal failure is 
characterised by an acute rapid phased dynamic evolving processes. Changes occurring 
during this initiating phase of renal failure could lead either to improvement or 
deterioration in the renal status. It is possible that any added trivial risk such as CM in 
the early phase of UrAc-induced renal insult, whereby there is continuous evolving
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process, could have triggered irreversible changes leading to ARF. CM-ARF that was 
induced at an early rather than at a late stage after UrAc-induced renal damage could 
emphasise the potential role of the degenerative or regenerative state of tubular cells in 
inducing or preventing CM-ARF. Repair of any renal damage few days after UrAc was 
illustrated by improvement in the declined renal function towards normal baseline levels 
which could indicate a competent regenerative healing process.
The advantages of this model of low dose UrAc (after 3-day interval from 3 
mg/kg UrAc) are:
1. Easy to induce as no surgical intervention was required
2. Induced within few days
3. Induced with a single renal insult rather than multiple insults with different 
pathophysiological backgrounds. The single insult could also decrease the wide range 
of fluctuations and decrease the number of control groups required.
4. Reproducible as shown by the impaired renal function parameters and clinical 
conditions.
Unless there is an end stage renal failure, ARF in general is a reversible condition 
which indicates that the kidney has the ability to recover from an almost complete loss of 
function. The kidney, like some other tissue such as the liver, possesses an efficient 
adaptive regenerating power that could compensate and recover after toxic tubular 
insults. Recovery from ischaemic and nephrotoxic acute renal failure requires the 
replacement of damaged tubule cells with new ones that restore the continuity of renal 
epithelium. This replacement could occur rapidly in all forms of acute renal injury, 
including that caused by ischaemia (Safirstein et al, 1990) and nephrotxins like 
gentamicin (Laurent et al, 1983) and cisplastin (Safirstein et al, 1987). The regenerative 
power may be impaired in some conditions, where CM that possess mild potential tubular 
cells injury could lead to renal failure. Likewise are the hepatocytes that regenerate after 
either two-third hepatectomy or toxic injury (Michalopoulos, 1990), so what is known 
about regeneration in the liver is likely to yield some insight into the process in the 
kidney. The kidney response to degeneration could be by an increased expression of 
growth factors that will induce tubular regeneration (Safirstein, 1994).
Other reported CM-ARF models of tubular necrosis-induced renal failure were 
illustrated by gentamicin (Irizar, 1991; Idee et al, 1995; Thomsen et al, 1990;
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1991; 1993). It was shown that iohexol induced dose-dependent changes in renal function 
parameters, urinary enzymes and histological profiles at an early phase (Thomsen et al, 
1991; 1993) and at a late phase after gentamicin (Thomsen et al, 1990). Iohexol 
increased plasma creatinine and urea only in the early degenerative phase model 
(Thomsen et al, 1991; 1993) however, renal function parameters showed a wide range of 
baseline values. Furthermore, urinary enzymes values were based on non-treated urine 
samples to remove all the inhibitory components. Distinctive pathological changes those 
of interstitial infiltration of mononuclear cell infiltration were apparent 3 days after high 
doses of 1-3.5 g Iohexol /kg from the background of gentamicin tubular necrosis.
In their efforts to induce CM-ARF Deray et al, (1990) tried single and multiple 
insult models without any success in developing a reproducible anim al model. The 
combination of one or more insults which included right nephrectomy, low salt diet, 
indomethacin, renal artery occlusion, fiirosemide, aortic clamp or intrarterial injection of 
CM failed to reproduce an animal model of CM-ARF. Eventually the multiple insults 
model of CM-ARF was described by Deray et al, (1990) by combining aortic clamping 
renal ischaemia, uninephrectomy with intrarterial injection of CM. It was further 
developed by Idee et al, (1995) as they added the degenerative effects of gentamicin to 
optimise a reproducible model of diatrizoate induced-ARF. However, in their model they 
did not include enough control groups for each insult, also as they compounded their 
model with three further insults those of intrarterial administration, uninephrectomy and 
renal ischaemia the role of gentamicin-induced tubular necrosis in this model was 
unclear.
Since the rat could tolerate high doses of CM, even with a compromised renal 
function, without consequential renal impairment attributed to CM, therefore, it was 
necessary to try multiple manoeuvres as shown above (Vari et al, 1988, Heyman et al, 
1988; Deray et al, 1990; Idee et al, 1995) or induce severe tubular necrosis by UrAc to 
induce CM-ARF. It could be concluded and in accord with others that the rat showed a 
strong resistance to develop CM-ARF (Morcos et al, 1997).
3.6.2 Dehydration risk
Before administering CM, dehydration by itself increased the magnitude of 
proteinuria and enzymuria as illustrated in a model of intravascular depletion and
149
repeated dehydration (Fig. 3.2 A,B). Another indication of the role of dehydration insult 
in potentiating CM was shown in UrAc susceptible cases. The iodixanol-depressed renal 
function that of increased plasma creatinine and decreased creatinine clearance in the 
UrAc model returned to “baseline levels” at 48 hours in the hydration protocol (Fig.
3.14.1 C& D) while it showed sustained renal dysfunction in cases of dehydration (Fig. 
3.15 C& D). To potentiate the dehydration insult in the development of UrAc model, 
dehydration was extended for a further 3 hours after CM administration , to simulate the 
situation in the angiography clinics. The UrAc-induced polyuria and diuresis, with an 
additional fluid deprivation by dehydration, depleted the animals from large amoimt of 
fluids which could increase the risk of dehydration. Fluid depletion by dehydration could 
be a major renal risk both due to decreased renal perfusion (prerenal) or increased tubular 
lumen concentration (postrenal). Other workers had shown similar effects as dehydration 
of animals prior to CM treatment led to increase in transient enzymuria (Thomsen et al, 
1988) and increase in GFR especially with the ionic CM (Nygren & Ufendahl, 1989).
3.6.3 Biochemical and functional renal parameters
The main indicator for any renal dysfunction remains the decline in GFR 
(creatinine clearance) shown as a rise in plasma creatinine and urea. Other renal 
parameters that were followed in this work were evaluated for their potential role as early 
markers of any subtle change that could cause declined renal function. The method 
employed to validate any renal marker in CM-ARF was by following renal parameters 
and relating them to impairment of renal function by simultaneous collections of serial 
plasma and urine samples. In this way early markers in the initiating period could be 
evaluated for their role as indicators of any late onset renal failure. Although CM showed 
consistent effects on urinary enzymes and proteins, their non-specific changes made their 
predictive role not very clear.
3.6 .3. a) Pair matching o f renal function
After following individual animal values in nephropathy models it was found that 
there were wide variations in the renal parameters and some renal values fluctuate within 
a wide range and with time, even before inflicting any renal insult by CM (Fig. 3.5D;
3.7 D; 3.11B; 3.13.2 A,B). Pair matching of different groups by their renal parameters 
was the only way to overcome the wide fluctuation in renal function and to validate
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whether any CM-induced changes were not due to baseline fluctuations. Therefore, it was 
essential that the renal function parameters especially those of creatinine and creatinine 
clearance were pair matched (Fig. 3.2D; 3.3D; 3.4D; 3.6.1A,B; 3.6.2A,B; 3.8D; 3.9; 
3.10.1; 3.12.2B,C; 3.14.1D; 3.15C,D; 3.16.1C,D; 3.18.2A,B; 3.19A,B) before any 
concluding remarks could be made about CM-induced changes.
3.6.3. b) Biochemical parameters
In general the pattern of changes in the urinary excretion of protein and enzymes 
was consistent after almost all types of CM that were tested and with different renal 
situations . Transient proteinuria was detected in the first few hours after CM 
administration (Fig. 3.1 A; 3.2A; 3.3A; 3.5A; 3.7A; 3.8 A; 3.9D; 3.10.2A; 3.11A; 
3.12.1A; 3.15 A; 3.16.1A; 3.17.2A; 3.18.1A). Enzymes released from the brush border 
showed an increase at the first few hours after CM adm inistration such as ALP (Fig. 3.1 
B; 3.2B; 3.3 B; 3.7B; 3.8B; 3.11D; 3.12.1B; 3.13.IB; 3.17.2B; 3.18.IB) ; and GGT 
(Fig. 3.5C; 3.12.ID; 3.13.1C; 3.17.2C; 3.18.1C), while increased NAG excretion 
occurred somewhat later at 6-24h (Fig. 3.1C; 3.2C; 3.3C; 3.7C; 3.8C;). Furthermore, 
the magnitude of enzymuria was higher and not related to that of proteinuria. Urinary 
enzymes were expressed per urine creatinine to overcome any dilution effect. It was 
shown that urine enzyme excretion depends on urine flow rate (Burchardt and Jung,
1992) which was suggested that that they were due to CM-induced diuresis and avulsion 
effects on the tubular brush border releasing extracellular enzymes. However, the effects 
on the delayed NAG release could not be related to a similar mechanism. It was also 
suggested that renal ischaemia could contribute to the release of PCT enzyme. The 
pattern of delayed NAG excretion after 24 hours in comparison to brush border enzymes 
was not identified previously, partly because most of the experimental designs were 
carried after 24 hour collection and difficult to identify the duration of the increased 
NAG excretion. Other workers illustrated an increased NAG excretion after 22 hours 
with iohexol (doses between 1.5-3.5 gl/kg) and a lower increase after 2 hours in 
comparison to LDH and GGT, however their model was that of gentamicin nephropathy 
whereby the increased NAG by gentamicin masked any additional effect by iohexol 
(Thomsen et al, 1993). Also diatrizoate increased NAG excretion after 24 hours with or 
without the gentamicin degenerative model of renal ischaemia (Idee et al, 1995 ). NAG
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was shown to be increased upon administration of nephrotoxic agents such as gentamicin 
and cyclosporin with an intracellular increase in lysosomes (Burchardt and Scherberich,
1993). NAG isoenzyme A is free in the lysosome and is secreted by exocytosis and by 
lysosomal turnover unlike isoenzyme B which is fixed to the lysosomal membrane and its 
occurrence in urine is regarded as a pathological changes. However, in this work no 
attempt was made to distinguish between the different isotypes of NAG.
Many workers reported various types of CM-induced different enzymuria patterns 
in the rat. The difference in the enzyme profile could be related to; variation in the 
animal species, design of the experiment, time interval between the induction of the 
model and CM infusion , method and interval of urine collection, urine storage and 
treatment method (Price, 1982; Hofineister et al, 1986; 1990; Jevinkar et al, 1988; 
Bhargave et al, 1992; Thomsen et al, 1988; 1990; 1991; 1993). A variety of techniques 
have been used to eliminate various inhibitors present in the urine that could affect 
urinary enzymes. In this study removal of the urinary salts was carried out by gel 
filtration techniques. Much of the published work with CM enzymuria did not consider 
these confounding effects by the presence of urinary inhibitors which could result in the 
wide range of values. For example in two control rat CM studies the range of baseline 
urinary enzymes were between 6-699 for NAG, 0-119 for GGT, 0-1160 for LDH 
(Thomsen et al, 1991), and 0-678 for ALP (Thomsen et al, 1993). These wide range 
variations of urinary enzymes were increased further after induction of lesions and 
administration of CM.
The magnitudes of these urinary enzymes and proteins showed different levels in 
different situation as differences were also between LO and HOCM. The HOCM 
iothalamate in old age nephropathy released more proteins (Fig. 3.7A); ALP (Fig. 3.7B 
iohexol) and NAG (Fig. 3.7C) in comparison to iodixanol. Similar findings were also 
shown with nephrectomy as iothalamate released significantly more proteinuria (Fig. 
3.10.2A). Alternatively, in the control, kidney, the LOCM iodixanol released more 
proteins (Fig. 3.17.2 A) ALP (Fig. 3.2B; 3.17.2 B), and GGT (Fig. 3.17.2C). However, 
there was no differences between the two types of CM in these parameters with the other 
renal models as shown with total protein (Fig. 3.2A; 3.11A; 3.14.1A; 3.15 A; 3.18.1A: 
3.19C), ALP (Fig. 3.7B iodixanol; 3.18B), GGT (Fig. 3.18.1C) nor NAG (Fig. 3.2C;
3.11C). This was most likely because the elevated values of urinary proteins and enzymes
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due to the renal lesions like old age (Fig. 3.5 A, B, & C; 3.8C) and UrAc (3.11 A;
3.12.1C; 3.13.1 A & D; 3.14.1 A & B; 3.18.1C; 3.19C) masked any further effect due 
to CM on these parameters.
Tubular insults by UrAc increased excretion of renal markers those of proteins, 
ALP, GGT, NAG and electrolytes by several-fold (3.16.2; 3.17.1 C& D) which is a 
clear indication that these markers are indicators of tubular damage. However, although 
the consistently increased levels of proteins and enzymes excreted shortly after CM was 
an indication of a direct tubular effect but was not necessarily damaging as that by UrAc 
and was not by itself an indication to progression to CM-ARF as illustrated with the 
functional parameters.
3.6.3. c) Functional parameters
Following the renal function parameters from cases of CM-induced renal failure 
illustrated that although protein and enzymes excretion were back to normal values, 
plasma creatinine and clearance showed a continuous decline of renal function.
Moreover, the CM-induced decline in renal function in some models was not related to 
elevation in urinary excretion of proteins and enzymes (Fig. 3.5 B,C & D; 3.8 A & B; 
3.11; 3.15) on one hand and CM-increased urinary enzymes and proteins with other 
models did not predispose to a decline in renal function. In an old age nephropathy model 
a persistent increased protein and enzymes excretion was concomitant with a declined 
renal function (3.7 A,B, C iothalamate group; 3.8 A,B,C; 3.16A) however, it is difficult 
to claim they were related.
This discrepancy between functional and biochemical markers indicated that the 
non-specific CM-induced changes in enzymes and proteins have little prognostic value for 
renal function in CM-ARF cases. Their follow up after CM would only indicate the 
degree of insult that was inflicted on the tubular cells but without any predictive value on 
the extent or the possibility of renal dysfunction.
3.6.3.d) Urinary electrolytes
Urine electrolytes were of the important renal tubular function markers that 
showed significant changes after CM. In clinical practice the sodium ion is the parameter 
that is used normally to follow renal electrolytes, but as most of the ionic CM contain 
sodium as the cation, this could contribute substantially to urinary sodium and is thus not
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a suitable indicator of CM-induced tubular dysfunction. Urinary electrolytes showed 
increased sodium excretion during the first 6  hours with iothalamate (Fig. 3.6.1C; 
3.6.2C,D; 3.10.2B; 3.14.2 C; 3.18.2D) and iodixanol (Fig. 3.16.2A & C ; 3.17.1D;
3.18.2D). With iothalamate it was mainly due to the sodium containing iothalamate 
which falsely gave positive high levels. Therefore, the potassium ion should be an 
alternative to sodium in assessing mbular electrolyte handling after ionic-CM (3.10.2C;
3.14.2 D; 3.15.2B,D; 3.16.2B; 3.17.1C;3.18.2C;3.19 D). As urinary electrolyte 
concentration could be affected by the amount of water reabsorbed by the kidney, this has 
to be taken into consideration especially in polyuria or oliguria. For this reason urinary 
electrolyte levels were expressed per creatinine clearance so that electrolyte values were 
presented as fractional excretion (FE) and renal failure index (RFI) of Na and K that 
corrected for electrolytes concentration. With the UrAc models of CM-ARF iodixanol 
showed an increased potassium and RFI (K) in the first 24 hours (Fig. 3.16.2B; 3.18.2C; 
3.19D) and RFI (Na) (3.16.2A; 3.18.2D) in the early initiating stages especially in cases 
that led to CM-ARF, emphasising urine electrolytes predictive role in CM-ARF. This 
could be due to an increased excretion of potassium due to impaired tubular cells 
homeostasis due to dysfunctional renal tubules. Most of the filtered Na and K is 
reabsorbed by the proximal tubule and the thick ascending limb of loop of Henle. Hence 
dysfunctional changes in these two renal parts would lead to increased levels in Na and K 
concentration and their fractional excretion (Miller et al, 1978). Any significant change 
in Na/K would thus be an indication of acute tubular dysfunction whether due to 
ischaemic or tubular cells damage (Kamel et al, 1989).
5.6.3. e) Urinary osmolarity
As osmolarity was affected by the state of hydration, type of CM (which was 
increased with HOCM), CM-induced diuresis, and changes in electrolyte excretion, 
therefore the osmolarity measurements are not good indicators of any renal or tubular 
dysfunction. After administering CM many factors affected the osmolarity which could 
mislead the osmolarity role as a diagnostic change for CM-ARF. Although, the first 
indication of any medullary injury manifests itself in the loss of the concentrating ability 
and the decreased osmolarity of urine.
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3.6.3.f) Albuminuria
It was shown that the increased total protein excretion was correlated with that of 
albumin as the trend of transient rise of albumin after CM was similar to that of protein 
from the same samples (Figure 3.24). This indicated that the ratio of albumin/total 
protein was almost kept constant after CM. CM-induced proteinuria and albuminuria 
were reported with all different types of CM, however in normal and nephropathy- 
induced models CM induced different magnitudes of proteinuria not related to CM group 
(Holtas etal, 1985; Thomsen aZ, 1991; 1993; 1995). In the gentamicin model minary 
albuminuria was greater after the HOCM diatrizoate than after the LOCM iohexol 
(Thomsen et al, 1993). Since the main plasma and urine protein is albumin, it could be 
suggested that CM freely passage through the GBM would affect the filtration rate 
illustrated by dramatically increased albuminuria (proteinuria) during the first few hours 
after CM.
3.6.3.g) IM W  proteinuria
Changes in the low and high MW protein profile excreted are important indicators 
of the type of renal pathology as they could differentiate between glomerular and tubular 
pathology. In old age nephropathy before CM administration proteinuria was mainly 
glomerular (Fig. 3.20-3.24, Table 3.3-3.5) in origin as it illustrated by increased albumin 
and HMW protein excreted. This old age protein profile is in contrast to young WA male 
rat urine protein profiles where there is low albumin but high levels of the age and sex- 
related LMW a2u-microgloulin proteins.
A relative increased tubular type proteinuria was shown in some cases within few 
hours (3-6 hours) after CM. Tubular proteinuria was shown as an increased levels of the 
LMW protein (al-microglobulin) illustrated roughly by an increased ratio of the a j- 
microglobulin to albumin by SDS gel electrophoresis. LMW proteinuria was another 
indication of the tubular re-absorption dysfunctional changes. This LMW proteinuria was 
in accord with other workers that had shown an increase in another LMW protein of 
a2u-microgloulin in the rat urine after CM (Donadio et al, 1991). It is concluded in 
agreement with these workers that CM decreased the kidney uptake of these LMW 
proteins. An immunospecific assay to measure aj-microglobulin quantitatively would 
have enabled an accurate follow up of this protein as a potential marker, but the lack of
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commercial antibodies against rat urine proteins precluded this approach. After isolating 
rat aj-microglobulin LMW protein, the use of available anti aj-microglobulin (human) 
failed to cross react with the rat protein. Time constraints precluded the raising of anti 
(rat) aj-microglobulin antibodies.
3.6.4 Radiology patients
Interpretation of data obtained from human urine samples (high doses of 
ioxaglate) presented a number of difficulties which may have been attributed to:
1. The allocation of different patients into matched groups.
2. Poor compliance as not all required data were collected form the patients also many 
patients did not meet the inclusive criteria that were set for the study.
3. Wide variation in renal markers in different individuals.
The best way to interpret this data is by comparing changes that had occurred in 
the same individual. Potential tubular markers such as urinary protein, the proteins 
profile and LMW metabolites for each patient were followed before and after CM.
CM-induced proteinuria was also illustrated in human samples, however the 
pattern of tubular proteinurea was not clear by electrophoresis(Figure 3.26). Two 
methods for concentrating human urine samples for the purpose of protein assays and 
separation were also evaluated as it required concentrating the urine samples for total 
protein to be measured by Coomassie. Furthermore, concentrated urine samples could be 
separated and developed by Coomassie so that they were scanned for the different protein 
profiles. After ioxaglate the protein concentration showed similar effects to those from 
experimental work by an increased protein excretion after CM. In accord with the 
experimental anim al work four out of six urine samples showed an increased protein 
concentration levels after CM (Table 3-6). However, protein electrophoresis could not 
show any tubular proteinuria in these samples (Figure 3.26). It could be with a larger 
scale of clinical study an earlier and frequent follow up of urine samples could illustrate 
early tubular changes.
The rationale behind the NMR spectroscopy of urine was to illustrate the effects 
of CM on different endogenous proximal tubule metabolites and by pattern recognition 
with a data base these different metabolites would illustrate the site specific effects of CM 
on tubular cells. Although it was shown that the signal from CM had masked most of the 
signals from potential endogenous proximal tubule metabolites from most of the scanned
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urine samples, with two (out of six) samples there was an indication of specific tubular 
injury. Of the potential metabolites that were shown in the human urine after ioxaglate 
were hippurate, acetacetate, a-glucose which are PCT Si specific, and glycine which is 
Si and S2 specific (Figure 3.27). There was mild glucosuria which is another indication 
of Si toxicity. Therefore, NMR spectra identified few potential tubular markers which 
are indicators of proximal tubular dysfunction and toxicity.
Urine samples from an animal experiment designed specifically for an NMR 
protocol for the NMR spectral analysis of endogenous proximal tubule metabolites. 
However this analytical work could not be completed but will be presented in future 
publications.
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3.7 Summary
In summary, increased tubular renal markers with the experimental animal models 
like those of enzymes, proteins, LMW proteins and electrolytes after CM were clear 
indications of the extent of tubular effects of CM. The sequence of enzyme release was 
fiirther indication of the effects of CM on tubular epithelia cell organelles but is still 
unclear whether they were due to direct or by other ischaemic changes. The release of 
brush border enzymes within 6 h and that of NAG peaking nearer to 24 hours suggests 
that the early effects of CM are on the brush border before the intracellular effects on 
lysosomal enzymes. The tubular dysfunction that led to tubular proteinurea and changes 
in electrolytes excretion emphasised the potential insult induced by CM on the tubules 
leading to tubular cells dysfunction. Only models with pre-induced tubular necrosis 
enhanced with tubular concentrating effects by dehydration precipitated CM-ARF. This 
was more pronounced with the viscous isosmolar dimers that lack the driving high 
osmotic diuretic effect.
In cases of tubular necrosis it is mostly the LG that contributed to CM-ARF, 
whilst in the old age model the HOCM iothalamate induced renal impairment. Therefore, 
as the two types of CM induced renal failure in two different models of renal impairment, 
it is likely that CM-ARF is a multifactorial condition.
This chapter describes different experimental renal models and potential markers 
of CM-ARF. Evidence is presented to suggest the role of CM in inflicting tubular cell 
injury based mainly on these findings:
• CM increased the release of tubular markers such as tubular enzymes of brush border 
and lysosomal origin.
• CM increased the excretion of urinary electrolytes specially in the initiating period for 
CM-ARF.
• Tubular proteinuria was illustrated with an increased excretion of LMW proteins after 
CM especially that of a j- microglobulin.
• Dehydration that leads to high filtrate concentration was a potential risk factor in 
increasing CM tubular effects and inducing CM-ARF.
• Irreversible renal failure was induced particularly after administering LOCM to 
animals with pre-induced tubular necrosis and significantly after dehydration.
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NMR spectra from human samples showed a possible association of proxunal tubule 
toxicity with the release of endogenous proximal metabolites.
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CHAPTER 4
CONTRAST MEDIA-INDUCED 
MORPHOLOGICAL AND 
CELLULAR CHANGES IN THE
KIDNEY
4. C O N T R A S T  MEDIA-INDUCED M O R PH O L O G IC A L  AN D  
C E L L U L A R  C H A N G E S  IN THE KIDNEY
4.1 Introduction
4.1.1 Structure of the Kidney
Much of the description below is classical structure of the kidney (as described by 
Tisher and Madsen, 1991; Kinter and Short, 1993).
The kidneys in rats and rabbits are simple uni-papillary in comparison to the 
multi-papillary kidneys seen in human, as the renal cortex surrounds single pyramid­
shaped medulla. The nephron is ^ e  structural unit that consists of a renal corpuscle 
connected to an elongated tubule component.
4.1.1.a) Cortex
The cortex is divided structurally into two parts. The first part is the medullary 
rays that contain straight proximal, straight distal tubules and the collecting ducts, while 
the second part is the labyrinth that contains the glomeruli, proximal (Si and S2) and 
distal convoluted tubules, interlobular vessels, and the rich capillary networks (Diagram 
4.1).
4.1.1.b) Medulla
The medulla is also divided structurally into two main outer and inner parts, while 
the papilla forms the innermost part of the medulla. After the cortex comes the outer 
medulla which is subdivided into outer and inner stripe. The outer stripe contains the 
terminal segments of the proximal straight tubules (S3) ,  the ascending limbs, and the 
collecting ducts, while the inner stripe contains thin descending limbs (TLH), thick 
ascending limbs (mTAL) and the collecting ducts (CD) (Diagram 4.1). The thick 
ascending limb arises in the inner stripe, enters the cortical medullary rays and eventually 
continues as macula densa part of the juxtaglomerular apparatus. There are no straight 
segments of the proximal tubule in the inner stripe. The junction between the outer and 
the inner strips is erroneously called the cortico-medullary junction, where the proximal
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tabule narrows down and becomes the thin limb of Henle (TLH). Cone shaped ascending 
and descending vasa recta (vascular bundles) develop in the outer stripe but are more 
prominent in the inner stripe. The inner medulla contains thin descending and ascending 
limbs of long loops and the collecting ducts and is characterised by the absence of thick 
ascending limbs. The ascending vasa recta are the draining vessels of the renal medulla. 
The descending limbs (of short loops of Henle) descend within vascular bundles for the 
countercurrent exchange process to occur between ascending vasa recta and the 
descending limbs, this part is prominent in the rat species due to the high urine 
concentration ability.
4.1.1. c) The juxtaglomerular apparatus (JGA)
The JGA is a structural complex that is located at the hilus of the renal glomerulus 
where the macula densa, a modified portion of the ascending thick limb, enters into 
intimate contact with the vascular pole of the same nephron. The physiological 
significance of JGA is that it produces renin. Changes in the sodium concentration in the 
early distal tubule can control the intrarenal release of renin, also alterations in the stretch 
receptors of afferent arterioles regulate renin release.
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Diagram 4-1 Topographical location of nephrons and collecting duct with various regions of the rat 
kidney. and early Sg segments are located within the cortical labyrinth, the late S 2  segments 
within the tips of the medullary rays, and the S 3  segments within the base of medullary rays and 
outer stripe of the outer medulla. TLH, thin limb of Henle; DT distal tubule; CD collecting duct.
4. l.l.d) Renal vascular supply
Renal blood flow, a quarter of the cardiac output and the highest in the body in 
relation to organ weight, is directed mostly to the cortex to optimise glomerular filtration 
rate and the reabsorption of solute. By contrast blood flow to the renal medulla is low to 
preserve osmotic gradients and enhance renal concentration (Brezis and Rosen, 1995). 
The renal artery divides into interlobar arteries and in the cortex each interlobar artery is 
divided into several interlobular arteries that give rise to the afferent arterioles which 
form part of the glomerular tufts with the efferent arterioles. The afferent and efferent 
arterioles are the principal resistance vessels that regulate the glomerular filtration. 
Efferent arterioles from superficial and mid cortical renal corpuscles give rise to tortuous 
peritubular capillary network in the cortical labyrinth associated with the cortical 
convoluted proximal and distal tubules, while the efferent arterioles of juxtamedullary 
renal corpuscles form the descending vasa recta which descends into the medulla giving 
rise to capillaries at all levels. Both the glomerular and postglomerular capillaries of the
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kidney form the portal system. Due to pressure difference between this peritubular 
capillaries' network and tubules' fluid favours absorption into these capillaries. As the 
cortex is compact, any increase in cortical pressure could press on these capillaries' 
networks leading to efferent arteries' pressure changes.
Oxygen diffuses from arterial to venous vasa recta, which leaves the outer 
medulla deficient in oxygen. The medullary partial pressure of oxygen in the medulla is 
in the range of 10-20 mm Hg contrasting with the partial pressure of oxygen in the cortex 
that is about 50 mm Hg (Brezis et al, 1994). Therefore, medullary hypoxic injury is an 
inevitable accompaniment of efficient urinary concentration, and when oxygen is further 
impaired in the medulla it will lead to necrosis of the tubules that are most remote from 
vessels. Tubule's potential to ischaemia and acute tubular damage is often a reflection of 
renal hypoperfusion (Howie and Lote, 1996). It was suggested that the hypoxic 
impairment of reabsorption ia the medullary thick limbs would reduce the glomerular 
filtration, which could relieve medullary oxygen insufficiency whenever the workload 
exceeds capacity this would form part of the tubulo-glomerular feedback (TG) mechanism 
(Brezis et al, 1994). Cells in this region are able to use anaerobic metabolism but this 
would be impaired by a long interval of the hypoxia (Howie and Lote, 1996).
4.1.Le) The Glomerulus
The renal corpuscle consists of a tuft of specialised capillaries attached to the 
mesangium and both are enclosed in a blind tubule forming the Bowman’s capsule. A 
reflection of squamous epithelial cells at the vascular pole where both the afferent and the 
efferent arteries pass and become the parietal cell layer of the Bowman’s capsule.
1) Endothelial cells spread along the GBM facing the capillary lumen, they are large flat 
cells with characteristic round fenestrae. Thin diaphragm extends across these fenestrae, 
but do not pose a significant barrier to the passage of macromolecules. This diaphragm 
forms the initial barrier keeping the blood cellular constituents while permitting dissolved 
solutes like CM to be filtered through the GBM into Bowman’s space.
2) The GBM is composed of a central dense layer, lamina densa, and two thinner layers 
the lamina externa and interna. The GBM possesses negative charges that influence and 
impede the positively charged macromolecules' filtration.
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3) Mesangial cells with the surrounding matrix compose the mesangium, which is 
separated from the capillary lumen by the endothelium
4) Epithelial cells also known as podocytes consist of large cell bodies which divide into 
foot processes and come into contact with the GBM. Between adjacent foot processes 
derived from different podocytes there are filtration slits spaces. Any pathological fusion 
of foot processes forms continuos cytoplasmic band along the lamina externa.
4.1. l.fi Renal tubules ' morphology
The proximal tubules consist of three morphologically distinct segments. The 
epithelial cells of the first convoluted part Sj are distinct by their tall brush border and 
well-developed vacuole system. Si epithelial cells are also filled with mitochondria as 
they are involved in active transport. The basolateral membrane is extensively 
interdigitated. The 8 2  cell posses fewer vacuoles and mitochondria and shorter brush 
border. The S3 comprises the distal portion of straight segments of the medullary rays 
with rare vacuoles. The proximal tubule is the most common site of nephrotoxicity, this 
could be due to many factors like the large volume of fluid entering and concentrated 
within the PCT, its cytoplasmic and mitochondrial enzyme activities, its active transport 
system and the associated high metabolic rate.
The cells in the thin limbs of Henle vary in cell height according to the different 
descending limb lengths (i.e. different nephron positions). The cells in the ascending limb 
decrease in size as the tubule ascends from the inner strip to the cortex. The numerous 
mitochondria consistent with the high Na-K-ATPase are involved in active transport in 
the thick ascending limb. The medullary thick ascending limb (mTAL) is very sensitive 
to ischaemic damage because of the high energy demand for the active transport and the 
limited availability of oxygen (Brezis and Rosen, 1995). The oxidative metabolism 
required in this segment put this segment at risk of ischaemia in the case of reduction in 
the oxygen delivery or increase of metabolic demand. Approximately 30% of the filtered 
Na and K are reabsorbed in the segments of loop of Henle.
Distal convoluted tubule cells are taller than the cells of the ascending thick limb 
and have microprojection on the luminal surface. These cells lack the brush border and 
the endocytic apparatus.
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4.1.1.g) The interstitium
The interstitium in the cortex and medulla is composed mainly of mononuclear 
cells, fibroblasts and different extracellualr matrix proteins. It forms 9% of the compact 
cortex and increases deep down in the medulla where it forms up to 40% of the papilla. 
The role of the different interstitial cells in nephrotoxicity is still not very clear. In 
interstitial injury, mononuclear cells and fibrotic tissue ramify throughout the interstitial 
space. Histological tubulointerstitial injury is functionally significant in that scores for 
such injury rather than glomerular injury correlate with renal functional decline in 
assorted renal diseases (Bohle et al, 1981; Nath, 1992). Although changes in tubules and 
interstitium usually occur together, but there are few exceptions that show that the state 
of tubules is more significant than the state of interstitial tissues in determining renal 
function (Howie and Lote, 1996). For instance, there is no difference in renal interstitial 
inflammation and oedema between people with ARP or those that recovered from it 
recently, but there are differences in extent of loss of brush border and necrosis of PCT 
(Solez et al, 1979). Not all tubular damage is necessarily followed by interstitial fibrosis 
as there are many complicated factors that determine the eventual outcome. Interstitial 
inflammation can damage tubules for instance by cytotoxic effects of lymphocytes, 
release of fibrosis factors from macrophages such as TGF-p, PDGF, bFGF, and IL-4 
(Fine et al, 1993). Tubulointerstitial infiltration and apart from inducing fibrosis that 
leads to reduction in the peritubular vascular supply , but there could also be release of 
vasoconstrictor agents such as endothelin which may aggravate tubular ischaemia and 
contribute to further tubular damage (Howie and Lote, 1996).
4.1.2 Tubular cells regeneration
Unlike other functional organs in the body such as the heart and brain, the kidney 
is unique in possessing a remarkable capacity for restoring its structural and functional 
capacity after renal injury including full recovery from renal failure. The two most 
susceptible regions of the kidney are the S3 and mTAL which forms the medullary rays. 
After an injury phase, as there could be damage to epithelial cell and loss of the necrotic 
epithelial cell lining in these segments, there would be an intense regenerative process. 
The surrounding surviving cells would dedifferentiate and undergo mitosis and 
differentiation until the nephron segment could be restored (Bacallo et al, 1989). Renal
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dysfunction in ATN is attributable to sublethally injured but viable cells capable of 
complete recovery once the toxic or ischaemic insult is removed. Sublethal injury leads to 
loss of cell polarity as well as to loss of ceU-substrate adhesion with shedding detachment 
of the viable cell from the tubular basement membrane into tubular lumen (Lieberthal and 
Levine, 1996). This necrosed cell detachment results in cast formation and tubular 
obstruction. Other cells that have no apparent damage may proliferate to re-form the 
damaged nephron segments. The recovery phase is dependent on the repair capacity of 
the kidney for replacing the necrotic epithelial cells (Lake and Humes, 1994).
Individual tubular epithelial cells may undergo one of several different fates upon 
exposure to a toxic or ischaemic insult (Majno and Joris, 1995; Lieberthal and Levine, 
1996) and these fates are either:
1. Necrosis of severely damaged cells.
2. Recovery of the non-lethally damaged cells, but might show subcellular signs of 
potential injury like blebbing of the endoplasm reticulum, sloughing of brush border and 
mitochondrial swelling.
3. Proliferating of the non-injured cells to re-form the damaged nephron segments.
4. Some cells undergo programmed cell death (apoptosis), not triggered by any lethal 
injury.
A number of other factors such as oxygen supply may influence the severity of 
injury suffered by cells in different regions of the kidney and therefore the fate of these 
cells following injury. Differences in oxygen tension between the cortex and medulla 
predispose cells in outer medulla to extreme oxygen deprivation more than those in the 
cortex and mner medulla. (Brezis and Rosen, 1995).
4.1.2. a) Tubular cell necrosis
Cellular necrosis results from severe ATP depletion and the consequent collapse 
of cellular homeostasis (Majno and Joris, 1995). Necrosis induced by rapid and severe 
depletion of cellular energy stores, leads to impaired membrane transport activity and a 
resultant influx of sodium and water into the dying cell, i.e. loss of the energy dependent 
sodium pump (Lieberthal and Levine, 1996). This results in cellular swelling, a
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characteristic finding in necrosis as well as loss of functional and structural integrity of 
plasma membrane. This is the principle behind the vital dye such as trypan blue used to 
assess the viability of cells. Loss of plasma membrane integrity also leads to leakage into 
the extracellular space of cytosolic contents. In contrast to necrosis, apoptotic cell 
excludes trypan blue (Majno and Joris, 1995).
Regeneration of epithelial cells after toxic insults like mercuric chloride 
administration had been observed within two days, and most tubules had been relined 
with new epithelium by the fifth day (Cuppage et al, 1972). A similar time course of 
tubular cell regeneration after bilateral renal occlusion was also reported (Humes et al, 
1989). The process of regeneration and repair by surviving epithelial cells at the edge of 
the injured segment is most likely dependent on growth factors production (Toback 1992; 
Bonventure, 1993). Of the most relevant regenerating growth factors are epidermal 
growth factor, platelet derived growth factor, insulin-like growth factors and hepatocyte 
growth factor. The role of growth factors in regeneration is based on functional and 
histological evidence from several experimental works (Miller, 1996).
4.1.2. b) Markers o f renal cells regeneration
Several techniques available to detect cellular regeneration, of the most commonly 
used are:
• [^H] Thymidine is used for incorporation into dividing cells mostly in cell culture.
However and as Thymidine is also incorporated into repaired DNA with any unscheduled 
DNA synthesis, therefore, it is less specific in detecting cellular regeneration.
• immunodetection of the proliferating cell nuclear antigen (PCNA)
• the incorporation of 5-Bromo-2-deoxyuridine (BrdU) is used in quantitation of 
regenerating cells. BrdU is an analogue of uridine and is incorporated specifically into 
DNA in place of thymidine. Cells can be pulse labelled with BrdU while they are in the S 
phase of cell cycle, so they will incorporate BrdU into their synthesising DNA.
4.1.3 CM-induced renal morphological changes
Case reports of CM-induced morphological changes are mainly from those of pre­
existing renal disease, thus virtually little is known about the normal kidney sustaining 
ARF after CM. As CM are usually not associated with pathological lesions that require
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biopsy, therefore, most of the morphological description of CM-induced morphological 
changes are based on experimental animal work. In most of the previous studies the renal 
structural lesions observed consisted of cytoplasmic vacuolation in the PCT epithelial 
cells, as different types and doses of CM produced vacuoles in clinical and experimental 
studies (Moreau et al, 1980; Holtz et al, 1987; Powell et al, 1985; 1989; Avades, 1992; 
Tervahartiala, 1993; Avades et al, 1994; Walday et al, 1995; Dobrota et al, 1995; 
Morcos et al, 1996; Tervahartiala et al, 1991; for further details see 1.5.4).
Due to the high osmolarity of the first generation of CM this process was first 
described as osmotic nephrosis (Moreau et al, 1980). These epithelial swellings begin an 
hour after the administration of the hyperosmolar solution and they reach their maximum 
at 48 hours but disappear in about 15 days. The explanation was that many compounds 
(such as sucrose) may produce hydropic vacuolisation of PCT cells if they are present in 
sufficient hyperosmolar concentration. Powell et al, (1985) observed that more vacuoles 
were present after the non-ionic LO dimer iodixanol than after the monomer iohexol. 
Vacuoles that follow acacia and gelatine administration are associated with the formation 
of similar morphological changes termed hyaline droplets, without any relation to 
hyperosmolarity. These hyaline droplets are eosinophilic masses found within the 
cytoplasm of the PCT. It was thought that these droplets were due to reabsorbed proteins 
which had been endocytosed by the tubular epithelium, but their origin is still not very 
clear (for further details see 1.4.4). As the extent of vacuolation is greater with the low 
osmolar the term osmotic nephrosis is not correct to describe them anymore. These 
vacuoles, are rather like enlarged hyaline droplets which vary in their electron density 
from almost empty vacuoles to the dense eosinophilic droplets associated with 
proteinuria.
Vacuoles are reported to stain positively for acid phosphatase (Avades, 1992; 
Rowlands et al, 1994), thus confirming their association with the endosome/lysosome 
compartment. The lysosomal changes reflect direct effects of the injected CM agents, 
although there is no clear experimental evidence to link vacuolation with CM-induced 
renal failure (Battenfeld et al, 1991). CM-induced vacuoles with various types of CM 
were formed after the induction of experimental lesions such as diabetes, dehydration, 
and haemorrhagic pancreatitis (Tervahartiala, 1993). These CM-induced vacuoles were 
shown to be reversible and not associated with any damage to vital organelles thus
168
Tervahartiala, (1993) concluded that these vacuoles were without any functional 
consequences. However, it is known that transient loss of renal function could occur 
without any apparent cellular damage.
Most CM were shown to induce vacuoles but the variant degree of CM vacuoles 
was found to be dose dependent (Powell et al, 1989; Laftah, 1993; Tervahartiala, 1993), 
and group dependent (Powell et al, 1985; Powell et al, 1989; Dobrota et al, 1995; 
Laftah, 1993). When comparing the extent of vacuolation by various CM it was found 
that more vacuoles were induced with iodixanol, iotrolan, ioxaglate, and to a lesser 
extent with iohexol and diatrizoate but least with iothalamate. Vacuolation also differs 
with different renal conditions (Tervahartiala, 1993; Avades et al, 1994). The extent of 
vacuole formation was shown to vary with intra tubular changes such as those of tubular 
casts' formation and lithium-induced polyuria (Avades et al, 1994).
4.1.4 Renal retention of CM
Experimental evidence is clear enough to show that the contents of these vacuoles 
are CM iodine that has entered the cells by endocytosis. High concentration of iodine 
signal was detected from these intracellular vacuoles (Nordby et al, 1990). Therefore, 
vacuole formation could reflect an internalisation of the filtered CM. The relation 
between the extent of vacuole formation and iodine retention in the kidney is another 
good evidence in respect to the iodine content of these vacuoles (Avades, 1992; Laftah, 
1993).
Although the various morphometric assessments that were used in previous iodine 
retention work were sufficient for comparative qualitative studies, but these subjective 
methods still need further quantitative evaluation. Delayed cortical enhancement was 
observed in patients with normal renal function (Love et al, 1989). Cases with persistent 
cortical nephrogram were reported after trauma, inflammatory renal diseases and renal 
infarction (Braedel et al, 1987). Persistent nephrograms following the use of low osmolar 
CM, have been associated with incomplete elimination rates. It was shown that different 
CM produced different degree of retention as the non-ionic dimer iodixanol caused more 
pronounced increased attenuation of the cortical region than any other CM, which 
remained high for more than 48 hours (Jakobsen et al, 1992). Some 2% of iodixanol dose 
is retained within the first 24 hours in healthy volunteers’ kidneys which may represent
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significant intracellular retention. However, it was concluded (Jakobsen et al, 1992) that 
the retention of CM was not correlated to any tubulotoxic effects (for further iodine 
retention details see 1.5.5)
4.1.4. a) Measurements o f iodine retention and excretion
Methods employed to quantitate CM retention and excretion in the kidney were 
either by the use of labeled CM (Heglund et al, 1995) or by radiological quantitation of the 
amount retained in the kidney by computerised tomography (CT) (Love et al, 1989; 1994; 
Jakobsen et al, 1992). However, each method has its drawbacks. So while the radio­
labelled method is sufficiently sensitive its drawbacks are:
1. The expensive procedures required to label the CM that are required to be examined
2. The study cannot be achieved to compare different CM as one labeled CM could be 
studied at a time.
3. The risk associated with the use of radioactive materials.
These practical difficulties make this approach not simple to assess iodine retention. 
Furthermore, the use of isotopes would normally preclude the use of such an approach in 
human studies.
On the other hand although the use of computerised tomography (CT) does allow in 
vivo assessment but it is more of a qualitative rather than an accurate quantitative method to 
asses CM retention. Also this method cannot be used to measure iodine concentration in 
urine and plasma.
Therefore, an accurate iodine measurement method which has fewer disadvantages 
was required to be developed for experimental study. After evaluation of different methods 
used to measure trace elements such as iodine further validation for the x-ray fluorescence 
for measurements of iodine retention was carried out.
4.1.4. b) What is X-ray fluorescence
X-ray fluorescence (XRF) is a technique used to identify and quantify chemical 
elements in a sample. XRF takes place at the atomic level, and is analogous to the effect 
produced from fluorescent paint when it is illuminated by light. The technique relies on 
the fact that when a sample is excited (irradiated) by a primary source of x-ray, these x-
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rays cause K-shell electrons in the atoms of the sample to jump to higher energy levels. 
On dropping back to the original energy levels the electrons emit precise energy, whose 
energies are characteristic of the specific element present, iodine in this case. The 
intensity of the x-ray emitted from the sample at a particular energy is directly 
proportional to the concentration of that element in the sample, so it is possible to 
identify and quantify the elements in the sample. These emitted X-rays are detected by a 
lithium silicon detector, almost the same principle behind x-ray imaging using iodine 
containing CM and X-ray film instead of the detector.
The first clinical use of X-ray fluorescence analysis in vivo was to image the 
distribution of naturally occurring stable iodine in the thyroid gland (Hoffer et al, 1968). 
This technique is the principle behind the analytical instrument RENALYZER® which is 
specially designed for quantitative determination of the iodine content in plasma or urine 
It enables measuring the disappearance from the plasma of injected CM especially the 
nonionic monomer iohexol (O’Reilly et al, 1986; Brown and O’Reilly, 1991) which has 
replaced the measurement of GFR by other techniques such as the use of ^ ^Cr-EDTA, 
radioactive inulin, ^^°^c-DTPA and creatinine clearance.
The same principle was used primarily to measure the amount of iodine retention 
in kidneys of experimental animals with different renal lesions (Avades, 1992; Avades et 
al, 1994). Vacuoles that were quantified by morphometric analysis were correlated with 
iodine retention, as a dose response was obtained with increasing amounts of the 
isosmolar dimers (Laftah, 1993). The lack of retention with high osmolar ionic CM was 
consistent with very low extent of vacuolation. Moreover, iodixanol retention values 
measured by X-ray fluorescence (Avades, 1992) were similar to those obtained by "^^ C- 
iodixanol (Morcos et al, 1996).
4.2 Methods
Animals from different experimental models (Chapter 3 section 3.3) were selected 
for the study of the CM-induced morphological and cellular changes.
4.2.1 Autopsy procedures
Animals were anaesthetised with Sagatal dose of O.lml/lOOg body weight (if 
perfusion fixation was carried out) or with CO2 asphyxia (if normal fixation). The
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abdominal cavity was opened. Blood samples were aspirated from the aorta (immediately 
before perfusion fixation ) or directly from the inferior vena cava and kept in heparin tubes. 
Perfusion fixation as described below was carried out on 2 animals in any subgroup of 5 
animals. For the remaining animals in the subgroup routine post-mortem was carried out.
Macroscopic examination of the viscera was carried out and kidneys were inspected 
grossly for any abnormal findings specially during cut sections.
4.2.2 Perfusion fixation
4.2.2. a) Materials
Perfusion saline buffer: 0.9% NaCl 
Perfusion fixative-which consists of the following:
125 ml of 8  % Paraformaldehyde 
50 ml 25% Glutaraldehyde 
350ml 0.2M Sodium cacodylate; Nitric acid .pH 7.4 
0.4% by weight Lidocaine 
Finally check pH and adjust to 7.4 if necessary and finally make up to 500 ml. Both the 
buffer and the fixative at 37°C were perfused at 100 mm Hg or at a rate of 10 ml/min 
(physiological rate).
4.2.2.b) Operative procedures
The following procedures were carried:
• Open the abdominal cavity and expose the aorta bifurcation below the kidney
• Loosely tie a ligature around the aorta
• Insert 2 cm of polypropylene cannula into the aorta from the bifurcation point and keep 
it in place by tightening the ligature
• Collect approximately 1 ml blood from cannula
• Insert perfusion connector into the cannula
• Immediately start pumping salme ensuring that an initial perfusion rate of just under 10 
ml/min is maintained or pressure of 100 mmHg (physiological flow rate of blood)
• Clamp the right renal artery.
• Clamp the aorta above the kidney (using Spencer-Wells forceps).
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• Cut vena cava , clamp the mesenteric vessels to insure saline and fixative are not wasted 
and the flow and pressure through the kidney is maintained.
• Cut the ureter.
• Open the thoracic cavity ,cut diaphragm, and move intestine to one side to expose the 
kidneys.
• Cut and weigh the right kidney which is used for iodine measurements
• Change to the perfusion fixative once the left kidney is blanched and clear of blood
• Remove the kidney once fixed (hard to the touch). Cut kidney longitudinally from 
capsule to the renal pelvis. Blanched of most white appearance of medulla indicates a 
successful fixation.
• Pieces from the perfused fixed left kidney cortex and medulla were cut into 0.5 mm 
cubes with a razor blade
• Keep pieces covered with a enough perfusion fixative (never let them to dry) until they
are tranksferred to buffered glutaraldehyde for 2-4 hours fixation {as in 4.2.4)
• Cut the rest of the perfused kidney longitudinally and keep it in 10% neutral buffered 
formalin for light microscopy {as in 4.2.3).
4.2.3 Preparation of specimens for histological examination:
4.2.3. a) Tissue processing
After at least one week in formalin the kidneys were taken and processed for 
histopathological examination. The tissue was embedded in paraffin wax by cutting a piece 
of tissue 2-3 mm in thickness from each sample and placed in a processing container 
together with the appropriate reference number. The container was placed in a tissue basket 
which was then fitted to the tissue processor (Histokinette ®). After this process the tissue 
container were transferred to be embedded in paraffin wax.
Sections were cut from the blocks by a microtome at a thickness of 4 pm. The 
sections were floated first on a solution of weak detergent and later transferred to distilled 
water at a temperature of 55°c. The sections were mounted on slides and dried on a hot 
oven for few hours to dry.
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4.2.3. b) Staining for histological examination
• Xylene 2 solutions for dewaxing 1 minutes in each
• Alcohol 100%, 100%, 95%, 70% 1 minute in each
• Rinse in distilled water for 2 minutes
• Routine haematoxylin and eosin staining and periodic acid schiff staining were carried 
out and as follows:
4.2.3.c) Haematoxylin and Eosin (H&E)
Bring section to water 
Haematoxylin 10 minutes
Rapid wash with water just to clear from blue colour 
Differentiate in 1 % HCl Acid alcohol until pink not more than 10 seconds.
Running tap water once turned blue not less than 5 min.
Check under microscope 
Counterstain with Eosin 10 minutes 
Tap water few seconds
4.2.3. d) Periodic Acid-Schiff (PAS)
• Bring section to water
• Oxidise in 1 % periodic acid 5 minutes
• Wash in running tap water 5 minutes
• Rinse in distilled water
• Treat with Schiffs reagent 30 minutes
• Running tab water 10 minutes
• Haematoxylin 10 minutes
• Wash m tap water
• Differentiate in 1 % acid alcohol
• Wash in tap water for 10 minutes
For both staining techniques, dehydration and mounting were as follows:
• Dehydrate with 75%, 90%, 100%, 100% alcohol 30 seconds by repeated dipping in 
each
• Then transfer to xylene and check the staining and moimt in DPX with cover slip.
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4.2.4 Electron microscopy methods
4.2.4. a) Preparation ofsamples for electron microscopy
Only the perfused kidney was taken for electron microscopy, pieces from cortex, 
medulla were cut into 0.5 mm cubes with a razor blade and left in buffered glutaraldehyde 
mixture for 2-4 hours fixation. After 4 hours material which was not processed for EM 
was transferred to storage buffer.
Tissue processing was carried as follows:
The pieces were washed many times with cacodylate buffer 0. IM 
Tissues was counterfixed with 2% buffered osmium acid in 0.1 M cacodylate HN03 
(pH7.3) at room temperature in fume cupboard for 1 hour.
2 X 10 minutes in each of 25%, 50%, 75%, 96%, and 100% alcohol.
2 X 10 m inutes in 1:1 propylene oxide :absolute alcohol.
2 X 10 m inutes in propylene oxide
One hour in a mixture of 1:1 propylene oxide and Epon® 812 (TAAB® Laboratories) 
resin
Chosen cubes were transferred to the resin -filled capsule, 2-3 blocks per capsule.
The surface of the resin was stirred slightly to make sure the blocks were not floating. 
The resin was polymerised for 12 hours at 60°C in TAAB embedding oven.
After polymerisation, ultra thin section were c u t , mounted on grids by the staff of the
Microstructural Studies unit and stained for toluidine blue stain for LM {as in 4.2.4.b) 
before selected samples were counterstained for EM.
4.2.4. b) Staining ultrathin sections for light microscopy:
• Transfer ultrathin 2pm sections to a small drop of 20% acetone on a clean glass slide.
• Heat the slide gently on a hot plate (60°C) to dry and flatten the sections.
• Cover sections with a drop of staining solution (1 % toluidine blue and 1 % azurll in
1 %borax) and heat gently for 1 minute.
• Do not allow solution to boil.
• Drain off excess stain and wash sections well with distilled waster.
• Shake off excess distilled water.
• Dry by warming gently. (Richardson et al, 1960)
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4.2 A. c) EM materials
Selected ultrathin grid sections from toluidine blue light microscopy assessment 
were chosen and counterstained with lead citrate and uranyl acetate for EM. All materials 
for EM preparations were obtained from "TAAB Laboratories™
1) Buffered Glutaraldehyde; 100 ml of 4% glutaraldehyde in 0.1 M Cacodylate buffer
2) Buffered 2% osmium acid. Mix equal amounts of osmium tetroxide (4%) and buffered 
cacodylate (0.2M sodium cacodylate pH 7.4 with H2NO3)
3) Storage fixative buffer (O.IM sodium cacodylate, 4% formaldehyde, 1% glutaraldehyde)
4) TAAB 812 RESIN ®: The mixture recommended for medium hardness blocks was made 
up as follows :
• 24 g TAAB 812 resin,
• 9.5 g DDSA EM grade,
• 16.5 g MNA EM grade
• Ig DMP-30,
5) The components were mixed well and fresh preparation was used for embedding 
samples. Freeze the rest of the mixture which could be used later on only after single 
thawing.
4.2.5 BrDU labelling of renal cells after CM
30 male Wistar albino rats 4 weeks of age were obtained from Bantin & Kingman. 
Animals were housed 2 per cage and all animal conditions were as described in 3.2.1. 
Animals were randomly allocated to 6  treatment groups (5 anim als/grou p ), for iv saline 
(group 1), 3 g I/kg iothalamate (group 2), 3 g I/kg iodixanol (group 3 and 6 ), 1 g I/kg 
iodixanol (group 4) and 0.3 g I/kg iodixanol (group 5). After iv dosing all animals 
received bromodeoxyuridine (BrDU) from miniosmotic pumps (Azlet 2MLI, release rate 
10 pi/ hour for 10 days). Animals were anaesthetised with halothane and the pumps 
implanted sc. in each animal. Each pump contained a filtered solution of BrDU at a
concentration of 50 mg/ml made up in 0.5M NaHC0 3  pH 8 . Filling was checked by
weighing and pumps were pre-primed for at least 1 hr in sterile saline before 
implantation.
After 10 days (5 days in group 6 ) animals were sacrificed by CO2 asphyxiation 
and examined for any macroscopic abnormalities. Terminal blood samples were taken
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from the inferior vena cava and transferred to heparinised tubes. Plasma was separated at 
10,000 RPM for 10 min.
Kidney samples were processed for histological examination (as described in 
4.2.3). Serial sections (4mn) of formalin fixed, wax embedded kidney tissue were stained 
with H&E, and PAS. Proliferating cells were demonstrated by double immunostainning 
for BrDU
4.2.5.a) BrDU labelling
Treat slide with Vectabond ® (from Vector™) 
cut 4-5 pm sections
include a section of control tissue (Testes sections) 
take sections to water (through xylene and ethanol) 
sections are allowed to drain before hotplatting at 60°c for 30min 
leave to dry on hot plate
dewax through xylene 2min X 2 and graded alcohol 30 sec in each 
wash thoroughly in DW
block for endogenous peroxidase with 0.3% H2O2  in methanol, for 20 mins ( 1  ml of 
30% w/v H2O2 in 100 ml methanol) 
wash in water then rinse in PBS
denature DNA by soaking slides in freshly prepared 2M HCl containing 0.2 mg/ml 
pepsin (P-7012® Sigma™) for 1 hour at RT. Pepsin dissolve slowly prepare early 
terminate acid hydrolysis by washing sections in borate buffer, pH 8.5 for 2 X5 min 
(0.62g boric acid +  0.95g sodium tetraborate in 100 ml DW) 
wash in PBS X 3 changes
microwave slides in 0.1 % citrate solution in 15 min 5 min x 3 intervals and topping 
the solution in between 
wash in PBS
apply horse serum (as the biotinylated 2nd layer was raised in horse) diluted in PBS 
(1% normal horse serum + 0.1% crystalline BSA in PBS which is solution A) for 30 
min.
• do not rinse off normal saline, just tap off excess liquid wipe around the section and 
apply the first layer AB, diluted in solution A for 3 hours room temeprature.
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• incubate sections with anti BrDU (DAKO™ monoclonal mouse Anti-BrDU clone 
BU20a code No M0744) 1:200 in solution A for 3 hrs RT
• wash slides 3 times in PBS
• apply biotin-conjugated anti-mouse Ig (dilutes 1:200 solution A) PBS for 30 min.
• wash thoroughly more than 3 times m PBS
• make up 3rd layer in 5ml solution A (add 2 drops of A and 2 drops solution B
streptavidin-biotin peroxidase complex ABC® Vector™) and allow to stand for 30 min
• apply 3rd layer of ABC for 30min.
• wash in 3 changes in PBS
• wash in running water
• prepare 500 ml of Tris-Hcl (125 ml 0.2M tris add to make 500 ml with DW pH 7.4) 
take 200 ml and add 2ml DAB solution of 25mg/ml, and 4 ml of 1 % cobalt chloride
• leave slides for 5 m in in the other 300 ml and then transfer to the 200 ml for 5 m in  
add 200ul of 30% H2O2 for 2.5 min, wash back in the Tris, and observe the staining
• counterstain in 20-60 sec with haematoxylin
• wash and counter stain for PAS.
4.2.5.b) Stereological and quantitative analysis o f  proleferating tubular cells
The number of proliferated cell nuclei were determined by the number of BrDU 
labelled nuclei. As the kidney is heterogeneous in structure and since the extent of 
regenerating renal tubule ceUs after injury depends upon the location of the tubule, 
comparison between different groups was achieved with similar topographic areas in the 
kidney. Brdu labelled hnmunostained nuclei were coimted in the cortex and subcortex 
area “corticomedullary junction” in the saline group and compared with the other five 
different CM groups.
For consistency in counting identical renal areas, topographical comparison was 
carried out. Kidney sections were placed under low power (X 10) so that the outer edge 
of the cortex would be lined up with the border of the eyepiece graticules before counting 
the stained nuclei under the grid at higher power (X 40). Counts from this area represent 
the cortex. For the subcortex area the microscope stage was moved one large square grid 
(XIO) to the edge of the corticomedullary junction and the stained nuclei were coimted at
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high power (X 40). The average of three counts from each area was taken from each 
section.
4.2.6 Assays of the kidney, tissue, urine and plasma samples for iodine content by
X-ray fluorescence
The percentage uptakes of iodine by the kidney and other tissues and the 
concentration of iodine in urine, stool and plasma samples were measured by x-ray 
fluorescence. The principle of X-ray fluorescence, as described in details in 4.1.4. b, was 
basically by irradiating the samples by intense beam of X-rays (from an Americium 
source).
For each of the iodine standard concentrations, urine and plasma samples a volume 
of 1 ml was transferred to plastic test tubes (of 1 0  ml), while for tissues geometrically 
equivalents to one gram were weighed and transferred to similar test tubes. Urine and 
plasma samples were diluted to 1 ml if required. Sample test tubes were placed in a purpose 
wooden made holder assembly 2.5 cm far from the source (see Fig. 4.1 A, B and 4.2A). 
This was necessary in order to retain a constant geometry throughout the measurement 
period. They were subjected to an intense beam of (59.5 KeV) X-rays from an 7.4 GBq 
source of a “^^^Am 200mCu in lead container with 1 mm aperture. The characteristic 
fluorescence X-rays, generating at Ka^ of 28.612 and Ka 2  of 28.3172 KeV from iodine 
atom photon which were emitted in a cone perpendicular to the source beam, were detected 
(Fig 4.2A, B and 4.3). These emitted X-rays were detected by a Lithium Silicon-detector 
type (EG & G Ortec® Ltd) and were recorded on a 4 k Multichannel Analyser MCA (Series 
20 Camberra™). A signal processor 2010 (supplied from Lmksystem ®) with an Amplifier 
2011 to intensify the signals were coimected between the detector and the MCA. The 
settings for the pulse processor were as follows: processing time 40; range 40; cal. 10; in 
put range limit 10; lower energy threshold 7. The MCA was set with a narrow window 
around the Ka line of 28.5KeV. Region of interest ROI (which represents area under the 
curve) and counts (which represent peak counts in the channel set exactly on the iodine Ka 
line) were collected over 100 seconds using live time. The plot of the different region of 
interest values were processed through a TNI PCA-II ® attached to the MCA with ORTEC 
533 DUAL SUM AND INVERT with a BORLAND C+ +  ® programme, and parameter 
settings were as follows; Mode PHA, Time Live, Scale (256-2K) ROI No 1, ROI ON,
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Gain 4096, Off set 0, Adc Add, Display 2048, Overlap Off, Chn 2578-2581. The distances 
and angles between the source, sample and the detector were optimised for the lowest 
background and the best yield signal as shown in Fig 4.1; 4.2 and 4.3.
Iodine standards were prepared in a range of concentrations from 0.01- 330 mg 1/ 
ml. The lowest detection limit of the method was 0.2 mg I/ml whüe the highest was 40 mg 
1/ ml since the curve was linear after 60 mg I/ml. Therefore the range of standard 
concentrations that were used was between 0.2- 20 mg I/ml. A yield factor for the samples 
was calculated 6 om a standard curve obtained with each run and as illustrated in Fig 4.3,
4.4, 4.5. Urine, plasma, liver, spleen, stool and kidney samples were collected as stated in 
the experimental protocol.
4.2.7 Experimental protocol for iodine excretion and retention
Four experimental animal groups were set up in order to examine the effects of 
different CM treatment, renal function status and intervals between CM adm inistration  
and autopsy as stated in the experimental groups. CM were administered iv. at a dose of 
3 g I/kg. Urine, plasma and autopsy tissue samples from the four experimental groups 
were collected for iodine X-ray fluorescence measurements as described in 4.2.6. Animal 
housing, food and water were as described in 3.2.1.
Animal experimental protocol for X-ray fluorescence
Group 1 (The effect of different CM in UrAc induced renal failure)
Thirty rats (320-400g) were divided into two subgroups of 15 rat each, the first subgroup 
being the control, while the second subgroup was that after 3 days from the 3 mg/kg 
UrAc-induced renal failure. Both subgroups were further subdivided into 3 groups for 
either iohexol, iodixanol, or iothalamate treatment. Kidneys were collected after 48 
hours.
Group 2 (The effect of different osmolarities in UrAc induced renal failure)
Twenty rats (320-400g) which had sc. 3 mg/kg UrAc-induced renal failure after 72 hours 
were divided into 4 subgroups for iv. saline, iodixanol (osmolarity 290), iodixanol with 
2 0 % Mannitol (osmolarity 1000), and iothalamate (osmolarity 2000) all were dehydrated 
overnight as above. Kidneys were collected after 96 hours.
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Group 3 (UrAc-induced renal failure)
Ten rats (320-400g) were divided into two groups of 5 each, the first group as the control 
without the UrAc. induced renal failure, the other group had sc. 3 mg/kg UrAc-induced 
renal failure and after 5 days both received iv. iodixanol after overnight dehydration, 
kidney samples were collected after 48 hours.
Group 4 (iodine retention after 2 week of UrAc induced renal failure)
Twelve rats (320-400g) were divided into 3 subgroups, 3 days after a dose of 3 mg/kg 
UrAc. Two subgroups received iv either. Ig I/kg of iodixanol or 3 g I/kg iodixanol after 
overnight dehydration the third subgroup was not dehydrated and received 3 g I/kg 
iodixanol. The iodine retention was determined 14 days after dosing.
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PURPOSE
MADE
HOLDER (H)
PCA MICRO 
COMPUTER
SIGNAL 
AMPLIFIER (A)-  MCA
LITHIUM/ 
SILICON 
DETECTOR(D)
AMERCIUM SOURCE (S) IN
1 MM APPERATURE LEAD 
CONTAINER (L)
Figure 4.1 A) Schematic representation of X-ray fluorescence set up.
in H saaam |n
Figure 4.1 B) Photograph of the set up for the measurement of iodine by X-ray fluorescence.
U= sample; 8= Americium^"*^ Source; D=Lithium/silicon detector; H= purpose made wooden sample 
holder; L= lead shield; N=Liquid Nitrogen; A=Signal Amplifier; M=MCA.
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Figure 4.2 The x-ray fluorescence set up and iodine peak as displayed by the MCA
(A) (Upper photograph) The purpose-made wooden sample holder (H) allows the accurate and 
reproducible location of the sample (U) in relation to the Americium source aperture (S) and detector 
(D)
(B) (lower photograph) The display from MCA; ROI for iodine is shown highlighted in red.
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X-RAY FLUORESENCE OF A RANGE OF STANDARD IODINE 
CONCENTRATIONS
60000 -P 1600
..1 4 0 0
50000
. .  1200
<  40000I
30000
. .  1000
ROI(NET)
5
z
800
COUNTS
600
O  20 0 0 0 ..
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10000 . .
200
0 ».
0 50 100 150 200 250 300 350
IODINE CONC. IN mg/ml
Figure 4.4 ROI(net area) and counts in 100 seconds of readings from a range of iodine 
concentrations . ROI measurements were compared to those of peak counts per 100 seconds. The 
sigmoid shape graph shows the limit of detection as 0 . 2  mg/ml iodine was the lowest (peak 
counts=18), at higher concentration the curve starts to be straight after 60 mg I /ml.
IODINE STANDARD CURVE BY X-RAY FLUORESENCE
25000
20000
y = 1163 .7x+ 348.14 
= 0.98985  15000
—  10000
5000
20 4 6 8 12 1610 14 18 20
IODINE CONC. mg/ml
Figure 4.5 Standard curve of different iodine concentrations (0.2-20 mgl/ml) calculated by X-ray 
fluorescence. The Region Of Interest (ROI) was chosen from a high iodine standard.
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4.3 Results
4.3.1 Renal morphology
This results section illustrates the pathological changes induced by different 
nephropathy models and C M  in the rat kidney. Each figure of four micrographs 
illustrates sections that were stained either by H&E, PAS or toluidine blue (TB). Electron 
microscopic findings are also presented to complement the ultrastructural changes. The 
legend beneath each micrograph illustrates the type of stain, anim al group, C M  used and 
magnification power (X); the figure legend illustrates different pathological findings as 
they are marked by corresponding letter between brackets.
4.3. La) Fixation and perfusion artefacts
For good tissue preservation it is preferable to fix by perfusion rather than 
immersion. Care in perfusion fixation is also required as high perfusion pressure could 
lead to separation between epithelial cells forming vacuole artifacts (Fig 4.7D). This was 
most likely due to the fact that the perfusion pressure was higher than the physiological 
flow rate.
4.3.Lb) Control rat model
In the control rat and after CM administration the renal morphology showed 
vacuole formation in the PCT cells mostly after the dimer (iodixanol) (Fig 4.6A). As 
these CM-induced vacuoles were different in size and some of them were smaller than the 
thickness of paraffin section, ultrathin grid sections of 1 pm thickness were stained for 
toluidine blue (TB) for additional quantitative analysis of these vacuoles, and for 
distinctive illustration of the brush border. The extensive vacuolation and brush border 
integrity were clearer with the ultrathin sections that were stained with TB (Fig 4.6 B & 
D)
In the control animals, apart from vacuole formation, no lesion could be detected 
that would indicate tubular or glomerular damage due to different CM. Although PCT 
cells showed high number of vacuoles after iodixanol but they had maintained their 
morphological integrity. TB thin sections (Fig 4.6 B) showed intact brush border which
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was uniformly arranged and lined the PCT cells. In general there was no indication of 
any cellular necrosis. Glomerular structure was also intact (not shown in these control 
group micrographs) and there were no signs of any interstitial infiltration. CM-induced 
vacuoles were characterised by different sizes and shapes which were identified at 
different levels just beneath the brush border at the lumen surface. In general they were 
round-oval in shape with different dense material inside them.
4.3.1. c) Old age nephropathy (Group D)
The glomeruli in old age ( > 1 6  months) nephropathy (Fig 4.6 C&D ) showed 
signs of sclerosis, the interstitium is infiltrated with mononuclear cells and fibrosis, 
many tubules showed epithelial cell atrophy with hyaline cast formation which were the 
main background pathological features of this model. Renal function assessment showed 
proteinuria with impaired renal function, these findings were in consistent with the 
degree of glomerulosclerosis and tubulointerstitial fibrosis {see section 3.5.2.d). After 
administering CM there were no detected changes in the extensive background pathology 
of old age nephropathy apart from CM-induced vacuolation. In general the extent of 
iodixanol-induced vacuolation was higher m the old age in comparison to those induced 
in the control group. Morphologically CM-induced vacuoles in old age were 
characterised by small rounded vacuoles with different densities giving the appearance of 
foamy tubules. Iothalamate, that hardly induced apparent vacuoles in the control, induced 
few vacuoles in the old age however at a lower extent in comparison to those by 
iodixanol.
It was observed that iothalamate induced transient increased plasma creatinine 
levels in this old age ( > 1 6  months) model {section 3.5.2 d). However, the transient 
renal impairment could not be illustrated by any distinct pathological change that would 
be attributed solely to further impairment of renal function. The pathological 
backgrounds of old age are variant to an extent that it was difficult to relate any 
pathological change (apart from vacuole formation) to CM.
Electron microscopic examination of the renal cortex was focused mainly on the 
glomeruli and the PCT, which consists of Si segment and the cortical part of 8 % segment. 
Ultrastructurally vacuoles were membrane bound as shown with those from old age 
nephropathy model treated with iodixanol (Fig 4.12 A) & iohexol (Fig 4.12 B & C).
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These vacuoles were of different densities and some contain different electron dense 
materials (Fig 4.12 C). Most vacuoles are large in size with >  Ip  in diameter and some 
were surrounded by small satellite like vacuoles (vesicles) which showed early signs of 
fusion to each other (Fig 4.7 A, B &C). In spite of the large number of CM-induced 
vacuoles ultrastructurally there were no other cellular changes. The nuclei as well as 
other vital organelles were intact and without any signs of necrosis or damage (Fig 4.12 
A&B).
4.3.1. d) Nephrectomy model
Renal ablation (5/6 nephrectomy) was characterised by features of compensatory 
renal hypertrophy of the remaining kidney. This was particularly prom inent with the 
glomeruli (Fig 4.7 A&C) as there was an average of 1.5-fold increase in glomerulus size 
(an average width of 55-60 on an arbitrary scale measured by the eyepiece graticule) in 
comparison to those of sham operated animals (with an average of 35 on the same 
arbitrary scale). Areas of interstitial infiltration and fibrosis were scattered in the whole 
renal mass intercalating between tubules characterised by islands of inflam m atory cell 
infiltration in different regions of the kidney (Fig. 4.7 A& B).  These mild pathological 
findings were in consistent with the mild degree of renal impairment that was 
encountered after 4 weeks of nephrectomy (see 3.5.3). After 96 hours of a repeated dose 
of CM (five days between two doses of 3 gl/kg of CM) iodixanol showed consistent signs 
of PCT vacuole formation and bleb formation, but with an intact brush border of the PT 
cells (FIG 4.7 A-D and 4.13 A-C). However, little if any vacuole formation was evident 
with iothalamate. Ultrastructural examination of tissue samples from the cortex of the 
remnant kidney showed thickening of GBM (Fig 4.13 D), with almost intact tubules (Fig 
4.13 A-C) which confirmed that the nephropathy was mainly glomerular rather than 
tubular. Larger size vacuoles were induced with iodixanol when compared with those 
formed in the control as they occupied large area of the cell. Vacuoles were even shown 
to be formed at the mesangium (Fig 4.13 D), although morphologically similar to those 
of CM-induced vacuoles these extra-tubular vacuoles could not be related to CM without 
further assessment.
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4.3.1. e) Uranyl acetate model
i) Large UrAc dose
Large doses of UrAc (lOmg/kg) caused severe renal damage (Fig 4.8 A) illustrated 
by tubular cell necrosis, wide areas of denuded BB, massive cellular necrosis with 
shedding of the PCT cells leading to hyaline cast formation, interstitial fibrosis with 
inflammatory cellular infiltration, associated with severe glomerulosclerosis and 
mesangial thickening (Fig 4.8 A). These pathological findings were in consistent with the 
severe declined renal function that showed increased creatinine and high brush border and 
NAG enzymes in addition to massive proteinuria {see section 3.5.4. a) Administration of 
iodixanol showed induction of massive and different size of PCT vacuolation.
ii) Low dose UrAc
With a low UrAc dose (3 mg/kg) model there was a moderate degree of renal 
pathology (Fig 4.8 B-D; 4.9 A-D; 4.10 A-D; 4.11 A-D; 4.14 A-D & 4.16 A-B). In 
comparison to the high dose (Fig 4.8 A), the low UrAc dose (3 mg/kg) showed decreased 
severity of tubular necrosis with spared areas from the UrAc-related denuded brush 
border. Interstitial fibrosis and low grade glomerular damage illustrated as mild matrix 
expansions with few scattered sclerosed glomemli were also apparent. In general there 
was a significant number of tubular epithelial cells with their brush borders were intact in 
addition to almost intact structure of most glomeruli (Fig. 4.8 C &D; 4.9 A-D). This 
was associated with a moderate degree of interstitial inflammatory cell infiltration and 
fibrosis. This lowered extent of renal damage was in consistent with a moderate level of 
renal dysfunction {see 3.5.4.b). The denuded brush border was also illustrated by the 
increased brush border enzymes levels, proteinuria and NAG as were all also increased 
after UrAc treatment.
In comparison to the control rat where iothalamate did not show any vacuolation, 
in UrAc nephropathy iothalamate-induced vacuolation was more prominent (Fig 4.9 A), 
as mild degree of vacuolation was illustrated in PCT. However, the extent of vacuolation 
was at a lower degree in comparison to that with iodixanol. Clearly these vacuoles were 
not due to any perfusion artefacts as they were also present in kidneys fixed by
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immersion (Fig 4.9C). The denuded brush border made the PCT epithelia's features 
appear similar to those of papillary or distal epithelial cells (Fig 4.16 A&B).
iii) Iodixanol in UrAc low dose
Both iodixanol and iohexol produced massive vacuoles in UrAc-induced renal 
lesion and for comparative purposes only sections from iodixanol-treated animals were 
shown. Administration of iodixanol to this low UrAc dose model produced massive 
vacuolation in almost all proximal tubular cells. The renal area and the interstitium 
adjacent to these severe vacuolated tubules showed significant increase of mononuclear 
cellular infiltration with fronds of fibrous tissue formation (Fig 4.8 B-D; 4.9 B-D).
After UrAc and at the urinary pole of the Bowman’s capsule there was large 
number of stratified layers of epithelial cells the term “tubulisation” was used to describe 
this pathology, which was also observed after 5/6 nephrecctomy (Fig 4.7D). These newly 
formed epithelial cells in Bowman’s capsule also showed distinctive vacuolation after 
iodixanol administration (Fig 4.10 A- C). Some of these tubular epithelia had even burst 
emptying their contents of clusters of vacuoles into the Bowman’s capsule and tubular 
lumen, giving morphological features which could be described as “tubular sickening” 
(Fig 4.10 D). Tubulisation and new epithelial formation in the glomeruli were illustrated 
further under electron microscopy in UrAc models (Fig 4.13D; 4.16 A&B). UrAc- 
induced tubulisation is a feature that is described by many other tubular-induced damages 
such as uranyl acetate, however vacuole formation and the rupture of these vacuole- 
formed tubular epithelial cell was a feature of vacuole forming CM such as iodixanol and 
iohexol.
Detached epithelial cells were encountered with UrAc in general. Other 
morphological features like bleb formations and detached epithelial cell masses with their 
vacuoles into the tubular lumens and Bowman’s capsules were illustrated mostly with 
iodixanol and iohexol (Fig 4.14 A-D). These epithelial in-origin masses consist of a 
grape-like formation of clusters of vacuoles.
These severe pathological findings of induced tubular necrosis, ruptured vacuole 
containing tubular cells coincided with the severe impairment of renal function induced 
by iodixanol (see 3.5.4.C sections ii &iii) as well as iohexol.
iv) Vacuole formation in other tissues
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With UrAc-induced renal damage and CM-ARF, CM-vacuoles were even formed 
at distant tissues such as the papilla (Fig 4.11 A; 4.16 A) and the liver (Fig 4.6 C). This 
distant vacuole formation, as was only seen with iodixanol and was illustrated with 
UrAc-nephropathy, indicated iodixanoTs potentials of inducing vacuole in different 
epithelial cells (and hepatocytes) in renal failure conditions.
Two weeks after iodixanol there was relining of tubular epithelia with brush 
border re-formation, few vacuoles were still present in these tubules, indicating retained 
CM for 2 weeks (Fig 4.1 ID).
4.3.2 Tubular cells proliferation
BrDu immunostained nuclei shown as dark-light brown in colour indicated a new 
formed cell or proliferated nuclei. In general there was an extensive degree of cell 
proliferation in all regions of the kidney regardless of the treatment and as shown (Fig 
4.17 - 4. 18). After statistical testing of the difference in the number of proliferating 
nuclei, it was found that there were no differences between saline, iothalamate and the 
four iodixanol treatment groups (i.e. with three doses and after a short interval) as shown 
in table 4.1. As illustrated in Fig 4.17 and 4,18 the areas that showed higher number of 
stained (proliferated) nuclei were the medullary rays and the corticomedullary junction, 
but due to wide variations in the number of counts there was no statistical differences 
between different renal regions. PCT cells that formed extensive vacuoles formation 
under the effect of iodixanol were also not associated with any significant increased rate 
of proliferation, as shown in Fig 17 A & B.
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Table 4-1: Counts of the proliferating nuclei in renal tubular epithelia with various CM
Sections from six groups after 10 days of saline, iothalamate (3 g I/kg), iodixanol with three doses 
(3,1 and 0.3 g I/kg) and 5 days from 3 gl/kg iodixanol were counted for the number of proliferating 
nuclei. Each number represents the mean (±SEM) of average numbers from 5 sections for each 
animal group, the average numbers are the mean of 3 readings from each section. Counts were 
from two topographical different areas.
ANIMAL GROUP (N=5) COUNTS FROM CORTEX AREA COUNTS FROM SUBCORTICAL 
(CORTICO-MEDULLARY) AREA
CONTROL 71 (22) 97 (30)
IOTHALAMATE 50 (27) 67 (25)
IODIXANOL 3 g I/kg -94(46) 139 (35)
IODIXANOL 1 g I/kg 61 (19) 126 (67)
IODIXANOL 0.3 g I/kg 79(21) 94(15)
IODIXANOL 3 g I/kg (AFTER 107 (37) 118(31)
5 DAYS)
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4.3.3 CM excretion and retention
To assess the effect of the renal status on CM excretion and retention, the x-ray 
fluorescence method was employed to measure iodine excretion and retention. CM 
recovery was followed in urine samples collected at successive intervals, as well as in 
plasma samples and different tissues taken after autopsy. Values were expressed as 
percentage of administered dose of CM. Retention of iodine in the kidney was compared 
with different renal condition groups. In the kidney the value of iodine retained in one 
kidney was multiplied by 2  for total kidney iodine, while iodine in other tissues like 
liver, spleen, GIT and that excreted with stool was measured per gram of the sample.
4.3.3. a) CM clearance
The renal clearance of iodine was impaired in UrAc-induced nephropathy (4.19 b) 
in comparison to the control (Fig. 4.19 A), as was expected. More than 95% of iodixanol 
and iohexol were excreted in the control in less than 24 hours. When renal lesion was 
induced by UrAc less than 15% of iodixanol and iohexol dose was cleared in urine after 
24 hours of administration (4.19 B). This low urinary excretion rate of CM in UrAc- 
induced renal lesion was sustained for more than 48 hours indicating failure of the renal 
route to excrete CM. However, different CM osmoahrities could not show any difference 
in the rate of CM excretion by the kidney as both iodixanol (290 mOsm) iodixanol with 
mannitol (lOOOmOsm) and iothalamate (1800 mOsm) showed similar patterns of 
excretion in UrAc-induced renal lesion within 48 hours (Fig 4.19 C). Iothalamate 
administration in UrAc induced diarrhoea in all the animals in this group soon after 
administration, an average of 0.5% of CM dose was recovered in each gram of the stool. 
With large quantities of stool formed in iothalamate group this indicated that the GIT was 
an alternative route of CM excretion in renal failure especially with the ionics.
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A)URINARY CM CLEARANCE IN CONTROL ANIMALS
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Figure 4.19 Effect of renal function on iodine excretion in male W/A rats.
Each point is the average of 3-5 samples (± SEM). Values represent the percentage of iodine 
excreted per dose injected at that time point. A) Urine samples collected from a control group. B) 
Urine samples collected from uranyl nephropathy (tubular degeneration) group. C) urine samples 
collected from uranyl nephropathy group (tubular degeneration) injected with CM of different 
osmolarities
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4.3.3. b) Urinary and plasma clearance o f  iodixanol in the control and UrAc renal
failure
The dose of 3 g I/kg of Iodixanol administration 3 days after UrAc treated group 
had induced renal failure as shown in section 3.5.4 c {group Cii and Ciii). Comparison 
between renal clearance of iodine in the control and UrAc-induced renal lesion as shown 
in Fig 4.20 illustrated a delayed urinary clearance of iodixanol leading to retention of 
iodixanol in the plasma 48 hours after administration. Some 1.4 % of the injected 
iodixanol was still present in each 1 ml of the plasma at 48 hr after administration (Fig 
4.20), while in the control group the rapid iodixanol excretion cleared all iodixanol from 
the plasma.
CUMULATIVE PERCENTAGES OF IODIXANOL URINARY CLEARANCE AND PLASMA RETENTION IN 
THE CONTROL AND URANYL-INDUCED RENAL FAILURE
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Figure 4.20 Urinary excretion and 48 hours plasma retention of iodine in both control and UrAc- 
induced nephropathy after administering 3 g I/kg iodixanol. Each value is the average from 3-5 
animals expressed per iodixanol dose injected.
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4.3.3x) Iodine retention
To test whether CM retention in the kidney was a cause or an effect of CM-ARF, 
iodine retention was followed in different renal function conditions. Retention of iodine 
was assessed in the plasma, kidney as well as in other parts of the body such as in the 
liver, GIT and spleen.
i) Renal failure
As shown in Fig 4.21 UrAc-induced nephropathy led to increased retention of 
iodine in different parts of the body 48 hours following CM administration in comparison 
to the control. In a normal functioning kidney only iodixanol and iohexol renal retention 
were detected in the kidney at 48 hours, while in UrAc-nephropathy (Fig 4.21A) and 
apart from more than 4-fold increased iodixanol and iohexol retention in the kidney, 
iodine was also detected in the plasma, liver, and even in the GIT and spleen (data not 
presented in this graph). Moreover, iothalamate retention that was undetected in rats with 
normal renal function showed an average of 0.05% renal retention in renal failure. In 
UrAc renal model of CM-ARF, each 1 ml plasma following 48 hours of CM 
administration retained an average of 1.4% of iodixanol dose, 1.1 % of iohexol and
0.03% of iothalamate.
ii) Iodixanol retention in the kidney 2 weeks after administration in different conditions
Administering a lower iodixanol dose (1 g instead of 3 gl/kg) or avoiding 
dehydration during CM administration by hydrating the animals decreased the amount of 
iodixanol recovered in each of the kidneys and liver in Ur-induced renal failure 14 days 
following CM administration (Fig 4.21B and Table 4-2) however this was not shown to 
be significant. This could illustrate the potential role played by higher doses of CM and 
dehydration in increasing CM retention in both the liver and kidney.
208
A) IODINE RECOVERY IN DIFFERENT SAMPLES 48 HOURS AFTER CM 
ADMINISTRATION IN URANYL-INDUCED NEPHROPATHY AND CONTRO L
ANIMALS
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Figure 4.21 : Effects of renal status on iodine retention in male W/A rats. Each point is the 
average value from 3-5 animals. Values represent the percentage of iodine retained per dose 
injected at that time point.
A) (Upper graph) Recovery (retention) of iodine in different samples and with 3 different types of 
CM in UrAc-induced renal lesion and the control at a dose of 3gl/kg.
B) (Lower graph) Recovery (retention) of iodixanol after 2 week of administering 3gl/kg, 1 gl/kg or 
3gl/kg with hydration in the liver and the kidney in UrAc renal failure.
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4.3.3.d) Iodixanol retention in the normal and compromised kidney
To assess whether the renal condition could affect the extent of iodine retention, 
the degree of retention was assessed in normal as well as in compromised renal 
condition. Since iodixanol showed the highest values of retention in the control, iodixanol 
retention was followed in different renal function states to evaluate whether iodine 
retention was a cause or an effect of renal failure, and as shown in Table 4-2. The 
percentage of CM retained in the control 48 hours following iodixanol was (1.32%) of 
the dose (predominantly cortical) which was not significantly lowered after 96 hours (1.2 
%).
Two UrAc-induced renal conditions were assessed for their degree of iodine 
retention. These renal conditions were sielected from UrAc-induced renal impairment, 
kidney retention values were compared after 48 hours, 96 hours and 14 days from 3 g 
1/kg iodixanol, which was administered either after a “late interval” regenerative model
i.e. 5 days after UrAc or at an “early interval” 3-day degenerative model and as stated in 
Table 4-2. These two conditions showed different response to CM, iodixanol induced 
renal failure with the degenerative model rather than with the regenerative one (as 
illustrated in 3.5.4). Furthermore, the “early interval” degenerative model developed 
irreversible renal failure after iodixanol and iohexol rather than by the ionic iothalamate. 
Iodixanol retention at similar time points in the two UrAc-induced models showed almost 
similar degree of retention with no significant differences. In cases of degenerative 
nephropathy models i.e. when iodixanol was administered at an early stage after UrAc, 
4% of iodixanol dose was recovered after 48 hours and 5.2% after 96 hours in 
comparison to those administered at a later stage when renal function recovery started as 
there was 3.78% of iodixanol dose after 48 hours.
The degree of iodixanol retention in UrAc-induced renal lesion was unchanged 96 
hours after increasing the osmolarity by infusing mannitol with iodixanol. Decreasing 
iodixanol dose (to 1 g instead of 3 g/kg) or hydrating the animals could lower the degree 
of iodixanol retention 14 days after administration to the degenerative tubules' model, 
however, the difference from the high dose with dehydration was statistically not
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significant. No iodine retention was detected in the medulla in the control, but iodixanol 
was recovered in the medulla after UrAc-induced renal damage.
Table 4-2 The percentage of iodixanol retention in the kidney in different renal conditions and at 
different time intervals.
Values presented are the average percentages of iodine retained/ g kidney from 4 animals (± SD) of 
the administered dose of 3 g Iodine of iodixanol/kg body weight ( g I/kg)
Time Interval after iodixanol % retention
control group
48h 1.32 (±0.34)
96h 1.20 (±0.20)
medulla(from 48/ 96h) 0.0
14 days 0.0
5 days after UrAc. (Regenerative tubules) with dehydration
48h 3.78 (±0.27)^
3 days after UrAc. (Degenerative tubules) with dehydration
48h 4.04 (±0.64)^
96h 5.2 (±0.12)^
96h with mannitol 4.2 (±0.64)1
medulla 96 h 0.15 1
3 days after UrAc. (Degenerative tubules)
3 g 1 /kg with 3.34 (±1.0)1
dehydration
14 days after 1 gl /kg with 1.9 (±1.11)1
iodixanol dehydration
3 g 1 /kg without 2.91 (±2.80)1
dehydration
 ^ significant increase (P<0.05%) in comparison to the control group at the same interval.
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4.4 Discussion
The morphological and structural changes related to CM in different animal 
models were examined by light and electron microscopy. Histological findings were 
compared to those of saline treated in the same model. CM were selected to represent 
different groups of CM with different physical and chemical criteria. The three iodine- 
containing CM were the conventional ionic high osmolarity iothalamate monomer, the 
non ionic iohexol and the low osmolar dimer iodixanol with its high viscosity.
Also the effects of different renal conditions on the retention and excretion of CM 
were evaluated by an X-ray fluorescence.
4.4.1 CM induced histological changes
The distinctive histological manifestation that was detected with CM was the PCT 
vacuole formation in cortical tubules. The non-ionic dimer iodixanol and with a lesser 
degree the monomer iohexol produced significantly larger numbers and sizes of vacuoles 
when compared to those of the ionic iothalamate. PCT epithelial cells from the untreated 
control, showed sporadic small vacuoles which were observed mostly just beneath the 
brush border in the cortical tubules. In general CM-induced vacuoles were larger in size 
and had different densities (Fig 4 .6  A& B ). CM-induced vacuoles were membrane bound, 
and most of these vacuoles contained granules of various electron densities (Fig. 4 .1 2 ) .  
These CM-related morphological changes of vacuolation were in accord with previous 
observations as CM vacuoles have been investigated extensively earlier (Moreau et al, 
1980; Holtz et al, 1987; Powell et al, 1989; Avades, 1 992 , Avades et al, 1993  
Tervahartiala 1993 , Walday et al, 1995). However, the use of 1-2 pm ultrathin sections 
with toluidine blue staining in this work had improved the assessment and contrast of 
small vacuole which were not big enough to be assessed by thick paraffin sections of 
more than 5 pm stained with H&E (Fig 4 .6  B; 4 .7 D ; 4 .8 ;  4 .9 ;  4 .1 0 ) .
The two nephropathy models of old age nephropathy (Fig 4 .6  C &  D ; 4 .1 2 )  and 
5 /6  nephrectomy (Fig. 4 .7 ; 4 .1 3 )  had shown a qualitative increase in the number and size 
of vacuoles, while with UrAc-induced tubular necrosis model there were severe and 
extensive vacuolations which were particularly induced by vacuole fo rm ing C M  like 
iodixanol and iohexol. Annuals with 5 /6  nephrectomy, with hypertrophied glomeruli.
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were able to tolerate CM and did not illustrate any further pathological changes which 
would indicate renal failure. In the reduced renal capacity anatomically (by 5/6 
nephrectomy) or functionally (as in old age or UrAc-induced renal damage) the same 
dose administered/ body weight would expose the renal nephrons to higher amount of 
CM, hence large size and number of vacuoles were encountered in these models.
Other features like bleb formation and detachment of total or part of tubular 
epithelial cells that were packed with vacuoles were also encountered but to a larger scale 
in severe tubular pathology like those in old age (Fig 4.6 C &D) and UrAc (Fig 4.8) 
models.
In the old age nephropathy the main significant changes that were shown by CM 
were those of PCT vacuolation (cortical) with bleb formation (Fig 4.6 C&D). Although 
different degrees of tubular damage were illustrated especially those of epithelial cell 
necrosis, brush border damage, interstitial infiltration and hyaline cast formation but they 
were more related to old age nephropathy backgrounds and could not be related to CM 
per se.
Chronic progressive nephropathy has been reported as an ageing process in albino 
rats. Old age renal nephropathy has its onset at the second year of life. It is characterised 
by changes of morphology those of mesangial and GBM thickening, and glomerular 
sclerosis. In the tubules there is cast formation, flattening of the epithelial cells and 
interstitial infiltration and tubular basement membrane thickening (Goldstein et al, 1988). 
Therefore, and apart form CM-vacuoles, it would be difficult to assign any pathological 
change to CM per se due to various and long standing old age background nephropathy.
In nephropathy models of high UrAc doses (10 mg/kg) there was a background of 
severe tubulo-interstitial pathology characterised by extensive tubular damage shown as 
denuded brush borders, tubular necrosis, intratublar hyaline cast formation, interstitial 
infiltration and fibrosis. The severe renal pathological lesions induced by high doses of 
UrAc masked any subsequent CM pathology that could be detected (Fig 4.8 A). On the 
other hand, in the low UrAc dose (3 mg/kg) models (especially the 3 day interval model) 
the kidney showed a relatively lowered degree of UrAc pathology especially those of 
interstitial infiltration, hyaline casts formation, brush border and tubular damage. CM 
administration to low dose UrAc model illustrated pathological changes which were 
characterised by CM-induced vacuoles of the Bowman’s capsule epithelia showing
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massive necrosis of epithelial cells that were packed with large number of vacuoles.
Some of the packed tubular epithelial cells with vacuoles ended up by rupturing and 
evacuating clusters of vacuoles into the tubular lumen and Bowman’s space, a condition 
that resembles throwing out and expulsion of vacuoles the term used to describe them 
was “sickening features of epithelial cells” (Fig 4.10; 4.14; 4.16). Therefore, it was only 
with these severe UrAc renal pathology, as there was massive tubular necrosis and 
vacuolation (Fig 4.8; 4.9; 4.10), that vacuole-inducing CM could induce irreversible 
renal failure with significant decline of renal function. These pathological changes were 
correlated with renal function parameters which were shown in chapter 3 {section 3.5.4.C  
sections ii and Hi). When iohexol and iodixanol (with their high ability to form vacuoles) 
were administrated at an early stage of UrAc-induced tubular cell degeneration they led 
to acute irreversible impairment of renal function. Therefore, it is tempting to conclude 
that these massive numbers of CM vacuoles formed in abnormal epithelial cells by 
UrAc-induced degenerative tubular necrosis predisposed the kidney to acute renal failure. 
It could also be suggested that CM with higher ability to induce vacuoles would 
predispose the necrosed and damaged tubular epithelia to detach and block the tubular 
lumen ending up into tubular obstruction and ARF.
In summary CM-induced vacuoles were shown in all CM groups especially with 
iodixanol and iohexol without any morphological changes that could indicate renal 
damage (glomerular or tubular). It was also concluded that CM vacuolisation is a 
reversible condition, as there were no vacuoles nor iodine retention 14 days after 
iodixanol in the control group. Although in some renal conditions like those of reversible 
UrAc induced renal failure it could last for more than 2 weeks. Walday et al, (1995) had 
also concluded that CM-related PCT vacuolation was fully reversible. However, in UrAc 
these vacuoles were enhanced in cases of tubular necrosis leading to renal morphological 
changes those of tubulisation and rupture of epithelial cells. It could be concluded that 
CM-vacuolation which were seen in cases of UrAc is early stage toward cellular necrosis 
rather than being a definite cellular damage. This was a clear indication that CM-induced 
vacuolar morphological changes alone had no role in inducing renal failure in normal and 
even compromised renal function as seen in nephrectomy and old age. However, in cases 
of severe tubular necrosis, as in early stages of UrAc-induced renal failure, vacuole
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formation had predisposed the PCT epithelial cells to further cellular necrosis pushing the 
kidney to the verge of an end stage renal failure.
CM-induced vacuoles are possibly due to residual secondary lysosomal 
compartment (Avades, 1992; Rowlands et al, 1994). This event plays no part in 
induction of renal failure in most cases. It was suggested by Dobrota et al, (1995) that 
vacuoles caused by CM are not associated with obvious impairment of tubular function. 
After correlating these CM related morphological changes from the above work with 
normal renal function tests (as seen from results o f chapter 3) it could be concluded that 
vacuole formation was not associated with any alteration in renal function which could 
indicate acute renal failure. It is still not clear whether vacuolation in UrAc by itself led 
to ARF or they induced further pathological changes that ended up into failure. Tubular 
obstruction is one of the possible outcomes after epithelial necrosis and shedding that 
could induce renal shut down.
There is enough evidence which indicate that ischaemia is an important 
pathophysiological cause leading to CM-ARF (Katzberg et al, 1983a; 1983b; Tomquist et 
al, 1984; Bishop and Rees, 1988; Nygren et al, 1988; Vari et a, 1988; Satoh et al, 1990; 
Heyman et al, 1994; Karstoft et al, 1995; Liss et al, 1996). Therefore, it could be that 
both renal insults, i.e. those of renal ischaemia and the direct tubular effects on the 
tubular epithelial cells could affect the renal tubules at the same time. Together these two 
renal insults could lead to tubular necrosis that could precipitate renal failure.
It is also most tempting to suggest that CM-direct tubular effects may involve 
cytokine and growth factors release. Of the important growth factors that are crucial to 
know their extents of expression are those that could enhance tubular cytotoxicity or 
induce vascular ischaemia. The role of one of the important growth factors in fibrosis and 
cytotoxicty had incited work to study the release of TGF-P after CM. It was observed 
that the non-ionic dimers with their high vacuole formation in the mesangial cell culture 
released higher levels of TGF-p than other CM monomers (Kolev et al, 1995). As the 
release of the vascular constrictor endothelin was shown to be increased after CM 
(Margulies et al, 1991; 1992; Heyman et al, 1992; 1994; Oldroyd et al, 1995), it is 
necessary to investigate the endothelin role further in CM-ARF.
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4.4.2 Tubular epithelial cells proliferation
Of the several techniques available to examine cell regeneration BrDu nuclear 
incorporation was selected to mark tubular epithelial cell proliferation. The main 
advantage of BrDu immuno-stainnig from other techniques in assessing cellular 
proliferation, such as thymidine incorporation, is that there is no radioactive material 
involved with all the hazard precautions required. The double staining by PAS 
histochemistry and BrDu immunostaining allowed the distinction of different nephron 
sites. More important and unlike thymidine, BrDu labelling is more specific and lacks the 
incorporation in any unscheduled DNA synthesis UDS which could give misleading 
results. However, as it is essential to achieve constant labelling through the required 
interval tested for proliferation, surgical implantation of miniosmotic pumps was 
necessary to infuse the BrDu in a sustained constant rate.
The rate of cellular proliferation was extensive enough under normal conditions m 
all areas of the renal mass (Fig. 4.17; 4.18). Large numbers of proliferating cells were 
shown even before any change in the renal status by CM. Furthermore both, iodixanol 
with it’s three doses' levels (Fig. 4.18 C&D) and iothalamate (Fig. 4.18 B) did not show 
any significant increase in tubular regeneration background (Fig. 4.18A). There was also 
no significant change in the degree of regeneration with or without vacuole formation in 
different CM groups and doses (Fig. 4.17 and 4.18). Different areas in the kidney 
showed different rates of proliferation (Fig. 4.17C and 4.18 A). Furthermore, 
comparing similar areas with different treatment groups did not shown any significant 
change in the rate of proliferation.
Since CM did not show any significant increase in the degree of proliferation, 
clearly none of the CM tested produced any significant cell damage which would have 
resulted in epithelial regeneration. However, it would be more accurate to assess and 
differentiate the degree of tubular proliferation in the different groups by a morphometric 
assessment using an image analysis instead of the subjective method used. However, the 
lack of time has hindered further development of any new morphometric programme by 
an image analysis to mark the rate of proliferation in different types and topographical 
areas of the tubules.
The extensive proliferating capacity of the tubular epithelia could also indicate 
that the regenerative power of the epithelial cells is sufficient enough that vacuole
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formation or any damaged PCT cells by CM treatment could be replaced by new cells. It 
is known that the kidney possesses a remarkable capacity for restoring its structural and 
functional capacity after an injury. Therefore, it could be due to the tubular regeneration 
capacity that these pathological manifestations especially vacuole and bleb formation or 
even tubular necrosis could be replaced without any irreversible end stage renal 
impairment. As it was shown in this work, even with the loss of 5/6 of the functioning 
rat kidney, the remnant renal mass led to reversible replacement of kidney function. 
Therefore, the renal tubule regenerative power is to an extent that could tolerate sublethal 
renal insults without deteriorating into irreversible renal failure.
Renal tubules under the effects of UrAc could behave like other chemicals such as 
mercuric chloride, as it is characterised by regeneration and relining of the epithelium 
within 5 days of the treatment (Cuppage et al, 1972). It was shown that after few days of 
UrAc induced renal failure there is reversal of the renal impairment (Anthony et al,
1994). It was suggested that the surviving cells situated close to or within the necrotic 
area dedifferentiate and enter mitotic cycle, redifferentiate until the nephron segment 
integrity would be restored (Bacallo and Fine, 1989; Lake and Humes, 1994). It was only 
at early stages of UrAc induced-tubular necrosis whereby CM such as iodixanol induced 
massive vacuole formation that loaded the epithelial cells which could lead to an end 
stage renal failure. The most likely hypothesis to this end stage renal failure is that 
administration of CM, before the start of any regenerative process in UrAc-induced renal 
damage, could have a synergism effects with UrAc leading to irreversible renal changes. 
It could also be that in cases of lower regenerative capacity, as it could be anticipated in 
old age rats, that CM had induced renal failure with some of the animals. In conclusion 
the proliferating capacity state of the renal tubules could also determine any susceptibility 
to CM-ARF. Further work is required to prove this and to understand the molecular basis 
behind it, potential proliferating growth factors should be studied to emphasise their role 
in this regenerative mechanism.
4.4.3 Role of renal dysfunction in excreting and retention of CM
Renal impairment causes large number of non-functioning atrophied nephrons, 
which means that the remaining functioning tubules are exposed to higher levels of CM 
for each functioning nephron. Although renal failure means the clearance of CM was
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proportionally reduced, but administering the calculated dose per body weight of CM 
with a lower number of functioning nephrons could lead to a higher proportion of CM in 
renal and systemic circulation. In renal impairment models of 5/6 nephrectomy, old age 
and UrAc-induced nephropathy comparatively higher number of vacuoles was formed in 
comparison to the control. This was an indication that the tubular epithelia were able to 
tolerate CM in most of these cases at even larger doses per lower number of nephrons.
4.4.3. a) Iodine excretion
In the normal functioning rat kidney more than 95 % of iohexol and iodixanol 
were excreted in the first 6  hours. These values obtained in normal rats were in accord 
with others that found after a low dose 1.2 g ^^I-iodixanol /kg 93% was excreted in the 
urine in 4 hours while 100 % were excreted in 24 hours. However, when adm inistering  
a high dose of 7.2 g ^^-iodixanol /kg only 60% were excreted in the first 4 hours, 72 % 
at 24 hours and 78% were excreted in urine in 7 days (Heglund et al, 1995). More than 
98% of iodixanol dose were shown to be excreted within the first 24 hours in healthy 
volunteers, while this percentage was significantly lowered in renal failure (Svaland et al, 
1992).
In UrAc induced renal failure there was a delayed excretion of CM as around 3% 
of the dose was found in the urine samples collected at 6  consecutive time intervals until 
48 hours, i.e. a total of less than 20% of both iodixanol and iohexol was excreted during 
this period. The use of osmolar diuretic mannitol could not change the pattern of 
iodixanol excretion in renal failure within 48 hours. As it is illustrated in Fig 4.19, there 
is decreased renal clearance of iodixanol and iohexol in cases of induced renal failure. 
More than 1 % of iodixanol and iohexol were recovered in each 1 ml of the plasma after 
48 hours in a renal shut down as it is the main route of CM clearance from the plasma 
while only 0.03% of the ionic iothalamate remained in the plasma. However, 0.5% of 
CM dose were recovered per gram of the stool with the three CM in cases of UrAc 
induced renal failure (4.3.3 a). From CM pharmacokinetics {see 1.1.2), it was shown that 
the decline in plasma CM concentration is dependant mainly on renal elimination in 
normal functioning kidney and only 2 % is extrarenal mainly faecal route, this extrarenal 
elimination increases to more than 7% in cases of renal failure (Jackobsen et al, 1994). 
This suggested that GIT is the other efficient route of CM excretion in cases of renal
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failure. It is possible that the state of diarrhoea (osmotic) that was attributed to the ionic 
CM iothalamate (not seen with the LO) led to clearance of iothalamate being 
predominantly via the GIT comparatively more than the LO.
4.4.3.b) Iodine retention
Although counting the vacuole formation is one way of assessing the degree of 
iodine retention, but it cannot be quantitatively accurate as it is not possible to count all 
the vacuoles formed precisely in the different groups and in different sections making it a 
very laborious way to assess iodine retention. Therefore, iodine retention measurement 
by x-ray fluorescence was more accurate and simple alternative method to be used.
In the normal functioning kidney iothalamate retention (48 hours after 
administration) was below the detection limit of the X-ray fluorescence method that was 
used, while an average of 0 . 1 2  % of iohexol dose was retained in the kidney and 1 0  fold 
more 1.3 % with iodixanol. Iodixanol with a lower osmolar load had caused higher 
iodine retention than iohexol which in turn was higher than iothalamate. Therefore and as 
with the decreased CM osmolarity there was an increased of iodine retention, this could 
suggest that there is a role of CM osmolar load on the extent of iodine retention.
However osmolarity is not the only factor in decreasing CM retention, since increasing 
CM and plasma osmolarity by infusing iodixanol with mannitol could not decrease the 
amount of iodine retention significantly (Fig 4.19 C; Table 4-1). The difference in iodine 
retention between different groups of CM could be also due to their physicochemical 
properties like molecular size, spatial conformation, as well as hydrophilicity which 
could determine the lysosomal alterations.
These iodine retention values obtained by XRF were proportionally similar to 
those reported from pre-clinical isotopes' studies carried out in normal rats. Although 
they used a higher (7.2) and a lower dose (1.2) of g ^^I-iodixanol /kg they obtained 
almost comparable results (Heglund et al, 1995). After 7 days 0.2 % of a low dose was 
recovered in the kidney, while 0 .6 % of the high dose were recovered in the kidney and
0 . 1 % was recovered in the whole liver and only 0 .0 1 % was recovered in the plasma. 
Furthermore, after 3 weeks 0.2% retention of the high dose was recovered in the kidney. 
Since the limit of detection of the x-ray fluorescence technique employed in this work 
could not detect low recovery values as the radiolabelled CM, such low iodine retention
219
values were undetected after two weeks from administering iodixanol to control groups.
It was also reported that 7% of the administered ^"^C-iodixanol to the rat appeared within 
15 minutes in the kidney, however these high iodine retention values in the first few 
hours is misleading as there CM are still filtering through the renal nephron rather than 
being trapped intracellularly.
The vacuole-forming CM such as iodixanol and iohexol showed high retention of 
iodine unlike iothalamate that hardly could form vacuoles nor any detected retention 
values. The extent of iodine retention in the kidney mainly in the cortex was related to 
the degree of vacuole formation in the PCT in different renal situation. Furthermore, 
iodine recovery in the liver which corresponded to vacuoles formed in the hepatocytes 
was a clear indication that these vacuoles contain iodine. It was also observed that the 
degree of different CM-induced vacuolation in the cortex was correlated with the amount 
of iodine retention (Avades, 1992; Laftah, 1993). The contents of CM-induced vacuoles 
have been investigated by Nordby et al, (1990) demonstrating high iodine content in 
these vacuoles.
CM retention was increased in cases of tubular necrosis induced by UrAc. UrAc- 
induced epithelial cell necrosis increased iothalamate, iohexol and iodixanol retention in 
the kidney, as well as in other tissues such as the liver and the spleen (Fig 4.21A). The 
delayed renal clearance of CM in cases of renal shut down led to delayed plasma 
clearance of CM for more than 48 hours associated with iodine recovery in other tissues, 
in addition to a significant increase of CM retention m the kidney. This indicated that 
plasma retention of CM with their ability to form vacuoles led to retention of CM in 
different tissues like the liver and spleen. These findings were complemented with 
detection of vacuoles in these tissues, which was not reported before, as iodixanol- 
induced vacuoles were observed in the hepatocytes (Fig 4.6) and in the papilla (Fig 4.11 
A and 4.16A). This was a clear indication that high concentration of CM especially 
iodixanol formed epithelial vacuoles which were mainly in PCT in normal functioning 
kidney, but other epithelial cells (hepatocytes) in the body could also form vacuoles when 
CM concentration was high enough as was the case after renal failure.
The two renal conditions of degenerative and regenerative tubular necrosis by 
UrAc-induced nephropathy did not show significant differences in the amount of iodine 
retention (Table 4-1). These two conditions had different outcomes, iodixanol could only
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induce renal failure in the degenerative model as was illustrated in 3.5.4. Therefore, the 
extent of iodine retention, at least in these two models, was not a good marker for CM- 
ARF. On the other hand, increased CM retention was an indication of decreased renal 
clearance, but not necessarily induced by CM. Therefore, it could be concluded that 
iodine retention was increased in renal failure but it is difficult to say that it had led to 
CM-ARF from these iodine retention data only.
Similar findings were also reported in human subjects. CM retention was 
determined by computed tomography (CT) in human patients. Published cases with 
persistent cortical nephrogram after CM included patients with renal trauma and different 
renal diseases like infarction (Braedel et al, 1987). It was suggested that CM retention in 
the kidney as demonstrated by CT may indicate CM-ARF (Love et al, 1989; 1994). In 
agreement with experimental data and extent of vacuolation caused by the isosmoalr CM, 
residual nephrogram in the renal cortex after injection of iohexol and iodixanol was also 
observed in healthy persons with normal renal function even after all CM was eliminated 
from blood and urine. This could only indicate an intracellular location of CM. It was 
illustrated that cortical attenuation increased more and persisted longer with iodixanol 
than with comparable doses of monomeric CM (Jakobsen, et al, 1992). There was no 
correlation between delayed cortical enhancement of CM and glomerular and tubular 
function parameters which lead them to suggest that iodine retention did not compromise 
renal function. In patients with renal failure and after 120 hours both iohexol and 
iodixanol showed increased attenuation (Jakobsen et al, 1996). However, the delayed 
clearance of serum iodine in these cases could be due to this attenuation. Unlike findings 
in this thesis, the human work could not prove that iodine retention was intracellular, as 
circulating serum CM could have been still excreted by the kidney leading to the 
persistent nephrogram appearance. In contrary to the rat as the perfusion wash of the 
kidney after autopsy with saline cleared the renal circulation from any retained plasma 
CM, and proved that any detected CM was intracellular retention (vacuole formation). 
Data collected from human patients also suggest that iodine retention is affected by the 
renal function, although it could not indicate whether iodine retention declined renal 
function further.
The degree of CM vacuolation and retention was related to the degree of renal 
function, as there were increased iodine retention and vacuole formation with UrAc-
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induced renal impairment. This could either be due to the damaged tubular epithelia or 
even due to CM sluggish passage movement. Stasis of CM could be caused in renal 
failure by detached tubular epithelial cells and tubular casts obstructing the renal tubules 
on one hand and on a low urine flow rate caused by oliguria on the other hand. Viscous 
CM, as with the dimers, could play an important role in increasing CM retention. 
Iodixanol dynamic viscosity at concentration of 320 mg I/ml and at 20° C is 20 mPa, 
which is almost comparable to iohexol but much higher than iothalamate (Eivindvik and 
Sjogren 1995). It was illustrated that the intratubualr hydrostatic pressure was increased 
with the viscous dimers (Ueda, et al, 1993), which may contribute to the slow passage of 
the filtering dimers and sluggish movement. All these factors that affect CM passage 
could lead to increased stasis time and longer contact between CM with tubular epithelia, 
ending up in higher cellular retention.
However, trying to increase the urine flow with mannitol or hydrating the animals 
instead of dehydration at the same time of CM administration could not prove any 
reduced iodixanol retention in UrAc renal failure, as the reduced values were not shown 
statistically (Fig 4.21 B; Table 4-2)
Other evidence for the role of CM stasis on iodine retention was based on 
previous work (Avades 1992, Avades et al, 1994) as:
1. Increased urine viscosity by the dimers had increased iodine retention in comparison 
to low viscosity and low retention with the ionics.
2. Lithium induced diuresis model in the rat had decreased the percentage of non-ionic 
dimers' retention in the rat kidney.
3. Oxalate crystals and cast formation that could block the tubular lumen had increased 
iodine retention in the rat kidney after iothalamate and iotrolan.
4.5 Summary
In summary, the pathological findings of different renal models and CM-induced 
renal changes were described. The mam CM-related pathological findings were illustrated 
in the tubular epithelia as CM showed vacuole formations and early signs of reversible 
changes such as bleb formation. Renal impairment by different conditions like old age, 
nephrectomy and UrAc-nephropathy caused comparatively larger sizes of CM vacuoles.
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The reproducible model of UrAc-induced CM-ARF that was characterised in 
chapter 3 (3.5.4) illustrated pathological changes characterised histologically by extensive 
tubular necrosis, significant increase in interstitial infiltration, tubular epithelia loaded 
with vacuoles, epithelial tubulisation with vacuole formation of the Bowman’s capsule. 
Vacuole formation in UrAc-induced renal damage was also detected in distant tissues 
apart from PCT like DT, papilla and hepatocytes.
Different CM groups and doses could not change the degree of regeneration of the 
rat nephron which could indicate that they did not inflict any significant damage on the 
tubular epithelia. Furthermore, the rat tubular epithelial regeneration capacity was to the 
extent that it could make the rat resistant to develop any CM-ARF.
An x-ray fluorescence method was developed which could replace other 
experimental methods to quantitate iodine retention in the kidney, urine, plasma and other 
tissues. This X-ray fluorescence method could be employed to study iodine retention in 
the kidney after manipulating different risk factors. The conjunction of UrAc renal model 
of CM-ARF with the x-ray fluorescence method to measure iodine was utilised to study 
and compare different chemical and physical groups of CM, doses and factors that could 
prevent or induce CM-ARF. It was demonstrated by X-ray fluorescence that the degree 
of CM retention in the kidney was determined by the following:
1. The type of CM as it was higher with the non-ionic dimers and monomers than with 
the ionic monomers.
2. Renal function as iodine retention was increased in renal failure, while renal clearance 
was decreased with any renal failure.
3. General factors could have the potentials to decrease iodme retention such as a lower 
CM dose and increased urine flow rate by preventing dehydration or usmg diuretics.
Increased CM retention was associated with ARF although this need not have 
been the cause of CM-ARF. Thus the extent of iodine retention could not be a marker for 
CM-ARF but it only indicated that there was declined renal function.
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CHAPTER 5
CONTRAST MEDIA-INDUCED 
BIOCHEMICAL AND 
FUNCTIONAL CHANGES IN THE 
ISOLATED PERFUSED RAT
KIDNEY
5. C O N T R A S T  M EDIA-INDUCED BIOCH EM ICAL AND 
FU N CTIO N A L C H A N G E S IN TH E ISO LA TED  P E R F U S E D  RA T 
KIDNEY
5.1 Introduction
Experiments on fully isolated rat kidneys were reported as early as 1959 by Weiss et 
al, The IPRK as an in vitro system with an intact renal morphology was uniquely suited for 
studying the relationship between renal perfusion and physiological functions such as GFR 
and electrolyte homeostasis. Work by a number of groups led to the development of optimal 
experimental conditions for the preparation (Bauman et al, 1963; Nishiitsutsuji-Uwo et al, 
1967). The study of intra-renal control mechanisms without the neuronal and hormonal 
effects was achieved by the use of artificial perfusion circuit with adequate nutrition like 
glucose, amino acids and oxygen and optimum pressure to keep the kidney viable and 
filtering.
The basic isolated perfused kidney preparation consists of the whole kidney isolated 
from the systemic circulation and perfused through the renal artery with a well-oxygenated 
synthetic nutrient. The perfusate is delivered into the renal vasculature in a controlled 
manner to achieve a constant mean arterial pressure. The initial in situ perfusion is achieved 
by replacing the blood with perfusate whilst maintaining adequate flow and pressure to 
prevent ischaemia. The perfused kidney will consistently display 85-90% of normal tubular 
transport activity, which is adequate for most metabolic and drug handling studies 
(Bowman, 1975). Major differences between isolated kidney techniques lie in the 
composition of the artificial perfusate solution employed.
5.1.1 Advantages of the IPRK
The IPRK is the only renal in vitro preparation in which glomerular filtration and 
tubular functions are retained. It is particularly useful for studying effects of chemicals on 
glomerular and tubular function and on renal perfusate flow. Ideally the system requires 
total isolation of the kidney from any systemic hormonal and neuronal effects. Therefore,
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any response to a chemical is purely due to its direct renal effect without the interference 
of other tissues. Furthermore, one of the main application of the IPRK lies in its ability to 
investigate the renal handling and biotransformation of xenobiotics at concentration of drugs 
which may not be possible in vivo (Diamond, 1996). It also provides the facility for 
controlled addition and removal of pharmacologically active substances and to study 
pharmacokinetics of chemicals that are excreted m ainly by the kidney.
5.1.2 Criteria for stable IPRK preparations
As a valid model the IPRK must be reliable and reproducible. This can best be 
achieved by: optimal design of the apparatus, selecting animals with identical age, weight 
and renal status, minimising animal stress during surgical operation and optim ising isolation 
procedures of the kidney, perfusion medium composition and lastly by meticulous attention 
to experimental protocol.
5.1.2. a) Renal function baseline
At the start of an IPRK experiment it is essential to achieve a constant renal 
function baseline (i.e. GFR and RPF). Once the stable baseline is achieved it is also 
important for this to be within acceptable range limits for a typical viable IPRK preparation. 
Variable baseline could be due to:
1) GFR and fractional fluid reabsorption can be altered within fairly wide limits depending 
on the conditions of perfusion and from kidney to kidney. GFR will increase with increase 
of the perfusion pressure and decrease of the oncotic material concentration in the 
perfusate. Although increased perfusion pressure would usually yield greater GFR, but 
tubular fluid reabsorption might be reduced due to the increase of pressiure difference 
between tubules and peritubular capillaries.
2) Ideally controlling renal perfusate constituents and pressure should yield constant GFR, 
but other factors may play a role, e.g. the glomerular filtration coefficient and the renal 
vascular resistance. The renal circulation is unique as it consists of two capillary beds m 
series, the glomerular capillaries followed by the peritubular capillaries, and any pressure 
differences between these two capillaries lead to pressure differences. Also, the independent 
resistance of the afferent and the efferent arterioles will determine the glomerular
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hydrostatic pressure. The renal perfusate flow autoregulatory mechanism has not been well 
characterised. This could be either due to arterial smooth muscle contraction and relaxation 
in response to increase or decrease in vascular wall tension respectively, or to the 
tubuloglomerular feedback between GFR (and its’ electrolytes) and RPF.
5.1.2.b) IPRK requirements
To achieve physiological and reproducible renal function the following procedures 
and parameters must be carefully controlled:
• Oxygen: The renal artery should be canulated with no disruption to renal blood flow 
avoiding any delay which might lead to transient renal ischaemia.
• Physiological temperature and pH.
• The composition of the perfusion medium which in this study consisted of the 
following:
1) Krebs-Henseleit: This physiological perfusion fluid was supplemented with 6.7% (w/v) 
bovine serum albumin (BSA) as the oncotic agent (Little & Cohen, 1974). It also contained 
2.5mM Ca'*’, which is the normal plasma concentration.
2) D-glucose was added to the perfusion medium at a concentration of 5 mM/1. This 
maintains optimum GFR and fractional sodium re-absorption (Ross et al, 1973; Frega et al, 
1977).
3) Amino acids: GFR is also stabilised by the addition of amino acids. Inclusion of 14 mM 
mixed amino acids are essential to the functional stability of the IPRK preparation (El Sayed 
etal, 1991).
4) Angiotensin: After isolation, the renal vasculature is vasodilated. In order to follow 
vasoconstrictor or vasodilator responses (e.g. to contrast media), the RPF was lowered by 
approximately 50% by the addition of angiotensin (at a dose of 5ng/mm).
5.1.3 The effects of CM on IPRK
Previous studies had illustrated the direct effect of CM on IPRK renal function (El 
Sayed et al, 1991; Haylor et al, 1991; Brown et al, 1992). These studies had shown that aU 
CM caused a significant reduction m GFR and RPF (due to increase in renal vascular 
resistance). Also high osmolar CM caused a significant fall in fractional reabsorption of 
sodium and a significant rise of fractional excretion of albumin. The system offered a way
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to separate the local effects of CM on the kidney from any systemic actions, and to follow 
the acute effects on renal vascular system. It is imclear whether the decrease of GFR is due 
to tubulo-glomerular effects or to decrease of RPF per se, and whether the increase of 
vascular resistance (decrease of perfusate flow) is due to the release of vasoconstrictor 
agents like endothelin or due to an increase of interstitial pressure. Also the consequences 
of decreased RPF on tubular function are not very well known.
5.1.3. a) Renal haemodynamic changes
Haemodynamic markers that indicate early changes in renal ftmction (e.g. due to 
CM) were followed with the IPRK. The IPRK model permits the measurements of early 
changes of RPF, GFR, and other glomerular and tubular parameters at rapid and short 
intervals over the duration of the whole experiment.
5.1.3.Z?) Endothelin release
The release of plasma and urine endothelin in response to CM, has been well 
established in rats (Heyman et al, 1992), dogs (Margulies et al, 1991), human (Margulies 
et al, 1992) and in cultured endothelial cells (Heyman et al, 1994). In an IPRK study an 
endothelin-A antagonist BQ123 was found to abolish the CM-induced renal vasoconstriction 
and reduced GFR (Oldroyd et al, 1995). Also it was demonstrated that Bosentan (an orally 
active nonselective endothelin receptor antagonist) produced an effect similar to that of 
BQ123 (Oldroyd et al, 1995). These findings support the role of endothelin in response to 
CM, although it is unclear if endothelin release was purely from the renal vasculature.
5.1.3. c) Renal enzymes and proteins
The IPRK has been used almost exclusively to evaluate physiological mechanism, 
rather than other biochemical changes. Although eu2ymuria and proteinuria represent 
routine parameters in the clinic and in animal experiments, these important indicators of 
renal function have not been reported as parameters of the functional integrity of the 
IPRK. Enzymuria after the effect of CM in vivo was shown in this work (as illustrated 
in 3.6.3.b) in accord with observation of other workers (for further details see 1.4.2. d). 
Evaluation of enzymuria originating from renal tubules is considered a valuable tool in the 
diagnosis of tubular function. Although the tubular epithehum is the main source of urinary
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enzymes, plasma enzymes may also represent a potential source for LMW enzymes that are 
filtrable by the glomeruli.
Increased protein excretion in the filtrate is an indicator of disturbed handling of 
protein by the kidney. The increase of high molecular weight proteins indicates glomerular 
damage while the excretion of low molecular weight proteins is due to decreased tubular re­
absorption {see also 1.4.3).
5,l,3.d) Renal electrolytes
Among the most sensitive fimctions of the kidney is the homeostasis of electrolytes, 
and electrolytes' changes are indications of renal dysfimction at different sites of the 
nephron {see also 1.4.Lb).
5.1.4 Rationale for the use of IPRK in CM nephrotoxicity studies
From the inyyivo studies {chapters 3 and 4) the following were observed:
• CM transiently increased excretion of urinary enzymes and proteins especially LMW.
• Increased excretion of sodium and potassium with increased RFlNay^  and FE^a^; 
filtration which indicate the effects of CM on the electrolytes handling by the tubules.
• Morphological changes like vacuole formation and brush border bleb formation, 
indicated that the PCT cells were morphologically altered.
• CM can induce renal failure in experimental models with tubular degeneration (induced 
by uranyl acetate).
• CM caused the release of endogenous proximal tubule biochemical metabolites.
These findings suggest that CM impaired tubular rather than glomerular function, 
although it is unclear whether CM cause direct tubular effects (and even damage) or 
indirect tubular damage by renal ischaemia. The ability to follow GFR and RPF separately 
and to correlate them independently cannot be achieved in vivo. The IPRK will allow serial 
measurements of rapid changes in renal flow, GFR, and even tubular biochemical changes 
which could be immediately followed CM treatment. The ability to follow rapidly different 
renal changes and their sequence would help to understand the pathophysiological changes 
that follow CM treatment. By isolating the kidney the direct effects of CM on renal tubules 
and vessels can be studied separately. Also by isolating the kidney it would be possible to
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isolate the effects of CM on other systems which might interfere with its direct renal 
response.
The aims of this work were:
1. To study the response of the IPRK after CM treatment and correlate renal vascular and 
perfusion changes with that of biochemical and morphological changes of particular 
interest were enzymes.
2. To study the effects of three CM with different osmolarity on renal function and 
biochemical changes.
3. To demonstrate the release of endothelin, after CM, by direct measurement of 
endothelin- 1  immunoreactivity.
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6.2 METHODS
5.2.1 ISOLATION OF THE KIDNEY
For a complete description of the IPRK procedures see Oldroyd, 1997 and El Sayed et al, 
1991.
5.2.1.a) Animals
Six Male Wistar rats {Sheffield University Field Laboratories) weighing 400^50g, 
aged 5-7 months were anaesthetised with thiopentone 125 mg/kg. Following IP injection of 
heparin (5000 lU/kg) careful canulation and initial perfusion of the right kidney which was 
removed and placed in the perfusion apparatus. The right kidney was removed by a non- 
ischaemic technique and perfused ex-vivo.
5.2.1.b) Operative procedures
Operative procedures were carried out by Dr J. Hay lor. S h ie ld  Kidney Institute. 
These procedures were completed within 30-35 minutes. Perfusion pressure was then 
maintained automatically at 100mm Hg with the aid of a peristaltic pump controlled by a 
pressure sensor and servo-control of perfusion pressure.
The isolated kidney was allowed to equihbrate until the perfusate flow became 
constant (usually 40 minutes).
5.2.2 Equipment
(For details see Oldroyd, 1997.)
5.2.2.Û) Renal pressure sensing
Pressure was measured within the renal artery using a modified double bore cannula 
method. A fine internal dental needle (27G) was placed inside the renal artery cannula 
(19G) and positioned to record pressure within the renal artery. This fine bore pressure 
sensing needle is connected via a fine cannula line (Portex, France) to a pressure transducer 
(Model No. P231D, Gould, UK) connected to an amplifier (Model No. 11-G4113-01, 
Gould, UK) to a flat-bed chart recorder.
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5.2.2. Z?) Servo-control unit
During perfusion the pressure was kept constant by servo-control of the speed of the 
peristaltic pump (RPF).
5.2.2. c) Chart recorder
A double channel chart recorder was used to record changes in the perfusion 
pressure and speed of the peristaltic punç (RPF). Both, pressure (in mmHg) and RPF (in 
ml/min) were recorded continuously.
S.lJl.d) Perfusate chamber and bubble trap
The perfusate chamber over which the kidney is suspended is a double walled glass 
condenser 65cm in length with outlet and inlet ports for water circulation and is 
manufactured "in house" (Dept, of Chemistry, University of Sheffield). This glass 
condenser serves as the kidney chamber, the perfusate reservoir and the oxygenation 
chamber. It has a side arm for delivery of a ^S%0JS%C02 oxygenation mixture, which 
has been warmed to 37°C and humidified. The glassware is removed from the circuit after 
each perfusion and cleaned by immersion in 5M nitric acid followed by numerous washings 
with a commercially available glass detergent.
5.2.3 Materials
5.2.3. a) Preparation o f perfusate fo r the IPRK
The same batch of solution which was prepared by the S h ie ld  Kidney Institute and 
contained in mmol/l Na"^  147, K+ 5.2, Ca"^  ^2.5, Mg'"^ 0.96 ,C1' 128, HC03' 25, S04'^
0.96, glucose 5.5, inorganic phosphate 1.4 and 6.7 w/v BSA ,14 mM of mixed amino acids 
(Vamin). The perfusate was gassed with 95% 02/ 5% C02 and temperature m aintained at 
37oC
5.2.3.Z?) The preconstricted IPRK
The RPF was lowered by approximately 50% by the infusion of angiotensin II 
(Sigma, UK) at a dose of 5ng/min into the perfusion circuit via a programmable syringe 
pump to a new baseline.
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5.2.3. c) Contrast media and dose
The water soluble CM that were used in these studies were:-
1. Ionic monomer iothalamate (325 mg iodine/ml with osmolality 1800 mOsm/kg H2O)
2. Non-ionic monomer iohexol (350mg iodine/ml with osmolality 661 mOsm/kg H2O).
3. Non-ionic dimer iodixanol (320 mg iodine/ml with osmolality 290 mOsm/kg H2 O)
The circulating concentration of contrast medium in the renal perfusate was 
calculated at 2 0  mg iodine/ml, which corresponded to approximately 1 0 ml of a 
commercially injectable solution of CM being added to the perfusion circuit, depending on 
the total perfusate volume in each experiment. This concentration is comparable to high 
intravenous dose of water soluble contrast medium ( 8  ml/kg body weight) used in vivo 
studies in the rat {see 3.2.2). This dose was calculated on the assumption of a circulating 
blood volume in 400-450g rats of between 15-20ml perfusing two native kidneys, whilst in 
the IPRK model only one kidney is perfused with approximately 150ml of perfusate.
5.2.4 Experimental protocol
The first 40 minutes of perfusion was an equilibration period during which time a 
continues' infusion of angiotensin was started and maintained throughout the experiment. 
A bolus dose of [^ "^ Cj carboxy inulin IpCi was also added to the perfusion solution for the 
measurement of GFR.
The following 20 minutes of perfusion was regarded as a baseline period.
5.2.4. a) Sample collection
Ten minutes after equilibration, filtrate and perfusate samples were collected 
simultaneously every 5 minute. Initial 3 perfusate and 2 filtrate samples were collected 
and were regarded as baseline samples. Then 10ml of CM (300 mg I/ml) (nothing in the 
control) was added to the perfusate reservoir to achieve an initial perfusate concentration 
20 mg I/ml, this was regarded as time 0. Filtrate and perfusate were collected at 5 minute 
intervals, i.e. 10 more filtrate and perfusate samples were collected for the following 50 
minutes. After measuring and noting the volume 1 ml of distilled water was added to 
each filtrate sample (important for subsequent correction when calculating filtrate data) 
from this diluted filtrate the following were taken:
• 0 . 6  ml for inulin measurements.
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• 1 0  pi for electrolytes measurements.
• 50pl for iodine measurements.
• 0.5 ml for enzymes and proteins’ measurements.
5.2.5 Measurement of renal function
5.2.5. ûj Glomerular filtration rate (GFR)
GFR was calculated from the renal clearance of exogenous carboxy inulin. 
Renal clearance was calculated as the urinary excretion rate per minute divided by the
perfusate counts (concentration) per millilitre. carboxy inulin containing IpCi 
(4.76 pCi/mmol, Amersham, UK) dissolved in normal saline was added to each perfusion 
during the equilibration period. The perfusate count (concentration) employed to
calculate clearance was the average of measurements obtained at the beginning and the end 
of each 5 minute clearance period. For carboxy inulin radioactivity measurements 0.6 
ml of each perfusate and diluted filtrate were added to 4 ml scintillation fluid (Scintran 
Cocktail T, BDH, UK) and counted in Packard® liquid scintillation counter (Packard 460D, 
USA).
5.2.5. Z?) Renal perfusion pressure
Perfusion pressure, as measured through the fine bore needle in the renal artery, 
was detected via a pressure transducer (Model No. P231D, Gould, UK) and recorded 
directly onto the chart recorder. Calibration of the pressure transducer to 100 mmHg was 
first performed using a mercury manometer.
5.2.5. c) Renal perfusate flow  (RPF)
RPF was continuously monitored as a function of the perfusion pump speed using a 
flat-bed chart recorder calibrated in ml/min. for the duration of each experiment, with 
urine/perfusate collection points being marked on the recording for reference accordingly. 
The system was first calibrated to a pressure of 100mm Hg using a mercury manometer, 
then the RPF was calibrated by manual measurement of the cannula output per minute and 
corresponding adjustment of the servo-control unit until the chart recording of RPF was 
directly proportional to the pump speed.
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5.2.5.d) Fractional excretion o f potassium (FE^
The urinary potassium concentration was measured by flame atomic absorption 
spectrometry with serial potassium standards (range between 1.5-55 mmol/l) (for further 
details see 2.5). Fractional excretion of potassium was calculated as urinary potassium / 
(plasma potassium x GFR).
5.2.5. e) Iodine clearance
The filtrate and perfusate iodine concentration were measured by x-ray fluorescence 
(for further details see 4.2.6)
5.2.5.)) Enzyme and protein assay
Desalt the filtrate through gel columns (for further details see 2.2) for protein and 
enzyme assay. Using Cobas Bio centrifugal analyser for measuring protein and enzymes 
assay (for further details see 2.3). The use of relevant kits and assay and as follows:
• GGT (Roche® kit for Cobas Bio)
• Alkaline phosphates (Boehringer® kit for Cobas Bio)
• NAG (PPR Diagnostics® kit for Cobas Bio)
• Protein assay Coomassie blue (Bio-Rad® assay). Standards were prepared from 
bovine serum albumin used to prepare the perfusion solution.
5.2.5. g) Gel electrophoresis (Phastsystem gel electrophoresis)
Perfusate (diluted 1:400) and filtrate samples were separated by SDS-PAGE gel 
electrophoresis (for father details see 2.9)
5.2.6 Endothelin assay
A variety of contrast media: iodixanol, iohexol, iopromide, iopamidol, ioversol, 
iopentol, iotrolan, iobitridol, iomeprol, and a control were tested in order to evaluate the 
IPRK for endothelin release. Samples were collected from 30 perfusion experiments (3 per 
single CM) (carried out by Dr J. Haylor, S h ie ld  Kidney Institute). In these experiments 
only the perfusate was collected for the endothelin assay other data were not presented here. 
CM solutions were adjusted to a concentration of 300 mg I/ml before 10 ml was added to 
the reservoir.
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For each IPRK experiment 10 ml of the perfusate was taken 10 minutes after 
equilibration and the other 10ml was collected at the end of the perfusion experiments (50 
minutes after CM administration). They were placed into prechilled tubes at 0°C 
containing EDTA (1 mg/ml) and Aprotinin (5000KIU/ml) and were stored at -70°C for 
Endothelin assay. All subsequent procedures were carried out as follows:
• Thaw the frozen samples gradually
• Add equal volume (10 ml) of 1 % TFA buffer (buffer A)
• Spin samples at 10 000 RPM at 4° C for 20 min.and take the supernatant
• Assemble CIS columns (Sep-Pak Cartridges from MILLIPORE) on a manifold which is 
connected to a vacuum pump
• Equilibrate the Cl 8  column with 1 ml of 60% acetonitrile in 1% TFA in distilled water 
(buffer B), and 3 times with 3 ml of buffer A.
• Apply samples on the columns (under vacuum pressure less than 1 inches.vac. /Hg ) .
• Wash the column with 6  ml buffer A
• Elute the peptide with 3 ml buffer B and collect the eluate in propylene cryo tubes 
(Nanc)
• Concentrate the samples for 1 hour at 40°C with a UNIVAP centrifugal evaporator.
• Freeze dry the concentrated samples
• Reconstitute the samples with 250ul RIA buffer (consisting of 19mM monobasic and 81 
mM dibasic sodium phosphate (pH 7.4), 0.05M NaCl, 0.1% BSA, 0.1% Triton X-100, 
and 0 .0 1 % NaNg)
• Vortex vigorously
• Spin at 4200 RPM for 20 minutes at 4 ®C and keep the supernatant.
• Carry out a standard double antibody radioimmunoassay with reagents all obtained from 
PENINSULA , and as follows:
Day 1
• After reconstituting the standard peptide with 1 ml RIA buffer store it on ice.
• Reconstitute the primary antibody rabbit anti endothelin antibody with 13 ml of RIA 
buffer.
• Prepare a series of the standards of these concentrations: 128, 64, 32,16, 8 , 4, 2, 1 
pg/tube the STD concentration.
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Prepare duplicates of200ul RIA buffer. Two will be for the total count (TC tubes 1 &
2), and two for non-specific binding (NSB tubes 3 & 4).
Prepare duplicate of lOOul RIA buffer will be for total binding (TB tubes 5&6).
Take 100 ul of each standard (tubes 7-22) and of unknown samples ( tubes 23 onwards) 
in duplicates.
Reconstituted primary antibody rabbit antiserum (PENINSULA) specific for endothelin 
(Porcine, human, rat) in 13 ml RIA buffer.
Add 100 ul to all tubes firom 5 onwards i.e. do not add to TC and NSB tubes.
Vortex each tube
Cover and incubate at 4 ^ C over night 
Day 2
Reconstitute the ^^^I-Endothelin with 1 ml RIA buffer and count 5 ul of it.
According to the count obtained firom the 5 ul, reconstitute the peptide in an appropriate 
volume to give an optimium count/1 OOul added to each tube, mix thoroughly.
Add 100 ul of the ^^^I-Endothelin to each tube.
Vortex, cover and incubate at 4 ^ C over night.
Day 3
• To all tubes add:
1. 1 OOul secondary antibody Goat Anti-Rabbit IgG serum (reconstituted in 13 ml RIA 
buffer)
2. lOOul Normal Rabbit Serum (reconstituted in 13 ml RIA buffer)
• Vortex and incubate for 90 minutes at room temperature.
• Add 500 ul of RIA buffer and vortex.
• Centrifuge at 3000 RPM for 20 minutes at 4 ^ C and keep the supernatant.
• Carefully aspirate the supernatant, not to lose the pellet and not to leave any liquid 
behind. Do not aspirate firom the TC tubes.
• Count and calculate the results according to the equation 
%B/Bo =(Average count)-Average NSB/(TB-NSB)
• Calculate the unknowns firom the standards curve.
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5.3 Results
Histology of the IPRK was also evaluated by examination of TB stained sections 
(not illustrated). Histology illustrated that the normal architecture of the tubules was well 
preserved. However some distention between epithelial cells was apparent as frequently 
observed with perfusion fixation. Some apical small, clear vacuoles were also observed. 
Both iohexol and iodixanol showed extensive vacuolation consisting hyaline droplets 
(containing protein and possibly CM). These histological changes were consistent with 
the extent of vacuole formation in these two CM in vivo.
The various IPRK parameters with different CM and control are presented in 
tables 5.1-5.4.2. These data are presented graphically in Figures 5.1.1-5.9 in order to 
better illustrate some of the important features of these results and to compare the 3 CM 
with the control.
IPRK after iohexol with a low RPF and low GFR (Table 5.4.2) showed severe 
renal haemodynamic changes compared with that with a normal perfusate flow and GFR 
(Table 5.4.1). Data from this low RPF and GFR experiment served to illustrate the 
variability and thus difficulties in interpretation of data from experiments which do not 
satisfy the criteria. It was not plotted graphically with other CM data.
The perfusion pressure was the only baseline parameter that was maintained 
constant at 100 mmHg. During all experiments by a sensing mechanism (servo-control of 
the speed of the peristaltic pump) to achieve almost similar renal perfusate pressure. Thus 
for any decrease in pressure (due to decrease vascular resistance) there was a 
corresponding increase in flow rate and vice versa. Other renal function parameters were 
different to start with as follows:
Control Iothalamate Iodixanol Iohexol
UFR(ml/min) 0 . 2 0 . 1 1 0.03 0.26
RPF(ml/min) 36 30 32 33
GFR(ml/min/g) 1.4 1 . 1 0 . 6 1
m 78 28 45 19
In view of the fact that all these parameters were variable at the start, therefore 
the effect of CM was expressed as percentage of change from the baseline (before CM).
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UVE LFR ŒR FEF FF M FB( m P31] F irym n U b lA m AJ% tsi
-50 02 1.41 350 59 757 108 17932 942 12 333 141.3 154
QO 02 1.17 æ o 53 756 124 175© 757 104 229 1166 158
50 02 1.17 æ o 53 752 123 12853 511 60 2134 848 100
100 02 122 350 54 655 103 1220 451 90 2329 856 96
150 02 1.10 355 50 655 11.9 13224 382 57 2407 695 104
200 02 121 37.5 52 77.7 124 12909 409 2 252 81.8 104
250 02 1.0B 350 26 655 11.8 11330 402 40 2041 723 72
300 02 1.10 37.5 29 764 153 16800 922 103 2909 1604 17.9
350 02 074 37.0 20 659 172 23338 1230 102 3506 187.5 153
400 01 001 37.5 24 556 124 17339 122 125 2566 1853 154
450 02 097 355 25 691 157 24404 1848 210 3758 2346 324
900 01 oæ 390 22 744 156 25779 2225 2© 3351 2896 346
TABLE 5.1. Control effects on IPRK parameters.
Time represents time in minutes before and after infusing the CM (nothing In control experiments) 
which was at 0 minutes.
UFR: is the filtrate flow rate calculated as filtrate volume in ml/5 minutes of the collection time. 
GFR: is inulin clearance in ml/minute/g wet kidney weight.
RPF: is renal perfusate flow in ml/minute
FF: is the Filtration factor [clearance(GFR) x100]/RPF
[K]: filtrate potassium concentration in mmol/L
FEk : is fractional excretion of potassium calculated as  : filtrate K/(perfusate K X Clearance/GFR) 
PI: is perfusate Iodine in mg/ml, FI is filtrate Iodine in mg/ml, GFRO) is Iodine clearance in 
ml/minutes/g wet kidney weight, calculated as filtrate Iodine x filtrate flow rate/ (perfusate Iodine x 
weight kidney weight)
[PTN]: Protein concentration in the filtrate in mg/L,
[GGT]: g- Glutamyl transferase enzyme concentration in the filtrate in U/L 
[ALP]: Alkaline phosphatase enzyme in the filtrate in U/L,
[NAG]: N-acetyl transferase concentration in the filtrate in U/minutes/L 
[PTN]/min: is the filtrate protein in mg/minutes (=[PTN] x UFR),
[GGT]/min: is the filtrate g- Glutamyl transferase in mu/min (=[GGT] X UFR)
[ALP]/min:is the filtrate Alkaline phosphatase in mu/min(=[ALP] x UFR)
[NAG]/min:is the filtrate N-acetyl transferase in mu/min (=[NAG] x UFR)
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WE FT“ “ TST " F 0 F IN iG sn “ P tq |W 3 HiNmn uaiAm AHmn
■6 Q11 1.1 300 35 27.93 51 299 ISO 57 31.6 330 17 63
0 Û09 09 300 30 2910 62 3177 171 85 361 285 15 77
5 032 1.8 352 51 1690 1.8 346 1679 525 132 751 530 165 41.6
10 048 08 355 23 576 20 25 392 06 1040 160 52 329 495 76 247
15 039 07 % 0 22 434 1.1 23 301 04 608 76 21 160 237 30 53
20 033 07 31.5 21 546 25 23 513 06 1500 193 42 57.9 SOI 65 141
25 030 06 255 20 627 21 23 657 07 1290 180 29 57 384 54 58
30 029 06 ZO 24 1111 34 22 81.5 09 1S9 249 48 27.6 458 73 14.1
35 027 06 24.0 24 1077 36 22 81.8 08 1544 2 2 43 293 414 70 11.5
40 025 06 225 28 7.C2 21 22 464 05 1203 209 27 241 313 54 69
45 025 06 21.5 27 a i3 30 20 61.7 07 1307 209 45 36 327 52 11.6
50 025 06 205 29 530 27 19 494 1 1378 222 42 258 347 56 106
Table 5.2-Effects of iothalamate on the IPRK
TWE CFR ~ G H T ~ R f f " ' FF “ T s r PP) P(l) "TPiN ICG!} [ALtj KiNmn ULii/mn fLMmn
-5 003 06 32 19 45 145 2449 1251 2395 7708 83 41.8 06
0 003 06 32 20 52 166 2966 1702 3415 5367 89 51.1 07
5 004 11 29 38 48 53 153 3944 2133 3948 8429 174 958 1.6
10 007 11 23 50 31 52 21.7 TO 02 2910 2282 4503 10956 209 1643 4.3
15 007 06 21 27 28 95 203 93 03 1138 1414 3155 651.7 84 1046 3L2
20 008 05 20 24 23 92 197 96 03 1115 1023 1959 3456 85 77.7 20
25 007 04 20 19 23 11.3 159 SB 03 806 912 1948 451.7 60 675 1.9
30 009 05 20 24 21 57 202 111 04 786 956 1057 5442 74 899 1.6
35 O10 05 20 24 25 107 19.8 106 04 899 908 1008 90 908 1.7
40 013 05 21 25 23 54 19.7 102 05 712 938 1495 90 1152 56
45 014 05 21 25 22 50 182 112 07 686 713 1151 95 954 53
50 014 05 21 25 22 51 126 733 819 1054 111 1147 50
Table 5.3-Effects of iodixanl on the IPRK
TIVE im ~ S T T " FF M FB< MD FIN iw q PINrm GjiJtm AHtmn
-6 025 10 33 30 •B 37 1025 99 10 109 Z9 Z 3
0 023 10 33 30 17 33 888 134 3 90 245 34 6
5 038 12 æ 32 19 32 1680 585 104 728 642 2Z 40
V 042 08 35 22 14 36 23 89 11 1300 580 108 790 574 235 43
15 034 06 31 20 8 25 25 74 07 917 308 3 1187 310 104 9
2D 034 06 28 22 5 14 23 81 08 729 3c9 37 1657 251 127 13
25 025 07 27 25 14 41 22 100 11 335 125 12 1353 133 43 4
3) 035 07 25 26 15 42 20 101 12 806 200 19 1285 279 69 7
35 034 07 25 26 13 35 20 97 11 S21 237 22 2233 313 81 7
4) 035 08 25 29 8 21 21 51 06 679 178 0 1139 239 63 0
45 031 07 26 28 7 18 20 44 05 704 200 10 1125 218 62 3
SD 028 08 Z 29 10 26 18 77 08 S5 385 40 1009 S I 109 11
Table 5.4.1-Effects of iohexol (1) on the IPRK
“TI5E" ItW “ S T T " Ft*- — FF— n — FB T" RO F(D PIN tOGO ÏA fJ PlNnkt UblAni AFftm
•5 QQ2 93 26 11 146 359 143 440 3 7 3
0 QOS 94 27 1.4 209 555 97 218 4 10 2
5 Q04 1.8 31 59 57 6 412 93 3493 1616 243 1002 133 61 9
10 916 24 29 84 22 2 20 491 92 1908 2150 421 1550 306 340 67
15 Û14 98 25 30 22 6 21 559 93 854 745 141 597 120 104 20
20 914 95 24 22 24 9 19 389 93 371 54 435 65 50 7
25 917 96 22 26 40 14 21 254 92 806 348 58 619 140 61 10
30 914 94 21 20 35 16 19 57.7 93 317 232 47 385 43 32 6
35 913 94 20 1.8 19 10 20 57.5 93 325 178 5 274 41 22 1
40 914 94 20 21 19 8 20 54.4 91 474 210 14 159 67 30 2
45 905 91 20 97 16 22 20 598 92 505 184 13 242 26 10 1
SD 9CB 9 3 19 1.5 16 12 19 1.0 112 338 34 651 9 27 3
Table 5.4.2 -Effects of iohexol (2) on the IPRK
Param eters described in these tables are exactly the sam e a s  in the legend to table 5.1
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5.3.1 Acute functional haemodynamic effects
5.3.1.aj Filtrate (Urine) flow rate (UFR)
All three CM increased UFR (Fig 5.1). Iothalamate (Table 5.2) increased UFR 
more than 4-fold above the baseline after 5-10 minutes, iohexol increased it only to 1.5- 
fold (Table 5.4.1); while iodixanol (Table 5.3) doubled the flow after 10 minutes and 
increased it 8 -fold after 50 minutes. In the control experiments UFR almost stayed at 
steady state (Table 5.1).
53A .b) Glomerular filtration rate(GFR)
All three CM increased GFR transiently (Fig. 5.2); iothalamate (Table 5.2) and 
iohexol (Table 5.4.1) caused a transient increase of GFR after 5 minutes and subsequent 
decrease to 50% after 20 minutes, while iodixanol (Table 5.3) induced transient rise of 
GFR which returned to near the baseline. In the control experiment (Table 5.1) GFR 
decreased gradually with time and get down to about 60% of baseline. At 20-30 minutes 
both iothalamate and iohexol reduced GFR to levels below the control and iodixanol
5.3.1. c) Renal Perfusate Flow
Iothalamate (Table 5.2) and iohexol (Table 5.4) caused transient increase in the 
first 1-3 minutes following CM infusion followed by sustained decrease of RPF, while 
iodixanol caused sustained decrease of RPF (Table 5.3) with no initial increase (Fig. 5.3 
and 5.3.1). All CM lead to almost 30% decrease of renal perfusate flow at the end of the 
50 minute’s period. In the control (Table 5.1) there were no changes of RPF which 
remained constant throughout the perfusion period, despite the drop of GFR.
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TIME IN MINUTES
FIG 5.1: Effects of different CM and the control on UFR in the IPRK
Contrast media were added to the perfusion system at time O(arrow), in the control nothing was 
added. Values represent percentage of change compared to a baseline values of 100%.
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-.^-.IODIXANOL 
. . . X - . .  IOHEXOL
TIME IN MINUTES
FIG 5.2: Effects of different CM and the control on GFR in the IPRK
Contrast media were added to the perfusion system at time O(arrow), in the control nothing was 
added. Values represent percentage of change compared to a baseline values of 100%.
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FIG 5.3: Effects of different CM and the control on RPF in the IPRK presented as percentages 
changes. Contrast media were added to the perfusion system at time 0(arrow), in the control nothing 
was added. Values represent percentage of change compared to a baseline values of 100%.
<11'c
<
FIG 5.3.1: Effects of different CM on perfusion pressure and RPF in IPRK
Upper line indicates pressure, the lower line is the RPF in each of the four graphs. Arrows indicate
the position when contrast media were added to the perfusion system.
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5.3.1. Filtration factor (FF)
The filtration factor (Fig. 5.4) as a value which represents the state of filtration 
was extrapolated from the equation FF= (clearance X 100/RPF). It was increased 5 
minutes after iothalamate (Table 5.2) and iodixanol (Table 5.3) and back to baseline with 
iodixanol but below that in iothalamate; with iohexol there were no changes of FF (Table
5.4.1 and 5.4.2). Also in the control (Table 5.1) there were no changes of the FF.
5.3.1. é) Potassium excretion and fractional excretion
As iothalamate and other ionic CM contain Na, measuring FE^a would not be 
appropriate. For this reason FEk was followed instead (Fig. 5.5). No changes were 
detected in K excretion in the control (Table 5.1). After CM there was more than 50% 
decrease in urinary K and its fractional excretion as with iothalamate (Table 5.2), 
iodixanol (Table 5.3), and iohexol (Table 5.4). Changes of FEk corresponded with 
changes in RPF.
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FIG 5.4: Effects of different CM and the control on the filtration factor in IPRK.
Contrast media were added to the perfusion system at time O(arrow), in the control nothing was 
added. Values represent ratio of GFR/ RPF percentage of change.
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FIG 6.5: Effects of different CM and the control on FEk in the IPRK.
Contrast media were added to the perfusion system at time O(arrow), in the control nothing was 
added. Values represent percentage of change compared to a baseline values of 100%.
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5.3.2 Urine proteins and enzymes
5.3.2. a) Proteins
There was an increase of renal protein excretion after CM (Fig 5.6) (expressed as 
total protein filtered/minute) (Table 5.2-5.4). There was also an increase in protein 
concentration in mg/ml with iohexol and iodixanol but not with the high osmolar CM 
iothalamate. This increase of urinary proteins was transient as all values returned to 
normal level by 50 minutes. No changes were detected with protein excretion in the 
control (Table 5.1).
5.3.2.b) Proteinuria profiles
Protein profiles (Fig. 5.12) showed that the composition of the filtrate (as 
determined by SDS-PAGE Phast system) is similar to that of the perfusate and there were 
no added new low or high molecular weight protein bands. Thus the detected filtrate 
proteins were all of perfusate origin and were filtered through the glomeruli with no 
added LMW proteins that could be detected which would indicate tubular proteinuria, 
indicating that proteinuria is attributable to glomerular filtration. Also there were no 
detected differences in protein profiles among the 3 different CM.
5.3.2. c) Enzymes
The brush border enzymes GGT (Fig 5.7) and ALP (Fig 5.8) are sensitive urinary 
markers of CM filtration in vivo (chapters 3). In these IPRK experiments both brush 
border enzymes were substantially increased soon after filtration of CM: up to 7-fold 
with iothalamate (Table 5.2), 4-fold with iodixanol (Table 5.3) and more than 10-fold 
with iohexol (Table 5.4.1 and 5.4.2). The enzymes after reaching a peak started to 
decline towards the pre-CM baseline values. There were no changes with time of either 
of these enzymes in the control.
The lysosomal enzyme NAG (Fig 5.9) did not show similar pattern to that of the
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FIG 5.6: Effects of different CM and the control on protein excretion / minute in the IPRK. Contrast 
media were added to the perfusion system at time O(arrow), in the control nothing was added. 
Values represent percentage of change compared to a baseline values of 100%.
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FIG 5.7: Effects of different CM and control on GGT excretion / minute in the IPRK. Contrast media 
were added to the perfusion system at time 0 (arrow), in the control nothing was added. Values 
represent percentage of changes compared to a baseline values of 1 0 0 %.
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FIG 5.8: Effects of different CM and control on ALP excretion / minute in the IPRK.
Contrast media were added to the perfusion system at time 0, in the control nothing was added. 
Values represent percentage of change compared to a baseline values of 100%.
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FIG 5.9: Effects of different CM and the control on NAG excretion / minute in the IPRK. Contrast 
media were added to the perfusion system at time 0, in the control nothing was added. Values 
represent percentage of change compared to a baseline values of 100%.
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brush border enzymes of increase and decrease to baseline after iothalamate and 
iodixanol. However NAG with iohexol started to rise after 10 minutes and reached peak 
levels after 30 minutes, a trend which was significantly different from other enzymes and 
with other CM.
5.3.3 Iodine pharmacokinetics
Iodine concentration in the perfusate was around 20 mg I/ml in the perfusate 
(Table 5.2-5.4), while there were different filtrate iodine concentration with different 
CM. Not surprisingly the iodine concentration of the filtrate varied with different CM 
indicating variation in filtration rates and as follows:
CM Range of filtrate iodine Filtrate/Perfusate
(mg/ml) iodine ratio
Iothalamate 30-80 1.5-4
Iohexol 80-100 4-5
Iodixanol 93-126 4.5-6.5
From the above table the Filtrate/Perfusate iodine ratio indicated that the tubules 
were able to concentrate the filtrate up to that limit only. Also the higher the number of 
iodine atoms /molecule of particulate in the filtrate and the lower the osmolarity of CM 
the higher the iodine concentration in the filtrate as with iodixanol.
5.3.4 Endothelin
Perfusate endothelin was elevated with 7 out of the 9 CM that were tested (Fig 5. 
11) (N=3 in each tested CM) in comparison to basal endothelin levels before the 
addition of CM. As it was significant (P<0.05) with iodixanol, iopromide, iopamidol, 
and iopentol but not significant with ioversol, iotrolan and iobitridol. Only with iohexol 
and iomeprol there were no changes. In 4 of the 27 CM perfusion experiments, 
endothelin was elevated to very high levels after CM; levels were with iodixanol (18 
pg/ml), iopentol ( 1 0  pg/ml) and with iopromide ( 8 6  & 1 2  pg/ml), in comparison to a 
baseline control which was less than Ipg/ml.
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FIG 5.10: SDS-PAGE protein profiles of the perfusate and filtrate before and after CM.
Lanes: 1: HMW STD, 2: normal rat urine, 3: filtrate 5 minutes after iothalamate, 4: filtrate before 
iohexol, 5: filtrate 5 minutes after iohexol, 6:filtrate 50 minutes after iohexol, 7: LMW STD, 8: diluted 
perfusate 1:100. For standard protein MW identity see (Chapter 2.9.1.a).
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FIG 5.11 Effects of different CM on the release of endothelin in the IPRK. Perfusate endothelin 
values before and 50 minutes after adding CM or nothing (in the control) were represented from 
each group of CM in the IPRK. * P<0.05 in comparison to basal level before adding CM. Each bar 
represents the average of 3 values (-SD)
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5.4 DISCUSSION
The variant renal function parameters before adding CM signify the different 
basal renal function. Data from two iohexol experiments served to illustrate the 
variability and thus difficulties in interpretation of data from experiments which do not 
satisfy the normal criteria. In the iohexol-tested IPRK with a low RPF and GFR there 
was a state similar to renal insufficiency. Ideally to compare different haemodynamic 
effects of different CM a number of IPRK preparations need to be examined for each CM 
to achieve an acceptable range. This was beyond the scope and aims of this work, which 
was essentially to correlate between the haemodynamic effects and the biochemical 
changes.
Generally the renal changes that accompanied CM with the IPRK system are 
consistent with in vivo observations. The data obtained with the IPRK is unique as the 
different renal haemodynamics and biochemical parameters could be followed and 
correlated with each other simultaneously. All three different types of CM tested 
exhibited acute effects on renal function and had direct haemodynamic and biochemical 
effects on the IPRK, although each CM exhibited different effects from each other. The 
pattern of haemodynamic changes on GFR and RPF being consistent with observation of 
other workers (El Sayed et al, 1991). In IPRK the GFR is 5-10 times lower than in vivo.
To maintain perfusion pressure constant at 100mm Hg any change in vascular 
pressure (resistance) should lead to changes in RPF. The immediate rise in RPF with 
iothalamate and iohexol, due to a decrease of the vascular resistance (vasodilatation), was 
followed within 2 minutes by depression of the RPF i.e. increased vascular resistance. 
With the nonionic dimer iodixanol there was no initial increase of RPF but sustained 
decrease of RPF. This vascular response to different CM was consistent with observation 
of other workers, as had been shown in the IPRK (El Sayed et al, 1991) and in vivo 
(Morris et al, 1978). The intrinsic property of the arterial smooth muscles might explain 
this biphasic response whereby they contract in response to increase vascular tension. So 
CM could cause increased arterial smooth muscle tension which leads to vasoconstriction.
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The significant elevation of endothelin in the perfusate after CM could suggest 
that it was a major trigger for vasoconstriction. Other factors might also contribute to the 
vascular response as well, as iohexol did not show significant increase in endothelin, but 
it decreased RPF. The association of endothelin with CM had been reported by others 
(Margulies et al, 1992; Heyman et al, 1992). Also the use of endothelin antagonists had 
abolished the vasoconstrictor effect of CM in IPRK (Oldroyd et al, 1995), which 
suggested that endothelin is the ultimate vasoconstrictor.
Generally a decline of RPF with CM suggests the potential for induction of renal 
ischaemic damage especially to the vulnerable parts of the tubules. As a result of the high 
oxygen requirement for active transport by the mTAL and the constraint imposed on 
medullary blood flow, there is marked impoverishment of oxygen supply in the deeper 
portions of the medulla, near the mTALs and away fi*om the vasa recta (Brezis et al, 1989). 
This decline started after 5 minutes from adding CM indicating direct and early vascular 
CM-induced changes rather than due to IPRK itself, as it was not seen in the control.
The trend of initial increase of both RPF and GFR followed by decrease was 
similar to the osmolar CM (iothalamate and iohexol), while with iodixanol surprisingly the 
initial decrease of RPF led to an increase of GFR. These changes in GFR were also 
reported by Brown et al, (1993). In order to understand this discrepancy between RPF 
and GFR in iodixanol we need to analyse the filtration forces. With the high osmolar CM 
the initial increase of GFR might partly be due to a slight increase of perfusate osmolarity 
or could be due to changes in glomerular filtration coefficient. However, the major effect 
should be due to changes of RPF and pressure. The decline of GFR afterwards with the 
three CM was progressive with time.
In the IPRK as well as in vivo the ultrafiltration forces are the differences between 
the glomerular and tubular hydrostatic pressures on one hand which are driving forces, and 
on the other hand they depend on the difference in their oncotic pressures which are the 
opposing forces. Changes in these four different filtration forces in IPRK after CM could be 
as follows:
1. There should be a decrease of around 7% in the glomerular oncotic pressure due to 
dilution of the perfusate albumin by adding 10 ml of protem free CM. This change of 
oncotic pressure after adding CM or any diluting solution should lead to increase filtration.
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In theory the filtration force due to this factor should persist for the rest of the experiment. 
The subsequent decrease in filtration indicates that other filtration forces were affecting the 
filtration.
2. The changes in the tubular oncotic pressure were negligible in comparison to that of the 
perfusate as protein concentration was slightly increased with a concentration of not more 
than 2 % of the perfusate.
3. There is no reason why the tubular fluid pressure should decrease which could lead to 
increase filtration, on the contrary and due to filtration of the CM there could be an 
increase in the tubular pressure rather than decrease which could decrease the filtration 
force (Ueda et al, 1992). As the filtrate was not concentrated to the same extent as in vivo, 
due to absence of ADH and the tubules were not concentrating the filtrate (as was shown 
by iodine concentration), therefore this opposing force would be negligible.
4. The main driving force that could lead to a significant increase of filtration is the 
glomerular hydrostatic pressure. Perfusion pressure to the glomeruli (afferent vessels) was 
maintained by the servo system, as any increase in pressure led to decrease flow. So if 
there was any increase in glomerular hydrostatic pressure it should be due to the difference 
between the afferent and efferent pressures. The increase in efferent pressure could be 
explained either by selective efferent arteriole’s constriction or could be due to an increase 
in the interstitial pressure i.e. increase in post efferent pressure in peritubular capillaries. At 
the moment the IPRK model does not provide enough evidence to distinguish between such 
possible causes.
The filtration factor as a ratio represents the relation between clearance and RPF 
(FF =  GFR/ RPF). As it was increased after CM this could indicate that there was a 
disturbed balance either by increased clearance or decreased RPF, but due to a feedback 
mechanism this increased FF was declined back to below baseline values . It was found 
by others that CM caused low filtration firaction, due to a higher perfusion flow rate and 
lower glomerular ultrafiltration coefficient (Gabbai et al, 1994). In general this factor was 
mcreased initially after the three CM but soon decreased to low levels. There could be an 
active tubular-glomerular feedback (TG) mechanism which reverses the situation back to 
normal and decreases the filtration. By blocking TG by furosemide or by the use of non 
filtering version of IPRK, Morcos et al, (1995) were able to significantly reduce the
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decrease in RPF after the diatrizoate. It was suggested that TG is partially responsible for 
the vasoconstrictor response to high osmolar CM but not the isosmolar (Morcos et 
al, 1995). Endothelin could be one of the vasoconstrictor factors that determined this TG.
In vivo the reduction of renal flow could lead to ischaemic changes especially to 
vulnerable parts of the kidney i.e. the inner medulla which received the lowest percentage 
of renal flow, and possess high metabolic rate (Brezis et al, 1991). In most IPRKs tubular 
cells of the medullary thick ascending limb of loop of Henle and the terminal segment of 
the proximal tubule undergo necrosis (Schurek et al, 1985). The sensitivity of these high 
metabolic rate cells for oxygen changes and hypoxia needs to be considered
As ionic CM, such as iothalamate, contain sodium as the cation, sodium is not a 
suitable indicator of electrolyte handling. In view of this, the effect of CM on the 
fractional excretion of potassium as percentage of filtered load has to be used as 
electrolyte indicator. The addition of the 3 CM caused a decrease of the filtrate potassium 
and FEk- These findings were different from those in vivo, as FE^ was elevated in the 
initiating period in cases of CM-ARF in vivo. The absence of aldosterone, that would 
control potassium, could be one of the main for this. Furthermore, the renal status in the 
IPRK is unlike that of renal failure in rats when urinary potassium was increased after 
CM administration.
Iodine concentrations in filtrate were in the range of 40-100 mg I/ml with 
different CM, i.e. 2-5 times the perfusate concentration. This indicated that the IPRKs 
were capable of concentrating the filtrate maximally 2-5 fold, whilst in vivo the filtrate is 
concentrated by some 100 fold. The inability of the IPRK to concentrate the filtrate is due 
partly to lack of ADH but is mostly due to impaired reabsorption by the proximal 
tubules. This could be either due to impairment of the sodium pump by the tubular cells 
or to the high perfusion pressure increasing peritubular capillary pressure leading to 
pressure difference with the tubules and opposing fluid reabsorption, or to the high flow 
which might decrease the medullary interstitium solute concentration and osmolarity with 
the result that filtrate concentration was not much greater than that of the perfusate (Maack, 
1986).
The difference in filtrate iodine concentration with different CM was also related 
to number of iodine atoms/ molecule of filtrate particulate and to their osmolarity. So 4
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molecules of iothalamate contain the same iodine atoms to one molecule of iodixanol. 
With an equivalent GFR the number of CM molecules filtered should be identical, and 
the iodine concentration would be equivalent to the ratio of iodine/ molecule.
Comparing CM clearance with inulin determined the way the kidney excreted 
CM. Iothalamate clearance values coincided well with inulin clearance. However, 
iodixanol and to a lesser extent iohexol clearance was less than inulin clearance this 
difference in clearance may be explained as follows:
1. The capacity of the IPRK glomerular basement membrane to filter different CM was 
different, due to the fact that there were differences in UFR
2. CM might increase the tubular pressure. In microperfusion studies there was enough 
evidence that increased tubular pressure with nonionic dimers can lead to decreased CM 
filtration (Ueda, 1991).
3. CM (iodine) had been retained or reabsorbed after filtration. Vacuole formation as 
observed with iodixanol and iohexol but not iothalamate indicating CM retention might 
explain part of this discrepancy, but this needs further validation.
The low and prolonged clearance of iodine in comparison to in vivo exposed the 
renal vessels and the glomeruli to repeated cycles of 20 mg I/ml which was less filtering 
than in the normal situation. This could lead to sustained CM effect on the IPRK.
After the rapid clearance of all three CM, tubular cells released brush border 
(GGT and ALP) and only iohexol released lysosmal (NAG) enzymes (tables 5.2-5.4). 
This rapid onset of enzymuria occurred before any decrease of RPF indicating that the 
tubular effects of CM were direct as well as due to lower perfusion (or ischaemic changes). 
The possible combined effects of osmotic damage, high IPRK filtrate flow, and the 
physico-osmotic effect of CM on the proximal tubular cells and their brush border might 
cause significant increase of urinary enzymes. Interestingly, the increase of the three 
enzymes was not consistent with the increase of proteinuria in terms of time course and 
magnitude. The three enzymes all have MW greater than 75 KDa proteins (ALP 75-124 
KDa, GGT 90-120 KDa, and NAG 150-160 KDa). The filtrate protein profiles showed no 
additional high MW bands that could be detected, indicating that em^ymuria alone did not 
contribute to proteinuria. As the measurement of enzyme activity is much more sensitive
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than protein estimation, it is unlikely that the enzyme bands would be detected as protein 
bands.
The increase of proteinuria and particularly albuminuria (as the major protein in 
the perfusate was albumin) after CM and from the protein profiles was mostly glomerular 
in origin. The sieving coefficient of albumin in IPRK is some 10 fold higher than that of in 
vivo (Stolte et al, 1979). This could be due either to an increase of RPF or due to changes 
of glomerular filtration coefficient. Brown et al, (1992) noticed that the increase of 
albumin excretion after diatrizoate was dose related, but also that the haemodynamic RPF 
changes were dose related. The increased excretion of protein had little effect on the 
oncotic pressure in Bowman’s capsule as the filtrate protein was negligible (less than 2%) 
in comparison to the perfusate.
The identical protein profiles of the filtrate and the perfusate suggest that the 
filtrate protein was of glomerular origin. Also the filtrate profile before and after CM 
remained unchanged indicating that CM-induced proteinuria was possibly due to 
increased glomerular filtration and RPF rather than any decrease of tubular reabsorption. 
The two biochemical changes, i.e. tubular enzymuria and glomerular albuminuria were 
not related, as enzymuria did not correlate with proteinuria (table 5.2-5.4).
5.5 Summary
Although the IPRK experiments indicated differences in renal parameters among 
the three CM it cannot be concluded that these differences were significant without 
sufficient numbers in each group to allow statistical analysis. The present data thus only 
indicate possible trends. Due to possible variables in the perfusate, operative procedures, 
renal status of the animal some of the effects could be attributed to the IPRK system 
rather than ascribed to CM per se.
The rapid filtration of CM was also accompanied by early renal changes. With the 
start of CM filtration there was increase of UFR (diuresis), GFR, RPF (except iodixanol 
which did not show any initial increase in RPF), also proteinuria and enzymuria. Apart 
from the absence of initial increase of RPF with iodixanol the three CM produced similar 
pattern of changes i.e. early increase followed by decline of all functional and
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biochemical parameters to baseline and even lower. All these indicate that there was 
initial fast response by the kidney to the haemodynamic and biochemical changes induced 
by CM that was compensated rapidly through feedback mechanism. As the renal vessels 
and tubules form the basis of this feedback mechanism, therefore it is tempting to 
speculate that CM must have direct effects on renal circulation and tubules. Also any 
vascular or tubular pathology could affect this feedback mechanism.
After adding CM there was an increased GFR and diuresis which could be due 
either to decreased oncotic pressure after adding a protein free CM-solution, or differences 
between afferent and efferent pressure, or increase perfusate osmolarity especially with the 
high osmolar, or changes of glomerular filtration coefficient.
After diuresis, CM triggered a sequence of events that led to persistent decline of 
RPF after an initial short rise. The decline of RPF could be through a feedback 
mechanism which could involve vasoconstrictor agents. As was shown endothelin was 
one of these triggers which was significantly increased after CM. Therefore, the 
significant increase of endothelin release with CM indicated that endothelin plays an 
important role in this feedback mechanism. Furthermore, the biphasic vascular changes 
were similar to the pharmacological effects of endothelin illustrated by short interval 
between vasodilatation and sustained vasoconstriction (Remuzzi and Benignie, 1993). The 
use of the IPRK model excluded interference from external sources of endothelin or other 
vasoconstrictors. Thus endothelin of renal origin was the vasoconstrictor released in 
response to CM treatment. Whether endothelin alone led to vascular changes or there 
were other tubuloglomerular effects due to filtrate changes, is still not clear.
Proteinuria and enzymuria were two biochemical changes that were observed after 
CM filtration. These changes were unrelated to each other or to the decline of RPF. 
Enzymuria was a clear indication that it was due to a direct effect of CM on PT cells and 
brush border, rather than indirect through decreased perfusion and any cell necrosis.
Despite its limitations the IPRK provided clear evidence that the acute effects of 
CM on renal tubules may cause renal damage:
1. Tubular cell enzymes were released during clearance of CM indicating a transient 
effect on these cells.
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2. Increased release of endothelin, which is in accord with decrease of RPF. Reduction of 
RPF may indicate a potential for ischaemia.
These changes indicated that proximal tubular cells were most vulnerable to direct 
effects by the filtering CM, and indirect effects induced by decreased RPF hence 
ischaemia. The poor water reabsorption in the system led to low CM concentrations in 
the filtrate. Since CM could induce direct tubule cellular effects at these low 
concentrations, then in vivo and at high filtrate CM concentrations there would be higher 
magnitude of CM effects.
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Chapter 6
GENERAL DISCUSSION AND 
CONCLUSIONS
6. GENERAL DISCUSSION AND CONCLUSIONS
6.1 General discussion
The aims of this project were to induce acute renal failure in rats after CM and to 
identify the changes in renal markers which were associated with the development of 
CM-ARF. This would lead to a better understanding of the pathophysiological 
mechanisms of CM-ARF. Without the induction of renal failure by CM, all renal changes 
after CM are simply direct concomitant effects with no diagnostic values rather than 
being predictors of CM-ARF.
6.1.1 Renal models
To mark out the vulnerable parts of the kidney that are more susceptible to the 
damaging effects of CM, animal models that were examined were based on different site 
specific renal injuries. These models were chosen on the basis of practicality and clinical 
relevance that resembled patient situations. However, the situation of patients suffering 
from chronic renal failure could not be reproduced easily in animal experiments, as most 
models induced part of the disease process that could occur in human. Renal insults were 
those of nephrectomy, chemically induced nephropathy and old age nephropathy. Other 
general factors of dehydration and large and repeated dosing of CM were also evaluated. 
It was important to compare potential renal toxicity of different types of contrast media 
under experimentally induced nephropathy. The types of CM chosen to represent extreme 
classes were, the ionic monomer iothalamate, non-ionic monomer iohexol and the non­
ionic dimer iodixanol.
6.1.1. a) Choice between single or multiple insults
Efforts in developing different models in this work were focused on inducing one 
renal insult with each model to reduce confounding effects of multiple insults. 
Experimental animal model protocols were aimed to achieve a renal state whereby any 
decreased renal function would be attributed to CM and not to inherent changes and 
natural course of the model itself. The majority of the reported models of CM-ARF were
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based on multiple subnephrotoxic renal insults and of the most cited were those described 
by Heyman et al, (1991) and by Idee et al, (1995). The former model was based on 
uninephrectomy, salt depletion, with the administration of indomethacin (prostaglandin 
inhibitor) and Airosemide, while the latter was based on uninephrectomy, short interval 
aorta clamping to induce renal ischaemia and gentamicin tubulotoxic effect. Induced renal 
failure by any insult is an evolving process, therefore, renal condition could be 
deteriorating due to inherent changes in the renal function rather than the tested CM.
Each one of these insults in the multiple models had its own evolving and continuos renal 
effects, therefore, renal changes could not be genuinely CM related. Acute impairment of 
renal function would be attributed specifically to CM when aetiology to other causes was 
excluded. Furthermore, the multiple insult models require large number of animals per 
each group to achieve statistical comparison as each insult requires its own control group. 
Therefore, it was decided to choose and develop single renal insults.
Moreover, renal function parameters, like other clinical parameters, fluctuate 
within a range. In multiple renal insult models renal function parameters would fluctuate 
within a wider range after each insult and the more the insults the wider the range of 
fluctuations would be. To evaluate the renal effects of CM on any animal model, the 
renal function of the different tested groups should be within a low range to start with to 
reduce the number of animals in each group for any statistical tests. Otherwise, to 
minimise any statistical error, and when there is a wide range of renal function 
parameters to start with, a sufficient larger number of animals in each group is required. 
The single renal insult model allowed comparison between different CM subgroups with 
lower number of animals in each subgroup, but it required matching of renal functions 
between paired animals in each subgroup to allow for significant comparison. A narrow 
range of parameters allowed the follow up of changes and the evaluation of the role of 
potential renal markers as indicators of CM-ARF.
ô .l.l.b ) Suitability o f the old age nephropathy model
Despite the short comings of the old age rats for the experimental protocol the 
following conclusion of the old age model can be made. Iothalamate showed only 
transient decline in renal function which was induced in old age rats matched for their 
renal function. However, as it was not possible to reproduce this model, it is difficult to
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claim that this was a genuine effect. The problem in this model was mainly due to the 
fact that old age animals in each group had a range of body weights which were not 
related to their renal function especially those of plasma creatinine and urinary proteins. 
The age and weight variables exhibit a confounding effect in old age rat model.
Therefore, even with paired matched animals for renal function, different doses were 
administered according to their different body weights. Therefore, definite effects on the 
renal function induced by CM were not conclusive as renal changes due to old age 
nephropathy could not be excluded. The nephropathy in old age is characterised by 
progressive changes ending up in thickening of glomerular basement membrane and the 
mesangium and eventually sclerosis of the capillary tuft. Also apparent were tubular 
hyaline casts, tubular epithelial cells' necrosis, focal brush border loss, bleb formations, 
and interstitial changes characterised by cellular infiltration and fibrosis (Fig 4.6 and 
4.12). These finding were consistent with well-established features of old age 
nephropathy in experimental rats (Anderson and Brenner, 1986; Goldstein et al, 1988).
Ageing in rats is associated with changes in glomerular permselectivity and 
proteinuria with progressive glomerular sclerosis which subsequently leads to renal 
insufficiency (Anderson and Brenner, 1986). It was shown that age related damage 
depends on animal diet protein, therefore, the renal function could depend on the food 
consumed through its life span (Bertani et al, 1989). As it is practically not feasible to 
control and follow different batches of diets over a duration of more than 16 months, 
fluctuation in the baseline renal status and renal damage could not be avoided in different 
animals. Rats in the old age model, due to these individual variations, were difficult to 
pair match. The wide variation in the renal status in the old age rats made this model not 
practical for CM studies, as it could not be reproducible.
Increased creatinine was pronounced after acidifying the urine for the potential 
release of iron from urinary transferrin. The essence of this protocol was that as a 
consequence of glomerular permeability in old age with the transient CM-induced 
proteinuria, it could be that proteins and particularly transferrin would accumulate in the 
lumen of proximal tubule. In an acidic media transferrin could release free iron which is 
known to be potentially toxic to tubular cells (Alfirey et al, 1989; Alfirey and Hammond, 
1990; Alfrey, 1992; Harris et al, 1995). However, the few cases of CM-ARF in this 
acidic urine model were mostly induced as old age rats consumed lower quantities of the
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acidic water (hence dehydrated for a longer period) adding another prolonged dehydration 
insult to the model. Also levels of the potential transferrin and iron insults were not 
possible to be monitored.
In conclusion, old age rats in general tolerated different types of CM without 
significant and reproducible renal impairment. The main drawbacks in the old age model 
were the difficulties encountered and the criteria required to match the groups. This made 
the old age rat model not suitable for CM-ARF studies. This conclusion was in accord 
with Vaamonde et al, (1989) who was unable to demonstrate that CM induced ARF in 
female old age nephropathy rats with diabetes and dehydration. However, CM-ARF in 
old age was reported by other workers in hypertensive old age rats (Duarte and Ellis, 
1990). Lastly, to reach the required age long duration of animal husbandry, more than 16 
months, is needed to reach the nephropathy model. On the basis of being unreliable, wide 
fluctuated renal function baseline, costs of maintenance, old age anim als were more 
aggressive and not practical to handle, the old age nephropathy was considered not 
suitable as a CM-ARF model.
6.1.1. c) Renal ablation
The widely used approach to induce renal failure by reducing the renal mass was 
also evaluated {see further details in 3.6.1.c). The consistent surgical resection achieved 
an impaired renal status that showed renal function parameters within almost a narrow 
range allowing efficient paired matching of subgroups. This renal ablation model was 
characterised mainly by glomerular hypertrophy and sclerosis at a later stage (as 
illustrated in Fig 4.7 and 4.13). Surgical reduction of renal mass resulted in 
glomerulopathy and glomerulosclerosis, resembling renal lesions in human, which led to 
increased creatinine, urea and decreased creatinine clearance (Fig 3.9- 3.10). The 
experimental model of 5/6 nephrectomy illustrated that the remnant renal mass with a 
two-fold increase of plasma creatinine and decline of creatinine clearance could tolerate 
CM. Even with the reduced nephron population which led to an increased dose of 
CM/nephron (that was administered according to body weight), neither iothalamate nor 
iodixanol induced any renal failure even after a second acute dose of CM. As discussed 
earlier {see 3.6.Lc) it could be that the cautious resections of renal mass and the short 
interval between the resection and CM adm inistration could avoid the development of a
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the required renal situation. These findings were in accord with others, as no 
reproducible results could be detected in another work after CM administration to 5/6 
nephrectomy model (Deray et al, 1990), however, their work was mainly a preliminary 
investigation to choose appropriate model from 10 other types of insults. The high costs 
incurred on inducing this animal model, anaesthesia and surgical requirements led not to 
continue trying to develop this model further. Also as the induction of progressive 
chronic renal failure could result in other organ damage such as the heart and blood 
vessels leading to hypertensive changes, the model was not considered suitable for CM- 
ARF studies.
ô .L l.d) Induced tubular necrosis
Apart from the glomerulus, the renal tubule is the other part of the nephron that 
was examined for its predisposing role in CM-ARF. Of the tubular toxins, Ur Ac was 
selected as it is well known to cause acute reversible and severe renal failure in rats 
(Stein et al, 1975; Honda and Hishida, 1993; Anthony et al, 1994b). UrAc induced 
renal insult is characterised by rapid renal injury (degeneration) soon after administration 
(within 2 days) followed by recovery (regeneration) after 4-5 days.
After a high dose the extensive renal pathology and the induced renal failure had 
masked any added effect by CM (Fig 4.8, and section 3.5.1.d). It was necessary to 
develop the model further by decreasing the dose and the interval after UrAc. In accord 
with reported findings (Stein et al, 1975; Honda and Hishida, 1993; Anthony et al, 
1994b) after a low dose of UrAc there was tubular epithelial cell necrosis and sloughing 
of necrotic epithelial cells into the tubule lumen, but minor or no evidence of glomerular 
damage or sclerosis (Fig 4.8-4.11, 4.14). UrAc-induced renal impairment was 
significantly potentiated with iodixanol and less so with iohexol as illustrated 
pathologically (Fig 4.8-4.11;4.14-4.16) and with renal function follow up (Fig 3.18- 
3.19).
Reproducible renal function impairment which resulted in anuria in some cases 
was illustrated mostly when iodixanol and iohexol were administered 3 days after a low 
dose (3 mg/kg) of UrAc-induced tubular necrosis in conjunction with dehydration. This 
same dose of UrAc could not induce similar results of CM-ARF when CM were 
administered at a later time point (5 days after UrAc-induced tubular necrosis). At the
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early stage, and when there was initiation of the degenerating state, administering CM 
(especially the dimers) just after the tubular necrosis (3 days after UrAc) caused further 
impairment of renal function or delayed the recovery from UrAc-induced renal 
impairment. Findings such as complete renal shut down and anuria were reproduced with 
iodixanol and iohexol as animals showed deterioration in their general condition and few 
were terminated at an early stage rather than to be followed for a longer time. It was 
suggested that the kidney was able to regenerate the damaged tubular cells, as CM at a 
later stage could not show any reproducible results. Surprisingly in this model, the 
LOCM iodixanol and iohexol, but not the HOCM iothalamate, had induced renal failure 
most likely due to differences in their physical and chemical criteria. Of these differences 
between CM could be the osmolarity, chemical structure, or viscosity, which all could 
have their implications in the induction of CM-ARF.
Reviewing previous animal models, other workers had also reported CM-ARF 
with another tubular-specific toxins whereby CM induced a transient renal dysfunction 
(Thomsen et al, 1991; 1993; Idee et al, 1995). The nephrotoxic potential of diatrizoate 
after intrarenal administration was greater than that of ioxaglate administered in the rat 
during the early degenerative phase of gentamicin-induced nephropathy (Idee et al,
1995). However this model also involved further two insults of uninephrectomy and 
clamping of the aorta. After comparing the histological and biochemical profiles of rats 
receiving an intravenous injection of CM either during the post-gentamicin regenerative 
phase (Thomsen et al, 1990) or during the initial degenerative phase of genatamicin 
nephropathy (Thomsen et al, 1991; 1993) it was demonstrated that the LOCM iohexol 
induced more interstitial infiltration and tubular necrosis in the regenerative phase, and it 
was diatrizoate that induced higher creatinine in the degenerative phase than iohexol 
(Thomsen et al, 1993). Although, the response to CM in gentamicin nephropathy was not 
uniform in different animal studies and with different CM, but clearly the role of 
gentamicin-induced tubular necrosis was the main denominator in these models.
It is possible that in all these tubulotoxin-induced renal models that the 
predisposing condition was the necrosis of renal tubules. CM-ARF could be developed as 
the nephron would be exposed to two different renal insults almost simultaneously. It was 
also shown from the pattern of endogenous biochemical metabolites that UrAc is S3 
specific renal toxin (Anthony et al, 1994b), likewise is the known nephrotoxin
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gentamicin, which could lead to potentiation of CM effects on tubular epithelia leading to 
irreversible ARF. CM and especially iodixanol and iohexol had shown Si-specific renal 
changes, as will be discussed further (discussed in detail in 6.1.3). Of these changes are 
morphological such as those of vacuole formation and biochemical, those of brush 
border and lysosomal enzymes release and LMW proteinuria which all are mainly 
indications of Si effects. Therefore, it is tempting to speculate that iodixanol and iohexol 
induced CM-ARF in UrAc model by tubular effects almost simultaneously at two 
different PCT sites. The second most likely cause that could explain CM-ARF in tubular 
necrosis models, is the possibility of tubular lumen blockage by shedding of the necrosed 
tubular cells and the formation of hyaline casts which could be potentiated by the filtering 
viscous dimer CM and dehydration. The sequence of these events would have occurred 
rapidly and before the start of reparative mechanism, in the light of extensive tubular 
damage.
ô .l.l.e ) Rat susceptibility and resistance to develop CM-ARF
After evaluating and following different experimental models of compromised 
renal function, it could be concluded that the rat kidney could tolerate high doses of CM 
those of 3 g I/kg which are some 10-fold higher than a “normal routine” human imaging 
dose without developing an end stage renal failure. Therefore, the rat is resistant to 
develop CM-ARF, that could only be induced in cases of severe renal insufficiency such 
as those induced by UrAc tubular necrosis or in old age nephropathy. This conclusion is 
in accord with many other workers, who encountered difficulties in setting a reproducible 
animal model of CM-ARF (Vammonde et al, 1989; Deray et al, 1990; Thomson et al, 
1990; 1991; 1993; Hanns et al, 1990; Idee et al, 1995; Morcos et al, 1996). This 
apparent resistance in the rat kidney, in comparison to a more susceptible human renal 
system (evidence of the comparatively high incidence rate of CM-ARF in human) could 
be due to the different renal function, anatomy, biochemistry and physiology. However, 
one of the important biological criteria that would affect the susceptibility and rapid 
recovery of the renal epithelial damage is the biological turnover which could be faster in 
the rat (Toback, 1991; Nonclerq et al, 1992; Safirstein et al, 1994; Bankir, 1996). It was 
shown in this work, and from induction of different experimental models, that the rat 
kidney possesses an efficient capacity for restoring its structural and functional capacity
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after severe injury such as UrAc. The kidney was able to recover even after the high dose 
of UrAc that induced severe tubular necrosis and renal impairment. Also with the loss of 
5/6 of the functioning rat kidney, the remnant renal mass could lead to reversible 
replacement of kidney function.
6.1.2 Testing the proliferating capacity of tubular epithelia
Tubular epithelia in the rat possess a natural potent proliferative capacity and as 
was illustrated in Fig 4.17- 4.18 and table A.l(discussedfurther in 4.3.2 and 4.4.2). 
Furthermore, CM did not show any significant increase in the potent cellular 
proliferation or regeneration of tubular epithelia. Different doses and time intervals of 
iodixanol and iothalamate did not increase cellular proliferating rate above that of the 
normal in the topographic distribution of cellular proliferation. Moreover, administration 
of high doses of CM to control animals produced no detectable cell damage or 
proliferation. It could be that the regenerative capacity of the tubular epithelia in the rat is 
sufficient and fast to tolerate any CM-affected epithelial cells or even damaged if there 
would be any.
Tubular regeneration occurring in response to nephrotoxin-induced tubular 
necrosis has been known since the early study of Cuppage et al, (1972), as after mercuric 
chloride administration the kidney showed extensive proliferative activity within the first 
2 days with immature epithelial cells relining the necrotic area by day 3 leading to the 
replacement of necrotic epithelium so that most tubules were relined with new epithelia 
by day 5. This initial observation was extended to other nephrotoxic compounds such as 
gentamicin and cisplatin (Safirstein et al, 1987; Nonclercq et al, 1992; Miller, 1996)
Even with high doses of gentamicin, tubular necrosis was rapidly compensated for by the 
renewal of tubular epithelia (Nonclercq et al, 1992; Humes, 1995). Tubular regeneration 
could account for the reversibility of kidney dysfunction associated with renal ischaemia 
or nephrotoxic tubular injury, the two most likely aetiologies of CM-ARF. Therefore, the 
renal tubular cell regenerative power, as any other epithelial cell, is broad enough to 
tolerate sublethal renal insults without deteriorating into irreversible renal failure.
In conclusion, the proliferating capacity state of the renal tubules could be more 
important than the state of renal function, in determining any susceptibility to CM-ARF. 
Animals with severe renal impairments, as seen with 5/6 nephrectomy, old age
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nephropathy models and 5 days after UrAc (the regenerative state), could tolerate further 
direct effects of CM. Therefore in the rat, and unless there is severe tubular necrosis or 
impairment of the regenerative power, the nephron could tolerate CM without any further 
deterioration in renal function even when administered to an impaired renal ftmction 
state.
6.1.3 Biochemical and renal function markers
6.J.3. a) CM-induced enzymuria and proteinuria
Total urinary proteins as well as enzymes of two tubular cell sites those of brush 
border (ALP and GGT) and lysosomes (NAG) were selected to be followed before and 
after CM. Urinary enzymes in general showed a consistent trend of transient elevation 
followed by recovery as observed with all CM and in all rat models (see 3.6.3 A). As 
both HOCM (iothalamate) and LOCM (iohexol and iodixanol) produced almost similar 
urinary changes after CM, it was concluded that these urinary biochemical changes were 
not attributed to CM different chemical or physical properties (such as osmolarity or 
viscosity). In general, elevation of urinary enzymes showed almost constant trend after 
CM in the different models. First and within 6  hours after CM there was increased level 
of brush border enzymes but it was mostly after a longer period that an increase of the 
lysosomal enzyme NAG was detected. The filtering CM via the glomeruli and further 
concentration by the nephron could expose the tubular epithelia to high CM 
concentration. Therefore, the sequence of enzyme release could be due to the fact that 
brush border enzymes, as they are located extracellularly, are the first to be released but 
in order to influence the lysosomal enzymes CM need to affect the intracellular 
endosome-lysosome system. It was demonstrated by Hofmeister et al, (1990) that there 
was a dose-dependant increase in urinary NAG and vacuole formation in PCT in first 18 
hours after iohexol, this suggested that lysosomes might play an important role in the 
release of NAG. However, increased NAG excretion was illustrated with other non­
vacuole forming CM such as diatrizoate (Thomsen et al,1990) iothalamate and ioxaglate 
(Bhargava et al, 1992). Since vacuole forming CM (such as iodixanol and iohexol) 
increased NAG as well as iothalamate, therefore vacuole formation cannot be the main 
mechanism in NAG release. Furthermore, this work could not show clear evidence of 
different magnitude of NAG release in the different rate of vacuole formations. The other
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possible cause of the enzyme release could be the role played by ischaemic-hypoxia in the 
release of tubular epithelium enzymes, as could be seen in most other organs (Burchardt 
and Scherberich, 1992). As the most susceptible part for hypoxia is the extracellular 
brush border followed by intracellular lysosomes, any possible CM-induced hypoxia 
would release brush border enzymes soon after administration followed by intracellular 
enzymes such as NAG.
It was shown from the in vitro IPRK model, that proteinuria and brush border 
enzymuria were the two biochemical changes that were increased immediately after CM 
administration and excretion. Since enzymuria and proteinuria preceded the decreased 
RPF in the IPRK, therefore, the IPRK could dismiss the role played by decreased RPF 
and renal ischaemia in the release of urinary brush border enzymes. In accord with the in 
vivo findings NAG was not shown to be increased after both iodixanol and iothalamate at 
least in the first 50 minutes after administration. Moreover, and due to the poor 
reabsorption mechanisms, CM concentration in the filtrate remained low. This could 
indicate that NAG would only be released at high CM concentrations or there could be a 
role of ischaemia in the release of the intracellular enzymes like NAG.
The transient CM-induced proteinuria in vivo and in vitro (IPRK) showed the 
same trend that was shown with the enzymes, i.e. that of increased levels followed by 
drop to baseline. The proteinuria was shown to be mainly albumin (further discussion
3.6.3.f). This proteinuria (mainly albuminuria) was also consistent with all types of CM 
however, proteinuria could not be seen when there was high baseline proteinuria as in 
severe glomerulopathy m old age and in large UrAc doses. In these cases the CM- 
induced proteinuria was masked by the already high urine protein values.
Many workers have reported similar effects of CM on transient proteinuria 
(albuminuria) (for further details see 1.5.3.d) (Holtas, 1978, 1984; Holtz aZ, 1987; 
Thomsen et al, 1991, 1993; Jackobsen et al, 1993, Walday et al, 1995). Also it is well 
reported on the consistent release of urinary enzymes after CM (for further details see
1.5.2.e) (Donadio et al, 1990; Thomsen et al, 1990; Hunter and Kind, 1992; Jackobsen 
et al, 1993). However, many of these reports have not attempted to differentiate or 
illustrated differences in the time scale of enzyme release and difference between brush 
border and NAG enzymes due mainly to their type of experimental designs. In concert 
with these studies, the magnitude of enzymuria and proteinuria reported was not related
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to declined renal function.
6.1.3. b) LMW proteinuria
The increased recovery of the LMW protein a l  microglobulin within few hours 
after CM was a clear indication of the tubular proteinuria which was another indication of 
direct effects of CM on tubular cells as CM could compete with the uptake of this LMW 
protein. The presence of CM in tubular fluid could overload the transporting system of 
the cells, as they share the same endosome-lysosome system for e lim ination (Sumpio and 
Hayslett, 1985). This LMW proteinuria was detected with a possible decreased capacity 
of protein reabsorption (further details in 3.6.3 g). These findings were in accord with 
others as it was shown that after co-administering a labelled LMW protein with CM there 
was significant LMW proteinuria (Dobrota et al, 1995). However, this LMW proteinuria 
was not detected when the labelled LMW protein was adm inistered after CM had induced 
the vacuoles. Indicating that the high capacity process of protein reabsorption by 
endocytosis could be transiently impaired by CM but soon could retain its function 
irrespective of the extent of formed vacuolation or indeed of CM retention, thus 
demonstrating a high capacity system. Others could not demonstrate any increased levels 
of ai-microglobulin after CM (Westhuyzen et al, 1996), however they used a rather 
simple not sensitive nephlometric assay to follow LMW proteins. Therefore, it could be 
concluded that the effects of CM on the increased LMW tubular protein aj- 
microglobulin, as shown in this work, was another indication of the direct effects of CM 
on the tubular cells but was transient and without any further correlation with renal 
dysfunction.
Many workers speculated that CM-induced changes of enzymuria and proteinuria 
could be indications of CM-induced tubular epithelia damage (for further details see
1.5.3.d & e). The normally low level of enzymes and proteins present in urine was 
increased transiently after CM. Even when renal function was compromised, such as in 
the models employed, there was no correlation between CM-induced changes in urinary 
enzymes and a stable renal function. Thus these markers indicated direct effects on the 
tubular epithelia with no obvious role in predicting or indeed inducing changes in renal 
function. It is thus most unlikely that these CM-induced changes could represent cellular 
damage.
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Although transient increase of urinary enzymes and proteins could be considered 
as tubular epithelial organelle-related biochemical changes (Schmid and Guder, 1992), it 
is still difficult to establish a correlation between pathological cellular alteration and 
biochemical disorders or to provide specific clues about renal impairment. This could be 
due to an adaptive mechanism allowing these cells to cope with various disorders. 
Changes in these markers in any chemically induced insults could only be indications of 
CM effects on PCT epithelia rather than indications of severe necrosis. However, the 
magnitude of enzyme release would be more important as diagnostic criteria, as low 
magnitude would indicate trivial adaptable effects while high values, as were shown with 
UrAc, indicated severe damaging effects. To evaluate the quantitative differences 
between enzyme release, large number of groups of animals is required to compare 
different ranges of enzyme levels. Rather than being a definite diagnostic and predictive 
tool in tubular toxins or CM-induced renal damage, these markers could be useful 
parameters for following the progression of CM and in the follow up of CM-ARF. In 
conclusion consistent increased excretions and very high levels of these enzymes are 
indications of tubular necrosis. Whether in the case of CM they represent increased 
susceptibility to induce tubular damage is still unclear, but on the weight of evidence 
presented this does seem rather unlikely.
6.1.3. c) Functional parameters and their relation to biochemical markers
The best definition of CM-ARF remains the persistent decline of GFR illustrated 
by a decreased creatinine clearance and increased plasma creatinine. As animals with 
compromised renal function (e.g. old age, 5/6 nephrectomy and UrAc-induced tubular 
necrosis) could tolerate CM, without further deterioration of the renal function, it would 
be rather more important to follow the rate of changes of renal function parameters.
It was clearly shown in this work that there was no correlation between the effects 
of CM on the selected urinary non-functional tubular markers such as enzymes and 
proteins and renal function parameters assessed by plasma urea, creatinine and creatinine 
clearance, even when followed for more than 4 days after CM (see also 3.6.3 b). The 
discrepancy between the biochemical markers those of urinary enzymes and proteins with 
those of functional changes would suggest that these “structural” biochemical renal 
markers were without any functional significance. Alternatively, it could also suggest that
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the tubular cells efficiently tolerated CM-induced biochemical changes without any 
further decline in the renal function, even when these biochemical markers were 
associated with injury to the tubular cells. Disruption of the cellular integrity could lead 
to a range of cellular structural damage from membrane dysfunction to complete cellular 
necrosis. Depending on the degree of injury that could affect tubular cells, various 
pathomorphological patterns of cellular damage could develop. Tubular markers such as 
enzymes and proteins are sensitive enough to be increased with trivial insults even if they 
do not cause any renal damage or failure. Many of these urinary changes could even be 
observed with physiological conditions, e.g. strenuous exercise could induce short 
reversible proteinuria, while diuresis and increased urine flow rate could lead to 
excretion of urinary enzymes and even the recovery of brush border. On the other hand, 
severe tubular necrosis induced by UrAc administration could greatly increase these 
biochemical markers. Since UrAc-induced tubular necrosis was shown to be a 
predisposing factor to CM-ARF, the high magnitude of urinary enzymes (see fig 3.11- 
3.19) could be an indication of the potential risk to develop CM-ARF. As these urinary 
enzymes were associated with UrAc-induced tubular pathology, their role could only be 
as potential biomarkers of the tubular epithelia structure without any diagnostic role in 
predicting functional changes in cases of CM-induced insults.
6.1.3. d) Urinary electrolytes
In comparison to enzymes and proteins that indicate structural changes mainly, 
urine electrolytes' disturbances are indicators of one of the important dysfunctional 
changes by the kidney which is electrolyte homeostasis. The urinary electrolytes, were 
predictive in cases of CM-ARF (discussed in detail in 3.6.3 d) and more diagnostic than 
other biochemical markers as they were related to tubular function (Fig. 3.16.2A & B; 
3.18.2C & D; 3.19D). Increased urinary electrolytes expressed as FE(Na/K) or RFI(Na/K) 
were predictors of renal failure especially in cases of UrAc induced CM-ARF. Both 
potassium and sodium (avoiding sodium in the ionic CM) showed significantly increased 
levels during the initiating stage before CM-ARF. As reabsorption of more than 90% of 
Na and K occurs in the proximal tubule and loop of Henle and more than 75 % of this is 
in PCT with an energy dependant mechanism of Na-K-ATPase, therefore disturbances in 
Na/K are good indication of tubular dysfunction (Pru and Kjellstrand, 1985).
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Since urinary electrolytes represent functional impairment at an early stage of 
ARF therefore, they were ideal markers to be followed before and after CM. 
Furthermore, urinary electrolytes (apart from sodium in ionic CM) are stable solutes and 
are not affected by other inhibitory factors unlike the labile urinary enzymes.
Other markers like decreased tubular concentration power and increased urine 
flow rates and osmolairty are also valuable indicators of tubular status but since CM have 
different diuretic and osmotic effects these concentration-related markers were not ideal 
as they were not specific to the effects of CM (see 3.6.3.d).
6.1.3. e) Endogenous PCT metabolites
Increased release of toxic proximal tubular cell metabolites after CM illustrated in 
the pilot human experiments (see 3.5.7) was another potential indication of CM-induced 
PCT effects. NMR profiles after CM illustrated the suitability of some of the PT 
biochemical metabolites, that had shown a toxic role with other nephrotoxins, to act as 
indicators of CM-ARF (further discussed in 3.6.4). In other studies these metabolites 
have proved to be excellent indicators of different site-specific renal insults with well- 
characterised nephrotoxic agents (Nicholson and Wilson, 1989; Anthony et al, 1994a; b;
1996). These NMR marker studies have never been applied to the study of CM effects on 
the kidney and this was the first attempt at such a study. In the light of how good the 
technique is to identify by pattern recognition other forms of nephrotoxins, this makes 
NMR very valuable in predicting and following CM changes.
From the preliminary human study, CM could induce the release of biochemical 
endogenous metabolic markers with toxic role in PCT. It could be concluded that these 
markers were another indication of CM-induced tubular effects. However, due to the 
intense and broad signal yielded by CM that masked most of the biochemical metabolites, 
this study failed to show the potential of this technique to identify specific markers. In 
view of the masking effect it is not always easy to detect all the PCT toxic metabolites 
that could have been released after CM. NMR work with CM needs to be further 
evaluated in a large controlled scale and consequently the method needs further 
development before any final conclusions could be made about the role of endogenous 
metabolites as markers of CM tubular effects.
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6.1.3.f) Evidence o f CM-induced tubular-related effects
In summary, CM induced tubular epithelial changes (Diagram 6-1) as shown by 
increased enzymes, proteins, LMW proteinuria, electrolytes' excretion, as well as 
endogenous proximal tubule metabolites. These CM-induced renal changes were transient 
as they returned to baseline values after CM clearance. These markers could be classified 
as ‘effect’ markers and functional markers. Although markers such as enzymes, proteins 
and endogenous metabolites, as any other biomarkers, may also represent functional 
markers, the transient nature of their response to CM is not a clear alteration of 
functional parameters but only represents an effect of the treatment. On the other hand, 
functional markers are those that indicated a disturbed renal function that is necessary for 
the normal renal function. Therefore, the loss of excretory or clearance function 
illustrated by creatinine or impaired electrolyte homeostasis is the essence of renal 
failure. What needs further evaluation in CM-ARF is markers of degree of susceptibility 
and extent of cytotoxicty. These markers could be defined as an inherited or acquired 
ability of an animal to respond to a challenge of exposure to a specific xenobiotic.
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1. Concentration of CM up to 100-fold
2. Possible impedance of filtrate flow
3. Formation of vacuoles in PCT cells
4. Transient effects on release of brush border and lysosomal enzymes
5. Transient effects on LMW proteins (LMW) and proteinuria; albumin (ALB) & transferrin (TRAS)
6. Increased urinary electrolytes; Na & K
7. Release of endogenous PCT metabolites (END MET)
8. Return to normal function once CM cleared
Diagram 6-1 Schem e of possible direct tubular effects and events of CM on tubular epithelial 
cells and the composition of urine/filtrate.
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6.1.4 Cellular changes and iodine retention
6.1 A m) Cell pathology after CM
PCT epithelial cell vacuoles were the most prominent morphological changes 
induced by CM, mainly with the non-ionic monomer iohexol and the dimer iodixanol. In 
accord with others the main site of vacuolisation was Sj (Powell et al, 1985; 1989; 
Battenfeld er û/, 1991; Dobrota gr aZ, 1995; Tervahartiala gr aZ, 1991; 1992; 1993;
1997). The degree of vacuole formation was always higher in iodixanol than iohexol but 
was hardly seen with iothalamate. In accord with other (Battenfeld et al, 1991; Dobrota 
et al, 1995), the lack of any obvious damage to other vital cellular structures could lead 
to conclude that CM-induced vacuolation was unlikely to induce renal failure. However, 
by rough quantitation of these vacuoles, it was illustrated that the extent of vacuolation 
could change with the different experimental and renal function conditions (further 
discussed in 4.4.1). Vacuolation was more prominent qualitatively with renal impairment 
such as old age, 5/6 nephrectomy and uranyl acetate than in the control. CM retention 
could increase the duration of intracellular exposure, however being an inert chemical it 
is unlikely that tubular epithelial cell susceptibility to CM would be enhanced simply by 
vacuole retention. In agreement with Dobrota et al, (1995), the intracellular uptake of 
CM therefore appears to occur by “fluid phase” endocytosis and results in the formation 
of vacuoles which could represent distinct class of lysososmes. This process of uptake 
thus appears to be similar to that of dextran (Christensen and Maunsbach, 1979)
It was shown experimentally that high doses of CM produce large vacuoles in the 
cells of PCT (Powell et al, 1985). These vacuoles were formed in normal healthy as well 
as diseased rats (Tervahartiala et al, 1991; 1993; 1997), and in humans (Moreau et al, 
1980). In general with normal and even with compromised renal function such as 5/6 
nephrectomy CM-induced vacuole formation per se was not associated with alteration in 
functional and biochemical parameters which could lead to acute renal failure. There was 
no clear evidence from this work nor from others (Battenfeld et al, 1991) to link these 
structural tubular changes of vacuoles in normal and compromised renal state with CM- 
induced renal changes. This was in accord with previous work that illustrated that these 
CM vacuoles were without accompanying alteration of functional parameters in other 
renal models (Battenfeld et al, 1991; Avades, 1992, Avades et al, 1994, Walday et al,
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It was further suggested by Dobrota et al, (1995) that CM vacuoles were not associated 
with obvious impairment of tubular function. However, vacuoles were enhanced in cases 
of UrAc-induced tubular necrosis leading to renal morphological features of 
“tubulisation” and rupture of vacuole-packed epithelial cells “tubular epithelial 
sickening”. Only the massive vacuolation, that was seen in UrAc model with iodixanol 
and to a lesser extent with iohexol, could have predisposed to irreversible renal failure.
In cases of CM-ARF tubular epithelia showed extensive necrosis and interstitial 
infiltration (Fig 4.8-4.11). Therefore, vacuoles as cellular morphological changes could 
be considered as early step that could end up into tubular necrosis in susceptible tubular 
epithelia such as in UrAc rather than being definite cellular damage in normal epithelia.
CM-induced vacuoles were due to residual secondary lysosomal compartment 
(Avades, 1992; Rowlands et al, 1994; Dobrota et al, 1995), that had taken no direct role 
in induction of renal failure in normal condition. Although similar structural renal lesions 
such as vacuolation, bleb formation besides enzymatic changes (such as those of NAG, 
ALP and GGT) were observed with other agents such as aminoglycosides (Kleinknecht 
et al, 1987), but it was only when definitive evidence of cellular necrosis and damage 
was observed that they were classified as nephrotoxins. As there is no clear evidence of 
such cellular damage with CM in normal and even compromised renal function, it is 
inappropriate to classify them as nephrotoxins. However as shown in this work, vacuoles 
could enhance UrAc-induced tubular necrosis and ARF.
Bleb formation and sequestration of PT cell material into the tubular lumen (tissue 
proteinurea or brush border histuria) were one of the pathological findings after CM.
Bleb formation is found under many pathological conditions associated with diminished 
energy supply by ischaemia. It was suggested that in the initial phases of renal ischaemia 
the depletion of cellular nucleotides associated with an energetic insufficiency in the PCT 
cells could lead to an extrusion of cytoplasm or protocytosis into the tubular lumen and a 
concomitant membrane loss leading to bleb formation (Scherberich et al, 1990; Burchardt 
and Scherberich, 1992). However, bleb formation could also be attributed to artefacts of 
preparation (e.g. perfusion fixation) poor histology or plasma membrane damage.
6.1.4.b) Iodine retention
The magnitude of CM-induced vacuolation by iothalamate, iodixanol and iohexol
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was related with the amount of iodine retention in the kidney (mainly cortex). This is a 
clear evidence that these CM-vacuoles are iodine-related. These findings were in accord 
with previous work that illustrated a correlation between iodine retention and vacuole 
formation (Avades, 1992; Laftah, 1993; Avades et al, 1994). Furthermore, a high local 
content of iodine after 24 hours from a bolus injection of iohexol was detected in grey 
regions (vacuoles) of moderate electron dense materials in the proximal tubular epithelial 
cell cytoplasm (Nordby et al, 1990). In agreement with human work, the cortical 
attenuation increased more, and persisted longer, with iodixanol than with comparable 
doses of monomeric CM (Jackobsen, et al, 1992). Others even detected 0.2% of injected 
"^^ C iodixanol 28 days after administration to normal ftmctioning kidney (Dobrota et al, 
1995).
Furthermore, as illustrated with UrAc model, the degree of CM-vacuolation and 
retention was increased with renal impairment. Iodine retention, hence vacuole 
formation, was detected by X-ray fluorescence 14 days after iodixanol in UrAc-induced 
renal impairment (see Fig 4.21). This was a clear indication that ARF and especially 
when induced by tubular necrosis could increase the degree of CM retention.
It was reported that a difftisely increased attenuation in the cortex of the kidney on 
CT is a sign of impaired renal ftmction (Jakobsen et al, 1996). Published cases with 
persistent cortical nephrograms after CM included patients with renal trauma and 
different renal diseases like infarction (Braedel et al, 1987). Delayed focal residual CM 
in the kidney 24 hours after angiography showed a higher incidence of injury to the renal 
parenchyma than previously detected by conventional radiology (Yamazaki et al, 1996). 
However, the delayed cortical enhancement of CM by itself was not correlated with 
changes in renal function (Jakobsen et al, 1992). Love et al,{\99A) concluded from a 24 
hour CT study that iodine retention had better predictive power for CM-ARF than 
creatinine, however their work was preliminary and based on only few patients' cases. In 
patients with renal failure, iohexol and iodixanol could show significant attenuation after 
120 hours (Jakobsen et al, 1996). However, the delayed clearance of serum iodine in 
human in renal failure (Jakobsen et al, 1992) could lead to this renal attenuation. 
Therefore, unlike this work, the human work could not prove that iodine retention was 
intracellular, as the retained circulating serum CM could still exist in the renal circulation 
or could be excreted slowly by the kidney leading to the persistent nephrogram
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appearance. In this work the perfusion wash of the rat kidney after autopsy could clear 
the renal circulation from any retained plasma CM, and could show that any detected CM 
was intracellular retention (vacuole formation).
6.1.4.C) Role o f dehydration and urine flow in iodine retention
The degree of CM retention was higher in dehydration in comparison to hydration 
or mannitol co-administration, but this was not strictly significant. As CM retention was 
shown to be dependant on urine viscosity, diuresis and tubular obstruction (Avades,
1992; Avades et al, 1994), therefore, there could be a link between changes in CM 
retention and urine flow. Factors that decrease urine flow rate such as tubular obstruction 
or dehydration will ultimately increase tubular fluid solute concentration which is further 
increased by countercurrent mechanisms. A rapid flow of CM would decrease the stasis 
time which could decrease intracellular CM retention. On the other hand, the increased 
osmolar clearance (as illustrated with iothalamate) corresponded to an increased osmotic 
load which could also increase the flow rate and decrease the retention. The LOCM 
iodixanol reached a higher concentration than the HOCM iothalamate when given in 
equivalent doses of iodine as illustrated in the IPRK {see 5.3.3). These findings were in 
accord with in vivo work as the dimers reached higher concentration in the tubules more 
than other CM (Dean et al, 1988). This suggests that iodixanol reduces tubular water 
reabsorption less than other CM, leading to relatively higher concentration of iodixanol 
being reached in the tubular lumen. The possibility of cast formation, by stacked or 
aggregated iodixanol dimers to form oligomers which would increase its viscosity, may 
play another role to predispose to tubular obstruction. In UrAc-induced tubular necrosis, 
both tubular obstructions by shedded epithelia and cast formation and the reduced urine 
flow rate by ARF oliguria could have contributed to the increased CM retention in this 
model.
6.1.4.d) CM clearance
It was confirmed that renal shut down decreased the plasma clearance of CM (see
4.3.3 a & b), leading to retention of CM in other tissues such as the liver (see 4.3.3 c 
&d). In these renal failure cases the osmolar property of the HOCM might be beneficial 
as they were excreted through the GIT route and induce even diarrhoea (further discussed
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4.4.3). The plasma retention of CM meant that the renal vasculature is exposed 
repeatedly to high CM concentrations. Since it was shown that CM induced direct effect 
on renal vasculature by decreasing RPF {shown in the IPRK and discussed further in 
6.1.5) this sustained circulation of high CM concentration would lead to longer duration 
of decreased RPF with its potential ischaemic effects. It was shown that CM (such as 
iohexol) with a low clearance in cases of ARF could induce further impairment in renal 
function, as the accelerated elimination of CM by prophylactic dialysis was beneficial in 
preventing further reduction in renal function after angiography in patients with impaired 
renal function (Moon et al, 1995).
In conclusion, failure of the kidney, as the main route of CM excretion, would 
predispose to retention of CM in the body which remain circulating in the blood unless 
they find another route for excretion (such as GIT in the case of the osmolar) or until the 
recovery of renal function and clearance. This repeated exposure of renal circulation to 
constant high concentration of CM could end up in irreversible ARF unless CM would be 
cleared from the body e.g. by dialysis.
6.1.5 Role of renal ischaemia in CM-ARF
Much of the recent work on the pathogenesis of CM-ARF has focused on 
ischaemic renal injury (Heyman et al, 1995; Idee et al, 1995; Oldroyd et al, 1995; 
Arakawa et al, 1996; Liss et al, 1996). Evidence of the beneficial use of vasodilatation or 
blockers of vasoconstriction has emphasised the effect of decreased renal blood flow in 
CM-ARF {see 1.3.2.1). As dehydration decreases renal blood flow and hence predisposes 
to further ischaemia this renal insult was shown to enhance any CM-induced renal 
ischaemia. Thus dehydration might have predisposed the kidney to develop CM-ARF in 
severe models such as the Ur Ac model. This was illustrated by an increased magnitude of 
CM effects on the proximal tubular cell parameters such as enzymes and proteins, also by 
potentiating the impaired renal function by different models in comparison to those that 
were hydrated before CM. This high solute concentration leads to prolonged exposure of 
tubular epithelial cells to solutes such as CM. The role of dehydration in increasing CM 
tubular changes such as tubular enzymes was an indication of either that the concentration 
of tubular fluid would intensify the direct CM effects on the epithelial cells or due to 
potentiation of the role of reduced RBF and ischaemia in the release of these enzymes.
The effect of dehydration on animal models was in accord with the reported role and
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extent of dehydration insult in CM-ARF (Mudge, 1982; Berkseth and Kjellstrand, 1984; 
Nygren and Ulfendahl, 1989). On the other hand the role of hydration and diuretics in 
lowering the susceptibility to develop CM-ARF was also shown by others (Bems, 1989; 
Solomon et al, 1994).
To understand the role of ischaemia and decreased perfusion flow on the nephron 
in the pathophysiological mechanisms that follow CM, an isolated perfused rat kidney 
(IPRK) was set up to follow simultaneously the biochemical renal parameters and 
correlate them with functional changes in GFR and RPF. Directly after administering CM 
there was an initial short rise (except for iodixanol) followed by persistent decline of RPF 
and decreased GFR with the three types of CM. This is in agreement with previous 
studies that illustrated similar effects of CM on IPRK renal function (El Sayed et al, 1991; 
Haylor et al, 1991; Browner a/, 1992; Oldroyd et al, 1995; Oldroyd, 1997). These studies 
showed that all CM caused a significant reduction in RPF (due to increase in renal vascular 
resistance). Of the possible causes, that would trigger declined RPF and increased 
vascular resistance, could be the release of vasoconstrictor agents. Endothelin is one of 
the potential potent vasoconstrictor agents that was shown to be increased after different 
groups of CM (see 5.3.4 and Fig 5.11). This work illustrated for the first time the effects 
of CM on increased endothelin release in the IPRK system, and it also showed that 
endothelin release was of a renal source which excluded interference firom external 
sources that could cause the vascular responses. The biphasic RPF response changes were 
similar to the pharmacological effects of endothelin illustrated by a short interval between 
vasodilatation and sustained vasoconstriction (Remuzzi and Benigni, 1993). Although it is 
clear that CM possess a vascular effect illustrated by increased endothelin release and 
decreased perfusion rate, but it is still not clear whether endothelin alone led to decreased 
RPF or there were other tubuloglomerular effects due to filtrate changes. The sequence 
follow up of IPRK illustrated that the vascular phase of decreased perfusion rate followed 
the tubular biochemical changes. This could indicate that the initial increased biochemical 
markers and apart from NAG were not related to the ischaemic tubular changes. 
Adenosine is the other vascular cytokine that could play a crucial role in decreasing RPF 
after CM (Amed et al, 1984; 1985; 1987; Deray et al, 1990; Arakawa et al, 1996; 
discussed in detail in 1.3.2.b).
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The three CM in the IPRK produced similar pattern of changes i.e. an early 
change followed by reverse of all functional and biochemical parameters’ changes to 
baseline levels. This indicated that there was an initial fast response by the kidney to the 
haemodynamic and biochemical changes induced by CM which was compensated and 
controlled rapidly by a feedback mechanism. As the renal vessels and tubules form the 
basis of this feedback mechanism, it is tempting to speculate that CM must have direct 
effect on renal circulation and tubules and any vascular or tubular pathology (such as 
tubular necrosis) would change this feedback mechanism.
6.1.6 The hypothesis of CM-ARF
I would like to suggest this hypothesis that could explain CM-ARF and the 
pathophysiological mechanisms that could lead to renal failure.
The normal functioning renal tubular epithelium is dependent on the structural 
integrity of the morphological relationships not only between adjacent tubular cells but 
also between epithelial cells and the underlying tubular basement membrane. Also the 
tight junctions between adjacent cells are believed to play a critical role in the 
maintenance of PCT lumen and limit the paracellular flux of intralum inal filtrate. Recent 
evidence has demonstrated that ischaemic and toxic injury to renal tubular cells lead to 
retraction of adjacent tubular cells, the development of a widened paracellular space, and 
the enhancement of paracellular transtubular backleak of intralum inal filtrate (Madra, 
1989; Olsen and Solez, 1993; Humes, 1995).
After ischaemic or toxic injury, which could be induced by any pathologically 
induced tubular necrosis, the fluid barrier (formed by the tubular cells and tight 
junctions) becomes increasingly permeable resulting in leakage of tubular fluid 
components (back leak) into the interstitium. CM may follow the tubular fluid and 
become trapped in the interstitium with resulting increased CM retention. As renal 
tubules and interstitium have close physiological association, damaged tubules can release 
mediators that affect interstitial tissues (Fine et al, 1993). Tubular fluid constituents 
leaked from a damaged tubule may attract growth factor or cytokine-related cells and thus 
set up a cascade of chemical messengers (Howie and Lote, 1996). Furthermore, leakage 
into the interstitium would possibly increase the interstitial pressure specially in a 
compact cortical interstitium which press on the renal vessels (increase postglomerular
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vascular resistance) inducing long lasting ischaemia which in turn may lead to further 
tubular and renal damage. Iscahemia could also be enhanced after renal failure-related 
decreased clearance and increased plasma retention of CM, which would expose the renal 
vasculature to repeated high concentration of CM with their potential vasoconstrictor 
effects.
It was also postulated that adherence of detached renal epithelial cells to 
sublethally injured cells that remain attached to the basement membrane as well as the 
aggregation to form casts might contribute to obstruction in ATN. This could possibly 
contribute to tubule obstruction after tubular necrosis which might be enhanced by 
another insult of CM. The abnormal cell-cell adhesion may be attributed to binding of pi- 
integrins expressed apically on injured cells to their receptors on fragments of matrix 
protein present on exfoliated renal cells (Molitoris et al, 1992; Goligorsky and DiBona 
1993;) The arginine-glycine-aspartic acid (RGD) is the most common domain contained 
in a variety of matrix proteins including Tamm Horsfall glycoprotein (THG) and serves 
as the recognition site for various integrin receptors (Ruoslahti et al, 1994). In Ur Ac- 
induced tubular necrosis, stasis of CM might be caused by the detached tubular epithelial 
cells and tubular cast formation obstructing the renal tubules on one hand and on the low 
urine flow rate caused by oliguria and viscous LOCM (as with the high MW dimers) on 
the other hand. lodixanoTs dynamic viscosity of 20 mPa at 320 mg I/ml (20° C) is higher 
than other CM (Smedby, 1992; Eivindvik and Sjogren, 1995). Increased viscosity of any 
solution is proportional to a reduced rate of flow through a standard thin capillary tube 
under standard pressure and temperature. Thus, it is likely that the viscous dimeric CM 
decreased the flow rate through the small diameter renal tubules leading to a high 
intratubular viscosity and iodine retention as indeed reported by Ueda et al, (1993), as 
there was an extremely high proximal and distal intratubular hydrostatic pressure with the 
dimeric but not with the monomeric. Furthermore, these dimers with their low 
osmolarity possess no osmotic diuretic effect (unlike the high osmolar) leading to higher 
tubular concentration and higher urine viscosity that could precipitate tubular obstruction 
(Fig 6.2). The single nephron glomerular filtration rate was decreased after the dimer 
iotrolan but not after diatrizoate or iohexol (Ueda et al, 1992).
The significant increase of iodine retention after iodixanol in UrAc renal 
impairment could either be due to increased CM intracellularly by vacuole formation or
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extracellularly by intraluminal or extraluminal i.e. interstitial. Intraluminal increased 
iodine as proposed might be due to tubular obstruction and sluggish CM movement 
through the renal tubules that might lead to increased stasis time and longer contact 
between the tubular epithelia and CM ending up in increased extent of vacuole formation. 
However, the major concern is when there is extraluminal iodine due to leaky tubules 
and as proposed in Fig 6.2. This was illustrated from this work as tubules epithelial cells 
packed with vacuoles were susceptible to rupture and to empty their contents, which 
could be into either sides of the tubular epithelia i.e. to the lumen or to the interstitium.
Furthermore, the IPRK system provided clear evidence of the direct acute effects 
of CM on renal haemodynamic and tubular epithelial cells. It was also shown that 
different groups of CM including iodixanol increased the release of the vasoconstrictor 
agent endothelin that could be one of the main triggers of decreased RPF. Also and in 
accord with the in vivo work there was release of PCT enzymes.
It was illustrated with iodixanol in UrAc model that there were increased CM 
retention and rupture of vacuole-packed tubules in addition to the potential decrease of 
RPF due to endothelin. All these factors together could induce ARF in UrAc-induced 
tubular necrosis model by iodixanol. Because of the synergism between the direct and 
ischaemic insult of CM, it seems likely that the time of greater risk to the kidney is 
during the first few hours after administration of CM. This is the time of coincidence 
between filtration of CM causing direct toxic effects and renal ischaemia induced by CM- 
related vasoconstriction. At this time, the concentration of CM perfusing the kidney is at 
its highest, before it equilibrates with the extracellular fluid and clears via the urine 
completely.
These direct tubular and vascular effects with their potential ischaemic effects may 
act together to induce tubular necrosis. However, this hypothesis explains mainly the 
potentials of vacuole fo rm ing C M  (iodixanol and iohexol)-induced A R F . But since it is 
well reported that the incidence of ionic C M -A R F  is higher in human patients than the 
non-ionics, therefore, C M  could have different renal effects in different renal situation. It 
is also possible that pathogenesis of C M -A R F  is multifactorial in many human cases. It 
might require more than one effect to induce C M -A R F . However, it is reasonable to 
believe from this work that changes in the tubule would play an important role.
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Other effects like extensive tubular necrosis and dehydration-induced ischamia or 
generalised renal nephropathy (such as in old age) might also induce predisposing 
conditions that would possibly lead to ARF with or without the subtle direct effects of 
CM. These generalised effects might involve almost all nephrons at the same time leaving 
no role for the kidney tolerance to function properly, or for any non-damaged tubular 
epithelia to proliferate and replace the damaged ones.
PCT as any other epithelial cells could multiply and form new cells by remnant 
cells even after necrotic damage inflicted on large number of these cells. The efficient 
regenerative mechanisms that would follow the immediate post-injury period could 
restore the structural and functional integrity of renal tubular epithelia (Bacilli and Fine, 
1989; Bacilli et al, 1989; Toback, 1992; Lake and Humes, 1994; Humes, 1995). 
Therefore, there is an important role of proliferative growth factors in renal repair after 
injury. On the other hand cytokines and growth factors, with cytotoxic role, could 
enhance the damaging effects of CM. There is increasing evidence that proximal tubular 
cells express a number of growth factors of autocrine (from the same tubular cells), 
paracrine (from inflammatory infiltrated cells and resident interstitial fibroblast) and 
pexicrine effects (with the incorporation of basement membrane). The increased 
expressions of growth factors appear to play an important role in the recovery from renal 
insults or might be involved in further damage (Lake and Humes, 1994; Humes, 1995). 
Typically, the increase of cell turnover in renal tubules was accompanied by stimulation 
of cell proliferation in the interstitial tissue of renal cortex.
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VASOCONST.
INCREASED
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iodine
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C M  
leak to 
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Viscous dimer RGD
Diagram 6-2 Schem e of the hypothesis of possible role of tubular necrosis and consequent 
tubular obstruction in increasing CM retention in uranyl acetate model.
Before glomerular filtration iodixanol will induce the release of endothelin from the renal endothelium 
that can decrease renal blood flow with an increased susceptibility to ischaemia. After filtration and 
with the tubular concentrating effect the dimer can stack and block the tubules together with casts 
and sublethal cells that will induce complete tubular obstruction. Leakage of iodixanol and tubular 
fluid to the interstitium will increase the interstitial pressure besides chemoattraction of inflammatory 
cells with the release of cytotoxic or proliferative growth factors. Damaged tubular cells will start a 
cascade of chemical reaction that can play a role in growth factor release by other tubular cells 
(GF=growth factors, 1= infiltrating cells, NC= Necrosed cell, RGD=Cell-Cell adhesion(see text), 
C=cast, interst= interstitium).
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6.2 Conclusions
It was concluded from the changes that followed CM administration that all three 
tested CM induced direct effects on tubular epithelial cells (fig 6.1), however the extent 
of these tubular effects was different between CM. These CM-induced tubular epithelial 
cell-related changes were shown in vitro in the IPRK, in vivo in different animal models, 
as well as in a human study. The tubular effects that were attributed to CM include:
1. CM-induced enzymuria and proteinuria that showed a similar pattern with the tested 
CM in all animal models as well as in the IPRK.
2. The pattern of increased enzymes firom different tubular sites as shown by an early 
effect on the extracellular brush border before affecting the intracellular lysosomes 
demonstrated that enzymatic changes were induced by the filtered CM.
3. Within a few hours following early CM excretion there was LMW proteinuria of 
microglobulin and increased LMW/albumin ratio which indicated a transient tubular 
proteinuria.
4. Formation of cytoplasmic vacuoles in proximal tubular cells which were associated 
with cortical iodine retention illustrated more with the non-ionic monomer and dimer. 
Other CM-related structural changes were those of bleb formation in the tubular 
epithelia, which was shown to be associated with renal ischaemia
5. The increased fractional excretion of Na and K electrolytes, which were illustrated in 
the initiating period of CM-induced ARF, are supportive evidence of the response of 
the PT cells to CM. Increased urinary electrolytes in other renal conditions were 
diagnostic indications of acute tubular damage whether induced by ischaemia or 
necrosis.
6. The released endogenous LMW metabolites from a pilot human experiment illustrated 
a direct effect of CM on proximal tubule metabolic pathways. In other studies these 
metabolites were shown to be indicative of tubular toxicity.
As these CM-induced biochemical, functional and structural changes in a normal, 
and even compromised renal function were reversible, it could be concluded that CM- 
induced effects were within the compensatory mechanism of the renal tubular cells and 
the affected nephrons did not show any dysfunctional renal failure.
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After surveying different animal models of 5/6 nephrectomy and old age it was 
concluded that the rat, even with a severely compromised renal function, showed 
resistance to develop renal failure after CM. The differences in the old age nephropathy 
backgrounds and its renal condition hindered repeated efforts to describe a reproducible 
model from the old age rat. It required paired matching of weight, age and renal function 
for iothalamate to induce renal failure in the old age. However, the old age model was 
considered unreliable and not a practical model for studying CM-ARF.
It was further observed after mducing a renal model of UrAc-induced tubular 
necrosis, that an important role is played by the tubular epithelia in the induction of a 
reproducible model of CM-ARF. This was only shown at an early degenerative phase 
after UrAc, as both iodixanol and iohexol induced significant impairment in renal 
function in this phase. Therefore, it was concluded that the state of the renal tubule was 
crucial in the susceptibility to develop CM-ARF.
It was also shown that in a normal functioning kidney the proliferating capacity of 
the tubular epithelial cells is not significantly different between the control and following 
the administration of iothalamate and any of the different doses of iodixanol. The 
functioning hypertrophied 1/6 of the rat kidney (after 5/6 nephrectomy) was an indication 
that the rat kidney could function almost normally, but not necessarily with its whole 
tissues intact. It was also shown that the kidney could even replace rapidly 
morphologically defected (by vacuoles) or UrAc-induced PCT cell's necrosis. Therefore, 
it could be concluded that in a normal functioning kidney, with efficient proliferating 
epithelial cells, CM-induced tubular effects were tolerated by the nephron, while, in 
severely damaged epithelial cells as shown with UrAc-induced tubular necrosis, CM 
caused an irreversible renal damage which could be due to CM tubular effects.
The nephron’s ability to sustain CM-induced renal effects reduced the validity of 
CM-induced changes as markers for CM-ARF. It was concluded that unless these 
markers indicated functional impairment, any early change that would follow CM could 
not be considered as predictive marker of CM-ARF.
In summary, CM-induced renal changes indicated that CM possess negligible 
nephrotoxic effects in the rat. Of the important markers that were monitored and 
indicated early functional impairments were the urine electrolytes presented per urine 
creatinine such as RFI and FE, besides creatinine clearance. CM-induced tubular
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changes could not ascribe CM as a nephrotoxic agent without functional changes that 
would indicate renal impairment. Therefore, the non specific biochemical markers of 
enzymes and proteins lack the predictive value in CM-ARF. This is possibly due to the 
extent of the compensatory mechanism of the rat renal tubule that could tolerate CM- 
induced effects without irreversible functional changes. The potential role of dehydration 
on either concentrating the tubular fluid or decreasing renal blood flow in CM-ARF was 
another indication for the role played by the tubules on the magnitude of CM tubular 
effects.
The biochemical changes such as high magnitude of enzymuria and proteinuria 
were also shown by the nephrotoxic UrAc insult, therefore and unlike in CM, these 
tubular changes in UrAc were concomitant with structural and functional changes. It was 
concluded that the only role that these markers would play is that they could indicate the 
state of tubular epithelia. Since tubular necrosis was a predisposing condition to develop 
CM-ARF in UrAc-induced tubular necrosis, the increased levels of tubular markers could 
be an indication of a predisposing renal condition that might develop CM-ARF.
It was also shown that CM retention as measured by a novel and simple technique 
of X-ray fluorescence, was not by itself a direct predisposmg factor for renal failure in 
normal functioning kidney nor did it induce a different pattern of biochemical and 
functional parameters. Alternatively, renal damage by tubular necrosis increased the 
degree of CM retention. CM-vacuolation correlated with the retention and both were 
increased with renal impairment (as illustrated with UrAc in comparison to the control) 
and they were even detected 14 days after iodixanol in UrAc-induced renal impairment. 
Therefore, CM retention or delayed cortical enhancement is a clear indication of renal 
failure whether it was a cause or an effect of CM-ARF is still not very clear. A 
component of this retention could be induced by CM-ARF as oliguria slowed down 
excretion allowing a higher proportion of CM to be taken up intracellularly. It was also 
shown that the degree of CM retention could be related to urine flow rate since the 
retention was higher in dehydration in comparison to hydration or mannitol co­
administration. The importance of this retention was shown in the recommendations to 
predict CM-ARF. The decreased clearance of CM in renal failure caused CM retention in 
plasma as well as other tissues, which could lead to further renal effects as there was 
continues circulating CM with its potential vascular effects.
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In spite of the limitation of IPRK, it was also clearly shown that different groups 
of CM (including iodixanol) increased the release of endothelin in IPRK system 
suggesting endothelin could be a trigger of CM-decreased RPF. This may indicate the 
potential of CM to induce ischaemia which would add to the risk of mbular necrosis by 
their direct effects. The IPRK system provided clear evidence of the direct acute effects 
of CM on renal haemodynamic and mbular epithelial cells. The effects on biochemical 
parameters preceded the changes in functional parameters especially the decreased renal 
perfusion rate which indicated that biochemical changes were not related to functional 
changes.
In summary, it was concluded that CM-ARF is a multi-factorial condition and the 
renal mbules play an important role in the induction of ARF. On one hand, CM 
illustrated clearly that they induce different mbular changes (with their rather potential 
damage), in addition to the induction of renal failure in a degenerative mbular necrosis 
model. On the other hand, CM also showed renal vascular effects as illustrated by 
reduced RPF and the release of the vasoconstrictor endothelin which could enhance the 
mbular effects predisposing to acute mbular damage. It was also concluded that CM 
could not be considered as nephrotoxic, at least in the rat which showed strong resistance 
to develop CM-ARF. Tubular epithelial tolerance was to an extent that CM-induced 
changes could not lead any detected damage or dysfunctional change. Tubular changes 
could be considered markers of CM-ARF if they show functional impairment such as 
urinary electrolytes while biochemical markers those of enzymuria and proteinuria have 
weak predictive role. Enzymuria and proteinuria might only indicate changes in the 
integrity of mbular epithelia such as in UrAc-induced mbular necrosis that could 
predispose an individual to CM-ARF. The increased CM retention and, hence vacuole 
formation in renal failure, could be a potential risk that requires further vigilance and 
follow up.
6.3 Recommendations to avoid or possibly predict CM-ARF in human 
patients
Whilst the exact mechanism of CM-induced ARF remains unresolved this smdy 
has indicated a number of areas which may play a role in reducing the risk of CM-ARF.
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In view of the knowledge of the high incidence of CM-ARF in high risk patients, it is
recommended to follow those cases rather more frequently. These points were drawn
from animal work but further extrapolation to human patients is necessary.
• It is recommended that the PT epithelial cell function should be assessed before and 
after achninistering CM in risk groups. Of the most important vital parameters are the 
urine electrolytes (expressed as RFI or fractional excretion of Na or better by K) as 
they are indicators of tubular function.
• Other important tubular epithelial cell markers that need to be assessed are those with 
mainly PCT origin like urinary enzymes and LMW proteins (especially aj- 
microglobulin) that might indicate tubular epithelial state.
• Declined GFR, which is measured by creatinine clearance, is still the early indicator 
of any renal dysfunction and should be followed in high risk groups. Animals with 
low creatinine clearance tolerated CM without further decline of renal function, 
therefore, it is the rate of deterioration of creatinine clearance values that is critical 
rather than the basic renal status. Any indication of increased urine electrolytes and 
low creatinine clearance that are associated with raised tubular markers of enzymes 
are an indication for impending renal effects that need to be followed.
• Risk factors with a generalised effect to all nephrons, such as dehydration before and 
after CM or large CM doses in renal failure, should be avoided.
• Generous hydration and the use of diuretics to increase urine flow rates are 
recommended. Both mannitol and hydration decreased the extent of CM renal 
retention, due possibly to an increase in the urine flow rate of CM. Although, there is 
still not enough evidence as to what extent their role in preventing CM-ARF is. The 
concentrating and osmolarity status are also useful parameters to be assessed before 
CM as they will determme the urine flow rate and therefore their levels would 
indicate whether there would be any tubular obstruction.
• Imaging procedures should be more cautious in patients who are on potential 
nephrotoxic drugs such as gentamicin, cyclosporin or cisplastin.
• Care in administering all different types of CM with no exception and including the 
LOCM. As LOCM such as iodixanol could possess the potential to precipitate tubular 
obstruction in cases of tubular necrosis.
• As CM retention (vacuole formation) is associated with ARF, a delayed nephrogram
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(or CT) must be considered as an early sign of CM-ARF. Because CM in ARF are 
retained intracellularly, and may continue exerting their tubular and cellular effects, a 
longer period of patient follow up is advisable.
6.4 Suggestion for further work
This work has illustrated the potential of CM to induce direct tubular effects with 
the proposed possibility of interstitial effects as CM may leak into the interstitium in 
severe tubular necrosis. There is growing evidence for the important role of the tubulo- 
interstitium in the induction of ARF. It has been shown that both tubular epithelial cells 
and interstitial cell (fibroblasts) express different growth factors with their role in injury 
and healing after renal insults. In man, enhanced expressions of growth factors have been 
seen in tubulointerstitial pathology insults. Therefore, irreversible CM-ARF may be 
intimately related to the degree of tubulointerstitial injury. The mechanism accounting for 
this association is poorly understood, and the role played by growth factors involved in 
CM-ARF mediation requires clarification. A fuller understanding of the mechanisms 
involved, and the identification of cytokines and growth factors responsible, will help to 
develop some forms of therapeutic intervention.
Further work is required to validate the role of proliferatmg capacity and the 
molecular basis behind it, potential proliferating growth factors should be studied to 
emphasise their role in this regenerative mechanism. Growth factors with evidence of 
their role in the regenerating mechanism need to be studied in cases of CM-ARF as their 
expression would form an index of tubular cell capacity to adapt and repair rapidly to any 
renal insult. A tool to evaluate the regenerating power of tubular cells wül be more 
predictive of induced renal failure by tubular insults than any other tubular markers such 
as urinary enzymes or proteios. New candidates of urinary biomarkers include cytokines 
and growth factors special focus on those with a proliferating role such as platelet derived 
(PDGF), insulin derived, and epidermal growth factors (EGF) which have mitogenic 
effects. Other growth factors with roles in healing and fibrosis would be important in the 
pathophysiological mechanism of CM-ARF such as TGF-p and bFGF with fibrotic 
potentials. The most important of these, as illustrated from this work, are the 
vasoconstrictors cytokines such as endotheliu and adenosine.
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Validation of the role of these different growth factors could be achieved by a 
follow up of sequential histological changes including the quantitative determination of 
inflammatory cell infiltration and growth factor expression (protein and gene). Quantitative 
analyses could be perfonned by the use of immunocytochemistry and in situ hybridisation 
analysis, together with image analysis to investigate the cellular composition especially 
leukocytes, macrophages, lymphocytes, neutrophils and interstitial myofibroblast which would 
assess the degree of inflammatory cell infiltration and the severity of disease activity. The 
potential growth factors and their receptor's expression at various intervals following CM 
adm inistration should be determined. Furthermore, it is necessary to follow the cell 
composition infiltrates and analysis of the relevant growth factor cytokines expression in 
different nephron segments by microdissection to define the change of distribution and intensity 
with time.
The clinical study (as a pilot study) was planned for the purpose of validation and 
characterisation of endogenous proximal tubule metabolites. With a larger number of 
patients and more frequent intervals of follow up, other renal markers such as urinary 
electrolytes, enzymes, and ai-microglobulin LMW proteins, besides the endogenous PT 
metabolites that were evaluated from this pilot work, and from experimental models, 
need to be validated further with human samples.
Identification of distal tubular segments as potential targets of injury is limited by 
the specialised function and morphology of these cells. Any structural damage to the 
more distal regions of the tubules is difficult to detect in the thin epithelial cell types 
which have no brush border. Therefore, rather than being spared from any damage, distal 
tubular effects may have been overlooked. Other techniques to detect subtle cellular 
injury by identification of endogenous PT metabolites using NMR could have a use for 
detecting distal tubule damage.
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Appendix 1
Cobas Bio™ instrument settings for the different assays
NAG ALP GGT Great. Urea Protei
a 11 11 11 11 13 11
Units pmol/h/L U/L U/L fimol/L MMOL/
L
mg/L
Calculation factor 0 1930 1754 0 0 0
Standard 1 conc. * 0 0 * * 1500
Standard 2 conc. * 0 0 * » 750
Standard 3 conc. * 0 0 * » 375
Limit 3000 .15 .34 850 50 2000
Temperature 37 30 37 37 37 30
Type of analysis 6 3 2 4 4 1
Wavelength 505 405 405 500 340 600
Sample volume 10 07 15 20 4 2
Diluent volume 30 10 25 30 20 30
Reagent vol. 150 275 125 150 250 200
Incubation time 600 30 0 0 0 0
Start reagent vol. 50 40 0 0 0 0
Time of first reading 0.5 10 60 30 40 20
Time interval 10 10 10 80 10 310
Number of readings 2 18 15 2 6 2
Blanking mode 1 1 1 1 1 1
Printout mode 1 1 1 1 1 1
* Calibrant values according to the assigned value
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Appendix II 
Radiology patients protocol 
Inclusion criteria (For Radiologist, Cardiologist, or whoever makes the decision)
1. Patients above 35 years receiving more than 1 ml/kg (70 ml) of any X-ray CM and 
admitted for at least 24h.
2. All patients with a known history of renal insufficiency irrespective of the volume of CM 
administered.
NOTE: Once the patient is included ensure that the patient form is completed and filed 
safely.
Instruction for urine collection (House officer, or Nurse)
• Collect urine sample before CM administration. If above criterion 1 not met discard this 
sample.
• Collect at least one post-CM urine sample. A number of samples over a period of 3h-96 
hours would be preferable.
• Measure total volume of urine and note this and other details on the provided label. 
Pour some 15-20 ml of urine into the sterile Universal bottle (approximately 3/4 full), 
stick label on the bottle and fireeze the sample immediately- fi-eezer compartment of 
fridge or better at -25°C.
• For longer term storage-before transfer to Guildford- samples should be kept at 
-25°C. (Refer to separate page for transport/storage).
Storage and transport of urine samples:
1. Patients samples:
Freeze and keep firo2
transport to University of Surrey/Guildford.
zen (preferably at -25° C) until sufficient numbers are collected for
Transport.
Pack in cardice in a well insulated stout polystyrene box just prior to arrival of Courier. 
Check with Courier services that delivery will be direct to Guildford (e.g. not via central 
transfer point where perhaps are left overnight)
Chose a Courier who can guarantee delivery before cardice evaporates!
Ensure that we are informed of the arrival time so that samples can be received during 
working hours and transferred to fireezers.
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